data_2ki7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ki7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' GLU . 77.9 p . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.948 0.404 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -38.93 -58.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.69 -8.81 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' SER . 47.0 tp10 -104.03 -37.98 7.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.156 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.444 ' HA ' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mm -95.66 22.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.482 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.76 117.43 26.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 105.12 -29.74 11.14 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 121.022 -0.609 . . . . 0.0 114.43 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -63.28 29.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.967 . . . . 0.0 110.882 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 25' ' ' GLY . 3.3 p -44.5 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.678 ' H ' ' C ' ' A' ' 26' ' ' ARG . 27.9 t-105 -57.86 -52.52 65.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.407 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' B' ' 27' ' ' ARG . 10.4 pt -69.73 -12.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.977 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -93.53 -11.07 32.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.471 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.06 -68.3 0.8 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.41 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.03 46.42 1.5 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -161.88 -34.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.518 ' NE2' ' OE2' ' A' ' 47' ' ' GLU . 19.6 t-80 -103.55 108.19 19.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.822 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.547 ' HA ' ' HE1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -149.56 9.51 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.783 ' O ' ' CD1' ' A' ' 101' ' ' TRP . . . -49.04 148.15 5.26 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -64.25 111.13 2.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 118.486 -1.285 . . . . 0.0 108.947 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.593 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 92.6 t -83.08 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.903 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.756 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -163.81 150.5 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.563 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 69.5 tttt -48.29 -56.67 7.44 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.753 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 54.2 pttt -61.63 -5.3 1.79 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.737 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 9.1 m120 -126.0 3.54 7.27 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.783 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.756 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.53 -42.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.072 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -94.48 -0.46 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.23 14.65 16.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.458 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.737 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -120.37 176.47 5.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.764 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.733 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -90.81 112.26 24.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.983 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' A' ' 49' ' ' ILE . 55.5 mt -74.39 114.14 12.42 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 4.5 mm -155.79 -40.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.761 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.604 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -131.84 -20.05 1.1 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.744 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD21 ' H ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -44.44 142.31 1.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' H ' HD21 ' A' ' 51' ' ' LEU . 3.2 ttpm? -92.13 131.54 37.3 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.813 HG23 ' H ' ' A' ' 54' ' ' ARG . 12.8 p -150.04 170.74 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.191 0.52 . . . . 0.0 111.282 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.813 ' H ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.42 152.44 51.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.898 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 65' ' ' GLY . 48.1 t -97.5 99.17 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.87 -50.89 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.841 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.47 120.75 27.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -147.06 173.28 12.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.245 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.626 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -109.95 78.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 59' ' ' THR . 17.4 m170 -168.72 102.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.328 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.73 -4.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.478 2.119 . . . . 0.0 113.822 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -130.2 22.46 4.75 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.193 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -141.0 -11.76 0.97 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.533 1.167 . . . . 0.0 111.513 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.2 m -72.98 131.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.02 5.21 90.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.664 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.616 ' CG2' ' NE1' ' A' ' 87' ' ' TRP . 9.0 tt -100.38 151.24 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 117.758 0.779 . . . . 0.0 112.345 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.687 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 2.7 tm-20 -118.0 132.71 56.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.25 173.22 27.47 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.853 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -96.5 114.93 26.63 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.533 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.8 t -48.77 146.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 79' ' ' VAL . 36.2 mt -140.02 -60.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.127 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -104.14 144.71 31.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.62 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 43.8 tp10 -148.18 106.17 3.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.986 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.447 ' HA ' HH21 ' B' ' 38' ' ' ARG . 1.8 p -137.04 179.9 6.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.726 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -17.01 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.144 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.453 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 41.1 t30 -137.54 13.52 2.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.85 159.02 39.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 118.728 -1.189 . . . . 0.0 113.957 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 7.2 tp -150.46 110.55 4.14 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' ILE . 91.1 t -112.1 146.37 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.533 HG23 ' N ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -129.1 147.44 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.972 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -123.08 137.59 54.89 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.577 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.76 152.06 23.79 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 84' ' ' ASN . 8.9 pt-20 38.06 -136.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.699 -0.295 . . . . 0.0 110.937 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 23.1 m120 -99.67 34.08 2.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.052 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.54 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 21.5 tptt -145.18 165.93 26.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.707 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.54 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 24.7 m -119.65 155.57 22.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.469 0.652 . . . . 0.0 110.693 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.687 ' CZ2' ' O ' ' A' ' 67' ' ' GLU . 1.4 m-90 -97.54 92.7 6.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.708 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -86.97 100.01 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -147.27 109.16 3.93 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.448 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.01 164.35 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.323 1.348 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.664 ' H ' ' CD ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -72.03 -31.43 66.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 16.9 p-10 -90.28 -5.69 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -97.5 0.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.286 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -166.27 174.42 9.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.926 -1.11 . . . . 0.0 113.654 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.22 124.01 65.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.702 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.659 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 59.7 m-85 -99.04 131.19 45.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 53' ' ' VAL . 18.5 tt0 -111.29 95.48 5.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.704 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 16.4 m-85 -89.58 146.01 24.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.16 132.4 36.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.729 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 104' ' ' THR . 16.9 m -65.85 142.41 57.94 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -62.43 -1.66 0.84 Allowed 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.919 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 100' ' ' THR . 86.9 m-20 -106.92 19.45 20.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.751 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.03 23.49 77.07 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.57 137.21 44.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.423 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -81.28 129.56 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 44.7 mt -104.41 134.7 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.578 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -117.86 102.04 8.78 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.3 138.06 45.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.691 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.7 p -78.26 123.22 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.487 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -53.2 -2.44 0.1 OUTLIER Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.592 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -81.77 -22.86 36.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.167 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -66.69 -46.34 75.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.17 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.68 28.68 1.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.28 105.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.73 -40.64 0.24 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 114.462 -1.245 . . . . 0.0 114.47 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.8 91.66 1.98 Allowed Pre-proline 0 N--CA 1.466 0.328 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.564 ' HB2' HH22 ' B' ' 17' ' ' ARG . 29.2 Cg_endo -69.76 -27.97 25.84 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.462 1.442 . . . . 0.0 108.752 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' A' ' 119' ' ' MET . 13.0 pt-20 -61.08 -52.27 65.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.222 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.556 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 31.3 ttp -36.16 -38.38 0.14 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.596 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.617 ' NH2' ' CZ2' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -81.57 -50.03 9.84 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.145 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -33.29 73.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.054 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.299 . . . . 0.0 111.054 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.703 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.522 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -79.3 -29.6 42.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.886 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -72.31 -33.58 67.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.723 1.249 . . . . 0.0 107.844 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.927 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.2 OUTLIER -62.94 -51.8 65.51 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.736 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.475 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.4 pt -65.73 -27.84 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.082 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.35 87.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.725 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.521 ' O ' HG21 ' B' ' 18' ' ' ILE . 18.6 mmtt -53.93 -50.97 65.24 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 109.514 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.697 ' O ' HG12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -73.17 -38.15 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.564 HH22 ' HB2' ' A' ' 117' ' ' PRO . 31.1 ttt180 -65.06 -52.91 53.06 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.521 0.676 . . . . 0.0 110.895 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 8.0 tp -56.74 -43.99 80.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.236 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.527 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 11.1 m-20 -67.29 -29.2 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.697 HG12 ' O ' ' B' ' 16' ' ' GLU . 26.4 mm -74.99 -58.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.45 -34.18 74.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 5.0 t80 -54.51 -50.32 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -71.44 -32.59 68.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.484 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.477 HD13 ' CG1' ' B' ' 28' ' ' VAL . 0.2 OUTLIER -66.29 -56.65 10.15 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.186 0.517 . . . . 0.0 109.641 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.25 40.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.205 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.841 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 62.2 mt-10 -69.07 -46.14 68.57 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.192 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.783 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 3.0 ttt-85 -70.97 -33.37 70.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.897 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.232 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.9 m -84.5 -49.36 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.552 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.748 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 24.6 t80 -36.48 -49.98 1.84 Allowed Pre-proline 0 C--N 1.351 0.632 0 CA-C-N 119.531 1.06 . . . . 0.0 109.439 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.864 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 40.6 Cg_endo -54.85 -47.41 26.8 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.509 -2.151 . . . . 0.0 106.509 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.864 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.7 t80 -94.44 -13.65 26.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.397 -2.183 . . . . 0.0 112.752 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.232 ' N ' ' O ' ' B' ' 28' ' ' VAL . 52.5 p -159.1 90.84 1.99 Allowed Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 51.5 Cg_exo -53.46 -45.0 44.24 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.711 2.274 . . . . 0.0 113.81 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' B' ' 38' ' ' ARG . 79.5 tt0 -64.37 -53.96 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.508 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 21.8 mt -51.73 -59.61 4.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.004 0.431 . . . . 0.0 111.155 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.599 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.45 -35.4 52.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.196 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.749 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.57 -36.06 73.41 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.001 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.706 ' HD3' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -65.47 -54.68 24.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.824 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.603 ' O ' ' N ' ' B' ' 42' ' ' LEU . 1.2 m-85 -59.58 -39.94 85.76 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.1 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.573 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.9 t -45.32 -41.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -64.43 -43.24 94.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' B' ' 39' ' ' TYR . 14.5 mt -64.55 -43.61 93.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -66.39 -31.51 72.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.243 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 0.8 OUTLIER -59.9 -53.86 52.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.795 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.1 pp -64.68 -41.01 96.36 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.743 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.514 ' N ' ' HG ' ' B' ' 45' ' ' LEU . 97.3 t -53.51 -42.46 49.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.266 0.555 . . . . 0.0 109.99 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.84 -55.28 17.92 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.301 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 3.0 pt20 -80.71 -53.08 6.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.795 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 26.6 mmtt -56.53 -41.19 76.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -90.23 -9.06 49.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 0.0 110.348 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.54 66.84 1.01 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.349 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.436 ' O ' ' HD2' ' B' ' 61' ' ' ARG . 10.1 m0 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.413 ' H ' ' HG3' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -68.99 -8.5 45.39 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.1 ptm180 -80.59 -18.69 47.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.398 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.769 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -142.97 11.88 1.81 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.511 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 92.0 t80 -119.98 158.64 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 2.0 t -126.28 120.64 30.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -85.97 5.28 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.249 0.547 . . . . 0.0 109.639 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.5 mmmm -97.75 -39.73 8.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.86 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 5.2 p -136.07 1.98 2.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.7 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 66' ' ' CYS . 6.8 m170 57.44 121.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.764 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . 176.17 -172.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.766 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.749 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.4 OUTLIER -121.35 104.7 9.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.769 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -109.81 145.7 36.28 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.348 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.404 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 92.3 t -128.44 117.76 20.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -45.95 125.34 8.21 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.029 1.819 . . . . 0.0 111.85 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.76 -29.82 11.7 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.41 -80.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.003 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -116.97 17.38 14.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.082 0.468 . . . . 0.0 109.886 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -179.844 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 121.221 0.534 . . . . 0.0 109.674 179.087 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 95.7 p . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.983 0.421 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 19' ' ' SER . 59.9 m-85 -33.7 -62.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.894 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.84 -22.08 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.325 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.2 tp10 -97.37 -34.59 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' B' ' 31' ' ' TYR . 1.8 mm -98.78 15.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.49 117.49 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.137 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.728 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 112.77 -35.5 4.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.889 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -61.07 25.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.958 0.879 . . . . 0.0 110.895 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.728 ' H ' ' C ' ' A' ' 25' ' ' GLY . 29.2 p -37.66 -17.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.513 0.673 . . . . 0.0 109.899 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' ARG . 17.7 t-105 -56.99 -56.34 22.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.689 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' B' ' 27' ' ' ARG . 13.5 pt -63.6 -17.91 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.269 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 18.1 m-85 -89.44 -16.89 29.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' CD ' ' HH ' ' A' ' 69' ' ' TYR . 5.1 mmt85 -90.91 -61.56 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.171 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' B' ' 27' ' ' ARG . . . -71.43 45.34 0.79 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -153.53 -36.15 0.1 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.557 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 2.0 t-80 -90.56 106.78 18.73 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.029 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' N ' ' HD1' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -132.66 0.83 3.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.434 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -54.28 146.41 24.66 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.544 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.1 ttm-85 -66.81 125.14 24.94 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.753 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -101.42 136.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.909 0.861 . . . . 0.0 113.301 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.632 ' O ' ' N ' ' A' ' 43' ' ' ILE . 38.5 m-80 -166.11 152.17 9.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.323 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 42' ' ' ASN . 20.8 ttmt -49.96 -51.93 37.53 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.91 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -60.22 -4.81 0.89 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.706 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 77.7 m-20 -122.53 -10.25 8.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.33 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -80.12 -41.06 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.616 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -89.1 9.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.87 1.319 . . . . 0.0 107.57 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.851 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -123.24 -25.37 4.49 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.81 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -79.0 146.28 33.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.788 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -70.89 111.48 6.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.566 ' C ' HG12 ' A' ' 49' ' ' ILE . 13.5 mt -68.73 115.87 8.58 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 HG12 ' C ' ' A' ' 48' ' ' LEU . 2.9 mm -157.42 -27.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.865 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -152.11 30.95 0.89 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.283 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.502 ' CD2' ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -98.38 156.13 16.89 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.502 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 3.4 tmtt? -98.04 127.0 43.73 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.427 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 54' ' ' ARG . 14.8 p -149.4 171.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.269 0.557 . . . . 0.0 111.871 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.92 152.62 49.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.799 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 65' ' ' GLY . 89.0 t -96.33 99.52 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.79 -51.97 13.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -129.03 118.61 22.83 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.331 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.556 ' OG ' ' CE1' ' A' ' 60' ' ' HIS . 5.2 t -149.36 173.35 13.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.331 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.738 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 10.8 t -108.32 75.46 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.294 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.738 ' CD2' ' O ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -168.59 93.08 0.59 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.745 178.035 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.2 -5.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.349 2.033 . . . . 0.0 113.263 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -109.55 9.06 32.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.366 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' O ' HG22 ' A' ' 66' ' ' ILE . 39.6 m-85 -140.74 -12.95 0.98 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.234 1.017 . . . . 0.0 112.255 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.2 m -72.0 132.66 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.129 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.5 6.39 88.66 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.335 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.584 ' CG2' ' NE1' ' A' ' 87' ' ' TRP . 11.0 tt -100.87 148.48 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.701 0.75 . . . . 0.0 112.055 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.664 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 4.8 tm-20 -119.7 129.98 54.79 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.69 174.24 25.74 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 116.412 -0.358 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.1 t80 -96.25 115.2 27.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.571 0.348 . . . . 0.0 110.093 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 1.5 t -48.21 142.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.727 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.2 mt -141.76 -39.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.686 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -121.82 143.43 49.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' N ' ' CZ ' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -157.21 106.48 2.18 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.589 ' HG1' ' N ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -137.82 -171.33 2.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.28 0.562 . . . . 0.0 111.084 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.589 ' N ' ' HG1' ' A' ' 74' ' ' THR . 29.1 ttt-85 -53.24 -24.7 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.125 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.467 ' H ' ' HG1' ' A' ' 74' ' ' THR . 1.3 m120 -138.43 30.93 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.473 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -164.68 169.6 16.69 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.687 -1.205 . . . . 0.0 113.91 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.4 tp -165.83 110.21 0.83 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' ILE . 98.0 t -116.41 146.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.527 HG21 ' C ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -126.89 145.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.229 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.18 136.13 53.96 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.532 . . . . 0.0 111.828 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.92 132.88 3.82 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 64.33 -123.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.808 -0.231 . . . . 0.0 110.643 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -116.31 33.22 5.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 110.618 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.584 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 6.1 tptp -145.25 170.75 15.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.584 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 7.8 m -124.28 156.11 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.701 0.762 . . . . 0.0 110.85 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.664 ' CZ2' ' O ' ' A' ' 67' ' ' GLU . 1.2 m-90 -99.11 119.73 38.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.623 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -107.98 104.47 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.28 96.26 3.97 Favored Pre-proline 0 N--CA 1.457 -0.115 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.92 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 92' ' ' ASP . 38.3 Cg_exo -54.16 126.76 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.095 1.197 . . . . 0.0 110.295 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.663 ' HZ2' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -43.78 -19.84 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.431 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' PRO . 5.3 p-10 -87.6 -6.92 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.507 ' O ' ' OG ' ' A' ' 58' ' ' SER . 2.2 t -133.72 33.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.714 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -167.09 158.06 11.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.712 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 73.1 mt -106.45 118.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.714 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 66.6 m-85 -99.08 131.12 45.35 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' ILE . 11.2 tt0 -115.49 94.87 4.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.645 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.84 143.58 26.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.85 ' OE2' ' N ' ' A' ' 104' ' ' THR . 2.5 tm-20 -90.99 127.52 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.485 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.921 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -58.98 143.27 48.7 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.817 -178.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.753 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -54.83 0.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.284 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 100' ' ' THR . 31.8 t70 -106.66 10.64 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.16 14.42 76.91 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.921 ' O ' ' OG1' ' A' ' 100' ' ' THR . 19.3 m -106.54 127.6 53.45 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -76.47 135.98 39.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.431 0.634 . . . . 0.0 111.581 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.473 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 70.2 mt -102.88 135.5 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.525 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 34.9 ttmt -107.9 101.92 11.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.07 139.19 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.353 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -79.29 145.49 33.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.773 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -70.88 -1.91 42.54 Favored Glycine 0 CA--C 1.507 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.087 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.94 -21.61 34.05 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.352 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -64.82 -47.08 79.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.419 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.29 28.58 2.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.776 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.501 ' O ' ' CG1' ' A' ' 114' ' ' VAL . 12.6 p -60.81 106.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.663 ' N ' ' HZ2' ' A' ' 91' ' ' LYS . . . 67.98 -40.2 0.25 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.104 -0.953 . . . . 0.0 114.162 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 114' ' ' VAL . 31.9 mtp180 -101.43 78.55 0.22 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.496 ' HB2' HH22 ' B' ' 17' ' ' ARG . 19.5 Cg_endo -66.59 -24.25 48.72 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.392 1.394 . . . . 0.0 108.984 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.487 ' CG ' ' H ' ' A' ' 119' ' ' MET . 9.3 pt-20 -62.94 -52.63 62.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.487 ' H ' ' CG ' ' A' ' 118' ' ' GLU . 1.4 mmt -35.01 -55.56 0.59 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.667 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' CE3' ' A' ' 45' ' ' TRP . 4.2 tpt180 -68.28 -40.69 81.76 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.963 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -62.1 -39.15 91.52 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE2' ' NZ ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.667 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -79.62 -33.45 41.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.764 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 8.9 tttp -73.45 -35.06 65.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.664 1.221 . . . . 0.0 108.485 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.949 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -61.1 -51.51 68.84 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.088 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.634 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 10.9 mt -69.59 -35.56 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.9 -53.6 56.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 12.9 mmmt -53.33 -50.96 63.9 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.734 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.53 -38.22 71.09 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.246 0.546 . . . . 0.0 110.755 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' B' ' 13' ' ' ILE . 7.0 ttt180 -58.84 -53.6 56.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.897 0.856 . . . . 0.0 109.844 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.451 HG21 ' O ' ' B' ' 15' ' ' LYS . 0.4 OUTLIER -59.36 -32.01 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.35 -50.13 73.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.417 HD13 ' CG ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -74.31 -49.61 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.658 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -56.0 -37.41 69.08 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 6.2 t80 -59.76 -51.99 67.41 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.425 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 64.6 p -69.68 -34.95 74.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.435 HD11 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -63.79 -56.26 16.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.181 0.515 . . . . 0.0 109.913 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.41 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.87 -34.51 41.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.832 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 1.7 tm-20 -74.19 -40.07 62.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.765 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 53.9 mtt180 -72.53 -34.74 67.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.215 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.7 m -85.83 -49.39 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.718 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 23.2 t80 -36.19 -49.85 1.69 Allowed Pre-proline 0 C--N 1.353 0.741 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.304 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.859 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 38.3 Cg_endo -54.58 -48.28 22.25 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.859 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.1 t80 -94.3 -10.8 31.62 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 112.473 -2.149 . . . . 0.0 112.773 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.215 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.0 p -165.03 95.13 0.88 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' B' ' 37' ' ' LYS . 33.2 Cg_exo -56.5 -39.12 93.5 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.503 2.135 . . . . 0.0 113.319 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -53.37 35.3 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.549 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 13.5 mt -54.36 -57.85 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.571 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -51.66 -31.24 24.81 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.185 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' O ' ' B' ' 69' ' ' PHE . 2.2 mptt -70.97 -41.17 71.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.761 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.727 ' NH2' ' O ' ' A' ' 71' ' ' ILE . 2.5 tmm_? -60.07 -54.34 47.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.951 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' B' ' 39' ' ' TYR . 0.5 OUTLIER -61.66 -39.29 90.85 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.718 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.1 t -45.64 -43.23 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.596 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.72 -43.64 98.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.628 ' O ' HG21 ' B' ' 46' ' ' VAL . 63.1 mt -64.8 -43.94 91.55 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.361 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -56.81 -30.86 64.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.534 ' CD1' ' OH ' ' B' ' 62' ' ' TYR . 7.3 mt -67.66 -54.83 16.34 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.47 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' B' ' 42' ' ' LEU . 1.3 pp -57.74 -28.25 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.745 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.628 HG21 ' O ' ' B' ' 42' ' ' LEU . 83.5 t -69.1 -48.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.153 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.08 -56.84 9.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 8.9 pt20 -80.75 -48.33 12.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -69.51 -33.85 73.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -89.38 -8.38 53.27 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? 64.82 71.15 0.46 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.834 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.646 ' O ' ' N ' ' B' ' 62' ' ' TYR . 2.0 m0 . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.52 -8.75 15.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.9 ptm180 -88.19 -26.4 22.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.264 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.742 ' NH1' ' CE2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -134.54 15.15 3.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.754 -177.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' B' ' 58' ' ' TRP . 23.5 t80 -111.82 151.13 29.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.63 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 0.0 OUTLIER -118.82 105.16 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.156 -178.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -92.86 -4.77 52.32 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' B' ' 66' ' ' CYS . 20.9 mmmt -78.57 -37.93 41.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.659 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 17.7 1.72 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.879 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.58 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.7 m80 53.96 95.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.902 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.4 -173.92 2.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.8 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.781 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -125.44 102.51 7.44 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.657 ' O ' ' CB ' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -99.97 154.4 18.42 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.814 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 42.9 t -131.12 115.15 16.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.424 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.0 122.49 4.33 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.224 1.949 . . . . 0.0 111.848 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.74 -26.77 23.25 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.05 -80.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 110.513 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -115.55 22.36 13.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.958 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.274 0.559 . . . . 0.0 111.972 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.342 0.591 . . . . 0.0 109.432 178.592 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 54.7 p . . . . . 0 C--O 1.226 -0.164 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLU . 37.0 m-85 -42.44 -58.52 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -43.72 -15.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' TYR . 38.2 tp10 -99.82 -32.62 10.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.327 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.633 HD12 ' OG ' ' B' ' 32' ' ' SER . 3.8 mm -109.11 19.15 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.457 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -80.35 117.13 25.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.543 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.26 -37.48 3.6 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.204 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 28' ' ' TRP . 1.9 mtt180 -62.26 30.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.552 0.676 . . . . 0.0 110.875 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.681 ' H ' ' C ' ' A' ' 25' ' ' GLY . 2.9 p -43.74 -12.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.747 0.784 . . . . 0.0 109.022 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.701 ' H ' ' C ' ' A' ' 26' ' ' ARG . 24.1 t-105 -58.24 -55.77 30.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.169 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' B' ' 27' ' ' ARG . 7.2 pt -64.66 -13.59 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 71' ' ' ILE . 60.5 m-85 -93.42 -16.5 24.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.9 mmm180 -89.13 -56.68 3.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.736 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' NE ' ' B' ' 27' ' ' ARG . . . -78.58 46.42 2.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.569 ' CA ' ' HG ' ' B' ' 23' ' ' SER . . . -153.12 -40.98 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.561 ' HD1' ' N ' ' A' ' 35' ' ' ARG . 2.4 t-80 -75.68 126.96 32.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.536 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.561 ' N ' ' HD1' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -154.78 -35.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.553 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' ARG . . . -32.29 144.77 0.02 OUTLIER Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 24.4 ttm105 -66.42 119.5 11.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.733 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -92.71 136.62 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.767 0.794 . . . . 0.0 113.115 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 43' ' ' ILE . 39.3 t30 -165.82 155.52 12.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 42' ' ' ASN . 86.3 tttt -52.21 -52.77 50.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.76 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.565 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 8.7 pttm -60.15 -4.24 0.76 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.748 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 72.3 m-20 -123.95 -3.41 8.13 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.228 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -86.41 -39.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 117.876 0.307 . . . . 0.0 111.466 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -88.43 3.12 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.848 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -114.65 -37.88 4.14 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.617 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.748 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -67.29 140.38 57.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.787 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -66.25 110.09 2.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.79 ' O ' HG12 ' A' ' 49' ' ' ILE . 5.0 mt -72.9 114.5 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.407 -1.317 . . . . 0.0 108.013 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.79 HG12 ' O ' ' A' ' 48' ' ' LEU . 4.7 mt -168.42 51.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 O-C-N 123.803 0.689 . . . . 0.0 109.491 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 150.16 -35.26 0.99 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.591 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 52' ' ' LYS . 1.6 tt -44.59 146.05 0.79 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 13.0 tmtt? -85.46 125.31 32.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.348 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.827 HG22 ' H ' ' A' ' 54' ' ' ARG . 12.0 p -149.1 171.02 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.434 0.635 . . . . 0.0 111.954 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.827 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.89 152.81 49.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.001 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 65' ' ' GLY . 31.6 t -100.44 99.46 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.58 -51.98 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.56 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -128.48 117.42 21.31 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.553 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.724 ' HG ' ' H ' ' A' ' 59' ' ' THR . 31.1 t -150.18 173.53 13.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.466 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.724 ' H ' ' HG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -101.36 79.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.68 ' CD2' ' O ' ' A' ' 59' ' ' THR . 37.3 m-70 -161.14 94.92 1.4 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.614 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.7 -5.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.177 1.918 . . . . 0.0 113.219 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -134.79 22.57 3.64 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.193 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' O ' HG21 ' A' ' 66' ' ' ILE . 27.2 m-85 -140.69 -10.85 1.03 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.628 1.214 . . . . 0.0 111.834 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.14 134.07 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.863 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 83.27 5.87 88.44 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.291 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.634 ' CG2' ' NE1' ' A' ' 87' ' ' TRP . 11.4 tt -104.54 153.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.66 0.73 . . . . 0.0 112.204 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.614 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.3 tm-20 -120.26 131.49 54.95 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.515 ' N ' ' OE2' ' A' ' 67' ' ' GLU . . . -147.31 173.29 27.49 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 116.341 -0.39 . . . . 0.0 112.502 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -96.45 117.89 31.83 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 51' ' ' LEU . 1.5 t -51.9 145.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.962 0.41 . . . . 0.0 111.654 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 30' ' ' PHE . 93.6 mt -140.32 -33.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.485 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.666 ' OD2' ' NH1' ' B' ' 38' ' ' ARG . 37.6 t0 -123.56 149.29 45.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.662 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 tm-20 -161.71 106.05 1.26 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.959 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.519 HG23 ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -148.45 -175.23 4.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.194 0.521 . . . . 0.0 110.964 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.473 HH12 HH21 ' A' ' 116' ' ' ARG . 37.1 ttt85 -53.17 -23.25 7.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.094 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -138.83 29.16 2.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -166.29 164.53 17.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 118.358 -1.337 . . . . 0.0 114.267 179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 10.5 tp -163.43 109.79 1.13 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 112.975 -1.92 . . . . 0.0 105.937 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 71' ' ' ILE . 83.3 t -118.24 146.3 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 112.474 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.541 HG23 ' C ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -127.6 147.09 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.357 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -122.69 137.47 54.9 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.597 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -155.52 124.96 1.57 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.411 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 17.6 tt0 64.8 -130.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 110.552 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.411 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -108.24 32.06 5.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.544 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 13.7 tttp -139.12 166.75 23.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.607 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 7.5 m -123.45 155.44 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.421 0.629 . . . . 0.0 110.611 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.634 ' NE1' ' CG2' ' A' ' 66' ' ' ILE . 1.6 m-90 -102.17 93.14 5.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.437 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.459 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 20.9 ttmt -91.3 104.84 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.928 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.462 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 2.5 m -157.24 95.85 2.1 Favored Pre-proline 0 N--CA 1.457 -0.123 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.563 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 32.0 Cg_exo -54.28 126.82 23.45 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.973 1.782 . . . . 0.0 111.687 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.708 ' HZ2' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -38.81 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.204 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 90' ' ' PRO . 4.0 p-10 -82.24 -6.11 58.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.06 33.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.271 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 90' ' ' PRO . 3.2 p -167.37 154.82 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.354 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.37 146.13 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.271 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.586 ' CB ' ' CZ ' ' A' ' 98' ' ' PHE . 50.3 m-85 -130.42 137.65 49.94 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.572 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 7.8 tt0 -119.65 94.0 4.26 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.586 ' CZ ' ' CB ' ' A' ' 96' ' ' PHE . 1.4 m-85 -87.69 144.82 26.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -90.01 131.6 35.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.317 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.67 143.39 57.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.693 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.733 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.45 -0.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.296 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 20.2 t0 -107.37 12.98 27.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.8 22.65 68.75 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.06 149.47 26.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.417 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.46 133.41 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.42 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.401 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 22.2 mt -107.16 134.9 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -115.65 102.63 9.93 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -151.38 139.92 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.933 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 111' ' ' GLU . 37.4 m -89.74 148.35 23.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.275 0.559 . . . . 0.0 111.449 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.34 -1.0 0.94 Allowed Glycine 0 CA--C 1.506 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.174 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -76.44 -23.75 53.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.287 -178.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -74.63 -47.56 31.4 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.303 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 28.41 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 116' ' ' ARG . 5.1 p -59.64 105.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.708 ' N ' ' HZ2' ' A' ' 91' ' ' LYS . . . 67.49 -41.02 0.23 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.792 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.473 HH21 HH12 ' A' ' 75' ' ' ARG . 7.0 mmt180 -100.79 79.72 0.23 Allowed Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.492 ' HB2' HH22 ' B' ' 17' ' ' ARG . 18.3 Cg_endo -64.83 -24.48 61.3 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -64.72 -57.31 9.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.446 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.463 ' C ' ' O ' ' A' ' 118' ' ' GLU . 2.6 tpt -31.81 -45.4 0.1 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.741 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.626 ' NE ' ' CZ3' ' A' ' 45' ' ' TRP . 6.8 tpm_? -70.9 -46.77 61.96 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.46 -41.35 97.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.97 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.618 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.55 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 2.6 pt-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' B' ' 11' ' ' LYS . 16.9 pttp -79.85 -41.49 26.21 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.965 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.773 ' H ' HH11 ' B' ' 12' ' ' ARG . 16.8 ttpt -72.85 -33.62 66.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 122.742 1.258 . . . . 0.0 108.431 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.937 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.5 mpt_? -61.8 -51.07 69.78 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.418 -2.173 . . . . 0.0 110.98 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' B' ' 17' ' ' ARG . 15.1 mt -68.33 -27.55 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.09 60.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.904 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.401 ' O ' HG23 ' B' ' 18' ' ' ILE . 29.5 mttp -54.16 -50.25 67.43 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.79 -37.49 70.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.302 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' B' ' 13' ' ' ILE . 17.6 ttt180 -61.79 -53.66 52.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.842 0.83 . . . . 0.0 110.163 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -57.35 -34.83 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.118 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -67.07 -31.28 71.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.143 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.462 HD12 HG21 ' B' ' 20' ' ' ILE . 31.3 mt -71.33 -56.88 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.605 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -65.14 -34.0 77.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.908 0.861 . . . . 0.0 109.087 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.6 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 14.0 t80 -53.09 -49.33 66.64 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.305 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.569 ' HG ' ' CA ' ' A' ' 33' ' ' ALA . 13.4 p -68.27 -37.21 80.48 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.123 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -60.4 -56.78 17.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.708 0.766 . . . . 0.0 110.032 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' CE2' ' B' ' 69' ' ' PHE . . . -51.57 -33.99 34.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.159 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.813 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 7.9 mm-40 -75.15 -43.51 52.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.583 0.706 . . . . 0.0 109.79 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.756 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 83.6 mtt-85 -72.69 -34.56 67.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.4 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.256 ' O ' ' N ' ' B' ' 32' ' ' SER . 3.6 m -85.19 -50.9 14.22 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.642 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.718 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 14.1 t80 -36.42 -49.73 1.81 Allowed Pre-proline 0 C--N 1.35 0.599 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.525 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.862 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 41.5 Cg_endo -55.39 -47.91 23.42 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 N-CA-C 106.893 -2.003 . . . . 0.0 106.893 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.862 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.2 t80 -94.47 -15.25 24.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.536 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.256 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -161.2 93.62 1.44 Allowed Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.6 ' CA ' ' HZ3' ' B' ' 37' ' ' LYS . 50.5 Cg_exo -53.7 -43.47 57.57 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.03 2.487 . . . . 0.0 114.158 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.08 -52.17 60.58 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.626 ' CD2' HH21 ' B' ' 38' ' ' ARG . 11.4 mt -51.3 -58.15 6.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -53.68 -34.04 57.37 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.354 0.597 . . . . 0.0 109.649 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.725 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -70.8 -41.06 72.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.391 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.666 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 3.6 ttm-85 -62.75 -51.54 66.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.406 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' B' ' 42' ' ' LEU . 1.5 m-30 -60.48 -41.19 93.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.097 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 3.1 t -45.27 -36.47 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.381 -1.281 . . . . 0.0 107.948 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 67.5 tt0 -67.87 -44.03 78.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' B' ' 39' ' ' TYR . 26.8 mt -66.17 -40.02 90.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.323 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.1 70.32 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.154 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 4.5 mt -63.16 -54.64 34.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.601 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.651 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.9 pp -60.2 -38.17 82.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.13 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 73.0 t -54.42 -44.37 66.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.451 0.643 . . . . 0.0 109.702 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.4 -55.16 17.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.761 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 13.3 pt20 -80.32 -52.27 7.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 13.9 mptt -61.7 -39.96 93.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.313 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -88.56 -11.65 45.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.07 67.63 0.84 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.112 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.899 178.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' B' ' 62' ' ' TYR . 7.7 m0 . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -69.04 -16.65 63.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' B' ' 60' ' ' ARG . 7.6 ptm85 -78.73 -20.37 50.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.558 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.903 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -140.71 17.87 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.138 -177.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' B' ' 58' ' ' TRP . 85.9 t80 -119.48 156.79 29.56 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.558 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.5 OUTLIER -127.22 124.08 38.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.043 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.51 4.48 49.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.507 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -97.53 -38.6 9.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.196 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.3 p -136.71 10.72 3.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.473 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' B' ' 66' ' ' CYS . 5.4 m-70 49.63 109.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.7 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.96 -170.04 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.725 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -122.85 105.06 9.68 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.903 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -109.47 141.69 41.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.814 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.7 t -119.71 121.01 30.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.09 122.92 6.87 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.017 1.811 . . . . 0.0 111.991 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 76' ' ' ALA . . . 101.78 -33.08 6.79 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.37 -77.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.773 0.321 . . . . 0.0 110.975 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -109.27 14.65 23.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.09 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' B' ' 73' ' ' GLY . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.71 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 121.368 0.604 . . . . 0.0 109.391 178.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.59 0.233 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.3 m-85 -49.85 -48.79 50.95 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.12 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -40.84 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 110.45 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -101.77 -35.56 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.616 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.47 ' HA ' ' CE2' ' B' ' 31' ' ' TYR . 3.6 mm -94.96 22.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -80.45 117.89 27.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.69 0.281 . . . . 0.0 111.712 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.711 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 107.07 -33.15 6.6 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.154 -0.546 . . . . 0.0 114.078 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.8 28.47 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.988 0.894 . . . . 0.0 111.038 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.711 ' H ' ' C ' ' A' ' 25' ' ' GLY . 16.5 p -42.76 -14.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.565 0.698 . . . . 0.0 109.397 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.653 ' N ' ' O ' ' A' ' 26' ' ' ARG . 18.9 t-105 -58.84 -59.53 5.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.263 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 ' CG1' ' CE1' ' A' ' 30' ' ' PHE . 11.9 pt -56.97 -12.97 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.576 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 27.4 m-85 -94.25 -29.62 14.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -74.65 -41.59 60.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.46 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.18 26.15 10.76 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.75 15.43 1.09 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -127.81 100.49 5.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.997 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.527 ' H ' HG13 ' B' ' 20' ' ' ILE . 5.3 mmt85 -138.87 -9.64 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.82 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.628 ' H ' ' CG1' ' B' ' 20' ' ' ILE . . . -45.52 145.05 2.9 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 28.7 ttt180 -66.87 118.26 10.12 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.738 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 61.8 t -93.64 136.5 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 43' ' ' ILE . 10.7 t-20 -165.86 150.93 8.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.279 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.542 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 88.0 tttt -48.45 -55.5 10.73 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.357 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.619 ' HZ3' ' ND2' ' A' ' 39' ' ' ASN . 6.3 pttp -59.31 -5.28 0.71 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.626 ' O ' ' CG ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER -125.12 0.5 7.86 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.231 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.9 -38.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.907 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.575 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -97.63 9.85 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.575 1.179 . . . . 0.0 108.015 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.797 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -125.82 6.44 7.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.535 -1.666 . . . . 0.0 107.664 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.694 ' C ' ' HE ' ' B' ' 17' ' ' ARG . 0.1 OUTLIER -107.97 176.16 5.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.687 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.708 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -94.57 111.75 23.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.593 ' C ' HG12 ' A' ' 49' ' ' ILE . 45.9 mt -75.21 115.39 14.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.63 ' CG2' ' CZ ' ' B' ' 39' ' ' TYR . 0.2 OUTLIER -161.02 -40.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -136.1 20.44 3.59 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -86.72 137.78 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' H ' HD21 ' A' ' 51' ' ' LEU . 76.2 tttt -71.1 135.89 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.669 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 1.8 p -149.48 171.89 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.442 0.639 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -146.98 140.27 25.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.901 178.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 65' ' ' GLY . 42.9 t -91.25 99.53 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.43 -50.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.457 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.33 117.9 13.89 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 4.5 t -150.27 174.02 13.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.758 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.691 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 1.4 p -97.14 78.84 2.79 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.691 ' CD2' ' O ' ' A' ' 59' ' ' THR . 71.1 m-70 -166.56 111.71 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.696 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.05 -6.03 17.23 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.88 1.72 . . . . 0.0 112.654 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.08 13.72 9.03 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.763 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 87' ' ' TRP . 30.5 m-85 -138.82 -22.74 0.95 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.345 1.072 . . . . 0.0 111.589 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.8 m -71.82 145.63 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.52 6.4 89.2 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.365 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.888 HD13 ' HE1' ' A' ' 87' ' ' TRP . 26.1 mt -111.9 158.4 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.597 ' H ' HG21 ' A' ' 66' ' ' ILE . 4.5 tt0 -115.13 120.54 40.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.88 171.37 26.86 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.145 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -91.03 129.91 36.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 51' ' ' LEU . 2.3 t -68.13 153.84 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.369 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.693 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 85.2 mt -141.59 -55.96 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.612 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 0.8 OUTLIER -106.41 150.21 26.26 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.666 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -156.68 107.05 2.33 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.477 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.73 -173.13 3.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 110.759 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -52.21 -29.5 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.581 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 10.3 t-20 -137.98 31.37 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.678 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -157.13 161.46 39.38 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 118.992 -1.083 . . . . 0.0 113.358 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.3 tp -161.93 109.23 1.37 Allowed 'General case' 0 C--O 1.243 0.748 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 72' ' ' ASP . 80.4 t -107.86 147.29 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -131.11 143.86 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.002 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.07 136.19 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.945 0.403 . . . . 0.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.86 136.89 5.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 51.77 -133.93 1.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.517 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -102.23 33.75 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 22.1 tptm -145.46 160.34 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.092 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 14.0 m -120.57 156.69 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.588 0.709 . . . . 0.0 110.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.888 ' HE1' HD13 ' A' ' 66' ' ' ILE . 2.6 m-90 -107.35 128.62 54.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.209 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' C ' ' CG2' ' A' ' 89' ' ' VAL . 83.0 tttt -118.64 106.54 12.71 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -152.31 99.58 2.85 Favored Pre-proline 0 CA--C 1.528 0.112 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.565 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.425 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 50.8 Cg_exo -50.66 137.9 41.16 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.812 1.675 . . . . 0.0 110.795 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.611 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -49.98 -19.9 0.81 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.787 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.611 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 1.2 p-10 -84.8 -6.17 59.34 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -125.12 5.89 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -142.34 139.41 31.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.117 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mt -85.71 116.99 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.698 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 53.1 m-85 -98.12 130.31 44.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.44 ' C ' HG22 ' A' ' 53' ' ' VAL . 38.3 tt0 -113.5 97.28 6.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.697 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 47.2 m-85 -90.28 145.14 25.21 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -90.62 127.04 36.15 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.773 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.662 ' HG1' ' CB ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -63.01 143.62 57.62 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.765 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.738 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.43 -0.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.402 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.7 t0 -106.85 13.38 27.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.23 21.92 69.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.662 ' CB ' ' HG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.58 149.77 26.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.625 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.619 ' N ' ' HZ1' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -91.05 132.4 36.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 20.6 mt -105.52 134.07 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.281 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -112.54 101.03 9.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -138.11 136.18 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.431 -177.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 111' ' ' GLU . 3.8 m -81.32 134.66 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.668 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' LYS . . . -59.33 -2.19 1.4 Allowed Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.829 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 pt-20 -86.19 -21.06 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.916 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -63.45 -44.33 94.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.92 27.72 3.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.216 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 116' ' ' ARG . 5.3 p -48.1 103.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.471 0.653 . . . . 0.0 112.333 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.509 ' H ' ' CG ' ' A' ' 91' ' ' LYS . . . 67.05 -41.44 0.2 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.725 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 114' ' ' VAL . 12.4 mtt85 -100.52 97.4 6.48 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HB2' ' NH2' ' B' ' 17' ' ' ARG . 24.7 Cg_endo -69.32 -30.16 24.78 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 N-CA-C 107.1 -1.923 . . . . 0.0 107.1 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -64.79 -53.3 49.13 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.703 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 118' ' ' GLU . 0.8 OUTLIER -29.37 -36.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.056 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.631 ' CZ ' ' CH2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -82.39 -53.32 6.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.017 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.42 -31.25 54.81 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.463 179.856 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.654 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -78.45 -37.88 42.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.576 -0.45 . . . . 0.0 112.161 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.81 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.3 OUTLIER -72.12 -33.24 67.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 122.958 1.361 . . . . 0.0 108.237 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.938 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -59.85 -51.01 71.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 112.013 -2.358 . . . . 0.0 111.216 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -69.68 -29.34 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.23 -48.57 64.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.503 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -50.75 -51.15 53.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' B' ' 13' ' ' ILE . 17.5 pt-20 -72.74 -36.7 67.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.206 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.694 ' HE ' ' C ' ' A' ' 46' ' ' HIS . 34.5 ttt-85 -60.92 -52.53 64.65 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.857 0.837 . . . . 0.0 110.606 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -35.91 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.422 -177.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.75 -32.15 72.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.628 ' CG1' ' H ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -73.78 -55.05 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.618 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.59 -34.45 75.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 2.0 t80 -54.43 -51.29 65.41 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.017 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -69.1 -31.53 70.3 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.501 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.492 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.3 OUTLIER -69.11 -54.4 15.17 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.3 31.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.614 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.837 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 49.6 mt-10 -73.89 -43.08 59.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.44 0.638 . . . . 0.0 110.437 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.773 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 86.0 mtt-85 -71.4 -35.42 71.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.384 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.205 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.4 m -82.33 -50.7 15.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 O-C-N 121.336 -0.853 . . . . 0.0 110.485 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.703 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 2.1 t80 -36.42 -51.2 1.84 Allowed Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.616 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.843 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 37.2 Cg_endo -53.66 -46.72 31.65 Favored 'Trans proline' 0 C--N 1.296 -2.188 0 N-CA-C 106.129 -2.297 . . . . 0.0 106.129 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.843 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.9 t80 -95.0 -14.32 24.46 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.139 -2.301 . . . . 0.0 113.269 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.205 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.6 p -157.91 96.24 1.95 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 52.7 Cg_exo -55.09 -47.4 26.62 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.967 2.445 . . . . 0.0 114.347 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.21 -53.2 56.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.523 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 62.0 mt -51.74 -60.25 3.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.984 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.616 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.8 -32.95 60.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.812 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.761 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.29 -38.46 75.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.702 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.693 ' NH2' ' O ' ' A' ' 71' ' ' ILE . 3.8 tmm_? -60.72 -50.35 73.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.027 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -64.26 -40.46 96.04 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.8 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.02 -37.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -66.97 -45.45 77.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.579 ' CD1' ' NH1' ' B' ' 38' ' ' ARG . 11.6 mt -63.37 -50.7 68.88 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.454 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.29 68.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.805 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 10.4 mt -65.33 -54.43 29.13 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' B' ' 49' ' ' LYS . 3.5 pp -59.6 -35.03 73.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.673 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.635 ' CG2' ' NH1' ' B' ' 17' ' ' ARG . 73.4 t -64.94 -49.89 77.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.435 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.11 -51.13 70.91 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.022 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 7.0 pt20 -78.85 -39.64 34.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.762 ' HD3' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -83.06 -42.21 17.72 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.089 -177.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -67.06 -14.87 63.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 mttm 72.54 52.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.021 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.995 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.623 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 36.2 m0 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.624 0.25 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -66.26 -17.06 64.52 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' B' ' 60' ' ' ARG . 9.6 ptp180 -76.17 -18.86 58.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.84 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -147.53 15.34 1.12 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.417 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 32.4 t80 -113.54 154.08 27.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.584 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 5.8 t -123.66 114.51 20.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.896 0.379 . . . . 0.0 111.448 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.36 3.89 12.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.921 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.41 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.8 mmmt -98.27 -43.49 6.94 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.482 ' C ' ' CG ' ' B' ' 67' ' ' HIS . 6.1 p -134.14 -2.64 2.84 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.599 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.482 ' CG ' ' C ' ' B' ' 66' ' ' CYS . 0.3 OUTLIER 61.94 134.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.513 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' B' ' 67' ' ' HIS . . . 164.97 -170.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.098 0.475 . . . . 0.0 110.783 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.761 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -117.96 103.92 10.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.785 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -110.23 117.35 33.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.45 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.44 ' CG2' ' CE2' ' B' ' 29' ' ' PHE . 1.5 t -101.59 121.06 52.63 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.939 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.15 124.79 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.792 1.662 . . . . 0.0 111.38 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.98 -33.93 6.18 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -96.78 -80.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.854 0.359 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.43 18.6 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.115 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.857 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 N--CA 1.465 0.315 0 O-C-N 123.502 0.501 . . . . 0.0 109.785 178.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 22' ' ' GLU . 8.6 m-85 -43.23 -57.23 3.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -38.62 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.902 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 20' ' ' TYR . 47.0 tp10 -104.13 -32.6 9.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' TYR . 3.1 mm -102.05 15.58 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.51 117.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.373 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.727 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.41 -36.42 4.06 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.328 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.676 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.32 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.631 0.716 . . . . 0.0 110.793 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.727 ' H ' ' C ' ' A' ' 25' ' ' GLY . 14.2 p -41.9 -14.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 109.601 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.676 ' N ' ' O ' ' A' ' 26' ' ' ARG . 23.2 t-105 -57.31 -53.74 54.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.212 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 HH11 ' B' ' 27' ' ' ARG . 8.6 pt -67.67 -13.11 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.082 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 71' ' ' ILE . 41.3 m-85 -92.8 -9.88 38.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.5 ttp180 -95.04 -64.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.77 31.74 0.38 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.647 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -146.63 -36.51 0.24 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -90.84 112.29 24.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' H ' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -148.47 2.13 0.63 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.943 -179.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.478 ' N ' HD13 ' B' ' 20' ' ' ILE . . . -45.91 153.56 0.8 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 9.2 ttm180 -67.69 117.73 10.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.757 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 47.0 t -95.25 134.2 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 43' ' ' ILE . 5.7 t-20 -166.1 149.94 7.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.276 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.562 ' C ' ' H ' ' A' ' 42' ' ' ASN . 11.3 tttm -48.26 -55.14 11.3 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.576 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 44.2 pttt -59.91 -4.86 0.81 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 10.8 m120 -123.77 -0.35 8.56 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.229 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.64 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.54 -39.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.562 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -92.3 9.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.833 1.301 . . . . 0.0 107.578 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -126.55 -6.44 6.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.849 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.756 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -93.35 147.1 23.23 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.866 ' OE1' ' NE ' ' B' ' 17' ' ' ARG . 0.4 OUTLIER -74.48 110.64 8.93 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.566 ' C ' HG12 ' A' ' 49' ' ' ILE . 15.8 mt -73.24 117.94 15.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 HG12 ' C ' ' A' ' 48' ' ' LEU . 4.4 mm -152.69 -30.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.763 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -146.76 0.03 0.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.541 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.611 ' CD2' ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -58.32 162.35 3.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.665 0.732 . . . . 0.0 109.488 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.611 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 11.9 tttt -106.73 125.16 50.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.472 0.177 . . . . 0.0 111.171 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.833 HG21 ' H ' ' A' ' 54' ' ' ARG . 14.5 p -148.97 170.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.443 0.639 . . . . 0.0 111.513 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.833 ' H ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -132.27 145.43 51.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.439 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 65' ' ' GLY . 23.7 t -100.83 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.34 -47.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.937 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -127.77 119.43 25.72 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.133 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.548 ' CB ' ' HD1' ' A' ' 60' ' ' HIS . 1.9 p -148.61 135.95 20.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.052 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.629 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -71.26 77.1 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.281 -1.368 . . . . 0.0 108.948 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.629 ' CG ' ' C ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -169.29 97.89 0.5 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.027 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.89 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.469 2.113 . . . . 0.0 113.774 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -124.0 24.43 6.33 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 120.402 -0.904 . . . . 0.0 114.407 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -141.05 -21.98 0.78 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.804 1.302 . . . . 0.0 111.694 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 58' ' ' SER . 3.1 m -72.96 145.08 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.75 5.31 89.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.919 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.562 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 1.1 mt -104.64 148.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 118.259 1.03 . . . . 0.0 111.538 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -114.71 126.97 55.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.81 173.37 27.9 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.981 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -95.85 120.21 35.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -53.12 141.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.117 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.729 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.6 mt -135.39 -36.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.971 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.7 t70 -121.83 141.68 50.99 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.614 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 5.0 tt0 -153.19 106.23 2.97 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -140.42 -176.77 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.125 0.488 . . . . 0.0 110.725 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 72.6 ttt-85 -57.96 -16.46 12.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.816 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -138.77 27.29 2.46 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.551 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 2.4 ptp -165.96 170.02 14.12 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 118.7 -1.2 . . . . 0.0 114.066 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 1.4 tp -166.13 110.24 0.8 Allowed 'General case' 0 C--O 1.252 1.233 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 71' ' ' ILE . 66.0 t -120.01 136.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -114.84 151.96 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -128.13 135.93 50.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.122 0.486 . . . . 0.0 111.82 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.434 ' N ' ' HZ3' ' A' ' 87' ' ' TRP . . . -157.53 122.64 1.19 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 66.73 -130.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -108.69 18.17 21.12 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.947 0.403 . . . . 0.0 110.101 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -119.56 144.51 47.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.425 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.73 155.47 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.512 0.673 . . . . 0.0 110.959 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.562 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 3.2 m-90 -99.39 137.69 37.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.294 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -128.95 93.74 3.67 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.14 107.35 2.63 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.366 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.29 165.0 2.42 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.794 1.662 . . . . 0.0 110.563 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HD2' ' H ' ' A' ' 115' ' ' GLY . 1.7 mttm -72.79 -21.42 60.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.68 -5.73 59.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.0 15.36 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 15.1 p -161.32 174.29 13.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.015 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.09 139.72 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.807 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.708 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 88.1 m-85 -121.66 131.31 54.03 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.525 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 43.9 tt0 -114.69 94.48 4.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.664 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 3.1 m-85 -86.74 145.24 26.73 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -89.78 129.4 36.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.659 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.06 143.36 57.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.729 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.757 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.37 0.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.55 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 84.8 m-20 -107.26 13.42 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.01 21.93 66.94 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.87 150.05 26.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.635 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 133.3 36.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 111.121 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.47 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 16.0 mt -106.49 134.03 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -115.93 102.98 10.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -147.8 140.93 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.34 -178.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' GLU . 10.5 p -88.38 150.71 23.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.435 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.34 -1.77 4.73 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.604 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -78.85 -21.55 47.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.658 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -73.66 -47.5 39.35 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.297 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 28.04 2.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.42 106.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.631 ' H ' ' HD2' ' A' ' 91' ' ' LYS . . . 68.2 -41.08 0.28 Allowed Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.476 -1.238 . . . . 0.0 114.464 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -101.92 87.87 1.13 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -69.47 -26.41 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 119' ' ' MET . 0.0 OUTLIER -65.99 -57.69 7.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.685 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.429 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 5.3 ttp -31.43 -54.35 0.24 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.767 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -45.21 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.298 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.463 ' CD2' ' O ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -48.06 -30.98 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.251 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.413 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.724 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 28.9 mt-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.07 44.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.951 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -33.93 64.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.68 1.229 . . . . 0.0 108.526 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.92 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -63.6 -51.7 64.14 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 112.322 -2.217 . . . . 0.0 111.722 -178.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.541 ' O ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -71.07 -27.12 28.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.95 80.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -63.17 -49.56 73.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.962 0.411 . . . . 0.0 110.488 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.521 ' C ' ' NH1' ' B' ' 17' ' ' ARG . 1.0 OUTLIER -69.34 -35.36 75.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.866 ' NE ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -62.16 -52.04 65.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.512 0.672 . . . . 0.0 111.342 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.99 -41.65 91.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.594 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 5.3 m-20 -69.78 -26.74 64.43 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.692 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.593 ' CD1' ' H ' ' A' ' 35' ' ' ARG . 5.7 mm -74.16 -57.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.608 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.67 -34.26 76.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 11.6 t80 -53.72 -47.89 70.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.381 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 37.7 m -70.95 -34.11 71.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.449 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.45 HD11 ' CG1' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -67.86 -55.18 13.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.552 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.48 ' CB ' ' CE2' ' B' ' 69' ' ' PHE . . . -50.62 -38.44 46.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.735 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.823 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 23.7 mt-10 -65.84 -46.79 77.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.15 0.5 . . . . 0.0 111.263 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.793 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 1.7 ttt-85 -72.17 -33.47 67.72 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.354 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.171 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.7 m -82.6 -50.71 15.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.424 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.727 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 1.6 t80 -36.39 -50.63 1.82 Allowed Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.842 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 37.3 Cg_endo -53.64 -46.36 34.27 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 N-CA-C 106.21 -2.265 . . . . 0.0 106.21 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.842 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 39.8 t80 -94.92 -12.66 26.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.028 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.171 ' N ' ' O ' ' B' ' 28' ' ' VAL . 60.5 p -160.34 96.67 1.48 Allowed Pre-proline 0 N--CA 1.472 0.654 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.64 -44.75 45.02 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.261 2.641 . . . . 0.0 114.439 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.34 -53.0 55.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.035 0.445 . . . . 0.0 112.133 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.509 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 24.3 mt -53.81 -61.14 2.5 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.093 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.55 -32.72 42.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.725 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.604 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.46 -41.05 73.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.079 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.729 ' NH2' ' O ' ' A' ' 71' ' ' ILE . 2.8 tmm_? -59.68 -53.58 56.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.555 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.584 ' N ' ' CD1' ' B' ' 39' ' ' TYR . 1.1 m-30 -58.88 -43.17 90.86 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 110.049 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.32 -40.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.902 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.95 -42.21 99.75 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' B' ' 39' ' ' TYR . 63.2 mt -67.39 -51.36 52.83 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.477 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -31.03 30.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.987 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 23.8 mt -65.33 -54.44 28.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.305 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 1.4 pp -62.02 -28.3 69.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.832 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 95.1 t -64.34 -48.87 83.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.602 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . 0.434 ' NE2' ' CD1' ' B' ' 18' ' ' ILE . 1.8 tp-100 -65.74 -57.41 8.09 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.8 pt20 -81.62 -52.16 7.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 5.4 tptt -62.96 -37.71 88.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.889 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -81.45 -0.71 42.9 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.725 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 63.61 69.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.744 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.743 179.012 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.626 ' O ' ' N ' ' B' ' 62' ' ' TYR . 6.0 m-90 . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.543 0.211 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -61.65 -19.66 62.55 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.81 -17.79 64.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.803 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -150.74 8.3 0.57 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.64 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' B' ' 58' ' ' TRP . 92.6 t80 -117.72 157.5 26.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.988 0.423 . . . . 0.0 110.551 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' B' ' 62' ' ' TYR . 22.6 t -126.99 129.99 49.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.042 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -87.33 3.13 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.79 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.1 mmpt? -108.16 -31.44 7.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.796 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' B' ' 67' ' ' HIS . 11.5 p -138.96 10.44 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.209 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.0 OUTLIER 37.12 103.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.985 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.25 -173.05 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.604 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -113.97 103.18 10.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.803 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -105.57 147.56 28.26 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.632 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.95 120.72 24.11 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.86 123.64 6.29 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.859 1.706 . . . . 0.0 111.654 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.13 -33.26 6.67 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.44 -80.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.86 22.64 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.225 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.51 -0.592 0 CA-C-O 120.516 0.198 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 14.1 mt . . . . . 0 C--N 1.329 -0.326 0 O-C-N 124.597 1.186 . . . . 0.0 108.279 177.657 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.951 0.405 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' A' ' 72' ' ' ASP . 54.0 m-85 -38.32 -62.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.915 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.39 -7.92 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.414 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.3 tp10 -97.9 -36.93 10.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' B' ' 32' ' ' SER . 2.5 mm -104.51 14.16 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.3 tp -79.98 118.8 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.413 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.685 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 120.07 -38.85 2.63 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -66.87 27.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.685 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -41.94 -14.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.739 0.78 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 28.1 t-105 -58.71 -54.44 47.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.329 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.523 ' O ' HD11 ' B' ' 24' ' ' LEU . 4.7 pt -66.2 -14.25 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -89.71 -34.35 16.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -86.98 -32.61 19.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.765 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' NH1' ' B' ' 27' ' ' ARG . . . -85.48 28.81 4.64 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -156.13 20.72 0.37 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -127.15 101.91 6.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.671 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.444 ' H ' ' CG1' ' B' ' 20' ' ' ILE . 23.0 mmt-85 -145.85 12.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.938 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.619 ' HA3' HH21 ' B' ' 17' ' ' ARG . . . -62.32 152.45 44.3 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.59 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 14.9 ttm180 -67.31 132.84 48.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.711 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 55.1 t -116.8 136.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.707 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.691 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -166.23 153.81 10.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.617 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 42' ' ' ASN . 28.8 tttm -49.83 -55.8 12.81 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.837 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.623 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 42.9 pttt -60.64 -3.51 0.72 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.747 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 31.6 m-20 -124.72 1.12 8.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.26 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -89.98 -42.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.876 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -89.7 0.79 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.809 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.23 18.04 14.59 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.008 -1.906 . . . . 0.0 107.68 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.747 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.23 126.58 45.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.925 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.672 ' H ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -59.28 113.42 2.15 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' C ' HG12 ' A' ' 49' ' ' ILE . 2.6 mt -78.13 122.18 25.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.759 0.314 . . . . 0.0 111.001 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.591 HG12 ' C ' ' A' ' 48' ' ' LEU . 2.0 mm -151.22 -46.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.936 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -127.57 -3.06 6.15 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.181 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -60.35 140.87 56.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.248 0.524 . . . . 0.0 110.358 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -75.38 135.56 40.8 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 2.7 p -148.75 170.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.611 HH22 ' HZ2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -150.33 140.52 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.855 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.4 t -88.19 100.79 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.5 -51.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 O-C-N 123.374 0.421 . . . . 0.0 110.512 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.7 118.75 15.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.182 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.752 ' HG ' ' ND1' ' A' ' 60' ' ' HIS . 23.3 t -148.74 174.23 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.96 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.703 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 5.9 t -103.11 78.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.752 ' ND1' ' HG ' ' A' ' 58' ' ' SER . 19.2 m80 -167.62 118.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.17 -5.29 15.48 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 121.73 1.62 . . . . 0.0 112.975 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.14 20.94 7.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.187 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.21 -23.09 0.75 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.905 1.352 . . . . 0.0 112.098 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.57 145.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.64 7.31 87.6 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.257 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.825 ' CD1' ' HE1' ' A' ' 87' ' ' TRP . 19.8 mt -108.05 159.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 66' ' ' ILE . 5.7 tm-20 -126.76 121.82 33.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.459 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.09 172.38 28.38 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.073 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 1.6 m-85 -87.32 123.56 32.42 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' ILE . 2.9 t -56.43 157.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' VAL . 93.9 mt -143.73 -60.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 62.0 t0 -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.828 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -153.72 106.56 2.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 178.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 76' ' ' ASN . 14.6 t -157.97 177.59 11.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.225 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -53.69 -5.12 0.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.274 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.601 ' N ' ' HZ1' ' A' ' 91' ' ' LYS . 78.3 m-20 -137.98 0.79 2.21 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 4.8 ptp -165.78 167.89 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 4.5 tp -151.16 109.72 3.81 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.1 t -113.71 147.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -127.99 141.57 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.999 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.46 136.48 49.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -151.56 119.0 0.94 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 3.5 tp10 65.07 -123.14 0.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.451 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 3.3 m120 -111.57 21.01 16.61 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.973 0.416 . . . . 0.0 110.475 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.542 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.0 tttp -130.66 164.46 24.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.481 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.481 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 29.2 m -120.67 156.28 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 110.637 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.825 ' HE1' ' CD1' ' A' ' 66' ' ' ILE . 2.5 m-90 -105.62 104.49 14.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.182 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.93 110.26 22.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.98 96.35 3.31 Favored Pre-proline 0 C--N 1.334 -0.097 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.224 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -55.75 146.31 66.99 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.882 1.721 . . . . 0.0 111.308 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HZ1' ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -53.68 -29.11 37.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.613 -178.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -6.96 59.55 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -126.13 22.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.509 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.662 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 24.6 p -165.27 158.3 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.457 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.58 124.62 69.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.627 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.662 ' CE2' ' SG ' ' A' ' 94' ' ' CYS . 72.4 m-85 -100.92 144.53 29.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 18.6 tt0 -125.75 97.59 5.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 8.1 m-85 -90.45 145.72 24.7 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -89.46 130.76 35.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.068 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -65.48 142.46 58.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.483 0.659 . . . . 0.0 110.265 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.711 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.24 0.19 0.11 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.678 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 100' ' ' THR . 55.1 t0 -107.15 4.43 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.77 23.2 36.64 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.659 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -107.05 150.16 26.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 110.35 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.611 ' HZ2' HH22 ' A' ' 54' ' ' ARG . 16.7 mmtp -90.52 128.8 36.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 111.359 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 14.1 mt -104.03 135.07 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -120.35 101.82 8.05 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.25 132.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.063 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 m -74.34 145.34 43.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.153 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -63.86 -2.52 6.48 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.546 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -81.46 -22.79 37.87 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.62 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -69.22 -44.56 71.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.022 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.0 29.38 3.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -54.36 105.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.4 ' H ' ' HD3' ' A' ' 91' ' ' LYS . . . 68.82 -40.49 0.31 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.685 -1.143 . . . . 0.0 114.735 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -100.49 85.75 0.57 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.68 -23.45 76.32 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -68.59 -57.25 6.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.489 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 118' ' ' GLU . 26.4 ttp -24.8 -48.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.572 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' GLU . 2.9 tpm_? -82.58 -49.18 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.852 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -52.15 -39.11 59.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.495 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 1.3 ptmt . . . . . 0 N--CA 1.462 0.163 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.917 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 13' ' ' ILE . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.51 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -53.73 -37.28 63.19 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.009 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.57 ' HG2' ' HD2' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -65.41 -46.64 79.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.276 1.036 . . . . 0.0 109.38 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.624 ' O ' ' CD ' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -64.92 -51.05 63.99 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.314 -1.767 . . . . 0.0 112.433 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.493 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.8 pt -62.61 -27.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.5 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.14 74.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.416 ' HZ2' ' HZ1' ' B' ' 11' ' ' LYS . 37.1 mttt -60.85 -47.2 87.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.702 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.624 ' CD ' ' O ' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -67.31 -38.43 84.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.366 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.697 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 2.6 mmp_? -67.39 -52.31 41.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.499 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -57.48 -42.53 81.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 6.9 m-20 -71.71 -32.42 67.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.45 ' O ' ' OG ' ' B' ' 23' ' ' SER . 1.2 mp -71.33 -53.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.633 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.1 -33.54 76.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 0.6 OUTLIER -52.1 -44.33 64.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.943 178.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 18.7 p -73.86 -31.9 63.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.331 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.56 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -68.46 -58.21 4.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.26 -42.41 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.82 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -60.03 -50.65 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.529 0.68 . . . . 0.0 110.031 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.775 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 2.9 ttm180 -67.9 -37.74 82.12 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.958 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.213 ' O ' ' N ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -86.75 -42.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.363 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.779 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 25.2 t80 -39.17 -49.11 4.44 Favored Pre-proline 0 CA--C 1.509 -0.624 0 CA-C-N 119.982 1.265 . . . . 0.0 108.689 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.874 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 40.3 Cg_endo -54.45 -46.85 30.35 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.389 2.06 . . . . 0.0 106.747 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.874 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 34.8 t80 -93.53 -14.51 26.52 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.534 -2.121 . . . . 0.0 112.37 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.213 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -163.49 95.98 1.05 Allowed Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' B' ' 29' ' ' PHE . 52.3 Cg_exo -54.63 -45.09 43.57 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.197 2.598 . . . . 0.0 114.684 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.77 -53.65 53.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.726 ' CD2' HH21 ' B' ' 38' ' ' ARG . 32.4 mt -51.78 -58.39 6.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.7 -30.92 34.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.398 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.641 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.02 -41.75 70.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.612 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.726 HH21 ' CD2' ' B' ' 35' ' ' LEU . 2.4 ttm-85 -63.26 -46.98 84.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' B' ' 42' ' ' LEU . 2.2 m-85 -67.91 -40.06 83.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.942 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 36' ' ' ALA . 2.4 t -46.63 -40.96 4.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.901 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.57 -38.73 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' B' ' 39' ' ' TYR . 17.9 mt -66.91 -45.43 77.96 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.718 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.0 -30.54 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 60.6 mt -69.02 -54.77 13.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.071 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 3.1 pp -57.4 -30.85 65.27 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 58.0 t -62.05 -47.13 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.525 0.679 . . . . 0.0 109.479 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.66 -56.12 10.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.384 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 5.7 pt20 -80.21 -46.74 15.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.21 -38.31 69.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.593 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -86.03 -9.63 56.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 63.02 74.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.307 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.221 178.42 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' B' ' 60' ' ' ARG . 5.0 m0 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -61.37 -6.84 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' B' ' 58' ' ' TRP . 11.8 ptp180 -93.08 -21.9 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.973 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.835 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -145.76 29.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.373 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 24.2 t80 -122.4 151.6 41.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.567 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 1.5 t -123.04 114.3 20.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.524 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -83.83 9.13 12.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 109.567 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.425 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 9.1 mmmt -99.34 -40.4 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.01 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.4 p -136.79 9.29 3.07 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.271 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' B' ' 66' ' ' CYS . 4.4 m80 54.84 122.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . 172.22 -171.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.163 0.506 . . . . 0.0 111.141 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.641 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 1.8 t80 -123.6 105.4 9.7 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.835 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.2 OUTLIER -111.42 124.97 53.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.507 -177.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.23 127.21 28.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.9 125.98 12.28 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.174 1.916 . . . . 0.0 112.372 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.24 -35.93 4.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.5 -76.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.22 19.29 13.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.047 -179.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 37.4 mt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.039 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 22' ' ' GLU . 96.4 p . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.751 0.31 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.419 ' C ' ' N ' ' A' ' 22' ' ' GLU . 8.1 m-85 -40.19 -58.85 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -49.57 -15.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.749 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' SER . 49.0 tp10 -104.49 -33.13 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 23' ' ' ILE . 6.6 mm -100.83 18.7 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.0 tp -79.66 117.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.421 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.66 -38.1 3.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.537 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.7 32.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.738 0.769 . . . . 0.0 111.32 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.668 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -44.82 -11.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.653 ' H ' ' C ' ' A' ' 26' ' ' ARG . 7.9 t-105 -59.74 -59.85 4.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 17.8 pt -60.93 -10.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.216 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.42 ' O ' ' CB ' ' A' ' 34' ' ' HIS . 39.3 m-85 -94.19 -19.26 20.92 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.537 ' C ' ' H ' ' A' ' 33' ' ' ALA . 6.5 mmm-85 -80.7 -69.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.528 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.33 44.16 1.11 Allowed Glycine 0 CA--C 1.518 0.276 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -158.09 -38.87 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 44.7 t-80 -109.49 100.05 9.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.776 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -154.03 13.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.788 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -43.51 163.55 0.04 OUTLIER Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.636 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 7.8 ttt180 -67.84 112.34 4.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.369 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.714 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 54.5 t -90.19 136.37 24.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -165.6 145.95 6.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.048 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 42' ' ' ASN . 59.9 tttm -47.14 -54.4 10.66 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.421 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 47.1 pttt -62.82 -4.46 2.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 7.0 m120 -121.68 -4.61 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.439 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.87 -40.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.745 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.586 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -87.38 10.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.993 1.378 . . . . 0.0 107.394 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -122.98 -38.4 2.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.975 -1.92 . . . . 0.0 107.636 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.684 ' HD1' ' CG2' ' B' ' 13' ' ' ILE . 0.0 OUTLIER -58.4 174.48 0.3 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.755 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' OE2' ' CZ ' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -100.76 109.05 21.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 176.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -76.54 117.05 17.79 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 117.585 -1.646 . . . . 0.0 108.055 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -162.56 40.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.93 -29.17 0.59 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.504 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.54 137.62 4.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -77.79 128.9 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CG2' ' N ' ' A' ' 54' ' ' ARG . 5.2 p -148.4 169.37 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.39 0.614 . . . . 0.0 111.211 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.623 ' N ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -139.26 146.98 41.08 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.994 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' GLY . 66.2 t -98.15 98.88 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -91.17 -51.57 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.996 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -126.06 118.32 25.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.467 ' HG ' ' HB2' ' A' ' 60' ' ' HIS . 4.0 p -148.72 159.97 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.454 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.591 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -88.64 80.43 7.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 59' ' ' THR . 5.7 m170 -167.62 116.27 0.66 Allowed Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.77 -4.85 14.11 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.817 1.678 . . . . 0.0 113.961 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.43 32.88 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.686 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -141.26 -21.32 0.77 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.032 0.916 . . . . 0.0 111.645 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -72.38 138.41 21.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 99.14 5.8 56.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.053 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.652 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.23 157.81 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.356 1.078 . . . . 0.0 112.047 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 tm-20 -123.9 126.83 47.07 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.28 174.19 27.15 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.862 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.627 ' C ' HG22 ' A' ' 80' ' ' ILE . 6.4 m-85 -95.09 120.34 35.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -48.77 151.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 111.55 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 79' ' ' VAL . 48.4 mt -142.64 -58.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.8 t0 -107.91 143.65 36.24 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 3.3 mp0 -146.38 106.92 4.07 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.955 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.723 ' HG1' ' N ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -138.41 -175.01 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.723 ' N ' ' HG1' ' A' ' 74' ' ' THR . 9.4 ttp180 -50.76 -31.85 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.124 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 75' ' ' ARG . 94.0 m-20 -138.11 31.66 2.41 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.502 ' HG3' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -155.12 158.97 39.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.784 -1.167 . . . . 0.0 113.713 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.621 ' HG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -156.6 110.01 2.65 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 71' ' ' ILE . 73.3 t -111.49 145.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.222 0.534 . . . . 0.0 112.319 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.627 HG22 ' C ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -133.82 140.25 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.261 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -113.37 135.57 53.72 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.95 0.405 . . . . 0.0 111.48 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -145.77 159.2 27.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 82' ' ' GLY . 5.1 pt-20 32.72 -109.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 110.847 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 63.6 m-80 -127.28 33.72 4.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.88 0.372 . . . . 0.0 110.46 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 23.9 tttp -143.1 160.49 40.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.398 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.426 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 4.2 m -114.07 155.4 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.721 0.772 . . . . 0.0 110.903 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.652 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 1.2 m-90 -97.71 135.29 39.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -125.97 96.04 4.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.41 101.61 3.78 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.429 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.512 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.6 Cg_exo -55.66 145.19 72.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.696 1.597 . . . . 0.0 111.064 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.711 ' HG3' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -53.28 -37.71 62.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.078 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.04 -6.38 56.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.22 29.81 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.41 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 31.6 p -168.02 165.32 13.6 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 118.931 -1.108 . . . . 0.0 113.926 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -114.46 133.97 58.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.157 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.698 ' CE2' ' SG ' ' A' ' 94' ' ' CYS . 50.0 m-85 -117.06 130.79 56.89 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' C ' HG21 ' A' ' 53' ' ' VAL . 6.4 tt0 -116.96 94.84 4.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.638 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -89.81 146.48 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 105' ' ' LYS . 45.9 tt0 -88.49 127.77 35.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.85 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -63.91 142.36 58.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.219 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.714 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.66 -0.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.668 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 101' ' ' TRP . 1.1 m-20 -107.19 16.51 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.95 23.72 73.9 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.63 149.7 26.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.646 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 99' ' ' GLU . 58.9 mmtt -92.15 131.86 37.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.731 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.433 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 27.5 mt -107.17 135.25 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.912 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -118.04 101.31 8.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.13 139.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.212 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 p -78.49 149.0 33.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.089 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -71.43 -1.87 46.13 Favored Glycine 0 CA--C 1.508 -0.368 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -86.9 -22.44 25.69 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.597 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -63.03 -47.69 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.221 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.601 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -95.2 28.43 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 116' ' ' ARG . 7.6 p -52.17 104.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.711 ' H ' ' HG3' ' A' ' 91' ' ' LYS . . . 68.14 -41.48 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.376 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 24.5 mmt180 -101.86 88.03 1.16 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.53 -25.49 34.97 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 N-CA-C 108.106 -1.536 . . . . 0.0 108.106 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.524 ' CD ' ' HZ2' ' A' ' 122' ' ' LYS . 12.8 pt-20 -66.21 -55.24 17.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.163 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.457 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 23.9 mmm -34.2 -41.74 0.12 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.128 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.664 ' HE ' ' CA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.93 -43.91 42.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.887 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.669 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -61.78 -41.09 97.27 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.146 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.524 ' HZ2' ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.831 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.814 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 7.4 pt-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -79.77 -45.89 18.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -72.44 -33.48 67.09 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.726 1.251 . . . . 0.0 108.617 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.982 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER -62.6 -51.86 65.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.658 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.684 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 33.5 mt -64.94 -27.51 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.5 73.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.244 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -52.18 -48.71 64.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.571 ' CD ' ' O ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -70.12 -38.03 75.47 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.965 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.633 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -65.82 -52.03 53.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.366 0.603 . . . . 0.0 110.451 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.55 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.85 -42.76 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.19 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 1.5 m-20 -71.82 -22.18 61.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.551 HD12 ' N ' ' B' ' 20' ' ' ILE . 1.2 mp -75.49 -56.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.667 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.98 -34.43 77.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 2.8 t80 -53.12 -44.06 67.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.921 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -64.66 -40.16 94.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.469 ' O ' ' CG1' ' B' ' 28' ' ' VAL . 1.9 mm? -56.9 -57.55 12.03 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.776 0.798 . . . . 0.0 109.297 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.04 -33.35 17.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.392 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.811 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 57.5 mt-10 -77.12 -55.82 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.914 0.864 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.759 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 79.9 mtt-85 -67.95 -35.88 79.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.474 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.182 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -85.48 -50.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.673 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.75 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 27.8 t80 -36.3 -49.34 1.73 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.173 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.862 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 36.5 Cg_endo -53.26 -47.86 25.17 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 N-CA-C 106.506 -2.151 . . . . 0.0 106.506 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.862 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 62.2 t80 -94.5 -15.17 24.41 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.289 -2.232 . . . . 0.0 113.08 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.182 ' N ' ' O ' ' B' ' 28' ' ' VAL . 43.0 p -158.04 91.19 2.21 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.84 -41.9 73.91 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.977 2.451 . . . . 0.0 113.88 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 55.8 mp0 -66.67 -54.25 25.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.524 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 25.9 mt -52.09 -55.38 21.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.985 0.422 . . . . 0.0 110.155 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.35 -30.24 50.96 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.331 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -47.11 57.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.884 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.701 ' C ' ' CD ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -60.54 -53.3 59.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.799 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.626 ' O ' ' N ' ' B' ' 42' ' ' LEU . 3.2 m-85 -59.69 -42.57 93.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' B' ' 39' ' ' TYR . 1.1 t -45.05 -34.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' B' ' 38' ' ' ARG . 0.0 OUTLIER -70.65 -44.86 66.25 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' TYR . 49.4 mt -65.45 -47.89 74.59 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.961 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.17 -31.16 65.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.73 -50.94 69.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.383 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.62 ' O ' ' N ' ' B' ' 49' ' ' LYS . 2.1 pp -61.95 -39.29 91.62 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.015 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.531 ' N ' ' HG ' ' B' ' 45' ' ' LEU . 40.2 t -61.22 -49.23 85.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 111.49 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -49.6 72.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.714 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.84 -55.96 4.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.986 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.62 ' N ' ' O ' ' B' ' 45' ' ' LEU . 6.6 mmpt? -59.0 -43.29 91.46 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -79.07 -16.21 57.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 50' ' ' ALA . 26.1 mttt 70.75 43.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.748 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.316 -0.885 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.745 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' NH1' ' B' ' 60' ' ' ARG . 5.4 m-90 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.75 -3.79 7.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' B' ' 58' ' ' TRP . 18.6 ptt-85 -82.28 -35.34 28.14 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.302 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -124.94 21.6 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.515 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -118.43 154.6 32.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 1.7 t -126.39 113.62 17.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.656 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -78.85 4.35 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.976 0.417 . . . . 0.0 109.986 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.436 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.4 OUTLIER -95.86 -38.23 10.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.538 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.0 p -138.72 -0.2 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.734 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' B' ' 66' ' ' CYS . 4.5 m80 61.52 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . 169.81 -171.41 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.065 0.46 . . . . 0.0 111.123 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.574 ' O ' ' CE2' ' B' ' 29' ' ' PHE . 13.2 t80 -121.19 103.02 8.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 0.4 OUTLIER -113.58 119.26 36.89 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.411 0.624 . . . . 0.0 112.441 -177.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' B' ' 29' ' ' PHE . 61.1 t -96.16 136.13 22.24 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.046 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.92 118.55 5.59 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.719 1.613 . . . . 0.0 111.531 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.64 -33.42 4.64 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.57 -78.09 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -116.77 19.76 14.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 109.749 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.929 179.545 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.752 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 22' ' ' GLU . 79.0 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' H ' ' HG ' ' A' ' 19' ' ' SER . 89.2 m-85 -37.45 -45.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.131 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -58.28 -21.58 49.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 19' ' ' SER . 4.5 tt0 -104.79 -38.0 6.83 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.458 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.61 24.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.462 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -80.01 118.98 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.712 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.724 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 83.68 -7.0 71.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.656 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.708 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -64.09 21.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.516 0.658 . . . . 0.0 109.887 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.724 ' H ' ' C ' ' A' ' 25' ' ' GLY . 7.0 p -38.13 -16.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.387 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.708 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.0 t-105 -58.67 -57.0 14.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.1 pt -65.68 -11.27 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.609 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.519 ' CD2' HD11 ' B' ' 24' ' ' LEU . 88.7 m-85 -96.32 -37.37 10.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.637 ' CZ ' ' HH ' ' A' ' 69' ' ' TYR . 9.8 mmt180 -61.0 -68.43 0.31 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.144 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.81 52.02 1.59 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -150.43 -40.19 0.13 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.763 ' CE1' ' H ' ' A' ' 51' ' ' LEU . 1.9 m-70 -91.1 100.15 13.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.218 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -125.71 -20.54 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.984 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -40.67 146.6 0.34 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.532 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.9 ttm180 -67.11 118.96 11.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.717 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.1 t -92.8 136.69 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -164.98 150.74 9.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.124 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 42' ' ' ASN . 43.8 tttm -50.04 -55.68 13.8 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.217 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.61 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 52.2 pttt -58.85 -4.09 0.41 Allowed 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 73.8 m-20 -126.06 0.48 7.21 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.27 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -89.41 -38.14 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.261 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -92.7 0.75 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.814 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.81 6.9 14.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.829 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.598 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -115.41 139.13 50.29 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.775 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.804 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -59.95 111.77 1.61 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.599 ' O ' ' CD ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -74.09 116.34 14.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 177.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.63 HG13 ' OE1' ' A' ' 47' ' ' GLU . 3.7 mm -153.64 -29.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.289 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.64 ' N ' ' NE2' ' A' ' 34' ' ' HIS . . . -138.22 -25.38 0.35 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.763 ' H ' ' CE1' ' A' ' 34' ' ' HIS . 1.5 tt -44.2 150.03 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.475 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 82.8 tttt -93.62 131.41 38.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.057 0.456 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.758 HG23 ' H ' ' A' ' 54' ' ' ARG . 7.9 p -148.77 166.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.758 ' H ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.0 t -94.61 98.87 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.18 -48.09 17.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.451 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -132.94 120.77 21.88 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.956 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 60' ' ' HIS . 1.5 p -147.25 172.71 13.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.093 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.623 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 4.4 t -104.14 77.08 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.062 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -169.28 96.87 0.51 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.72 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 -4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.324 2.016 . . . . 0.0 113.237 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -122.74 19.28 7.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.507 -0.854 . . . . 0.0 114.474 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' CE1' ' N ' ' A' ' 88' ' ' LYS . 54.8 m-85 -142.34 -23.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.181 1.491 . . . . 0.0 112.28 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.411 HG12 ' OG ' ' A' ' 58' ' ' SER . 1.5 m -74.04 144.36 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 85.86 5.61 83.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.51 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.564 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 1.2 mt -107.53 153.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.924 0.862 . . . . 0.0 111.59 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' C ' ' CZ2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.58 126.46 53.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.3 173.78 27.31 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.93 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.637 ' HH ' ' CZ ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.73 117.69 31.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.634 0.374 . . . . 0.0 110.098 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.544 ' O ' ' O ' ' A' ' 49' ' ' ILE . 1.9 t -50.15 148.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.693 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.709 ' N ' ' O ' ' A' ' 79' ' ' VAL . 95.0 mt -143.87 -60.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -108.01 134.79 50.41 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.606 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -144.69 107.14 4.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 77' ' ' MET . 2.6 p -132.96 -169.6 2.29 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -52.76 -27.44 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -138.71 31.59 2.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.887 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 2.0 ptp -153.75 160.82 42.41 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.934 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 7.3 tp -163.86 110.15 1.09 Allowed 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 71' ' ' ILE . 74.5 t -117.25 129.75 73.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.747 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -111.55 152.36 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.027 178.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -129.02 136.89 50.91 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.351 0.596 . . . . 0.0 112.417 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -152.32 158.74 28.0 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' GLY . 14.0 pt-20 33.89 -128.52 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.749 0.275 . . . . 0.0 110.622 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -110.17 33.68 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 110.526 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 3.1 tppt? -138.09 151.9 48.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.413 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 31.1 m -118.31 156.17 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.351 0.596 . . . . 0.0 110.709 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 2.0 m-90 -97.96 140.52 32.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.732 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.431 ' N ' ' CE1' ' A' ' 63' ' ' TYR . 72.3 tttt -127.92 92.76 3.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.46 107.05 3.12 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.757 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.64 164.27 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.74 1.626 . . . . 0.0 111.31 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HB2' ' H ' ' A' ' 115' ' ' GLY . 10.1 mttt -67.84 -27.17 66.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 14.5 p-10 -90.55 -5.29 56.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 9.86 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.966 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -161.23 173.99 14.25 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.916 -1.114 . . . . 0.0 113.077 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.2 mt -111.97 130.73 65.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.71 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.698 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 97.1 m-85 -108.96 126.1 52.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 26.8 tt0 -107.97 93.97 4.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 48' ' ' LEU . 37.1 m-85 -80.0 143.66 33.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.85 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -93.47 129.61 39.59 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.687 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -72.68 143.32 48.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.123 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.717 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.35 -0.93 0.28 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.621 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.511 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 27.5 t70 -107.14 20.18 19.36 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.33 22.62 78.56 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.578 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.29 149.76 26.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.475 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -93.48 131.0 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.153 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 10.4 mt -103.81 133.83 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -114.56 100.83 8.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.09 132.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.059 -178.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 111' ' ' GLU . 13.8 p -79.57 144.95 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.213 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.35 4.01 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -80.42 -22.59 41.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.4 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -69.89 -47.3 63.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.417 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -95.88 28.67 3.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 116' ' ' ARG . 7.2 p -45.77 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.617 0.723 . . . . 0.0 112.876 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 91' ' ' LYS . . . 66.83 -42.29 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.674 175.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 114' ' ' VAL . 71.1 mtm180 -101.89 99.17 11.38 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.7 Cg_endo -70.12 -26.54 25.75 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 N-CA-C 107.294 -1.849 . . . . 0.0 107.294 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' B' ' 45' ' ' LEU . 6.1 pt-20 -65.45 -45.87 82.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.516 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.9 tpt -39.74 -33.71 0.21 Allowed 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -78.75 -56.74 4.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.652 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.668 ' O ' ' NZ ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -58.56 -42.32 87.67 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 118.313 -1.355 . . . . 0.0 107.836 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.501 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.645 ' H ' ' NE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -78.72 -31.45 46.4 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.241 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.682 ' H ' HH11 ' B' ' 12' ' ' ARG . 8.7 ttpt -73.86 -34.18 64.38 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.809 1.29 . . . . 0.0 108.122 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.894 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 4.7 mpt_? -60.96 -51.33 69.72 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.777 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.512 HG12 ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -72.97 -29.06 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.543 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . . . -70.56 -51.77 26.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.49 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' B' ' 16' ' ' GLU . 0.6 OUTLIER -55.28 -46.81 76.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.515 ' N ' ' HD3' ' B' ' 15' ' ' LYS . 9.3 pt-20 -72.08 -38.08 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.603 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.558 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 39.3 ttt180 -62.63 -54.19 43.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.703 0.763 . . . . 0.0 110.387 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -56.73 -34.28 42.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.519 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.42 -33.28 72.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.604 ' CG2' ' CD2' ' A' ' 34' ' ' HIS . 94.7 mt -69.61 -58.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.67 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.05 -35.4 76.81 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 4.1 t80 -53.79 -38.94 65.03 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.05 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.7 m -66.9 -40.27 87.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.431 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.519 HD11 ' CD2' ' A' ' 30' ' ' PHE . 2.3 mm? -61.23 -58.79 6.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.524 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.46 -36.48 22.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.527 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.805 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -71.73 -60.26 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.407 0.623 . . . . 0.0 109.875 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.747 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 6.8 ttm-85 -64.43 -37.4 87.39 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.992 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.144 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.3 m -84.12 -50.86 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.275 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.726 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 29.7 t80 -36.37 -49.9 1.79 Allowed Pre-proline 0 CA--C 1.51 -0.572 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.359 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.87 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 35.7 Cg_endo -51.93 -46.13 34.23 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.87 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 10.2 t80 -92.87 -32.21 14.69 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.101 -2.318 . . . . 0.0 112.678 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.144 ' N ' ' O ' ' B' ' 28' ' ' VAL . 61.7 p -144.2 96.91 5.29 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.646 ' CB ' ' HZ3' ' B' ' 37' ' ' LYS . 32.1 Cg_exo -55.88 -42.13 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.791 2.327 . . . . 0.0 114.019 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.96 -53.77 28.44 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 10.6 mt -51.05 -53.21 35.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.262 0.554 . . . . 0.0 110.281 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.505 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.59 -34.14 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.11 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.646 ' HZ3' ' CB ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.45 -41.78 69.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.626 ' HD3' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -58.79 -53.96 52.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.306 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' B' ' 42' ' ' LEU . 1.3 m-85 -60.68 -39.04 86.98 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.94 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.434 ' O ' HD21 ' B' ' 44' ' ' LEU . 3.7 t -45.87 -34.96 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 50.7 tt0 -72.21 -43.92 63.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.6 mt -63.78 -46.63 84.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.88 -34.03 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.796 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.507 HD21 ' N ' ' B' ' 44' ' ' LEU . 1.6 mm? -64.43 -45.02 89.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.592 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -63.91 -34.56 78.23 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.521 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 51.0 t -70.88 -56.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.16 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.447 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 17.0 pt20 -71.86 -51.06 24.21 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.332 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 121' ' ' LEU . 5.0 tmtt? -82.27 -35.64 27.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.375 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -65.4 -12.41 51.94 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.21 30.48 15.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.046 179.373 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.677 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 17.4 m0 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.767 0.318 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -62.63 -7.86 5.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' B' ' 58' ' ' TRP . 18.1 ptt180 -87.85 -21.66 24.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.442 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.81 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -146.88 20.23 1.27 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.094 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' B' ' 58' ' ' TRP . 50.1 t80 -114.78 154.42 28.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.7 OUTLIER -126.41 116.97 21.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.135 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -87.02 16.28 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.481 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.0 OUTLIER -116.59 -22.06 8.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.741 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.669 ' O ' ' O ' ' B' ' 67' ' ' HIS . 0.8 OUTLIER -153.73 21.59 0.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.869 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.669 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.2 OUTLIER 34.37 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 111.877 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -177.45 -176.99 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' NH1' ' B' ' 61' ' ' ARG . 0.5 OUTLIER -115.37 104.61 11.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.81 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -106.62 129.46 54.53 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.75 -177.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 48.7 t -113.38 124.16 31.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.053 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -46.89 126.1 10.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.886 1.724 . . . . 0.0 112.119 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.98 -36.54 3.97 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.5 -77.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.66 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.23 19.65 16.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.266 -179.634 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.732 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 22' ' ' GLU . 93.1 p . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 19' ' ' SER . 83.1 m-85 -35.49 -63.41 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.094 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -16.37 39.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.194 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 19' ' ' SER . 41.8 tp10 -92.06 -30.4 16.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 23' ' ' ILE . 6.2 mm -106.7 13.55 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -79.34 126.87 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.853 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 106.78 -35.17 5.21 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.38 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -64.15 27.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.975 0.388 . . . . 0.0 110.736 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.673 ' H ' ' C ' ' A' ' 25' ' ' GLY . 13.9 p -43.75 -14.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.884 0.849 . . . . 0.0 108.745 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.703 ' HE1' HH12 ' B' ' 27' ' ' ARG . 38.1 t-105 -57.85 -52.52 65.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.294 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.422 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 12.7 pt -71.88 -11.8 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.587 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.87 -23.46 21.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.73 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.4 tpp85 -80.88 -68.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.56 35.67 0.17 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.73 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -145.41 -39.02 0.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -95.95 105.93 18.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.92 1.33 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.45 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -47.25 156.95 0.68 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.611 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 6.1 ttm-85 -67.98 118.49 11.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.8 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 42.2 t -97.48 139.31 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.677 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -166.66 154.65 9.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.435 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 42' ' ' ASN . 75.9 tttt -51.72 -55.94 16.69 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' CD2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -59.15 -3.79 0.43 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 55.0 m-20 -125.41 2.61 7.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.815 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.76 -39.75 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.563 0.221 . . . . 0.0 110.935 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -91.81 4.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 108.084 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.877 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.46 -21.92 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.04 -179.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.701 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.8 146.92 29.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.655 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.26 108.74 1.67 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.829 ' O ' HG12 ' A' ' 49' ' ' ILE . 8.2 mt -76.21 110.45 10.72 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.829 HG12 ' O ' ' A' ' 48' ' ' LEU . 3.9 mt -170.78 55.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 124.032 0.832 . . . . 0.0 109.496 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 143.95 -27.82 2.02 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.14 133.5 39.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.904 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.487 ' HZ2' ' CD ' ' A' ' 67' ' ' GLU . 1.7 tmtp? -69.61 124.38 23.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.097 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.852 HG23 ' H ' ' A' ' 54' ' ' ARG . 13.8 p -149.19 169.7 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.108 0.48 . . . . 0.0 110.654 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.852 ' H ' HG23 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.65 149.62 46.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.138 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 65' ' ' GLY . 92.2 t -99.4 100.23 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.28 -36.98 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.433 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -135.1 120.19 18.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 110.476 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.754 ' HG ' ' HD1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -147.83 166.35 27.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.665 179.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.587 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 1.7 t -103.52 75.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.754 ' HD1' ' HG ' ' A' ' 58' ' ' SER . 0.8 OUTLIER -169.82 105.34 0.45 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.545 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.18 -4.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 122.178 1.919 . . . . 0.0 113.909 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -129.4 31.13 3.49 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.645 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -141.31 -21.59 0.76 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.876 1.338 . . . . 0.0 111.794 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.0 144.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 84.02 6.52 86.55 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.152 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.611 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 118.447 1.124 . . . . 0.0 111.79 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 tt0 -120.1 125.88 49.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.44 172.88 26.89 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.527 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.618 ' C ' HG21 ' A' ' 80' ' ' ILE . 3.9 m-85 -99.57 121.73 41.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.423 ' H ' HG21 ' A' ' 70' ' ' VAL . 1.6 t -48.76 148.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.903 0.383 . . . . 0.0 111.572 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 79' ' ' VAL . 79.2 mt -138.51 -60.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.962 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.759 ' CG ' ' HE ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -101.99 140.25 36.54 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.767 ' O ' ' NH1' ' B' ' 38' ' ' ARG . 70.6 tt0 -149.62 105.05 3.4 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.187 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.684 ' CG2' HH22 ' B' ' 38' ' ' ARG . 6.8 t -152.01 -178.92 7.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.543 0.687 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.67 ' HE ' HH22 ' A' ' 116' ' ' ARG . 32.5 ttm180 -55.07 -6.79 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.227 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -138.52 0.0 2.01 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.579 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 2.4 ptp -165.44 149.99 8.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 117.952 -1.499 . . . . 0.0 114.794 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 5.9 tp -135.09 110.71 9.2 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.6 t -114.41 147.2 18.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 121.441 0.638 . . . . 0.0 112.553 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.618 HG21 ' C ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -131.4 142.18 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.278 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -114.83 135.29 54.35 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.864 -0.523 . . . . 0.0 111.746 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -153.4 125.66 1.81 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 69.09 -115.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -124.62 19.98 8.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.415 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 17.8 tttp -126.19 167.33 15.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.344 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 5.7 m -121.55 153.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 110.596 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.611 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 1.4 m-90 -99.14 110.8 23.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.475 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -108.03 96.7 6.56 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.079 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.87 95.7 3.88 Favored Pre-proline 0 CA--C 1.518 -0.264 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.073 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -43.23 161.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 120.942 1.095 . . . . 0.0 110.518 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.667 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -63.53 -30.31 71.45 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -89.17 -4.95 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.506 ' H ' HG23 ' A' ' 93' ' ' VAL . 2.5 m -112.41 11.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.72 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -167.19 169.23 12.82 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.856 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.38 140.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.343 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.72 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 87.0 m-85 -117.61 131.67 56.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 54' ' ' ARG . 21.3 tt0 -115.04 95.07 5.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -90.89 145.49 24.7 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 0.6 OUTLIER -89.68 133.17 34.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.243 0.544 . . . . 0.0 111.604 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.605 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -70.87 144.05 50.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.849 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.8 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.1 0.12 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.221 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.574 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 74.4 m-20 -107.52 15.17 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.12 22.9 72.83 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.17 146.56 30.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.756 0.312 . . . . 0.0 110.358 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -90.74 132.82 35.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 11.3 mt -105.72 134.42 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -120.27 106.49 11.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.61 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.216 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.6 p -94.99 145.68 24.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.22 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.62 -1.65 0.36 Allowed Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.43 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 109' ' ' SER . 21.0 pt-20 -68.26 -31.5 71.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.678 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -75.13 -47.44 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.493 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 29.1 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 114' ' ' VAL . 9.9 p -63.71 106.06 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.667 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.46 -40.47 0.29 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 114.551 -1.204 . . . . 0.0 114.034 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.67 HH22 ' HE ' ' A' ' 75' ' ' ARG . 5.6 mmp_? -100.59 85.06 0.51 Allowed Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.44 ' HB2' HH22 ' B' ' 17' ' ' ARG . 26.9 Cg_endo -66.74 -26.01 45.78 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 119' ' ' MET . 6.0 pt-20 -67.99 -48.46 65.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.545 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 37.6 tpp -36.37 -47.1 0.58 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.724 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -71.61 -47.91 51.54 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.368 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -62.29 -31.87 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 118' ' ' GLU . 3.8 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.869 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.609 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 4.3 mm-40 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -79.35 -32.05 43.14 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.911 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.654 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.6 OUTLIER -73.2 -33.96 65.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.708 1.242 . . . . 0.0 108.159 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.89 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 5.0 mpt_? -60.99 -51.38 69.5 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.392 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.643 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 10.3 mt -70.44 -26.72 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.124 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.19 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.584 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.421 ' O ' HG21 ' B' ' 18' ' ' ILE . 4.1 ptmm? -57.54 -48.42 79.36 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.546 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -68.94 -37.35 78.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.342 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.663 ' HE ' ' CG2' ' B' ' 46' ' ' VAL . 3.0 ttt180 -62.72 -52.07 64.71 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.542 0.686 . . . . 0.0 110.673 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.73 -35.55 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.098 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.41 -27.04 63.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.42 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.447 ' O ' ' OG ' ' B' ' 23' ' ' SER . 8.6 mt -69.15 -58.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.08 -33.34 75.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.894 0.854 . . . . 0.0 108.832 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.623 ' CE1' ' NE1' ' B' ' 58' ' ' TRP . 2.0 t80 -52.92 -46.51 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.073 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 11.6 p -64.8 -42.04 95.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.496 ' CD1' ' CG1' ' B' ' 28' ' ' VAL . 0.3 OUTLIER -56.1 -58.42 7.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.493 0.664 . . . . 0.0 110.096 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -35.56 26.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.449 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.788 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.9 OUTLIER -71.58 -57.12 4.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.388 0.614 . . . . 0.0 110.774 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.788 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 5.2 ttt-85 -70.22 -32.5 70.4 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.73 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.184 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.2 m -83.78 -50.44 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.725 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 33.8 t80 -36.23 -49.73 1.71 Allowed Pre-proline 0 CA--C 1.509 -0.625 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.293 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.86 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 39.1 Cg_endo -54.02 -46.86 30.5 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 N-CA-C 106.532 -2.142 . . . . 0.0 106.532 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.86 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 48.6 t80 -94.54 -17.04 22.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.928 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.184 ' N ' ' O ' ' B' ' 28' ' ' VAL . 27.6 p -155.81 90.39 2.81 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.41 ' HB3' ' HZ1' ' B' ' 37' ' ' LYS . 51.0 Cg_exo -55.01 -42.98 63.93 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.883 2.389 . . . . 0.0 113.792 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -66.44 -53.9 30.23 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.548 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 9.0 mt -52.52 -56.73 13.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 120.951 0.405 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.44 -29.78 26.25 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.054 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.41 ' HZ1' ' HB3' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.7 -47.84 51.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.726 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.767 ' NH1' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.48 -35.55 81.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' B' ' 35' ' ' LEU . 3.5 m-85 -71.15 -44.43 65.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.957 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.51 -38.93 2.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.719 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.9 -42.37 81.25 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.548 ' O ' HG23 ' B' ' 46' ' ' VAL . 48.3 mt -64.26 -47.75 78.4 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.601 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.53 -31.3 61.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.434 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 0.8 OUTLIER -64.08 -54.39 34.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 4.1 pp -61.61 -27.48 68.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.365 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.663 ' CG2' ' HE ' ' B' ' 17' ' ' ARG . 63.8 t -64.41 -47.24 90.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.32 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -66.5 -57.09 8.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.61 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 12.8 pt20 -81.96 -49.58 10.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.77 -33.48 75.97 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -92.64 5.83 49.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 mttm 54.01 75.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.502 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.306 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.623 ' NE1' ' CE1' ' B' ' 22' ' ' PHE . 14.2 m0 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.914 0.388 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -68.18 -3.62 11.18 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' B' ' 58' ' ' TRP . 5.9 ptm180 -83.67 -30.74 26.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.888 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.712 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -130.45 21.78 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.938 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 81.9 t80 -118.95 155.76 30.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.334 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 3.5 t -127.17 126.08 42.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.266 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -87.91 6.54 35.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 109.908 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.459 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 0.0 OUTLIER -107.26 -22.97 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.381 -178.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . 0.582 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.5 p -150.84 17.11 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.335 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.582 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.9 OUTLIER 35.21 106.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 111.443 179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.75 -175.04 3.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' B' ' 61' ' ' ARG . 9.4 t80 -118.17 102.93 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.712 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.4 OUTLIER -110.77 120.72 43.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.857 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.6 t -92.78 117.42 67.56 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.061 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.24 119.38 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.307 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.73 -41.96 1.86 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.538 HG22 ' H ' ' B' ' 75' ' ' ASN . 3.8 tt -102.95 -65.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 117.219 0.51 . . . . 0.0 111.293 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.538 ' H ' HG22 ' B' ' 74' ' ' ILE . 5.8 t-20 -112.26 12.97 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.748 0.309 . . . . 0.0 110.856 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.273 0.559 . . . . 0.0 111.306 -179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 110.688 -0.115 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--O 1.232 0.151 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.126 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLU . 80.3 p . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 121.065 0.459 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.402 ' C ' ' H ' ' A' ' 22' ' ' GLU . 52.8 m-85 -40.45 -61.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.384 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.06 -8.79 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 19' ' ' SER . 42.5 tp10 -103.95 -40.72 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.263 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.449 ' HA ' ' CE2' ' B' ' 31' ' ' TYR . 3.5 mm -95.19 32.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 111.09 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -81.2 127.34 39.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.704 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 82.15 -18.1 14.93 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.81 27.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.826 1.313 . . . . 0.0 110.793 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.704 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -42.03 -15.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 33.6 t-105 -57.17 -53.81 53.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.46 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 16.8 pt -69.31 -11.86 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.609 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' B' ' 24' ' ' LEU . 33.7 m-85 -91.15 -26.37 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -70.07 -64.59 0.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.173 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.86 48.65 3.31 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 29' ' ' ILE . . . -162.38 -38.35 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.628 ' CD2' ' H ' ' A' ' 50' ' ' GLY . 38.9 t-80 -110.71 100.37 9.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.613 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -150.75 10.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.427 ' H ' HG12 ' B' ' 20' ' ' ILE . . . -41.77 164.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.646 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 33.9 ttp180 -66.59 133.02 49.44 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.709 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 63.2 t -113.26 135.66 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.666 ' O ' ' N ' ' A' ' 42' ' ' ASN . 6.0 m120 -166.3 149.07 7.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.831 -1.532 . . . . 0.0 108.016 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 42' ' ' ASN . 56.1 tttp -46.04 -53.79 9.58 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.197 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 13.4 pttp -60.84 -4.63 1.04 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.072 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.736 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 88.9 m-20 -125.13 0.23 7.83 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.082 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.602 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.45 -39.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.06 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -91.06 5.25 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.829 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -119.92 -6.18 10.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.869 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.736 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -98.74 151.64 20.54 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.735 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.676 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -72.73 110.83 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.555 ' O ' ' CD1' ' A' ' 49' ' ' ILE . 12.5 mt -74.21 116.1 14.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.641 HG22 ' CE1' ' B' ' 39' ' ' TYR . 1.1 mm -155.28 -31.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.596 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.628 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -134.5 -22.23 0.71 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.912 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -44.82 153.25 0.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HZ2' ' HB3' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -100.49 128.49 46.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.845 HG22 ' H ' ' A' ' 54' ' ' ARG . 12.9 p -149.16 171.52 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.399 0.618 . . . . 0.0 111.572 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.845 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.51 152.28 51.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 65' ' ' GLY . 59.9 t -96.22 98.95 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.31 -51.86 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.415 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -128.53 118.35 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.707 ' HG ' ' HD1' ' A' ' 60' ' ' HIS . 47.9 t -149.07 173.53 13.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.184 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 33.7 p -102.98 78.6 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.724 ' CD2' ' O ' ' A' ' 59' ' ' THR . 21.6 m80 -166.57 96.15 0.72 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.251 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.11 -4.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.535 2.157 . . . . 0.0 114.015 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -132.0 23.32 4.16 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.638 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -141.11 -14.1 0.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.793 1.296 . . . . 0.0 111.615 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.62 138.89 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.9 6.71 88.74 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.35 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.796 HG22 ' NE1' ' A' ' 87' ' ' TRP . 2.3 tt -108.32 146.92 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 117.712 0.756 . . . . 0.0 112.243 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 6.9 tm-20 -116.15 131.87 56.82 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . . . -147.24 174.95 26.85 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.487 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.55 115.72 28.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.584 ' N ' HG21 ' A' ' 80' ' ' ILE . 1.9 t -45.19 145.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.015 0.436 . . . . 0.0 111.457 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 79' ' ' VAL . 15.8 mt -136.48 -61.51 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 19.9 t0 -94.89 148.01 22.76 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.833 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 10.7 tt0 -156.52 105.11 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 75' ' ' ARG . 14.6 t -162.49 176.68 10.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 111.798 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.709 ' H ' ' HG1' ' A' ' 74' ' ' THR . 54.5 ttt85 -58.72 -1.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.864 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' THR . 7.6 t-20 -133.47 -11.58 2.77 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -166.66 156.21 11.25 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.669 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.48 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 5.3 tp -139.33 110.94 7.11 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.675 ' O ' ' N ' ' A' ' 71' ' ' ILE . 61.3 t -119.95 145.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.673 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -117.88 152.25 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.142 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -125.12 136.44 53.63 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.108 0.48 . . . . 0.0 111.963 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -149.91 155.78 26.42 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 82' ' ' GLY . 6.1 pt-20 31.83 -115.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.561 0.219 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -121.24 33.31 5.59 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.917 0.389 . . . . 0.0 110.176 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 30.4 tttp -133.52 158.84 42.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.631 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 16.1 m -123.62 155.54 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 110.688 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.796 ' NE1' HG22 ' A' ' 66' ' ' ILE . 2.5 m-90 -100.35 145.49 28.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.325 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -128.22 94.13 3.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.36 99.17 4.21 Favored Pre-proline 0 C--N 1.342 0.266 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.253 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.33 146.03 84.63 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.483 1.455 . . . . 0.0 110.231 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 27.2 mttm -54.17 -22.13 10.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -90.63 -6.38 54.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.574 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -128.52 35.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.644 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -166.95 155.72 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.027 179.142 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 77.2 mt -111.14 116.11 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.644 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 88.1 m-85 -98.53 127.11 44.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.536 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 24.3 tt0 -110.12 94.74 5.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.652 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 4.8 m-85 -87.55 145.66 26.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -90.2 127.39 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.804 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -62.8 142.88 58.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.389 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.709 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.19 0.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.605 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.552 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 75.6 m-20 -106.85 13.39 27.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.36 21.64 66.71 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 100' ' ' THR . 16.7 m -106.74 150.0 26.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.477 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -91.16 134.28 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 7.7 mt -110.59 132.62 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -118.55 102.9 9.24 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.65 139.41 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.974 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 m -88.55 148.49 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.994 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.47 -0.59 4.9 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.018 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.65 -22.72 60.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -80.11 -47.55 14.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.362 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 28.13 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.1 p -59.32 106.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.512 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.84 -40.89 0.32 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.496 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 116' ' ' ARG . 1.0 OUTLIER -101.18 87.63 0.92 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -176.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.542 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.1 Cg_endo -67.34 -29.16 38.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.25 1.3 . . . . 0.0 108.828 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 119' ' ' MET . 8.1 pt-20 -56.66 -49.51 74.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.915 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.404 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 9.7 ttm -34.67 -64.83 0.24 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.821 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -59.17 -44.93 92.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.843 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -60.27 -40.32 89.95 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.752 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLU . . . . . 0.627 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.63 -30.47 46.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.747 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.0 OUTLIER -73.72 -34.25 64.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.799 1.285 . . . . 0.0 108.301 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.916 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -61.85 -51.26 68.94 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 112.126 -2.306 . . . . 0.0 111.667 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -71.32 -34.92 55.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.87 91.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.049 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.481 ' O ' HG23 ' B' ' 18' ' ' ILE . 6.8 tptm -58.85 -51.0 71.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.233 0.539 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.63 -37.14 70.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.882 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.542 HH22 ' HB2' ' A' ' 117' ' ' PRO . 9.7 ttt180 -60.56 -51.02 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.593 0.711 . . . . 0.0 110.668 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.499 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -60.53 -38.33 77.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.17 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 13.2 m-20 -68.23 -30.44 69.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.492 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.455 HD12 ' N ' ' B' ' 20' ' ' ILE . 1.1 mp -71.53 -57.68 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.638 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.2 -35.06 76.16 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.596 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 5.4 t80 -53.75 -39.36 65.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.047 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -67.77 -40.8 83.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.383 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.464 ' CD1' ' CG1' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -56.25 -58.02 9.76 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.731 0.777 . . . . 0.0 109.396 179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' B' ' 29' ' ' PHE . . . -49.23 -37.52 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.562 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.84 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -68.97 -59.27 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.313 0.577 . . . . 0.0 110.087 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.784 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 7.2 ttm-85 -66.6 -36.91 83.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.809 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 1.199 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -82.99 -50.69 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.321 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.748 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 41.1 t80 -36.75 -50.26 1.99 Allowed Pre-proline 0 CA--C 1.509 -0.63 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' PRO . . . . . 0.854 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 37.4 Cg_endo -54.01 -46.84 30.62 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 106.576 -2.124 . . . . 0.0 106.576 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.854 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 49.4 t80 -94.42 -13.24 26.46 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.335 -2.211 . . . . 0.0 112.708 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 1.199 ' N ' ' O ' ' B' ' 28' ' ' VAL . 57.4 p -160.51 92.87 1.6 Allowed Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.439 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 47.3 Cg_exo -55.67 -41.59 76.06 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.736 2.291 . . . . 0.0 113.673 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.59 -54.41 23.81 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' LEU . . . . . 0.522 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 7.7 mt -52.22 -55.04 23.73 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.205 0.526 . . . . 0.0 110.604 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.529 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.77 -30.24 60.95 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.076 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.63 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.77 -48.93 43.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.543 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.95 -38.7 89.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.77 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 49' ' ' ILE . 3.5 m-85 -64.43 -44.71 90.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 118.627 -1.229 . . . . 0.0 108.327 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.155 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.95 -41.5 77.94 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.1 mt -65.48 -44.71 86.26 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.41 -30.66 63.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.946 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.72 -54.34 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.588 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.781 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.6 pp -57.25 -27.32 61.95 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.747 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . 0.781 ' N ' HD12 ' B' ' 45' ' ' LEU . 86.0 t -68.27 -46.38 81.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.017 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -57.1 8.3 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.818 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 8.4 pt20 -81.32 -47.35 13.43 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 7.4 tptt -70.04 -32.74 71.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -88.22 -3.98 58.79 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.419 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mttp 62.59 73.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.691 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.734 179.266 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.568 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 5.2 m-90 . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -65.89 -6.87 13.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' B' ' 58' ' ' TRP . 12.1 ptp180 -81.35 -25.44 36.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.808 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -141.25 22.97 2.2 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.418 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.416 ' CZ ' ' HA ' ' B' ' 67' ' ' HIS . 51.8 t80 -116.15 148.6 40.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.019 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' CYS . . . . . 0.581 ' C ' ' H ' ' B' ' 65' ' ' LYS . 8.2 t -126.54 107.79 10.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.633 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' B' ' 64' ' ' LYS . 1.1 mptp? -66.21 5.47 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.664 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -105.96 -17.66 14.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.609 -178.061 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 14.5 p -150.81 6.75 0.53 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' B' ' 63' ' ' CYS . 2.0 m80 42.74 78.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.679 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.16 -172.14 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.303 0.573 . . . . 0.0 111.268 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' PHE . . . . . 0.63 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 4.7 t80 -117.73 105.09 11.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.808 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.6 OUTLIER -109.35 126.29 53.24 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -103.17 121.92 47.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.886 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.63 127.2 15.81 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.981 1.787 . . . . 0.0 111.733 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.67 -34.01 6.02 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.539 ' CG2' HD21 ' B' ' 75' ' ' ASN . 96.6 mt -93.89 -79.99 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASN . . . . . 0.539 HD21 ' CG2' ' B' ' 74' ' ' ILE . 1.9 m-80 -110.86 15.94 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 -179.818 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.85 149.4 16.89 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' GLU . 77.9 p -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.948 0.404 . . . . 0.0 110.464 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -38.93 -58.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.69 -8.81 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' SER . 47.0 tp10 -104.03 -37.98 7.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.156 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.444 ' HA ' ' CE2' ' B' ' 31' ' ' TYR . 4.3 mm -95.66 22.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.482 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.76 117.43 26.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 105.12 -29.74 11.14 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 121.022 -0.609 . . . . 0.0 114.43 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -63.28 29.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.967 . . . . 0.0 110.882 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.674 ' H ' ' C ' ' A' ' 25' ' ' GLY . 3.3 p -44.5 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.678 ' H ' ' C ' ' A' ' 26' ' ' ARG . 27.9 t-105 -57.86 -52.52 65.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.407 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' B' ' 27' ' ' ARG . 10.4 pt -69.73 -12.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.977 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -93.53 -11.07 32.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.06 -68.3 0.8 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.41 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.03 46.42 1.5 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -161.88 -34.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.518 ' NE2' ' OE2' ' A' ' 47' ' ' GLU . 19.6 t-80 -103.55 108.19 19.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.822 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.547 ' HA ' ' HE1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -149.56 9.51 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.783 ' O ' ' CD1' ' A' ' 101' ' ' TRP . . . -49.04 148.15 5.26 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -64.25 111.13 2.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 118.486 -1.285 . . . . 0.0 108.947 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.593 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 92.6 t -83.08 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.903 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.756 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -163.81 150.5 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.563 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 69.5 tttt -48.29 -56.67 7.44 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.753 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 54.2 pttt -61.63 -5.3 1.79 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.737 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 9.1 m120 -126.0 3.54 7.27 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.783 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.756 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.53 -42.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.072 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -94.48 -0.46 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.23 14.65 16.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.458 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.737 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -120.37 176.47 5.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.764 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.733 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -90.81 112.26 24.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.983 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' A' ' 49' ' ' ILE . 55.5 mt -74.39 114.14 12.42 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 4.5 mm -155.79 -40.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.761 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.604 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -131.84 -20.05 1.1 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.744 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD21 ' H ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -44.44 142.31 1.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' H ' HD21 ' A' ' 51' ' ' LEU . 3.2 ttpm? -92.13 131.54 37.3 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.813 HG23 ' H ' ' A' ' 54' ' ' ARG . 12.8 p -150.04 170.74 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.191 0.52 . . . . 0.0 111.282 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.813 ' H ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.42 152.44 51.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.898 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 65' ' ' GLY . 48.1 t -97.5 99.17 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.87 -50.89 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.841 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.47 120.75 27.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -147.06 173.28 12.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.245 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.626 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -109.95 78.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 59' ' ' THR . 17.4 m170 -168.72 102.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.328 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.73 -4.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.478 2.119 . . . . 0.0 113.822 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -130.2 22.46 4.75 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.193 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -141.0 -11.76 0.97 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.533 1.167 . . . . 0.0 111.513 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 2.2 m -72.98 131.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.02 5.21 90.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.664 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.616 ' CG2' ' NE1' ' A' ' 87' ' ' TRP . 9.0 tt -100.38 151.24 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 117.758 0.779 . . . . 0.0 112.345 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.687 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 2.7 tm-20 -118.0 132.71 56.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.25 173.22 27.47 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.853 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -96.5 114.93 26.63 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.533 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.8 t -48.77 146.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 79' ' ' VAL . 36.2 mt -140.02 -60.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.127 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -104.14 144.71 31.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.62 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 43.8 tp10 -148.18 106.17 3.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.986 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.447 ' HA ' HH21 ' B' ' 38' ' ' ARG . 1.8 p -137.04 179.9 6.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.726 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -17.01 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.144 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.453 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 41.1 t30 -137.54 13.52 2.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.85 159.02 39.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 118.728 -1.189 . . . . 0.0 113.957 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 7.2 tp -150.46 110.55 4.14 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' ILE . 91.1 t -112.1 146.37 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.533 HG23 ' N ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -129.1 147.44 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.972 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -123.08 137.59 54.89 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.577 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.76 152.06 23.79 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 84' ' ' ASN . 8.9 pt-20 38.06 -136.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.699 -0.295 . . . . 0.0 110.937 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 23.1 m120 -99.67 34.08 2.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.052 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.54 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 21.5 tptt -145.18 165.93 26.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.707 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.54 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 24.7 m -119.65 155.57 22.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.469 0.652 . . . . 0.0 110.693 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.687 ' CZ2' ' O ' ' A' ' 67' ' ' GLU . 1.4 m-90 -97.54 92.7 6.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.708 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -86.97 100.01 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 t -147.27 109.16 3.93 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.448 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.01 164.35 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.323 1.348 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.664 ' H ' ' CD ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -72.03 -31.43 66.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 16.9 p-10 -90.28 -5.69 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -97.5 0.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.286 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -166.27 174.42 9.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.926 -1.11 . . . . 0.0 113.654 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.22 124.01 65.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.702 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.659 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 59.7 m-85 -99.04 131.19 45.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 53' ' ' VAL . 18.5 tt0 -111.29 95.48 5.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.704 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 16.4 m-85 -89.58 146.01 24.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.16 132.4 36.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.729 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 104' ' ' THR . 16.9 m -65.85 142.41 57.94 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -62.43 -1.66 0.84 Allowed 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.919 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 100' ' ' THR . 86.9 m-20 -106.92 19.45 20.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.751 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.03 23.49 77.07 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.57 137.21 44.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.423 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -81.28 129.56 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 44.7 mt -104.41 134.7 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.578 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -117.86 102.04 8.78 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.3 138.06 45.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.691 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.7 p -78.26 123.22 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.487 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -53.2 -2.44 0.1 OUTLIER Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.592 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -81.77 -22.86 36.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.167 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -66.69 -46.34 75.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.17 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.68 28.68 1.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.28 105.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.73 -40.64 0.24 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 114.462 -1.245 . . . . 0.0 114.47 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.8 91.66 1.98 Allowed Pre-proline 0 N--CA 1.466 0.328 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.564 ' HB2' HH22 ' B' ' 17' ' ' ARG . 29.2 Cg_endo -69.76 -27.97 25.84 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.462 1.442 . . . . 0.0 108.752 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.556 ' CG ' ' N ' ' A' ' 119' ' ' MET . 13.0 pt-20 -61.08 -52.27 65.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.222 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.556 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 31.3 ttp -36.16 -38.38 0.14 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.596 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.617 ' NH2' ' CZ2' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -81.57 -50.03 9.84 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.145 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -33.29 73.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.054 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -103.87 18.39 22.08 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.299 . . . . 0.0 111.054 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 57.34 168.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 123' ' ' LYS . 2.7 mtp180 -43.93 168.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -43.83 147.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.529 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -90.72 112.76 24.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.676 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.481 179.799 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.703 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.522 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -79.3 -29.6 42.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.886 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -72.31 -33.58 67.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.723 1.249 . . . . 0.0 107.844 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.927 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.2 OUTLIER -62.94 -51.8 65.51 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.736 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.475 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.4 pt -65.73 -27.84 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.082 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.35 87.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.725 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.521 ' O ' HG21 ' B' ' 18' ' ' ILE . 18.6 mmtt -53.93 -50.97 65.24 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 109.514 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.697 ' O ' HG12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -73.17 -38.15 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.564 HH22 ' HB2' ' A' ' 117' ' ' PRO . 31.1 ttt180 -65.06 -52.91 53.06 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.521 0.676 . . . . 0.0 110.895 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.527 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 8.0 tp -56.74 -43.99 80.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.236 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.527 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 11.1 m-20 -67.29 -29.2 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.697 HG12 ' O ' ' B' ' 16' ' ' GLU . 26.4 mm -74.99 -58.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.45 -34.18 74.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 5.0 t80 -54.51 -50.32 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -71.44 -32.59 68.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.484 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.477 HD13 ' CG1' ' B' ' 28' ' ' VAL . 0.2 OUTLIER -66.29 -56.65 10.15 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.186 0.517 . . . . 0.0 109.641 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.25 40.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.205 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.841 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 62.2 mt-10 -69.07 -46.14 68.57 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.192 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.783 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 3.0 ttt-85 -70.97 -33.37 70.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.897 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.232 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.9 m -84.5 -49.36 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.552 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.748 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 24.6 t80 -36.48 -49.98 1.84 Allowed Pre-proline 0 C--N 1.351 0.632 0 CA-C-N 119.531 1.06 . . . . 0.0 109.439 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.864 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 40.6 Cg_endo -54.85 -47.41 26.8 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.509 -2.151 . . . . 0.0 106.509 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.864 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.7 t80 -94.44 -13.65 26.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.397 -2.183 . . . . 0.0 112.752 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.232 ' N ' ' O ' ' B' ' 28' ' ' VAL . 52.5 p -159.1 90.84 1.99 Allowed Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 51.5 Cg_exo -53.46 -45.0 44.24 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.711 2.274 . . . . 0.0 113.81 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' B' ' 38' ' ' ARG . 79.5 tt0 -64.37 -53.96 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.508 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 21.8 mt -51.73 -59.61 4.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.004 0.431 . . . . 0.0 111.155 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.599 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.45 -35.4 52.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.196 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.749 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.57 -36.06 73.41 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.001 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.706 ' HD3' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -65.47 -54.68 24.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.824 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.603 ' O ' ' N ' ' B' ' 42' ' ' LEU . 1.2 m-85 -59.58 -39.94 85.76 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.1 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.573 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.9 t -45.32 -41.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -64.43 -43.24 94.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' B' ' 39' ' ' TYR . 14.5 mt -64.55 -43.61 93.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -66.39 -31.51 72.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.243 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 0.8 OUTLIER -59.9 -53.86 52.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.795 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.1 pp -64.68 -41.01 96.36 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.743 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.514 ' N ' ' HG ' ' B' ' 45' ' ' LEU . 97.3 t -53.51 -42.46 49.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.266 0.555 . . . . 0.0 109.99 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.84 -55.28 17.92 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.301 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 3.0 pt20 -80.71 -53.08 6.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.795 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 26.6 mmtt -56.53 -41.19 76.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -90.23 -9.06 49.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 0.0 110.348 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.54 66.84 1.01 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' B' ' 53' ' ' LYS . 1.6 t -109.56 -147.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.349 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.519 ' H ' ' CG1' ' B' ' 52' ' ' VAL . 92.9 mttt -63.24 143.85 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.049 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 mm -88.94 134.68 33.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.812 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.07 142.34 87.07 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.856 1.704 . . . . 0.0 111.571 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' B' ' 59' ' ' LYS . 5.5 ptp180 -142.13 -61.25 0.45 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.619 ' C ' ' H ' ' B' ' 59' ' ' LYS . 58.8 pttt -87.09 -38.23 16.68 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.696 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.436 ' O ' ' HD2' ' B' ' 61' ' ' ARG . 10.1 m0 -47.05 -8.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.619 ' H ' ' C ' ' B' ' 57' ' ' LYS . 0.0 OUTLIER -68.99 -8.5 45.39 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.1 ptm180 -80.59 -18.69 47.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.398 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.769 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -142.97 11.88 1.81 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.511 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 92.0 t80 -119.98 158.64 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 2.0 t -126.28 120.64 30.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -85.97 5.28 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.249 0.547 . . . . 0.0 109.639 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.673 ' HZ2' ' CD2' ' B' ' 97' ' ' HIS . 2.5 mmmm -97.75 -39.73 8.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.86 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 5.2 p -136.07 1.98 2.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.7 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 66' ' ' CYS . 6.8 m170 57.44 121.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.764 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . 176.17 -172.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.766 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.749 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.4 OUTLIER -121.35 104.7 9.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.769 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -109.81 145.7 36.28 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.348 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.404 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 92.3 t -128.44 117.76 20.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -45.95 125.34 8.21 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.029 1.819 . . . . 0.0 111.85 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.76 -29.82 11.7 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.41 -80.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.003 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -116.97 17.38 14.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.082 0.468 . . . . 0.0 109.886 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.23 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -142.49 130.6 21.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 18.2 m -134.08 132.55 55.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.893 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -140.17 130.78 25.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 110.623 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 1.3 pp -126.55 132.28 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.656 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mtp85 -138.01 140.31 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 83' ' ' LYS . 2.0 pt20 -88.09 -165.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' B' ' 82' ' ' GLN . 66.5 tttt 98.88 77.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.314 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 73.27 85.07 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.751 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.523 ' O ' ' CD2' ' B' ' 87' ' ' HIS . 0.0 OUTLIER 61.79 87.08 0.14 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.03 145.47 91.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.589 2.193 . . . . 0.0 111.991 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 85' ' ' MET . 89.7 m-70 -133.13 136.92 46.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.436 HG13 ' HB3' ' B' ' 80' ' ' LEU . 0.0 OUTLIER -99.11 139.51 20.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.906 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 17.6 t -109.04 122.11 63.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.8 140.35 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -153.54 143.63 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.949 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.682 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.5 OUTLIER -82.73 125.1 30.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.096 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.03 -8.77 58.56 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.221 0.534 . . . . 0.0 109.674 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.18 -54.75 4.42 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.852 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 5.2 p -115.81 75.07 0.92 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.39 93.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 122.254 0.919 . . . . 0.0 110.948 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.673 ' CD2' ' HZ2' ' B' ' 65' ' ' LYS . 0.1 OUTLIER -124.67 134.38 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.337 -1.431 . . . . 0.0 109.355 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 2.1 mt -92.68 123.2 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.903 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.451 ' CG ' ' HZ3' ' B' ' 65' ' ' LYS . 55.6 mmm -132.78 159.64 39.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -134.11 155.04 50.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.33 96.49 2.65 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.7 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.78 170.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.38 2.054 . . . . 0.0 112.12 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -125.42 119.74 29.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.899 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.37 128.4 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 66.7 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.398 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.19 -144.25 1.46 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 95.7 p -58.17 -41.11 83.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.421 . . . . 0.0 110.256 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 19' ' ' SER . 59.9 m-85 -33.7 -62.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.894 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.84 -22.08 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.325 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.2 tp10 -97.37 -34.59 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' B' ' 31' ' ' TYR . 1.8 mm -98.78 15.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.49 117.49 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.137 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.728 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 112.77 -35.5 4.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.889 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -61.07 25.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.958 0.879 . . . . 0.0 110.895 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.728 ' H ' ' C ' ' A' ' 25' ' ' GLY . 29.2 p -37.66 -17.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.513 0.673 . . . . 0.0 109.899 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' ARG . 17.7 t-105 -56.99 -56.34 22.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.689 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' B' ' 27' ' ' ARG . 13.5 pt -63.6 -17.91 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.269 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 18.1 m-85 -89.44 -16.89 29.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' CD ' ' HH ' ' A' ' 69' ' ' TYR . 5.1 mmt85 -90.91 -61.56 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.171 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' B' ' 27' ' ' ARG . . . -71.43 45.34 0.79 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -153.53 -36.15 0.1 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.557 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 2.0 t-80 -90.56 106.78 18.73 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.029 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' N ' ' HD1' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -132.66 0.83 3.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.434 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -54.28 146.41 24.66 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.544 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.1 ttm-85 -66.81 125.14 24.94 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.753 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -101.42 136.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.909 0.861 . . . . 0.0 113.301 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.632 ' O ' ' N ' ' A' ' 43' ' ' ILE . 38.5 m-80 -166.11 152.17 9.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.323 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 42' ' ' ASN . 20.8 ttmt -49.96 -51.93 37.53 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.91 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -60.22 -4.81 0.89 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.706 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 77.7 m-20 -122.53 -10.25 8.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.33 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -80.12 -41.06 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.616 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -89.1 9.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.87 1.319 . . . . 0.0 107.57 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.851 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -123.24 -25.37 4.49 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.81 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.706 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -79.0 146.28 33.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.788 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -70.89 111.48 6.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.566 ' C ' HG12 ' A' ' 49' ' ' ILE . 13.5 mt -68.73 115.87 8.58 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 HG12 ' C ' ' A' ' 48' ' ' LEU . 2.9 mm -157.42 -27.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.865 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -152.11 30.95 0.89 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.283 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.502 ' CD2' ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -98.38 156.13 16.89 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.502 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 3.4 tmtt? -98.04 127.0 43.73 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.427 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.839 HG22 ' H ' ' A' ' 54' ' ' ARG . 14.8 p -149.4 171.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.269 0.557 . . . . 0.0 111.871 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.839 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.92 152.62 49.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.799 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 65' ' ' GLY . 89.0 t -96.33 99.52 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.79 -51.97 13.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -129.03 118.61 22.83 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.331 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.556 ' OG ' ' CE1' ' A' ' 60' ' ' HIS . 5.2 t -149.36 173.35 13.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.331 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.738 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 10.8 t -108.32 75.46 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.294 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.738 ' CD2' ' O ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -168.59 93.08 0.59 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.745 178.035 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.2 -5.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.349 2.033 . . . . 0.0 113.263 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -109.55 9.06 32.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.366 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' O ' HG22 ' A' ' 66' ' ' ILE . 39.6 m-85 -140.74 -12.95 0.98 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.234 1.017 . . . . 0.0 112.255 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.2 m -72.0 132.66 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.129 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.5 6.39 88.66 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.335 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.584 ' CG2' ' NE1' ' A' ' 87' ' ' TRP . 11.0 tt -100.87 148.48 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.701 0.75 . . . . 0.0 112.055 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.664 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 4.8 tm-20 -119.7 129.98 54.79 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.69 174.24 25.74 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 116.412 -0.358 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.1 t80 -96.25 115.2 27.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.571 0.348 . . . . 0.0 110.093 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 1.5 t -48.21 142.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.727 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.2 mt -141.76 -39.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.686 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -121.82 143.43 49.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' N ' ' CZ ' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -157.21 106.48 2.18 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.589 ' HG1' ' N ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -137.82 -171.33 2.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.28 0.562 . . . . 0.0 111.084 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.589 ' N ' ' HG1' ' A' ' 74' ' ' THR . 29.1 ttt-85 -53.24 -24.7 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.125 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.467 ' H ' ' HG1' ' A' ' 74' ' ' THR . 1.3 m120 -138.43 30.93 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.473 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -164.68 169.6 16.69 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.687 -1.205 . . . . 0.0 113.91 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.4 tp -165.83 110.21 0.83 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' ILE . 98.0 t -116.41 146.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.527 HG21 ' C ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -126.89 145.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.229 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.18 136.13 53.96 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.532 . . . . 0.0 111.828 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.92 132.88 3.82 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 64.33 -123.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.808 -0.231 . . . . 0.0 110.643 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -116.31 33.22 5.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 110.618 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.584 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 6.1 tptp -145.25 170.75 15.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.584 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 7.8 m -124.28 156.11 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.701 0.762 . . . . 0.0 110.85 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.664 ' CZ2' ' O ' ' A' ' 67' ' ' GLU . 1.2 m-90 -99.11 119.73 38.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.623 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -107.98 104.47 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.28 96.26 3.97 Favored Pre-proline 0 N--CA 1.457 -0.115 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.92 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 92' ' ' ASP . 38.3 Cg_exo -54.16 126.76 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.095 1.197 . . . . 0.0 110.295 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.663 ' HZ2' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -43.78 -19.84 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.431 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' PRO . 5.3 p-10 -87.6 -6.92 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.507 ' O ' ' OG ' ' A' ' 58' ' ' SER . 2.2 t -133.72 33.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.714 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -167.09 158.06 11.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.712 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 73.1 mt -106.45 118.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.714 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 66.6 m-85 -99.08 131.12 45.35 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 106' ' ' ILE . 11.2 tt0 -115.49 94.87 4.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.645 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.84 143.58 26.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.85 ' OE2' ' N ' ' A' ' 104' ' ' THR . 2.5 tm-20 -90.99 127.52 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.485 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.921 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -58.98 143.27 48.7 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.817 -178.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.753 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -54.83 0.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.284 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 100' ' ' THR . 31.8 t70 -106.66 10.64 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.16 14.42 76.91 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.921 ' O ' ' OG1' ' A' ' 100' ' ' THR . 19.3 m -106.54 127.6 53.45 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -76.47 135.98 39.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.431 0.634 . . . . 0.0 111.581 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.473 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 70.2 mt -102.88 135.5 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.525 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 34.9 ttmt -107.9 101.92 11.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.07 139.19 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.353 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -79.29 145.49 33.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.773 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -70.88 -1.91 42.54 Favored Glycine 0 CA--C 1.507 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.087 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.94 -21.61 34.05 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.352 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -64.82 -47.08 79.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.419 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.29 28.58 2.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.776 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.501 ' O ' ' CG1' ' A' ' 114' ' ' VAL . 12.6 p -60.81 106.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.663 ' N ' ' HZ2' ' A' ' 91' ' ' LYS . . . 67.98 -40.2 0.25 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.104 -0.953 . . . . 0.0 114.162 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 114' ' ' VAL . 31.9 mtp180 -101.43 78.55 0.22 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.496 ' HB2' HH22 ' B' ' 17' ' ' ARG . 19.5 Cg_endo -66.59 -24.25 48.72 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.392 1.394 . . . . 0.0 108.984 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.487 ' CG ' ' H ' ' A' ' 119' ' ' MET . 9.3 pt-20 -62.94 -52.63 62.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.487 ' H ' ' CG ' ' A' ' 118' ' ' GLU . 1.4 mmt -35.01 -55.56 0.59 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.667 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' CE3' ' A' ' 45' ' ' TRP . 4.2 tpt180 -68.28 -40.69 81.76 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.963 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -62.1 -39.15 91.52 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' HE2' ' NZ ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -96.48 6.02 49.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.6 tttm 64.33 149.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.769 0.319 . . . . 0.0 110.799 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -69.18 -39.09 78.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.747 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -86.24 142.0 28.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' LYS . 75.8 ttt-85 -129.24 103.31 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.732 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 126' ' ' ARG . 23.4 tttm . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.576 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.667 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -79.62 -33.45 41.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.764 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 8.9 tttp -73.45 -35.06 65.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.664 1.221 . . . . 0.0 108.485 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.949 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -61.1 -51.51 68.84 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.088 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.634 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 10.9 mt -69.59 -35.56 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.9 -53.6 56.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' B' ' 11' ' ' LYS . 12.9 mmmt -53.33 -50.96 63.9 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.734 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.53 -38.22 71.09 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.246 0.546 . . . . 0.0 110.755 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' B' ' 13' ' ' ILE . 7.0 ttt180 -58.84 -53.6 56.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.897 0.856 . . . . 0.0 109.844 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.451 HG21 ' O ' ' B' ' 15' ' ' LYS . 0.4 OUTLIER -59.36 -32.01 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.35 -50.13 73.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.417 HD13 ' CG ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -74.31 -49.61 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.658 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -56.0 -37.41 69.08 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 6.2 t80 -59.76 -51.99 67.41 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.425 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 64.6 p -69.68 -34.95 74.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.435 HD11 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -63.79 -56.26 16.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.181 0.515 . . . . 0.0 109.913 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.41 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.87 -34.51 41.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.832 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 1.7 tm-20 -74.19 -40.07 62.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.765 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 53.9 mtt180 -72.53 -34.74 67.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.215 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.7 m -85.83 -49.39 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.718 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 23.2 t80 -36.19 -49.85 1.69 Allowed Pre-proline 0 C--N 1.353 0.741 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.304 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.859 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 38.3 Cg_endo -54.58 -48.28 22.25 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.859 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.1 t80 -94.3 -10.8 31.62 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 112.473 -2.149 . . . . 0.0 112.773 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.215 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.0 p -165.03 95.13 0.88 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' B' ' 37' ' ' LYS . 33.2 Cg_exo -56.5 -39.12 93.5 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.503 2.135 . . . . 0.0 113.319 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -53.37 35.3 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.549 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 13.5 mt -54.36 -57.85 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.571 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -51.66 -31.24 24.81 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.185 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' O ' ' B' ' 69' ' ' PHE . 2.2 mptt -70.97 -41.17 71.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.761 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.727 ' NH2' ' O ' ' A' ' 71' ' ' ILE . 2.5 tmm_? -60.07 -54.34 47.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.951 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' B' ' 39' ' ' TYR . 0.5 OUTLIER -61.66 -39.29 90.85 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.718 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.1 t -45.64 -43.23 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.596 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.72 -43.64 98.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.628 ' O ' HG21 ' B' ' 46' ' ' VAL . 63.1 mt -64.8 -43.94 91.55 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.361 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -56.81 -30.86 64.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.534 ' CD1' ' OH ' ' B' ' 62' ' ' TYR . 7.3 mt -67.66 -54.83 16.34 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.47 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' B' ' 42' ' ' LEU . 1.3 pp -57.74 -28.25 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.745 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.628 HG21 ' O ' ' B' ' 42' ' ' LEU . 83.5 t -69.1 -48.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.153 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.514 ' CD ' ' HE ' ' B' ' 56' ' ' ARG . 2.0 tt0 -66.08 -56.84 9.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 8.9 pt20 -80.75 -48.33 12.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -69.51 -33.85 73.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -89.38 -8.38 53.27 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? 64.82 71.15 0.46 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.66 133.64 64.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.99 109.52 14.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.067 0.461 . . . . 0.0 110.943 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' B' ' 55' ' ' PRO . 7.3 mm -135.33 134.85 21.59 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.357 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 54' ' ' ILE . 94.8 Cg_exo -37.82 117.16 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.942 1.761 . . . . 0.0 111.409 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.514 ' HE ' ' CD ' ' B' ' 47' ' ' GLN . 48.8 mtt85 -95.34 77.81 3.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.866 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' B' ' 59' ' ' LYS . 57.2 pttt -74.13 -24.17 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.646 ' O ' ' N ' ' B' ' 62' ' ' TYR . 2.0 m0 -55.48 -2.89 0.05 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' B' ' 57' ' ' LYS . 15.9 pttp -64.52 -8.75 15.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.9 ptm180 -88.19 -26.4 22.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.264 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.742 ' NH1' ' CE2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -134.54 15.15 3.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.754 -177.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.646 ' N ' ' O ' ' B' ' 58' ' ' TRP . 23.5 t80 -111.82 151.13 29.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.63 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 0.0 OUTLIER -118.82 105.16 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.156 -178.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -92.86 -4.77 52.32 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' B' ' 66' ' ' CYS . 20.9 mmmt -78.57 -37.93 41.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.659 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 17.7 1.72 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.879 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.58 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.7 m80 53.96 95.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.902 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.4 -173.92 2.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.8 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.781 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -125.44 102.51 7.44 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.657 ' O ' ' CB ' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -99.97 154.4 18.42 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.814 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 42.9 t -131.12 115.15 16.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.424 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.0 122.49 4.33 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.224 1.949 . . . . 0.0 111.848 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.74 -26.77 23.25 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 56.1 mt -105.05 -80.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 110.513 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -115.55 22.36 13.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.958 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.75 161.75 42.04 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.274 0.559 . . . . 0.0 111.972 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -149.94 127.16 11.33 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.144 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 19.5 m -139.27 118.34 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.529 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' B' ' 88' ' ' ILE . 9.8 mtt85 -131.73 145.08 51.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 110.378 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 2.0 pp -114.62 117.77 31.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.362 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -137.72 147.51 44.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -64.96 -120.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.814 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' B' ' 84' ' ' ARG . 29.3 mtpt 60.35 103.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' B' ' 83' ' ' LYS . 38.4 ttt85 41.96 100.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.952 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.446 ' O ' ' O ' ' B' ' 84' ' ' ARG . 12.7 ttm 48.94 99.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.95 140.57 31.17 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.192 1.928 . . . . 0.0 112.16 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -154.77 145.57 22.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.46 ' CG1' ' HB3' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -96.54 123.98 49.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 2.5 p -84.62 118.66 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.164 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 m -121.82 134.17 65.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -146.89 134.35 20.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.463 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' B' ' 95' ' ' CYS . 8.3 m -68.52 109.76 3.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.245 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 92.9 mt -87.34 -6.81 58.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.342 0.591 . . . . 0.0 109.432 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -99.44 -18.09 17.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -143.8 72.01 1.34 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.022 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.71 91.12 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.458 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.579 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.6 OUTLIER -131.31 124.57 30.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.177 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 79.8 mt -87.9 121.91 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.033 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.545 ' CG ' ' NZ ' ' B' ' 65' ' ' LYS . 17.7 mmm -136.02 165.67 25.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.292 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -141.73 135.87 30.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.403 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.49 96.05 48.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.388 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.53 161.53 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.862 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -142.95 103.88 4.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.615 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.74 125.49 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.343 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.72 177.89 29.54 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 54.7 p -81.05 -22.86 38.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLU . 37.0 m-85 -42.44 -58.52 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -43.72 -15.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' TYR . 38.2 tp10 -99.82 -32.62 10.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.327 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.633 HD12 ' OG ' ' B' ' 32' ' ' SER . 3.8 mm -109.11 19.15 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.457 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -80.35 117.13 25.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.543 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.26 -37.48 3.6 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.204 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 28' ' ' TRP . 1.9 mtt180 -62.26 30.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.552 0.676 . . . . 0.0 110.875 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.681 ' H ' ' C ' ' A' ' 25' ' ' GLY . 2.9 p -43.74 -12.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.747 0.784 . . . . 0.0 109.022 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.701 ' H ' ' C ' ' A' ' 26' ' ' ARG . 24.1 t-105 -58.24 -55.77 30.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.169 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' B' ' 27' ' ' ARG . 7.2 pt -64.66 -13.59 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CE2' HG12 ' A' ' 71' ' ' ILE . 60.5 m-85 -93.42 -16.5 24.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.9 mmm180 -89.13 -56.68 3.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.736 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' NE ' ' B' ' 27' ' ' ARG . . . -78.58 46.42 2.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.569 ' CA ' ' HG ' ' B' ' 23' ' ' SER . . . -153.12 -40.98 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.561 ' HD1' ' N ' ' A' ' 35' ' ' ARG . 2.4 t-80 -75.68 126.96 32.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.536 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.561 ' N ' ' HD1' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -154.78 -35.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.553 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' ARG . . . -32.29 144.77 0.02 OUTLIER Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 24.4 ttm105 -66.42 119.5 11.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.733 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -92.71 136.62 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.767 0.794 . . . . 0.0 113.115 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 43' ' ' ILE . 39.3 t30 -165.82 155.52 12.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 42' ' ' ASN . 86.3 tttt -52.21 -52.77 50.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.76 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.565 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 8.7 pttm -60.15 -4.24 0.76 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.748 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 72.3 m-20 -123.95 -3.41 8.13 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.228 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -86.41 -39.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 117.876 0.307 . . . . 0.0 111.466 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.545 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -88.43 3.12 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.848 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -114.65 -37.88 4.14 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.617 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.748 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -67.29 140.38 57.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.787 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -66.25 110.09 2.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.79 ' O ' HG12 ' A' ' 49' ' ' ILE . 5.0 mt -72.9 114.5 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.407 -1.317 . . . . 0.0 108.013 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.79 HG12 ' O ' ' A' ' 48' ' ' LEU . 4.7 mt -168.42 51.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 O-C-N 123.803 0.689 . . . . 0.0 109.491 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 150.16 -35.26 0.99 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.591 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 52' ' ' LYS . 1.6 tt -44.59 146.05 0.79 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 13.0 tmtt? -85.46 125.31 32.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.348 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.827 HG22 ' H ' ' A' ' 54' ' ' ARG . 12.0 p -149.1 171.02 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.434 0.635 . . . . 0.0 111.954 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.827 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.89 152.81 49.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.001 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 65' ' ' GLY . 31.6 t -100.44 99.46 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.58 -51.98 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.56 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -128.48 117.42 21.31 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.553 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.724 ' HG ' ' H ' ' A' ' 59' ' ' THR . 31.1 t -150.18 173.53 13.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.466 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.724 ' H ' ' HG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -101.36 79.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.68 ' CD2' ' O ' ' A' ' 59' ' ' THR . 37.3 m-70 -161.14 94.92 1.4 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.614 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.7 -5.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.177 1.918 . . . . 0.0 113.219 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -134.79 22.57 3.64 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.193 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' O ' HG21 ' A' ' 66' ' ' ILE . 27.2 m-85 -140.69 -10.85 1.03 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.628 1.214 . . . . 0.0 111.834 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.14 134.07 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.863 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 83.27 5.87 88.44 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.291 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.634 ' CG2' ' NE1' ' A' ' 87' ' ' TRP . 11.4 tt -104.54 153.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.66 0.73 . . . . 0.0 112.204 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.614 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.3 tm-20 -120.26 131.49 54.95 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.515 ' N ' ' OE2' ' A' ' 67' ' ' GLU . . . -147.31 173.29 27.49 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 116.341 -0.39 . . . . 0.0 112.502 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -96.45 117.89 31.83 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 51' ' ' LEU . 1.5 t -51.9 145.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.962 0.41 . . . . 0.0 111.654 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.43 HG12 ' CE2' ' A' ' 30' ' ' PHE . 93.6 mt -140.32 -33.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.485 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.666 ' OD2' ' NH1' ' B' ' 38' ' ' ARG . 37.6 t0 -123.56 149.29 45.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.662 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 tm-20 -161.71 106.05 1.26 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.959 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.519 HG23 ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -148.45 -175.23 4.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.194 0.521 . . . . 0.0 110.964 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.473 HH12 HH21 ' A' ' 116' ' ' ARG . 37.1 ttt85 -53.17 -23.25 7.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.094 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -138.83 29.16 2.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -166.29 164.53 17.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 118.358 -1.337 . . . . 0.0 114.267 179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.532 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 10.5 tp -163.43 109.79 1.13 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 112.975 -1.92 . . . . 0.0 105.937 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 71' ' ' ILE . 83.3 t -118.24 146.3 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 112.474 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.541 HG23 ' C ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -127.6 147.09 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.357 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -122.69 137.47 54.9 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.597 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -155.52 124.96 1.57 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.411 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 17.6 tt0 64.8 -130.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 110.552 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.411 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -108.24 32.06 5.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.544 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 13.7 tttp -139.12 166.75 23.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.607 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 7.5 m -123.45 155.44 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.421 0.629 . . . . 0.0 110.611 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.634 ' NE1' ' CG2' ' A' ' 66' ' ' ILE . 1.6 m-90 -102.17 93.14 5.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.437 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.459 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 20.9 ttmt -91.3 104.84 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.928 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.462 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 2.5 m -157.24 95.85 2.1 Favored Pre-proline 0 N--CA 1.457 -0.123 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.563 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 32.0 Cg_exo -54.28 126.82 23.45 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.973 1.782 . . . . 0.0 111.687 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.708 ' HZ2' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -38.81 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.204 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 90' ' ' PRO . 4.0 p-10 -82.24 -6.11 58.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.06 33.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.271 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 90' ' ' PRO . 3.2 p -167.37 154.82 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.354 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.37 146.13 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.271 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.586 ' CB ' ' CZ ' ' A' ' 98' ' ' PHE . 50.3 m-85 -130.42 137.65 49.94 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.572 ' OE1' ' NH2' ' A' ' 54' ' ' ARG . 7.8 tt0 -119.65 94.0 4.26 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.586 ' CZ ' ' CB ' ' A' ' 96' ' ' PHE . 1.4 m-85 -87.69 144.82 26.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -90.01 131.6 35.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.317 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.67 143.39 57.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.693 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.733 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.45 -0.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.296 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 20.2 t0 -107.37 12.98 27.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.8 22.65 68.75 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.06 149.47 26.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.417 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.46 133.41 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.42 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.401 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 22.2 mt -107.16 134.9 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -115.65 102.63 9.93 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -151.38 139.92 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.933 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 111' ' ' GLU . 37.4 m -89.74 148.35 23.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.275 0.559 . . . . 0.0 111.449 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.34 -1.0 0.94 Allowed Glycine 0 CA--C 1.506 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.174 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -76.44 -23.75 53.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.287 -178.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -74.63 -47.56 31.4 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.303 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.81 28.41 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 116' ' ' ARG . 5.1 p -59.64 105.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.708 ' N ' ' HZ2' ' A' ' 91' ' ' LYS . . . 67.49 -41.02 0.23 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.792 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.473 HH21 HH12 ' A' ' 75' ' ' ARG . 7.0 mmt180 -100.79 79.72 0.23 Allowed Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.492 ' HB2' HH22 ' B' ' 17' ' ' ARG . 18.3 Cg_endo -64.83 -24.48 61.3 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -64.72 -57.31 9.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.446 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 123' ' ' LYS . 2.6 tpt -31.81 -45.4 0.1 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.741 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.626 ' NE ' ' CZ3' ' A' ' 45' ' ' TRP . 6.8 tpm_? -70.9 -46.77 61.96 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.46 -41.35 97.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.97 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.45 17.94 22.95 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.618 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 119' ' ' MET . 42.4 mtmt 47.12 -145.42 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.876 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -100.13 167.13 10.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -105.05 -5.14 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.586 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 126' ' ' ARG . 40.2 mtp-105 -58.51 131.94 52.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.671 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.578 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.55 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 2.6 pt-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' B' ' 11' ' ' LYS . 16.9 pttp -79.85 -41.49 26.21 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.965 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.773 ' H ' HH11 ' B' ' 12' ' ' ARG . 16.8 ttpt -72.85 -33.62 66.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 122.742 1.258 . . . . 0.0 108.431 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.937 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.5 mpt_? -61.8 -51.07 69.78 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.418 -2.173 . . . . 0.0 110.98 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' B' ' 17' ' ' ARG . 15.1 mt -68.33 -27.55 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.09 60.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.904 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.401 ' O ' HG23 ' B' ' 18' ' ' ILE . 29.5 mttp -54.16 -50.25 67.43 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.79 -37.49 70.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.302 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' B' ' 13' ' ' ILE . 17.6 ttt180 -61.79 -53.66 52.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.842 0.83 . . . . 0.0 110.163 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -57.35 -34.83 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.118 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -67.07 -31.28 71.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.143 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.462 HD12 HG21 ' B' ' 20' ' ' ILE . 31.3 mt -71.33 -56.88 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.605 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -65.14 -34.0 77.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.908 0.861 . . . . 0.0 109.087 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.6 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 14.0 t80 -53.09 -49.33 66.64 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.305 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.569 ' HG ' ' CA ' ' A' ' 33' ' ' ALA . 13.4 p -68.27 -37.21 80.48 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.123 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -60.4 -56.78 17.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.708 0.766 . . . . 0.0 110.032 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' CE2' ' B' ' 69' ' ' PHE . . . -51.57 -33.99 34.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.159 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.813 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 7.9 mm-40 -75.15 -43.51 52.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.583 0.706 . . . . 0.0 109.79 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.756 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 83.6 mtt-85 -72.69 -34.56 67.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.4 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.256 ' O ' ' N ' ' B' ' 32' ' ' SER . 3.6 m -85.19 -50.9 14.22 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.642 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.718 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 14.1 t80 -36.42 -49.73 1.81 Allowed Pre-proline 0 C--N 1.35 0.599 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.525 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.862 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 41.5 Cg_endo -55.39 -47.91 23.42 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 N-CA-C 106.893 -2.003 . . . . 0.0 106.893 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.862 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.2 t80 -94.47 -15.25 24.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.536 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.256 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -161.2 93.62 1.44 Allowed Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.6 ' CA ' ' HZ3' ' B' ' 37' ' ' LYS . 50.5 Cg_exo -53.7 -43.47 57.57 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.03 2.487 . . . . 0.0 114.158 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.08 -52.17 60.58 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.626 ' CD2' HH21 ' B' ' 38' ' ' ARG . 11.4 mt -51.3 -58.15 6.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -53.68 -34.04 57.37 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.354 0.597 . . . . 0.0 109.649 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.725 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -70.8 -41.06 72.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.391 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.666 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 3.6 ttm-85 -62.75 -51.54 66.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.406 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' B' ' 42' ' ' LEU . 1.5 m-30 -60.48 -41.19 93.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.097 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 3.1 t -45.27 -36.47 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.381 -1.281 . . . . 0.0 107.948 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 67.5 tt0 -67.87 -44.03 78.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' B' ' 39' ' ' TYR . 26.8 mt -66.17 -40.02 90.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.323 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -31.1 70.32 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.154 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 4.5 mt -63.16 -54.64 34.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.601 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.651 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.9 pp -60.2 -38.17 82.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.13 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 73.0 t -54.42 -44.37 66.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.451 0.643 . . . . 0.0 109.702 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.4 -55.16 17.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.761 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 13.3 pt20 -80.32 -52.27 7.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 13.9 mptt -61.7 -39.96 93.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.313 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -88.56 -11.65 45.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.07 67.63 0.84 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.112 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.93 137.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.899 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -44.54 141.41 1.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.145 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' B' ' 55' ' ' PRO . 6.7 tt -107.61 102.79 46.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' B' ' 54' ' ' ILE . 52.1 Cg_exo -51.24 -134.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.532 2.154 . . . . 0.0 112.235 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.484 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 0.8 OUTLIER -166.67 -16.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.628 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -58.68 -40.33 83.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.124 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' B' ' 62' ' ' TYR . 7.7 m0 -67.17 -3.51 7.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' B' ' 56' ' ' ARG . 2.7 pttt -69.04 -16.65 63.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' B' ' 60' ' ' ARG . 7.6 ptm85 -78.73 -20.37 50.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.558 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.903 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -140.71 17.87 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.138 -177.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' B' ' 58' ' ' TRP . 85.9 t80 -119.48 156.79 29.56 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.558 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.5 OUTLIER -127.22 124.08 38.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.043 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.51 4.48 49.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.507 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -97.53 -38.6 9.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.196 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.3 p -136.71 10.72 3.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.473 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' B' ' 66' ' ' CYS . 5.4 m-70 49.63 109.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.7 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.96 -170.04 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.725 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -122.85 105.06 9.68 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.903 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -109.47 141.69 41.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.814 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.7 t -119.71 121.01 30.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.09 122.92 6.87 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.017 1.811 . . . . 0.0 111.991 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 76' ' ' ALA . . . 101.78 -33.08 6.79 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.37 -77.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.773 0.321 . . . . 0.0 110.975 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -109.27 14.65 23.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.09 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' B' ' 73' ' ' GLY . . . -152.87 161.87 42.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -142.0 136.5 30.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.732 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 33.1 m -130.79 100.3 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 O-C-N 123.36 0.413 . . . . 0.0 111.489 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -165.41 120.06 1.27 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.196 0.522 . . . . 0.0 111.02 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.679 ' HB3' ' C ' ' B' ' 87' ' ' HIS . 21.7 tp -136.3 141.36 43.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.005 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . 0.597 ' O ' ' HB2' ' B' ' 82' ' ' GLN . 16.3 ptt180 -61.57 -179.61 0.19 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.02 0.438 . . . . 0.0 111.214 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' B' ' 81' ' ' ARG . 30.3 mm-40 132.12 143.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.995 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -103.31 -73.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.402 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -85.83 -5.91 59.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.383 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.541 ' O ' ' CE1' ' B' ' 87' ' ' HIS . 13.0 mtm -135.92 57.96 21.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.23 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -41.4 119.05 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.918 2.412 . . . . 0.0 112.852 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . 0.679 ' C ' ' HB3' ' B' ' 80' ' ' LEU . 3.7 m-70 -114.6 -179.19 3.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.555 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.63 ' CA ' ' HB3' ' B' ' 80' ' ' LEU . 1.2 mm -144.14 134.37 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.587 ' N ' ' HB2' ' B' ' 80' ' ' LEU . 53.3 t -95.67 116.41 37.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.62 118.86 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -136.02 145.98 46.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.59 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.2 OUTLIER -82.35 127.19 32.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.737 178.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.67 -3.85 58.69 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.368 0.604 . . . . 0.0 109.391 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.36 -51.42 5.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.842 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 4.7 p -118.42 76.26 1.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.73 93.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -128.04 126.41 41.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.651 -1.275 . . . . 0.0 109.984 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 tt -90.19 121.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.464 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 4.2 mtt -124.82 173.01 8.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.975 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 100' ' ' ARG . 33.4 mtm180 -128.05 155.3 44.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.438 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 3.7 t80 -157.93 91.52 2.22 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.181 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.82 164.61 9.5 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.147 1.898 . . . . 0.0 111.962 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -141.61 109.42 5.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.914 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.53 127.87 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.344 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.46 160.93 24.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.7 t -85.34 -10.83 55.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.674 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.3 m-85 -49.85 -48.79 50.95 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.12 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -40.84 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 110.45 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -101.77 -35.56 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.616 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.47 ' HA ' ' CE2' ' B' ' 31' ' ' TYR . 3.6 mm -94.96 22.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -80.45 117.89 27.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.69 0.281 . . . . 0.0 111.712 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.711 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 107.07 -33.15 6.6 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.154 -0.546 . . . . 0.0 114.078 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.8 28.47 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.988 0.894 . . . . 0.0 111.038 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.711 ' H ' ' C ' ' A' ' 25' ' ' GLY . 16.5 p -42.76 -14.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.565 0.698 . . . . 0.0 109.397 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.653 ' N ' ' O ' ' A' ' 26' ' ' ARG . 18.9 t-105 -58.84 -59.53 5.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.263 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 ' CG1' ' CE1' ' A' ' 30' ' ' PHE . 11.9 pt -56.97 -12.97 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.576 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 27.4 m-85 -94.25 -29.62 14.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -74.65 -41.59 60.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.46 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.18 26.15 10.76 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.75 15.43 1.09 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -127.81 100.49 5.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.997 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.527 ' H ' HG13 ' B' ' 20' ' ' ILE . 5.3 mmt85 -138.87 -9.64 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.82 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.628 ' H ' ' CG1' ' B' ' 20' ' ' ILE . . . -45.52 145.05 2.9 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 28.7 ttt180 -66.87 118.26 10.12 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.738 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 61.8 t -93.64 136.5 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 43' ' ' ILE . 10.7 t-20 -165.86 150.93 8.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.279 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.542 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 88.0 tttt -48.45 -55.5 10.73 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.357 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.619 ' HZ3' ' ND2' ' A' ' 39' ' ' ASN . 6.3 pttp -59.31 -5.28 0.71 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.626 ' O ' ' CG ' ' A' ' 46' ' ' HIS . 0.7 OUTLIER -125.12 0.5 7.86 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.231 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.65 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.9 -38.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.907 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.575 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -97.63 9.85 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.575 1.179 . . . . 0.0 108.015 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.797 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -125.82 6.44 7.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.535 -1.666 . . . . 0.0 107.664 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.694 ' C ' ' HE ' ' B' ' 17' ' ' ARG . 0.1 OUTLIER -107.97 176.16 5.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.687 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.708 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -94.57 111.75 23.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' C ' HG12 ' A' ' 49' ' ' ILE . 45.9 mt -75.21 115.39 14.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.63 ' CG2' ' CZ ' ' B' ' 39' ' ' TYR . 0.2 OUTLIER -161.02 -40.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -136.1 20.44 3.59 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -86.72 137.78 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' H ' HD21 ' A' ' 51' ' ' LEU . 76.2 tttt -71.1 135.89 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.669 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 1.8 p -149.48 171.89 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.442 0.639 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -146.98 140.27 25.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.901 178.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 65' ' ' GLY . 42.9 t -91.25 99.53 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.43 -50.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.457 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.33 117.9 13.89 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 4.5 t -150.27 174.02 13.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.758 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.691 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 1.4 p -97.14 78.84 2.79 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.691 ' CD2' ' O ' ' A' ' 59' ' ' THR . 71.1 m-70 -166.56 111.71 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.696 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.05 -6.03 17.23 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.88 1.72 . . . . 0.0 112.654 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.08 13.72 9.03 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.763 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 87' ' ' TRP . 30.5 m-85 -138.82 -22.74 0.95 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.345 1.072 . . . . 0.0 111.589 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.8 m -71.82 145.63 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.52 6.4 89.2 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.365 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.888 HD13 ' HE1' ' A' ' 87' ' ' TRP . 26.1 mt -111.9 158.4 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.597 ' H ' HG21 ' A' ' 66' ' ' ILE . 4.5 tt0 -115.13 120.54 40.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.88 171.37 26.86 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.145 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -91.03 129.91 36.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 51' ' ' LEU . 2.3 t -68.13 153.84 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.369 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.693 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 85.2 mt -141.59 -55.96 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.612 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 0.8 OUTLIER -106.41 150.21 26.26 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.666 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -156.68 107.05 2.33 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.477 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.73 -173.13 3.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 110.759 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -52.21 -29.5 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.581 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 10.3 t-20 -137.98 31.37 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.678 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -157.13 161.46 39.38 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 118.992 -1.083 . . . . 0.0 113.358 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.3 tp -161.93 109.23 1.37 Allowed 'General case' 0 C--O 1.243 0.748 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 72' ' ' ASP . 80.4 t -107.86 147.29 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -131.11 143.86 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.002 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.07 136.19 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.945 0.403 . . . . 0.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.86 136.89 5.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 51.77 -133.93 1.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.517 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -102.23 33.75 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 22.1 tptm -145.46 160.34 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.092 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 14.0 m -120.57 156.69 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.588 0.709 . . . . 0.0 110.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.888 ' HE1' HD13 ' A' ' 66' ' ' ILE . 2.6 m-90 -107.35 128.62 54.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.209 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' C ' ' CG2' ' A' ' 89' ' ' VAL . 83.0 tttt -118.64 106.54 12.71 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -152.31 99.58 2.85 Favored Pre-proline 0 CA--C 1.528 0.112 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.565 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.425 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 50.8 Cg_exo -50.66 137.9 41.16 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.812 1.675 . . . . 0.0 110.795 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.611 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -49.98 -19.9 0.81 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.787 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.611 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 1.2 p-10 -84.8 -6.17 59.34 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -125.12 5.89 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -142.34 139.41 31.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.117 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mt -85.71 116.99 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.698 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 53.1 m-85 -98.12 130.31 44.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.44 ' C ' HG22 ' A' ' 53' ' ' VAL . 38.3 tt0 -113.5 97.28 6.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.697 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 47.2 m-85 -90.28 145.14 25.21 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -90.62 127.04 36.15 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.773 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.662 ' HG1' ' CB ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -63.01 143.62 57.62 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.765 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.738 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.43 -0.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.402 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.7 t0 -106.85 13.38 27.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.23 21.92 69.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.662 ' CB ' ' HG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.58 149.77 26.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.625 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.619 ' N ' ' HZ1' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -91.05 132.4 36.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 20.6 mt -105.52 134.07 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.281 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -112.54 101.03 9.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -138.11 136.18 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.431 -177.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 111' ' ' GLU . 3.8 m -81.32 134.66 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.668 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' LYS . . . -59.33 -2.19 1.4 Allowed Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.829 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 pt-20 -86.19 -21.06 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.916 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -63.45 -44.33 94.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.92 27.72 3.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.216 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 116' ' ' ARG . 5.3 p -48.1 103.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.471 0.653 . . . . 0.0 112.333 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.509 ' H ' ' CG ' ' A' ' 91' ' ' LYS . . . 67.05 -41.44 0.2 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.725 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 114' ' ' VAL . 12.4 mtt85 -100.52 97.4 6.48 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HB2' ' NH2' ' B' ' 17' ' ' ARG . 24.7 Cg_endo -69.32 -30.16 24.78 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 N-CA-C 107.1 -1.923 . . . . 0.0 107.1 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -64.79 -53.3 49.13 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.703 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 118' ' ' GLU . 0.8 OUTLIER -29.37 -36.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.056 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.631 ' CZ ' ' CH2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -82.39 -53.32 6.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.017 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.42 -31.25 54.81 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.613 ' O ' ' C ' ' A' ' 123' ' ' LYS . 6.8 mtpp -84.71 -8.53 58.81 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.463 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.613 ' C ' ' O ' ' A' ' 122' ' ' LYS . 61.7 tttt -5.04 115.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.8 0.333 . . . . 0.0 111.833 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 126' ' ' ARG . 6.2 ttm-85 -55.26 -96.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.293 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 67.76 -40.15 0.4 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 124' ' ' ARG . 53.8 ttt85 -58.93 133.2 55.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.377 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.488 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.654 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -78.45 -37.88 42.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.576 -0.45 . . . . 0.0 112.161 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.81 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.3 OUTLIER -72.12 -33.24 67.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 122.958 1.361 . . . . 0.0 108.237 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.938 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -59.85 -51.01 71.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 112.013 -2.358 . . . . 0.0 111.216 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -69.68 -29.34 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.23 -48.57 64.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.503 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -50.75 -51.15 53.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' B' ' 13' ' ' ILE . 17.5 pt-20 -72.74 -36.7 67.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.206 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.694 ' HE ' ' C ' ' A' ' 46' ' ' HIS . 34.5 ttt-85 -60.92 -52.53 64.65 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.857 0.837 . . . . 0.0 110.606 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -35.91 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.422 -177.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.75 -32.15 72.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.628 ' CG1' ' H ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -73.78 -55.05 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.618 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.59 -34.45 75.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 2.0 t80 -54.43 -51.29 65.41 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.017 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -69.1 -31.53 70.3 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.501 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.492 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.3 OUTLIER -69.11 -54.4 15.17 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.3 31.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.614 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.837 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 49.6 mt-10 -73.89 -43.08 59.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.44 0.638 . . . . 0.0 110.437 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.773 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 86.0 mtt-85 -71.4 -35.42 71.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.384 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.205 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.4 m -82.33 -50.7 15.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 O-C-N 121.336 -0.853 . . . . 0.0 110.485 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.703 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 2.1 t80 -36.42 -51.2 1.84 Allowed Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.616 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.843 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 37.2 Cg_endo -53.66 -46.72 31.65 Favored 'Trans proline' 0 C--N 1.296 -2.188 0 N-CA-C 106.129 -2.297 . . . . 0.0 106.129 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.843 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.9 t80 -95.0 -14.32 24.46 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.139 -2.301 . . . . 0.0 113.269 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.205 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.6 p -157.91 96.24 1.95 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 52.7 Cg_exo -55.09 -47.4 26.62 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.967 2.445 . . . . 0.0 114.347 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.21 -53.2 56.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.523 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 62.0 mt -51.74 -60.25 3.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.984 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.616 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.8 -32.95 60.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.812 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.761 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.29 -38.46 75.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.702 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.693 ' NH2' ' O ' ' A' ' 71' ' ' ILE . 3.8 tmm_? -60.72 -50.35 73.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.027 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.63 ' CZ ' ' CG2' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -64.26 -40.46 96.04 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.8 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.02 -37.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -66.97 -45.45 77.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.579 ' CD1' ' NH1' ' B' ' 38' ' ' ARG . 11.6 mt -63.37 -50.7 68.88 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.454 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.29 68.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.805 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 10.4 mt -65.33 -54.43 29.13 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' B' ' 49' ' ' LYS . 3.5 pp -59.6 -35.03 73.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.673 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.635 ' CG2' ' NH1' ' B' ' 17' ' ' ARG . 73.4 t -64.94 -49.89 77.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.435 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.11 -51.13 70.91 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.022 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 7.0 pt20 -78.85 -39.64 34.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.762 ' HD3' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -83.06 -42.21 17.72 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.089 -177.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -67.06 -14.87 63.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 mttm 72.54 52.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.021 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.476 HG13 ' H ' ' B' ' 53' ' ' LYS . 0.2 OUTLIER -101.45 -178.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.995 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.476 ' H ' HG13 ' B' ' 52' ' ' VAL . 12.4 mtmm -71.16 162.47 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.56 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.417 HD12 ' N ' ' B' ' 54' ' ' ILE . 0.1 OUTLIER -78.06 148.29 74.78 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.69 -69.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.592 2.195 . . . . 0.0 112.342 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 77.32 -83.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.362 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.617 ' O ' ' NE ' ' B' ' 60' ' ' ARG . 11.3 pttm -55.96 -39.69 72.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.623 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 36.2 m0 -61.89 1.5 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' B' ' 57' ' ' LYS . 7.5 pttp -66.26 -17.06 64.52 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' B' ' 57' ' ' LYS . 9.6 ptp180 -76.17 -18.86 58.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.84 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.785 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -147.53 15.34 1.12 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.417 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 32.4 t80 -113.54 154.08 27.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.584 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 5.8 t -123.66 114.51 20.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.896 0.379 . . . . 0.0 111.448 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.36 3.89 12.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.921 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.541 ' HB2' ' SG ' ' B' ' 95' ' ' CYS . 1.8 mmmt -98.27 -43.49 6.94 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.482 ' C ' ' CG ' ' B' ' 67' ' ' HIS . 6.1 p -134.14 -2.64 2.84 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.599 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.482 ' CG ' ' C ' ' B' ' 66' ' ' CYS . 0.3 OUTLIER 61.94 134.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.513 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' B' ' 67' ' ' HIS . . . 164.97 -170.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.098 0.475 . . . . 0.0 110.783 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.761 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -117.96 103.92 10.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.785 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -110.23 117.35 33.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.45 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.44 ' CG2' ' CE2' ' B' ' 29' ' ' PHE . 1.5 t -101.59 121.06 52.63 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.939 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.15 124.79 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.792 1.662 . . . . 0.0 111.38 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.98 -33.93 6.18 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -96.78 -80.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.854 0.359 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.43 18.6 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.115 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.0 164.44 33.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.591 HH21 ' NH1' ' B' ' 79' ' ' ARG . 79.7 mtp180 -144.17 129.64 18.99 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.478 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' B' ' 78' ' ' VAL . 15.5 m -138.07 104.67 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.591 ' NH1' HH21 ' B' ' 77' ' ' ARG . 18.7 mtm-85 -128.08 145.2 51.07 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.256 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 1.5 pp -125.39 124.22 41.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.668 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -137.65 155.07 49.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.61 ' C ' ' H ' ' B' ' 84' ' ' ARG . 12.7 mp0 -85.6 -97.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.466 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 23.4 tttt 67.9 -13.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.076 0.465 . . . . 0.0 109.988 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.61 ' H ' ' C ' ' B' ' 82' ' ' GLN . 5.5 ptp180 179.53 -24.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.499 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' MET . . . . . . . . . . . . . 1.2 mtt 177.56 136.8 0.22 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.061 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.52 103.4 1.42 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.105 1.87 . . . . 0.0 112.16 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . 0.411 ' ND1' ' HA ' ' B' ' 102' ' ' PRO . 5.3 m-70 -127.41 132.16 50.16 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.936 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.464 HG21 HD11 ' B' ' 88' ' ' ILE . 1.0 OUTLIER -84.26 135.89 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 7.1 p -106.09 119.42 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -112.32 129.55 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -147.87 144.74 28.33 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.638 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.804 ' H ' ' HD1' ' B' ' 97' ' ' HIS . 1.1 t -81.33 131.98 35.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.224 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -95.78 0.34 52.21 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.502 0.501 . . . . 0.0 109.785 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -44.9 7.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.856 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 4.6 p -129.95 79.5 1.91 Allowed 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.066 -1.879 . . . . 0.0 106.235 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.2 94.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 122.197 0.887 . . . . 0.0 111.936 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.804 ' HD1' ' H ' ' B' ' 92' ' ' CYS . 0.1 OUTLIER -118.76 120.71 38.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.412 -1.394 . . . . 0.0 108.931 178.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 79.3 mt -91.51 120.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.839 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 16.6 mmm -132.25 165.15 24.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.99 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -129.5 154.64 46.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -155.95 106.63 2.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.258 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.411 ' HA ' ' ND1' ' B' ' 87' ' ' HIS . 58.4 Cg_exo -47.44 170.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.362 2.042 . . . . 0.0 112.478 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -115.94 75.87 0.98 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.926 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.78 115.17 45.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.341 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 59.1 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.41 179.819 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.72 145.09 12.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -92.0 -4.29 54.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.298 . . . . 0.0 110.644 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 22' ' ' GLU . 8.6 m-85 -43.23 -57.23 3.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -38.62 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.902 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 20' ' ' TYR . 47.0 tp10 -104.13 -32.6 9.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' TYR . 3.1 mm -102.05 15.58 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.51 117.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.373 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.727 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.41 -36.42 4.06 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.328 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.676 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.32 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.631 0.716 . . . . 0.0 110.793 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.727 ' H ' ' C ' ' A' ' 25' ' ' GLY . 14.2 p -41.9 -14.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 109.601 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.676 ' N ' ' O ' ' A' ' 26' ' ' ARG . 23.2 t-105 -57.31 -53.74 54.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.212 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 HH11 ' B' ' 27' ' ' ARG . 8.6 pt -67.67 -13.11 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.082 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 71' ' ' ILE . 41.3 m-85 -92.8 -9.88 38.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.5 ttp180 -95.04 -64.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.77 31.74 0.38 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.647 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -146.63 -36.51 0.24 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -90.84 112.29 24.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' H ' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -148.47 2.13 0.63 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.943 -179.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.478 ' N ' HD13 ' B' ' 20' ' ' ILE . . . -45.91 153.56 0.8 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 9.2 ttm180 -67.69 117.73 10.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.757 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 47.0 t -95.25 134.2 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 43' ' ' ILE . 5.7 t-20 -166.1 149.94 7.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.276 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.562 ' C ' ' H ' ' A' ' 42' ' ' ASN . 11.3 tttm -48.26 -55.14 11.3 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 44.2 pttt -59.91 -4.86 0.81 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.756 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 10.8 m120 -123.77 -0.35 8.56 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.229 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.64 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.54 -39.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.562 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -92.3 9.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.833 1.301 . . . . 0.0 107.578 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -126.55 -6.44 6.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.849 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.756 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -93.35 147.1 23.23 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.866 ' OE1' ' NE ' ' B' ' 17' ' ' ARG . 0.4 OUTLIER -74.48 110.64 8.93 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.566 ' C ' HG12 ' A' ' 49' ' ' ILE . 15.8 mt -73.24 117.94 15.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 HG12 ' C ' ' A' ' 48' ' ' LEU . 4.4 mm -152.69 -30.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.763 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -146.76 0.03 0.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.541 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.611 ' CD2' ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -58.32 162.35 3.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.665 0.732 . . . . 0.0 109.488 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.611 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 11.9 tttt -106.73 125.16 50.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.472 0.177 . . . . 0.0 111.171 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.833 HG21 ' H ' ' A' ' 54' ' ' ARG . 14.5 p -148.97 170.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.443 0.639 . . . . 0.0 111.513 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.833 ' H ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -132.27 145.43 51.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.439 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 65' ' ' GLY . 23.7 t -100.83 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.34 -47.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.937 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -127.77 119.43 25.72 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.133 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.548 ' CB ' ' HD1' ' A' ' 60' ' ' HIS . 1.9 p -148.61 135.95 20.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.052 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.629 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -71.26 77.1 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.281 -1.368 . . . . 0.0 108.948 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.629 ' CG ' ' C ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -169.29 97.89 0.5 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.027 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.89 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.469 2.113 . . . . 0.0 113.774 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -124.0 24.43 6.33 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 120.402 -0.904 . . . . 0.0 114.407 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -141.05 -21.98 0.78 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.804 1.302 . . . . 0.0 111.694 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 58' ' ' SER . 3.1 m -72.96 145.08 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.75 5.31 89.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.919 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.562 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 1.1 mt -104.64 148.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 118.259 1.03 . . . . 0.0 111.538 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -114.71 126.97 55.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.81 173.37 27.9 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.981 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -95.85 120.21 35.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -53.12 141.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.117 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.729 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.6 mt -135.39 -36.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.971 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.7 t70 -121.83 141.68 50.99 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.614 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 5.0 tt0 -153.19 106.23 2.97 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -140.42 -176.77 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.125 0.488 . . . . 0.0 110.725 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 72.6 ttt-85 -57.96 -16.46 12.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.816 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -138.77 27.29 2.46 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.551 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 2.4 ptp -165.96 170.02 14.12 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 118.7 -1.2 . . . . 0.0 114.066 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 1.4 tp -166.13 110.24 0.8 Allowed 'General case' 0 C--O 1.252 1.233 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 71' ' ' ILE . 66.0 t -120.01 136.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.687 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -114.84 151.96 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -128.13 135.93 50.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.122 0.486 . . . . 0.0 111.82 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.434 ' N ' ' HZ3' ' A' ' 87' ' ' TRP . . . -157.53 122.64 1.19 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 66.73 -130.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -108.69 18.17 21.12 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.947 0.403 . . . . 0.0 110.101 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -119.56 144.51 47.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.425 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.73 155.47 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.512 0.673 . . . . 0.0 110.959 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.562 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 3.2 m-90 -99.39 137.69 37.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.294 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -128.95 93.74 3.67 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.14 107.35 2.63 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.366 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.29 165.0 2.42 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.794 1.662 . . . . 0.0 110.563 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HD2' ' H ' ' A' ' 115' ' ' GLY . 1.7 mttm -72.79 -21.42 60.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.68 -5.73 59.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.0 15.36 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 15.1 p -161.32 174.29 13.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.015 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.09 139.72 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.807 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.708 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 88.1 m-85 -121.66 131.31 54.03 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.525 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 43.9 tt0 -114.69 94.48 4.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.664 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 3.1 m-85 -86.74 145.24 26.73 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -89.78 129.4 36.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.659 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.06 143.36 57.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.729 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.757 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.37 0.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.55 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 84.8 m-20 -107.26 13.42 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.01 21.93 66.94 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.87 150.05 26.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.635 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 133.3 36.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 111.121 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.47 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 16.0 mt -106.49 134.03 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -115.93 102.98 10.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -147.8 140.93 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.34 -178.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' GLU . 10.5 p -88.38 150.71 23.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.435 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.34 -1.77 4.73 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.604 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -78.85 -21.55 47.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.658 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -73.66 -47.5 39.35 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.297 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.75 28.04 2.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.42 106.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.631 ' H ' ' HD2' ' A' ' 91' ' ' LYS . . . 68.2 -41.08 0.28 Allowed Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.476 -1.238 . . . . 0.0 114.464 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -101.92 87.87 1.13 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -69.47 -26.41 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 119' ' ' MET . 0.0 OUTLIER -65.99 -57.69 7.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.685 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.429 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 5.3 ttp -31.43 -54.35 0.24 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.767 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -45.21 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.298 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.463 ' CD2' ' O ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -48.06 -30.98 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.251 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -103.54 -18.59 14.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.413 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 122' ' ' LYS . 37.6 ttmt 58.86 145.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt85 -93.8 133.63 36.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.609 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -170.34 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.18 148.81 27.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.361 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.572 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.724 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 28.9 mt-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -29.07 44.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.951 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -33.93 64.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.68 1.229 . . . . 0.0 108.526 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.92 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -63.6 -51.7 64.14 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 112.322 -2.217 . . . . 0.0 111.722 -178.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.541 ' O ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -71.07 -27.12 28.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.95 80.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.1 mttt -63.17 -49.56 73.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.962 0.411 . . . . 0.0 110.488 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.521 ' C ' ' NH1' ' B' ' 17' ' ' ARG . 1.0 OUTLIER -69.34 -35.36 75.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.866 ' NE ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -62.16 -52.04 65.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.512 0.672 . . . . 0.0 111.342 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.99 -41.65 91.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.594 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 5.3 m-20 -69.78 -26.74 64.43 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.692 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.593 ' CD1' ' H ' ' A' ' 35' ' ' ARG . 5.7 mm -74.16 -57.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.608 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.67 -34.26 76.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 11.6 t80 -53.72 -47.89 70.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.381 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 37.7 m -70.95 -34.11 71.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.449 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.45 HD11 ' CG1' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -67.86 -55.18 13.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.552 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.48 ' CB ' ' CE2' ' B' ' 69' ' ' PHE . . . -50.62 -38.44 46.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.735 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.823 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 23.7 mt-10 -65.84 -46.79 77.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.15 0.5 . . . . 0.0 111.263 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.793 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 1.7 ttt-85 -72.17 -33.47 67.72 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.354 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.171 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.7 m -82.6 -50.71 15.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.424 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.727 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 1.6 t80 -36.39 -50.63 1.82 Allowed Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.842 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 37.3 Cg_endo -53.64 -46.36 34.27 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 N-CA-C 106.21 -2.265 . . . . 0.0 106.21 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.842 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 39.8 t80 -94.92 -12.66 26.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.028 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.171 ' N ' ' O ' ' B' ' 28' ' ' VAL . 60.5 p -160.34 96.67 1.48 Allowed Pre-proline 0 N--CA 1.472 0.654 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.64 -44.75 45.02 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.261 2.641 . . . . 0.0 114.439 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.34 -53.0 55.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.035 0.445 . . . . 0.0 112.133 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.509 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 24.3 mt -53.81 -61.14 2.5 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.093 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.55 -32.72 42.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.725 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.604 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.46 -41.05 73.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.079 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.729 ' NH2' ' O ' ' A' ' 71' ' ' ILE . 2.8 tmm_? -59.68 -53.58 56.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.555 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.584 ' N ' ' CD1' ' B' ' 39' ' ' TYR . 1.1 m-30 -58.88 -43.17 90.86 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 110.049 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.32 -40.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.902 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.95 -42.21 99.75 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' B' ' 39' ' ' TYR . 63.2 mt -67.39 -51.36 52.83 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.477 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -31.03 30.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.987 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 23.8 mt -65.33 -54.44 28.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.305 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.523 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 1.4 pp -62.02 -28.3 69.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.832 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 95.1 t -64.34 -48.87 83.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.602 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . 0.434 ' NE2' ' CD1' ' B' ' 18' ' ' ILE . 1.8 tp-100 -65.74 -57.41 8.09 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.8 pt20 -81.62 -52.16 7.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 5.4 tptt -62.96 -37.71 88.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.889 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -81.45 -0.71 42.9 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.725 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 63.61 69.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.744 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -132.06 156.88 42.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.743 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.405 ' HG2' ' HZ2' ' B' ' 53' ' ' LYS . 1.0 OUTLIER -44.9 145.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tt -112.25 94.28 25.75 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.747 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.66 177.74 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.451 2.101 . . . . 0.0 110.997 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.444 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 77.4 mtp180 -149.25 24.37 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.907 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.63 ' C ' ' H ' ' B' ' 59' ' ' LYS . 17.3 ptmt -86.97 -38.38 16.68 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.626 ' O ' ' N ' ' B' ' 62' ' ' TYR . 6.0 m-90 -49.5 -2.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.63 ' H ' ' C ' ' B' ' 57' ' ' LYS . 24.4 mtpp -61.65 -19.66 62.55 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.81 -17.79 64.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.803 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -150.74 8.3 0.57 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.64 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' B' ' 58' ' ' TRP . 92.6 t80 -117.72 157.5 26.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.988 0.423 . . . . 0.0 110.551 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' B' ' 62' ' ' TYR . 22.6 t -126.99 129.99 49.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.042 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -87.33 3.13 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.79 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' B' ' 97' ' ' HIS . 1.1 mmpt? -108.16 -31.44 7.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.796 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' B' ' 67' ' ' HIS . 11.5 p -138.96 10.44 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.209 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.0 OUTLIER 37.12 103.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.985 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.25 -173.05 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.122 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.604 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -113.97 103.18 10.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.803 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -105.57 147.56 28.26 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.632 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.95 120.72 24.11 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.86 123.64 6.29 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.859 1.706 . . . . 0.0 111.654 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.13 -33.26 6.67 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 94.8 mt -94.44 -80.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.615 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.86 22.64 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.29 157.76 42.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.225 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.12 138.42 23.98 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.745 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 20.8 m -138.82 119.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -130.66 146.21 52.1 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 1.5 pp -125.97 126.93 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.937 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.74 158.54 44.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.44 . . . . 0.0 111.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' B' ' 83' ' ' LYS . 4.1 pt20 -76.72 -130.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.3 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 82' ' ' GLN . 14.4 tptm 83.7 70.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.013 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' B' ' 85' ' ' MET . 0.9 OUTLIER 45.07 93.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.768 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' B' ' 84' ' ' ARG . 1.7 tmm? 85.75 110.24 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.798 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.05 136.18 19.96 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.175 1.917 . . . . 0.0 112.149 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -144.19 146.26 32.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.044 0.45 . . . . 0.0 111.248 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' B' ' 80' ' ' LEU . 0.0 OUTLIER -102.02 137.1 31.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.933 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 8.3 t -103.42 110.89 31.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.279 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.09 135.81 60.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . 0.615 ' HA ' ' O ' ' B' ' 97' ' ' HIS . 5.9 tttp -154.22 153.73 32.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.479 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.565 ' H ' ' HB3' ' B' ' 97' ' ' HIS . 12.1 t -81.26 130.79 35.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 14.1 mt -108.79 17.26 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.597 1.186 . . . . 0.0 108.279 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . 0.539 ' OE2' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -95.41 -30.46 13.88 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.881 ' SG ' ' N ' ' B' ' 96' ' ' GLY . 21.5 p -144.21 -104.17 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.407 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.881 ' N ' ' SG ' ' B' ' 95' ' ' CYS . . . -159.88 98.21 0.17 Allowed Glycine 0 C--N 1.315 -0.631 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' B' ' 91' ' ' LYS . 20.0 t-160 -122.34 113.47 19.44 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.888 0.844 . . . . 0.0 111.05 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mt -94.33 119.67 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 6.2 mmt -141.54 159.9 41.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.472 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -141.71 141.21 33.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.002 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -136.32 103.64 9.55 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.008 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.25 166.05 3.66 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.253 1.969 . . . . 0.0 112.495 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -142.37 74.5 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.32 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 76.8 mt -100.5 135.07 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.511 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.11 129.86 21.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -90.76 -21.29 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' A' ' 72' ' ' ASP . 54.0 m-85 -38.32 -62.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.915 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.39 -7.92 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.414 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.3 tp10 -97.9 -36.93 10.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' B' ' 32' ' ' SER . 2.5 mm -104.51 14.16 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.3 tp -79.98 118.8 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.413 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.685 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 120.07 -38.85 2.63 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -66.87 27.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.685 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -41.94 -14.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.739 0.78 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 28.1 t-105 -58.71 -54.44 47.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.329 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.523 ' O ' HD11 ' B' ' 24' ' ' LEU . 4.7 pt -66.2 -14.25 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -89.71 -34.35 16.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -86.98 -32.61 19.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.765 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' NH1' ' B' ' 27' ' ' ARG . . . -85.48 28.81 4.64 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -156.13 20.72 0.37 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -127.15 101.91 6.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.671 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.444 ' H ' ' CG1' ' B' ' 20' ' ' ILE . 23.0 mmt-85 -145.85 12.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.938 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.619 ' HA3' HH21 ' B' ' 17' ' ' ARG . . . -62.32 152.45 44.3 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.59 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 14.9 ttm180 -67.31 132.84 48.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.711 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 55.1 t -116.8 136.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.707 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.691 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -166.23 153.81 10.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.617 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' A' ' 42' ' ' ASN . 28.8 tttm -49.83 -55.8 12.81 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.837 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.623 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 42.9 pttt -60.64 -3.51 0.72 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.747 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 31.6 m-20 -124.72 1.12 8.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.26 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -89.98 -42.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.876 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -89.7 0.79 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.809 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -117.23 18.04 14.59 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.008 -1.906 . . . . 0.0 107.68 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.747 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.23 126.58 45.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.925 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.672 ' H ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -59.28 113.42 2.15 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' C ' HG12 ' A' ' 49' ' ' ILE . 2.6 mt -78.13 122.18 25.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.759 0.314 . . . . 0.0 111.001 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.591 HG12 ' C ' ' A' ' 48' ' ' LEU . 2.0 mm -151.22 -46.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.936 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -127.57 -3.06 6.15 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.181 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -60.35 140.87 56.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.248 0.524 . . . . 0.0 110.358 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -75.38 135.56 40.8 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 2.7 p -148.75 170.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.611 HH22 ' HZ2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -150.33 140.52 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.855 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.4 t -88.19 100.79 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.5 -51.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 O-C-N 123.374 0.421 . . . . 0.0 110.512 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.7 118.75 15.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.182 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.752 ' HG ' ' ND1' ' A' ' 60' ' ' HIS . 23.3 t -148.74 174.23 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.96 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.703 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 5.9 t -103.11 78.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.752 ' ND1' ' HG ' ' A' ' 58' ' ' SER . 19.2 m80 -167.62 118.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.17 -5.29 15.48 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 121.73 1.62 . . . . 0.0 112.975 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.14 20.94 7.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.187 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.21 -23.09 0.75 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.905 1.352 . . . . 0.0 112.098 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.57 145.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.64 7.31 87.6 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.257 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.825 ' CD1' ' HE1' ' A' ' 87' ' ' TRP . 19.8 mt -108.05 159.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 66' ' ' ILE . 5.7 tm-20 -126.76 121.82 33.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.459 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.09 172.38 28.38 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.073 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 1.6 m-85 -87.32 123.56 32.42 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' ILE . 2.9 t -56.43 157.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 79' ' ' VAL . 93.9 mt -143.73 -60.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 62.0 t0 -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.828 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -153.72 106.56 2.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 178.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 76' ' ' ASN . 14.6 t -157.97 177.59 11.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.225 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -53.69 -5.12 0.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.274 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.601 ' N ' ' HZ1' ' A' ' 91' ' ' LYS . 78.3 m-20 -137.98 0.79 2.21 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.425 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 4.8 ptp -165.78 167.89 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 4.5 tp -151.16 109.72 3.81 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.1 t -113.71 147.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -127.99 141.57 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.999 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.46 136.48 49.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -151.56 119.0 0.94 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 3.5 tp10 65.07 -123.14 0.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.451 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 3.3 m120 -111.57 21.01 16.61 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.973 0.416 . . . . 0.0 110.475 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.542 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.0 tttp -130.66 164.46 24.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.481 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.481 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 29.2 m -120.67 156.28 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 110.637 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.825 ' HE1' ' CD1' ' A' ' 66' ' ' ILE . 2.5 m-90 -105.62 104.49 14.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.182 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.93 110.26 22.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.98 96.35 3.31 Favored Pre-proline 0 C--N 1.334 -0.097 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.224 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -55.75 146.31 66.99 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.882 1.721 . . . . 0.0 111.308 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HZ1' ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -53.68 -29.11 37.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.613 -178.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -6.96 59.55 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -126.13 22.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.509 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.662 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 24.6 p -165.27 158.3 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.457 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.5 mt -112.58 124.62 69.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.627 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.662 ' CE2' ' SG ' ' A' ' 94' ' ' CYS . 72.4 m-85 -100.92 144.53 29.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 18.6 tt0 -125.75 97.59 5.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 8.1 m-85 -90.45 145.72 24.7 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -89.46 130.76 35.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.068 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -65.48 142.46 58.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.483 0.659 . . . . 0.0 110.265 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.711 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.24 0.19 0.11 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.678 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 100' ' ' THR . 55.1 t0 -107.15 4.43 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.77 23.2 36.64 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.659 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -107.05 150.16 26.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 110.35 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.611 ' HZ2' HH22 ' A' ' 54' ' ' ARG . 16.7 mmtp -90.52 128.8 36.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 111.359 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.449 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 14.1 mt -104.03 135.07 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -120.35 101.82 8.05 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.25 132.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.063 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 m -74.34 145.34 43.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.153 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -63.86 -2.52 6.48 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.546 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -81.46 -22.79 37.87 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.62 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -69.22 -44.56 71.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.022 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.0 29.38 3.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 p -54.36 105.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.4 ' H ' ' HD3' ' A' ' 91' ' ' LYS . . . 68.82 -40.49 0.31 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.685 -1.143 . . . . 0.0 114.735 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -100.49 85.75 0.57 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.68 -23.45 76.32 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -68.59 -57.25 6.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.489 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 118' ' ' GLU . 26.4 ttp -24.8 -48.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.572 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' GLU . 2.9 tpm_? -82.58 -49.18 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.852 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -52.15 -39.11 59.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.495 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 123' ' ' LYS . 1.3 ptmt -88.22 -34.92 17.6 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.917 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 122' ' ' LYS . 87.7 tttt 56.57 146.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.149 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.31 150.32 51.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.46 ' CD2' ' N ' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -95.35 -52.5 4.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 46.2 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.572 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.2 mttm . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.286 179.728 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.493 ' O ' HG12 ' B' ' 13' ' ' ILE . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.51 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -53.73 -37.28 63.19 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.009 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.57 ' HG2' ' HD2' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -65.41 -46.64 79.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.276 1.036 . . . . 0.0 109.38 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.624 ' O ' ' CD ' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -64.92 -51.05 63.99 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.314 -1.767 . . . . 0.0 112.433 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.493 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.8 pt -62.61 -27.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.5 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.57 -38.14 74.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.416 ' HZ2' ' HZ1' ' B' ' 11' ' ' LYS . 37.1 mttt -60.85 -47.2 87.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.702 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.624 ' CD ' ' O ' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -67.31 -38.43 84.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.366 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.697 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 2.6 mmp_? -67.39 -52.31 41.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.499 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -57.48 -42.53 81.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 6.9 m-20 -71.71 -32.42 67.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.45 ' O ' ' OG ' ' B' ' 23' ' ' SER . 1.2 mp -71.33 -53.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.633 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -66.1 -33.54 76.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 0.6 OUTLIER -52.1 -44.33 64.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.943 178.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 18.7 p -73.86 -31.9 63.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.331 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.56 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -68.46 -58.21 4.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.26 -42.41 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.82 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -60.03 -50.65 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.529 0.68 . . . . 0.0 110.031 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.775 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 2.9 ttm180 -67.9 -37.74 82.12 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.958 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.213 ' O ' ' N ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -86.75 -42.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.363 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.779 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 25.2 t80 -39.17 -49.11 4.44 Favored Pre-proline 0 CA--C 1.509 -0.624 0 CA-C-N 119.982 1.265 . . . . 0.0 108.689 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.874 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 40.3 Cg_endo -54.45 -46.85 30.35 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.389 2.06 . . . . 0.0 106.747 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.874 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 34.8 t80 -93.53 -14.51 26.52 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.534 -2.121 . . . . 0.0 112.37 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.213 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -163.49 95.98 1.05 Allowed Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' B' ' 29' ' ' PHE . 52.3 Cg_exo -54.63 -45.09 43.57 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.197 2.598 . . . . 0.0 114.684 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.77 -53.65 53.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.726 ' CD2' HH21 ' B' ' 38' ' ' ARG . 32.4 mt -51.78 -58.39 6.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.7 -30.92 34.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.398 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.641 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.02 -41.75 70.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.612 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.726 HH21 ' CD2' ' B' ' 35' ' ' LEU . 2.4 ttm-85 -63.26 -46.98 84.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' B' ' 42' ' ' LEU . 2.2 m-85 -67.91 -40.06 83.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.942 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 36' ' ' ALA . 2.4 t -46.63 -40.96 4.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.901 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.57 -38.73 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' B' ' 39' ' ' TYR . 17.9 mt -66.91 -45.43 77.96 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.718 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.0 -30.54 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 60.6 mt -69.02 -54.77 13.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.071 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 3.1 pp -57.4 -30.85 65.27 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 58.0 t -62.05 -47.13 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.525 0.679 . . . . 0.0 109.479 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.66 -56.12 10.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.384 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 5.7 pt20 -80.21 -46.74 15.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.21 -38.31 69.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.593 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -86.03 -9.63 56.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 63.02 74.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.307 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.35 154.84 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.221 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -113.63 117.09 30.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.776 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.471 HG23 ' H ' ' B' ' 56' ' ' ARG . 0.4 OUTLIER -135.61 142.99 43.08 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.962 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . 0.408 ' O ' ' CB ' ' B' ' 56' ' ' ARG . 19.7 Cg_endo -59.47 -32.26 96.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.123 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.471 ' H ' HG23 ' B' ' 54' ' ' ILE . 48.8 ttm-85 78.37 81.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' B' ' 59' ' ' LYS . 0.5 OUTLIER -79.7 -22.94 42.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.82 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' B' ' 60' ' ' ARG . 5.0 m0 -58.51 -0.15 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.524 ' H ' ' C ' ' B' ' 57' ' ' LYS . 25.6 pttt -61.37 -6.84 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' B' ' 58' ' ' TRP . 11.8 ptp180 -93.08 -21.9 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.973 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.835 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -145.76 29.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.373 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 24.2 t80 -122.4 151.6 41.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.567 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 1.5 t -123.04 114.3 20.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.524 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -83.83 9.13 12.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 109.567 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB2' ' SG ' ' B' ' 95' ' ' CYS . 9.1 mmmt -99.34 -40.4 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.01 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.507 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.4 p -136.79 9.29 3.07 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.271 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' B' ' 66' ' ' CYS . 4.4 m80 54.84 122.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . 172.22 -171.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.163 0.506 . . . . 0.0 111.141 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.641 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 1.8 t80 -123.6 105.4 9.7 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.835 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.2 OUTLIER -111.42 124.97 53.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.507 -177.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.23 127.21 28.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.9 125.98 12.28 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.174 1.916 . . . . 0.0 112.372 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.24 -35.93 4.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.5 -76.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.22 19.29 13.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.31 166.78 28.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.047 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -147.43 134.73 20.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.886 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 34.5 m -133.15 111.89 17.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.093 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -142.66 149.74 39.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.468 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.503 ' CD2' ' O ' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -123.09 142.46 50.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.653 0.739 . . . . 0.0 112.187 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -88.3 136.27 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.56 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.28 98.93 10.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.6 ' O ' ' O ' ' B' ' 84' ' ' ARG . 4.3 tptp -166.89 98.72 0.55 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.599 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.6 ' O ' ' O ' ' B' ' 83' ' ' LYS . 52.1 mtt-85 41.15 105.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 110.328 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.541 ' O ' ' CE1' ' B' ' 87' ' ' HIS . 5.7 mtt 58.15 61.86 5.25 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -37.68 159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.321 2.68 . . . . 0.0 112.607 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' B' ' 85' ' ' MET . 1.2 m80 -142.03 131.6 23.94 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.4 OUTLIER -84.05 148.07 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.816 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 23.4 t -120.35 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.105 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -118.9 131.34 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -144.33 148.73 35.13 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.054 -1.059 . . . . 0.0 113.462 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.577 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.3 OUTLIER -85.33 129.0 34.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.499 179.428 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 37.4 mt -93.18 0.35 57.12 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -92.16 -51.68 5.06 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.848 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 6.2 p -121.18 78.48 1.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.48 94.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.41 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -127.94 132.88 49.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.69 -1.255 . . . . 0.0 109.77 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.4 HD13 HG21 ' B' ' 98' ' ' ILE . 83.5 mt -100.85 122.89 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.712 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 18.7 mtt -121.8 148.46 44.64 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.092 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -109.05 148.2 31.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.672 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' B' ' 88' ' ' ILE . 0.3 OUTLIER -145.11 95.98 5.04 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.453 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.06 168.51 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.214 1.943 . . . . 0.0 112.316 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.445 ' HH ' ' HZ3' ' B' ' 105' ' ' LYS . 12.1 t80 -140.89 86.15 2.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.042 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 mt -109.64 129.55 64.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.78 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . 0.445 ' HZ3' ' HH ' ' B' ' 103' ' ' TYR . 10.4 mttp . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.319 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.84 0.44 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 22' ' ' GLU . 96.4 p -62.66 -24.99 67.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.751 0.31 . . . . 0.0 110.682 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.419 ' C ' ' N ' ' A' ' 22' ' ' GLU . 8.1 m-85 -40.19 -58.85 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -49.57 -15.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.749 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' SER . 49.0 tp10 -104.49 -33.13 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 23' ' ' ILE . 6.6 mm -100.83 18.7 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.0 tp -79.66 117.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.421 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.66 -38.1 3.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.537 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.7 32.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.738 0.769 . . . . 0.0 111.32 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.668 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -44.82 -11.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.653 ' H ' ' C ' ' A' ' 26' ' ' ARG . 7.9 t-105 -59.74 -59.85 4.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.511 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 17.8 pt -60.93 -10.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.216 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.42 ' O ' ' CB ' ' A' ' 34' ' ' HIS . 39.3 m-85 -94.19 -19.26 20.92 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.537 ' C ' ' H ' ' A' ' 33' ' ' ALA . 6.5 mmm-85 -80.7 -69.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.528 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.33 44.16 1.11 Allowed Glycine 0 CA--C 1.518 0.276 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -158.09 -38.87 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.42 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 44.7 t-80 -109.49 100.05 9.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.776 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -154.03 13.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.788 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -43.51 163.55 0.04 OUTLIER Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.636 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 7.8 ttt180 -67.84 112.34 4.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.369 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.714 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 54.5 t -90.19 136.37 24.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -165.6 145.95 6.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.048 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 42' ' ' ASN . 59.9 tttm -47.14 -54.4 10.66 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.421 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 47.1 pttt -62.82 -4.46 2.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 7.0 m120 -121.68 -4.61 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.439 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.87 -40.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.745 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.586 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -87.38 10.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.993 1.378 . . . . 0.0 107.394 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.811 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -122.98 -38.4 2.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.975 -1.92 . . . . 0.0 107.636 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.684 ' HD1' ' CG2' ' B' ' 13' ' ' ILE . 0.0 OUTLIER -58.4 174.48 0.3 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.755 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' OE2' ' CZ ' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -100.76 109.05 21.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 176.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -76.54 117.05 17.79 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 117.585 -1.646 . . . . 0.0 108.055 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -162.56 40.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.93 -29.17 0.59 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.504 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.54 137.62 4.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -77.79 128.9 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CG2' ' N ' ' A' ' 54' ' ' ARG . 5.2 p -148.4 169.37 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.39 0.614 . . . . 0.0 111.211 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.623 ' N ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -139.26 146.98 41.08 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.994 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' GLY . 66.2 t -98.15 98.88 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -91.17 -51.57 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.996 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -126.06 118.32 25.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.467 ' HG ' ' HB2' ' A' ' 60' ' ' HIS . 4.0 p -148.72 159.97 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.454 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.591 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -88.64 80.43 7.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 59' ' ' THR . 5.7 m170 -167.62 116.27 0.66 Allowed Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.77 -4.85 14.11 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.817 1.678 . . . . 0.0 113.961 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.43 32.88 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.686 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -141.26 -21.32 0.77 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.032 0.916 . . . . 0.0 111.645 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -72.38 138.41 21.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 99.14 5.8 56.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.053 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.652 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.23 157.81 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.356 1.078 . . . . 0.0 112.047 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 tm-20 -123.9 126.83 47.07 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.28 174.19 27.15 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.862 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.627 ' C ' HG22 ' A' ' 80' ' ' ILE . 6.4 m-85 -95.09 120.34 35.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -48.77 151.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 111.55 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 79' ' ' VAL . 48.4 mt -142.64 -58.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.8 t0 -107.91 143.65 36.24 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 3.3 mp0 -146.38 106.92 4.07 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.955 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.723 ' HG1' ' N ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -138.41 -175.01 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.723 ' N ' ' HG1' ' A' ' 74' ' ' THR . 9.4 ttp180 -50.76 -31.85 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.124 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 75' ' ' ARG . 94.0 m-20 -138.11 31.66 2.41 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.502 ' HG3' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -155.12 158.97 39.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.784 -1.167 . . . . 0.0 113.713 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.621 ' HG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -156.6 110.01 2.65 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 71' ' ' ILE . 73.3 t -111.49 145.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.222 0.534 . . . . 0.0 112.319 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.627 HG22 ' C ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -133.82 140.25 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.261 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -113.37 135.57 53.72 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.95 0.405 . . . . 0.0 111.48 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -145.77 159.2 27.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 82' ' ' GLY . 5.1 pt-20 32.72 -109.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 110.847 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 63.6 m-80 -127.28 33.72 4.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.88 0.372 . . . . 0.0 110.46 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 23.9 tttp -143.1 160.49 40.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.398 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.426 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 4.2 m -114.07 155.4 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.721 0.772 . . . . 0.0 110.903 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.652 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 1.2 m-90 -97.71 135.29 39.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -125.97 96.04 4.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.41 101.61 3.78 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.429 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.512 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.6 Cg_exo -55.66 145.19 72.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.696 1.597 . . . . 0.0 111.064 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.711 ' HG3' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -53.28 -37.71 62.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.078 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.04 -6.38 56.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.22 29.81 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.41 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 31.6 p -168.02 165.32 13.6 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 118.931 -1.108 . . . . 0.0 113.926 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -114.46 133.97 58.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.157 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.698 ' CE2' ' SG ' ' A' ' 94' ' ' CYS . 50.0 m-85 -117.06 130.79 56.89 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' C ' HG21 ' A' ' 53' ' ' VAL . 6.4 tt0 -116.96 94.84 4.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.638 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -89.81 146.48 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 105' ' ' LYS . 45.9 tt0 -88.49 127.77 35.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.85 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -63.91 142.36 58.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.219 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.714 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.66 -0.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.668 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 101' ' ' TRP . 1.1 m-20 -107.19 16.51 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.95 23.72 73.9 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.63 149.7 26.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.646 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 99' ' ' GLU . 58.9 mmtt -92.15 131.86 37.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.731 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.433 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 27.5 mt -107.17 135.25 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.912 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -118.04 101.31 8.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.13 139.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.212 -177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.4 p -78.49 149.0 33.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.089 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -71.43 -1.87 46.13 Favored Glycine 0 CA--C 1.508 -0.368 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -86.9 -22.44 25.69 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.597 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -63.03 -47.69 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.221 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.601 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -95.2 28.43 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 116' ' ' ARG . 7.6 p -52.17 104.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.711 ' H ' ' HG3' ' A' ' 91' ' ' LYS . . . 68.14 -41.48 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.376 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 24.5 mmt180 -101.86 88.03 1.16 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.53 -25.49 34.97 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 N-CA-C 108.106 -1.536 . . . . 0.0 108.106 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.524 ' CD ' ' HZ2' ' A' ' 122' ' ' LYS . 12.8 pt-20 -66.21 -55.24 17.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.163 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.457 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 23.9 mmm -34.2 -41.74 0.12 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.128 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.664 ' HE ' ' CA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.93 -43.91 42.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.887 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.669 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -61.78 -41.09 97.27 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.146 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.524 ' HZ2' ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -85.21 -25.16 27.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.831 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 122' ' ' LYS . 21.2 ttpp 35.5 82.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.036 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -139.31 124.82 19.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.119 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -40.9 156.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.161 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 126' ' ' ARG . 4.7 mtt180 -37.78 89.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 125' ' ' TRP . 35.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.48 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.814 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 7.4 pt-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -79.77 -45.89 18.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -72.44 -33.48 67.09 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.726 1.251 . . . . 0.0 108.617 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.982 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER -62.6 -51.86 65.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.658 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.684 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 33.5 mt -64.94 -27.51 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.27 -48.5 73.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.244 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -52.18 -48.71 64.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.571 ' CD ' ' O ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -70.12 -38.03 75.47 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.965 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.633 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -65.82 -52.03 53.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.366 0.603 . . . . 0.0 110.451 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.55 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.85 -42.76 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.19 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 1.5 m-20 -71.82 -22.18 61.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.551 HD12 ' N ' ' B' ' 20' ' ' ILE . 1.2 mp -75.49 -56.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.667 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -62.98 -34.43 77.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 2.8 t80 -53.12 -44.06 67.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.921 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -64.66 -40.16 94.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.469 ' O ' ' CG1' ' B' ' 28' ' ' VAL . 1.9 mm? -56.9 -57.55 12.03 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.776 0.798 . . . . 0.0 109.297 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.04 -33.35 17.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.392 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.811 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 57.5 mt-10 -77.12 -55.82 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.914 0.864 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.759 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 79.9 mtt-85 -67.95 -35.88 79.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.474 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.182 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -85.48 -50.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.673 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.75 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 27.8 t80 -36.3 -49.34 1.73 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.173 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.862 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 36.5 Cg_endo -53.26 -47.86 25.17 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 N-CA-C 106.506 -2.151 . . . . 0.0 106.506 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.862 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 62.2 t80 -94.5 -15.17 24.41 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.289 -2.232 . . . . 0.0 113.08 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.182 ' N ' ' O ' ' B' ' 28' ' ' VAL . 43.0 p -158.04 91.19 2.21 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.84 -41.9 73.91 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.977 2.451 . . . . 0.0 113.88 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 55.8 mp0 -66.67 -54.25 25.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.524 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 25.9 mt -52.09 -55.38 21.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.985 0.422 . . . . 0.0 110.155 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.35 -30.24 50.96 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.331 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -47.11 57.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.884 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.701 ' C ' ' CD ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -60.54 -53.3 59.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.799 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.626 ' O ' ' N ' ' B' ' 42' ' ' LEU . 3.2 m-85 -59.69 -42.57 93.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' B' ' 39' ' ' TYR . 1.1 t -45.05 -34.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' B' ' 38' ' ' ARG . 0.0 OUTLIER -70.65 -44.86 66.25 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' TYR . 49.4 mt -65.45 -47.89 74.59 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.961 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.17 -31.16 65.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.535 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.73 -50.94 69.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.383 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.62 ' O ' ' N ' ' B' ' 49' ' ' LYS . 2.1 pp -61.95 -39.29 91.62 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.015 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.531 ' N ' ' HG ' ' B' ' 45' ' ' LEU . 40.2 t -61.22 -49.23 85.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 111.49 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -49.6 72.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.714 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.84 -55.96 4.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.986 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.62 ' N ' ' O ' ' B' ' 45' ' ' LEU . 6.6 mmpt? -59.0 -43.29 91.46 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -79.07 -16.21 57.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 50' ' ' ALA . 26.1 mttt 70.75 43.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.748 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.74 124.77 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -108.87 108.06 18.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.15 0.5 . . . . 0.0 110.664 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' B' ' 55' ' ' PRO . 5.7 tt -137.4 128.56 16.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.442 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' ILE . 67.9 Cg_exo -33.84 116.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.201 1.934 . . . . 0.0 111.976 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.429 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 1.5 mpp_? -92.16 83.08 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.698 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.661 ' C ' ' H ' ' B' ' 59' ' ' LYS . 55.0 pttt -86.47 -11.76 50.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' NH1' ' B' ' 60' ' ' ARG . 5.4 m-90 -51.2 4.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.225 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.661 ' H ' ' C ' ' B' ' 57' ' ' LYS . 3.1 mptp? -66.75 -3.79 7.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' B' ' 58' ' ' TRP . 18.6 ptt-85 -82.28 -35.34 28.14 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.302 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -124.94 21.6 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.515 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -118.43 154.6 32.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 1.7 t -126.39 113.62 17.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.656 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -78.85 4.35 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.976 0.417 . . . . 0.0 109.986 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.536 ' HG3' ' CG ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -95.86 -38.23 10.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.538 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.0 p -138.72 -0.2 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.734 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' B' ' 66' ' ' CYS . 4.5 m80 61.52 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . 169.81 -171.41 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.065 0.46 . . . . 0.0 111.123 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.574 ' O ' ' CE2' ' B' ' 29' ' ' PHE . 13.2 t80 -121.19 103.02 8.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 0.4 OUTLIER -113.58 119.26 36.89 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.411 0.624 . . . . 0.0 112.441 -177.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' B' ' 29' ' ' PHE . 61.1 t -96.16 136.13 22.24 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.046 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.92 118.55 5.59 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.719 1.613 . . . . 0.0 111.531 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.64 -33.42 4.64 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.57 -78.09 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -116.77 19.76 14.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 109.749 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.3 158.8 43.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.929 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -148.46 130.12 15.02 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.441 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.423 ' O ' ' CG2' ' B' ' 78' ' ' VAL . 35.1 m -131.23 103.86 8.14 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.306 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -132.45 140.47 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.133 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' B' ' 80' ' ' LEU . 0.2 OUTLIER -126.28 143.93 50.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.797 0.808 . . . . 0.0 111.939 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 86' ' ' PRO . 0.2 OUTLIER -109.13 164.91 12.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 74.67 172.19 0.28 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.116 0.885 . . . . 0.0 111.477 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.654 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 97.2 mttt -150.16 116.46 5.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.593 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.654 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 73.4 ttt180 119.07 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.542 ' N ' ' HD3' ' B' ' 86' ' ' PRO . 9.7 ttt -157.38 54.14 0.78 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.451 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' B' ' 85' ' ' MET . 62.6 Cg_endo -83.87 179.85 4.52 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.358 2.705 . . . . 0.0 113.88 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . 0.483 ' CD2' ' C ' ' B' ' 86' ' ' PRO . 1.5 m-70 -150.32 130.88 13.92 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.647 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' B' ' 101' ' ' TYR . 0.9 OUTLIER -88.96 150.49 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.28 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 3.6 m -114.35 120.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.18 131.81 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 97' ' ' HIS . 40.3 tttt -146.37 148.56 32.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.957 -1.097 . . . . 0.0 113.008 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.638 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.5 OUTLIER -88.45 127.31 35.51 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.88 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt -88.5 -2.63 58.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.79 -55.56 3.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.854 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 5.1 p -115.79 76.72 1.03 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.5 94.16 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.977 -175.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.625 ' HD1' ' HB2' ' B' ' 92' ' ' CYS . 0.2 OUTLIER -119.69 128.72 54.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.833 -1.184 . . . . 0.0 109.043 177.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 37.9 mt -99.28 119.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.929 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 3.6 mmt -128.71 164.36 23.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' B' ' 100' ' ' ARG . 0.4 OUTLIER -120.95 155.82 33.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.553 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' B' ' 88' ' ' ILE . 0.8 OUTLIER -146.41 91.47 5.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.817 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.31 166.13 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.297 1.998 . . . . 0.0 111.743 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -99.7 84.03 2.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.767 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.19 116.94 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.491 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 tttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.559 -179.805 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.58 97.24 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 22' ' ' GLU . 79.0 p -59.99 -49.59 77.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' H ' ' HG ' ' A' ' 19' ' ' SER . 89.2 m-85 -37.45 -45.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.131 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -58.28 -21.58 49.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 19' ' ' SER . 4.5 tt0 -104.79 -38.0 6.83 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.458 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.61 24.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.462 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.509 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -80.01 118.98 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.712 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.724 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 83.68 -7.0 71.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.656 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.708 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -64.09 21.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.516 0.658 . . . . 0.0 109.887 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.724 ' H ' ' C ' ' A' ' 25' ' ' GLY . 7.0 p -38.13 -16.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.387 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.708 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.0 t-105 -58.67 -57.0 14.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.1 pt -65.68 -11.27 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.609 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.519 ' CD2' HD11 ' B' ' 24' ' ' LEU . 88.7 m-85 -96.32 -37.37 10.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.637 ' CZ ' ' HH ' ' A' ' 69' ' ' TYR . 9.8 mmt180 -61.0 -68.43 0.31 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.144 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.81 52.02 1.59 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -150.43 -40.19 0.13 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.763 ' CE1' ' H ' ' A' ' 51' ' ' LEU . 1.9 m-70 -91.1 100.15 13.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.218 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -125.71 -20.54 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.984 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -40.67 146.6 0.34 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.532 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.9 ttm180 -67.11 118.96 11.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.717 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.1 t -92.8 136.69 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -164.98 150.74 9.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.124 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 42' ' ' ASN . 43.8 tttm -50.04 -55.68 13.8 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.217 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.61 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 52.2 pttt -58.85 -4.09 0.41 Allowed 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 73.8 m-20 -126.06 0.48 7.21 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.27 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -89.41 -38.14 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.261 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -92.7 0.75 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.814 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.81 6.9 14.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.829 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.598 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -115.41 139.13 50.29 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.775 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.804 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -59.95 111.77 1.61 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.599 ' O ' ' CD ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -74.09 116.34 14.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 177.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.63 HG13 ' OE1' ' A' ' 47' ' ' GLU . 3.7 mm -153.64 -29.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.289 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.64 ' N ' ' NE2' ' A' ' 34' ' ' HIS . . . -138.22 -25.38 0.35 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.763 ' H ' ' CE1' ' A' ' 34' ' ' HIS . 1.5 tt -44.2 150.03 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.475 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 82.8 tttt -93.62 131.41 38.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.057 0.456 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.758 HG23 ' H ' ' A' ' 54' ' ' ARG . 7.9 p -148.77 166.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.758 ' H ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.0 t -94.61 98.87 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.18 -48.09 17.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.451 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -132.94 120.77 21.88 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.956 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' ND1' ' A' ' 60' ' ' HIS . 1.5 p -147.25 172.71 13.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.093 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.623 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 4.4 t -104.14 77.08 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.062 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -169.28 96.87 0.51 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.72 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 -4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.324 2.016 . . . . 0.0 113.237 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -122.74 19.28 7.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.507 -0.854 . . . . 0.0 114.474 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' CE1' ' N ' ' A' ' 88' ' ' LYS . 54.8 m-85 -142.34 -23.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.181 1.491 . . . . 0.0 112.28 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.411 HG12 ' OG ' ' A' ' 58' ' ' SER . 1.5 m -74.04 144.36 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 85.86 5.61 83.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.51 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.564 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 1.2 mt -107.53 153.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.924 0.862 . . . . 0.0 111.59 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' C ' ' CZ2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.58 126.46 53.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.3 173.78 27.31 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.93 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.637 ' HH ' ' CZ ' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -96.73 117.69 31.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.634 0.374 . . . . 0.0 110.098 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.544 ' O ' ' O ' ' A' ' 49' ' ' ILE . 1.9 t -50.15 148.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.693 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.709 ' N ' ' O ' ' A' ' 79' ' ' VAL . 95.0 mt -143.87 -60.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -108.01 134.79 50.41 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.606 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -144.69 107.14 4.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 77' ' ' MET . 2.6 p -132.96 -169.6 2.29 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -52.76 -27.44 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -138.71 31.59 2.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.887 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 2.0 ptp -153.75 160.82 42.41 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.934 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 7.3 tp -163.86 110.15 1.09 Allowed 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 71' ' ' ILE . 74.5 t -117.25 129.75 73.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.747 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -111.55 152.36 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.027 178.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -129.02 136.89 50.91 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.351 0.596 . . . . 0.0 112.417 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -152.32 158.74 28.0 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' GLY . 14.0 pt-20 33.89 -128.52 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.749 0.275 . . . . 0.0 110.622 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -110.17 33.68 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 110.526 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 3.1 tppt? -138.09 151.9 48.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.413 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 31.1 m -118.31 156.17 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.351 0.596 . . . . 0.0 110.709 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 2.0 m-90 -97.96 140.52 32.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.732 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.431 ' N ' ' CE1' ' A' ' 63' ' ' TYR . 72.3 tttt -127.92 92.76 3.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.46 107.05 3.12 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.757 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.64 164.27 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.74 1.626 . . . . 0.0 111.31 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HB2' ' H ' ' A' ' 115' ' ' GLY . 10.1 mttt -67.84 -27.17 66.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 14.5 p-10 -90.55 -5.29 56.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 9.86 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.966 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -161.23 173.99 14.25 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.916 -1.114 . . . . 0.0 113.077 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.2 mt -111.97 130.73 65.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.71 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.698 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 97.1 m-85 -108.96 126.1 52.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 26.8 tt0 -107.97 93.97 4.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 48' ' ' LEU . 37.1 m-85 -80.0 143.66 33.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.85 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -93.47 129.61 39.59 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.687 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -72.68 143.32 48.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.123 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.717 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.35 -0.93 0.28 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.621 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.511 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 27.5 t70 -107.14 20.18 19.36 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.33 22.62 78.56 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.578 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.29 149.76 26.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.475 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -93.48 131.0 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.153 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 10.4 mt -103.81 133.83 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -114.56 100.83 8.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.09 132.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.059 -178.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 111' ' ' GLU . 13.8 p -79.57 144.95 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.213 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.35 4.01 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -80.42 -22.59 41.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.4 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -69.89 -47.3 63.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.417 ' CD2' ' CD1' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -95.88 28.67 3.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 116' ' ' ARG . 7.2 p -45.77 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.617 0.723 . . . . 0.0 112.876 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' A' ' 91' ' ' LYS . . . 66.83 -42.29 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.674 175.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 114' ' ' VAL . 71.1 mtm180 -101.89 99.17 11.38 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.7 Cg_endo -70.12 -26.54 25.75 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 N-CA-C 107.294 -1.849 . . . . 0.0 107.294 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' B' ' 45' ' ' LEU . 6.1 pt-20 -65.45 -45.87 82.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.516 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.9 tpt -39.74 -33.71 0.21 Allowed 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -78.75 -56.74 4.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.652 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.668 ' O ' ' NZ ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -58.56 -42.32 87.67 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 118.313 -1.355 . . . . 0.0 107.836 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -84.91 1.02 49.11 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.501 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' CA ' ' O ' ' A' ' 119' ' ' MET . 10.3 mtpm? 46.48 -175.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -66.3 127.03 30.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 26.3 t-105 -137.34 -140.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.915 0.388 . . . . 0.0 110.763 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -92.68 -107.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.759 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.542 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.645 ' H ' ' NE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -78.72 -31.45 46.4 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.241 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.682 ' H ' HH11 ' B' ' 12' ' ' ARG . 8.7 ttpt -73.86 -34.18 64.38 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.809 1.29 . . . . 0.0 108.122 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.894 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 4.7 mpt_? -60.96 -51.33 69.72 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.777 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.512 HG12 ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -72.97 -29.06 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.543 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' B' ' 50' ' ' ALA . . . -70.56 -51.77 26.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.49 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' B' ' 16' ' ' GLU . 0.6 OUTLIER -55.28 -46.81 76.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.515 ' N ' ' HD3' ' B' ' 15' ' ' LYS . 9.3 pt-20 -72.08 -38.08 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.603 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.558 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 39.3 ttt180 -62.63 -54.19 43.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.703 0.763 . . . . 0.0 110.387 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -56.73 -34.28 42.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.519 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.42 -33.28 72.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.604 ' CG2' ' CD2' ' A' ' 34' ' ' HIS . 94.7 mt -69.61 -58.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.67 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.05 -35.4 76.81 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 4.1 t80 -53.79 -38.94 65.03 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.05 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.7 m -66.9 -40.27 87.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.431 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.519 HD11 ' CD2' ' A' ' 30' ' ' PHE . 2.3 mm? -61.23 -58.79 6.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.524 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.46 -36.48 22.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.527 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.805 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -71.73 -60.26 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.407 0.623 . . . . 0.0 109.875 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.747 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 6.8 ttm-85 -64.43 -37.4 87.39 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.992 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.144 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.3 m -84.12 -50.86 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.275 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.726 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 29.7 t80 -36.37 -49.9 1.79 Allowed Pre-proline 0 CA--C 1.51 -0.572 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.359 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.87 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 35.7 Cg_endo -51.93 -46.13 34.23 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.87 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 10.2 t80 -92.87 -32.21 14.69 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.101 -2.318 . . . . 0.0 112.678 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.144 ' N ' ' O ' ' B' ' 28' ' ' VAL . 61.7 p -144.2 96.91 5.29 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.646 ' CB ' ' HZ3' ' B' ' 37' ' ' LYS . 32.1 Cg_exo -55.88 -42.13 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.791 2.327 . . . . 0.0 114.019 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.96 -53.77 28.44 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 10.6 mt -51.05 -53.21 35.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.262 0.554 . . . . 0.0 110.281 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.505 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.59 -34.14 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.11 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.646 ' HZ3' ' CB ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.45 -41.78 69.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.626 ' HD3' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -58.79 -53.96 52.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.306 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' B' ' 42' ' ' LEU . 1.3 m-85 -60.68 -39.04 86.98 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.94 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.434 ' O ' HD21 ' B' ' 44' ' ' LEU . 3.7 t -45.87 -34.96 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 50.7 tt0 -72.21 -43.92 63.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.6 mt -63.78 -46.63 84.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.88 -34.03 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.796 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.507 HD21 ' N ' ' B' ' 44' ' ' LEU . 1.6 mm? -64.43 -45.02 89.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.592 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -63.91 -34.56 78.23 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.521 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.63 ' O ' ' CB ' ' B' ' 50' ' ' ALA . 51.0 t -70.88 -56.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.16 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.447 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 17.0 pt20 -71.86 -51.06 24.21 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.332 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 121' ' ' LEU . 5.0 tmtt? -82.27 -35.64 27.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.375 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -65.4 -12.41 51.94 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.21 30.48 15.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 t -96.56 92.54 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.046 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -84.18 117.95 23.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.588 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.87 151.1 75.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.011 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.2 127.48 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.116 1.878 . . . . 0.0 111.574 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' B' ' 58' ' ' TRP . 89.3 mtt-85 -87.89 45.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.614 ' C ' ' H ' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -45.57 -25.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.677 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 17.4 m0 -55.65 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.398 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.614 ' H ' ' C ' ' B' ' 57' ' ' LYS . 37.3 mtpt -62.63 -7.86 5.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' B' ' 58' ' ' TRP . 18.1 ptt180 -87.85 -21.66 24.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.442 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.81 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -146.88 20.23 1.27 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.094 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' B' ' 58' ' ' TRP . 50.1 t80 -114.78 154.42 28.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.7 OUTLIER -126.41 116.97 21.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.135 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -87.02 16.28 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.481 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.0 OUTLIER -116.59 -22.06 8.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.741 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.669 ' O ' ' O ' ' B' ' 67' ' ' HIS . 0.8 OUTLIER -153.73 21.59 0.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.869 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.669 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.2 OUTLIER 34.37 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 111.877 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -177.45 -176.99 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' NH1' ' B' ' 61' ' ' ARG . 0.5 OUTLIER -115.37 104.61 11.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.81 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -106.62 129.46 54.53 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.75 -177.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 48.7 t -113.38 124.16 31.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.053 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -46.89 126.1 10.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.886 1.724 . . . . 0.0 112.119 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.98 -36.54 3.97 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.5 -77.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.66 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.23 19.65 16.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.65 171.53 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.266 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -147.08 132.61 18.71 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.027 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 15.5 m -138.89 120.75 16.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -153.8 147.23 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' B' ' 80' ' ' LEU . 0.0 OUTLIER -126.07 141.61 51.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.536 0.684 . . . . 0.0 111.927 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . 0.736 ' HE ' ' N ' ' B' ' 81' ' ' ARG . 0.0 OUTLIER -94.58 136.25 35.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.536 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -100.26 -7.23 24.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -42.52 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.935 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -81.04 -78.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.729 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.75 126.28 23.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.228 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.97 101.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.435 2.09 . . . . 0.0 112.709 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' B' ' 80' ' ' LEU . 25.6 m-70 -129.41 129.58 44.88 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.749 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.7 151.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.267 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 1.4 p -126.71 126.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.979 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.71 132.81 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -148.51 147.08 28.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.049 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.599 ' HB2' ' HD1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -86.52 128.51 34.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.962 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -89.79 0.43 57.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -91.49 -52.87 4.57 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.797 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 14.1 p -120.86 79.05 1.45 Allowed 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 112.9 -1.954 . . . . 0.0 105.877 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.33 93.71 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.117 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.599 ' HD1' ' HB2' ' B' ' 92' ' ' CYS . 0.1 OUTLIER -124.1 134.53 53.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.843 -1.178 . . . . 0.0 109.569 179.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.04 121.94 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.993 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 2.9 mmt -129.14 160.69 32.05 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.935 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.82 154.5 42.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.129 0.49 . . . . 0.0 111.247 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -152.04 91.1 3.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.632 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . 0.456 ' HA ' ' HD1' ' B' ' 87' ' ' HIS . 23.4 Cg_exo -59.13 164.79 9.81 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.41 2.073 . . . . 0.0 112.771 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -142.87 97.11 3.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.497 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.01 145.08 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.45 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tptm . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.429 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 18' ' ' GLY . 31.7 tt0 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 17' ' ' GLN . . . -19.96 107.06 0.01 OUTLIER Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.896 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 22' ' ' GLU . 93.1 p -60.36 -29.42 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 19' ' ' SER . 83.1 m-85 -35.49 -63.41 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.094 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -16.37 39.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.194 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 19' ' ' SER . 41.8 tp10 -92.06 -30.4 16.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 23' ' ' ILE . 6.2 mm -106.7 13.55 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -79.34 126.87 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.853 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 106.78 -35.17 5.21 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.38 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -64.15 27.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.975 0.388 . . . . 0.0 110.736 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.673 ' H ' ' C ' ' A' ' 25' ' ' GLY . 13.9 p -43.75 -14.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.884 0.849 . . . . 0.0 108.745 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.703 ' HE1' HH12 ' B' ' 27' ' ' ARG . 38.1 t-105 -57.85 -52.52 65.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.294 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.422 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 12.7 pt -71.88 -11.8 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.587 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -89.87 -23.46 21.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.73 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.4 tpp85 -80.88 -68.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.56 35.67 0.17 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.73 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -145.41 -39.02 0.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -95.95 105.93 18.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.92 1.33 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.45 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -47.25 156.95 0.68 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.611 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 6.1 ttm-85 -67.98 118.49 11.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.8 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 42.2 t -97.48 139.31 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.677 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -166.66 154.65 9.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.435 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 42' ' ' ASN . 75.9 tttt -51.72 -55.94 16.69 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' CD2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -59.15 -3.79 0.43 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 55.0 m-20 -125.41 2.61 7.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.815 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.677 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.76 -39.75 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.563 0.221 . . . . 0.0 110.935 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -91.81 4.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 108.084 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.877 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.46 -21.92 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.04 -179.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.701 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.8 146.92 29.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.655 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.26 108.74 1.67 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.829 ' O ' HG12 ' A' ' 49' ' ' ILE . 8.2 mt -76.21 110.45 10.72 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.829 HG12 ' O ' ' A' ' 48' ' ' LEU . 3.9 mt -170.78 55.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 124.032 0.832 . . . . 0.0 109.496 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 143.95 -27.82 2.02 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.14 133.5 39.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.904 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.487 ' HZ2' ' CD ' ' A' ' 67' ' ' GLU . 1.7 tmtp? -69.61 124.38 23.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.097 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.852 HG23 ' H ' ' A' ' 54' ' ' ARG . 13.8 p -149.19 169.7 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.108 0.48 . . . . 0.0 110.654 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.852 ' H ' HG23 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.65 149.62 46.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.138 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 65' ' ' GLY . 92.2 t -99.4 100.23 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.28 -36.98 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.433 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -135.1 120.19 18.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 110.476 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.754 ' HG ' ' HD1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -147.83 166.35 27.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.665 179.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.587 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 1.7 t -103.52 75.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.754 ' HD1' ' HG ' ' A' ' 58' ' ' SER . 0.8 OUTLIER -169.82 105.34 0.45 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.545 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.18 -4.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 122.178 1.919 . . . . 0.0 113.909 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -129.4 31.13 3.49 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.645 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -141.31 -21.59 0.76 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.876 1.338 . . . . 0.0 111.794 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.0 144.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 84.02 6.52 86.55 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.152 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.611 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 118.447 1.124 . . . . 0.0 111.79 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 tt0 -120.1 125.88 49.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.44 172.88 26.89 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.527 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.618 ' C ' HG21 ' A' ' 80' ' ' ILE . 3.9 m-85 -99.57 121.73 41.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' H ' HG21 ' A' ' 70' ' ' VAL . 1.6 t -48.76 148.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.903 0.383 . . . . 0.0 111.572 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 79' ' ' VAL . 79.2 mt -138.51 -60.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.962 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.759 ' CG ' ' HE ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -101.99 140.25 36.54 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.767 ' O ' ' NH1' ' B' ' 38' ' ' ARG . 70.6 tt0 -149.62 105.05 3.4 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.187 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.684 ' CG2' HH22 ' B' ' 38' ' ' ARG . 6.8 t -152.01 -178.92 7.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.543 0.687 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.67 ' HE ' HH22 ' A' ' 116' ' ' ARG . 32.5 ttm180 -55.07 -6.79 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.227 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -138.52 0.0 2.01 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.579 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 2.4 ptp -165.44 149.99 8.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 117.952 -1.499 . . . . 0.0 114.794 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 5.9 tp -135.09 110.71 9.2 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.6 t -114.41 147.2 18.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 121.441 0.638 . . . . 0.0 112.553 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.618 HG21 ' C ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -131.4 142.18 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.278 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -114.83 135.29 54.35 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.864 -0.523 . . . . 0.0 111.746 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -153.4 125.66 1.81 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 69.09 -115.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -124.62 19.98 8.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.415 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 17.8 tttp -126.19 167.33 15.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.344 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 5.7 m -121.55 153.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 110.596 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.611 ' NE1' ' HB ' ' A' ' 66' ' ' ILE . 1.4 m-90 -99.14 110.8 23.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.475 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -108.03 96.7 6.56 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.079 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.87 95.7 3.88 Favored Pre-proline 0 CA--C 1.518 -0.264 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.073 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -43.23 161.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 120.942 1.095 . . . . 0.0 110.518 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.667 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -63.53 -30.31 71.45 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -89.17 -4.95 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.506 ' H ' HG23 ' A' ' 93' ' ' VAL . 2.5 m -112.41 11.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.72 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -167.19 169.23 12.82 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.856 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.38 140.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.343 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.72 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 87.0 m-85 -117.61 131.67 56.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 54' ' ' ARG . 21.3 tt0 -115.04 95.07 5.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -90.89 145.49 24.7 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 0.6 OUTLIER -89.68 133.17 34.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.243 0.544 . . . . 0.0 111.604 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.605 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -70.87 144.05 50.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.849 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.8 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.1 0.12 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.221 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.574 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 74.4 m-20 -107.52 15.17 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.12 22.9 72.83 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.17 146.56 30.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.756 0.312 . . . . 0.0 110.358 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -90.74 132.82 35.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 11.3 mt -105.72 134.42 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -120.27 106.49 11.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.61 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.216 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.6 p -94.99 145.68 24.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.22 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.62 -1.65 0.36 Allowed Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.43 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 109' ' ' SER . 21.0 pt-20 -68.26 -31.5 71.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.678 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -75.13 -47.44 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.493 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 29.1 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 114' ' ' VAL . 9.9 p -63.71 106.06 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.667 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.46 -40.47 0.29 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 114.551 -1.204 . . . . 0.0 114.034 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.67 HH22 ' HE ' ' A' ' 75' ' ' ARG . 5.6 mmp_? -100.59 85.06 0.51 Allowed Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.44 ' HB2' HH22 ' B' ' 17' ' ' ARG . 26.9 Cg_endo -66.74 -26.01 45.78 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 119' ' ' MET . 6.0 pt-20 -67.99 -48.46 65.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' LYS . 37.6 tpp -36.37 -47.1 0.58 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.724 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -71.61 -47.91 51.54 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.368 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -62.29 -31.87 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 118' ' ' GLU . 3.8 mmtt -85.26 -33.8 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.869 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 25.13 99.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -57.3 138.31 54.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.217 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.15 52.6 2.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.884 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 40.86 66.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.623 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.609 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 4.3 mm-40 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -79.35 -32.05 43.14 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.911 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.654 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.6 OUTLIER -73.2 -33.96 65.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.708 1.242 . . . . 0.0 108.159 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.89 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 5.0 mpt_? -60.99 -51.38 69.5 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.392 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.643 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 10.3 mt -70.44 -26.72 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.124 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.19 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.584 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.421 ' O ' HG21 ' B' ' 18' ' ' ILE . 4.1 ptmm? -57.54 -48.42 79.36 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.546 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -68.94 -37.35 78.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.342 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.663 ' HE ' ' CG2' ' B' ' 46' ' ' VAL . 3.0 ttt180 -62.72 -52.07 64.71 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.542 0.686 . . . . 0.0 110.673 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.73 -35.55 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.098 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.41 -27.04 63.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.42 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.447 ' O ' ' OG ' ' B' ' 23' ' ' SER . 8.6 mt -69.15 -58.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.08 -33.34 75.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.894 0.854 . . . . 0.0 108.832 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.623 ' CE1' ' NE1' ' B' ' 58' ' ' TRP . 2.0 t80 -52.92 -46.51 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.073 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 11.6 p -64.8 -42.04 95.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.496 ' CD1' ' CG1' ' B' ' 28' ' ' VAL . 0.3 OUTLIER -56.1 -58.42 7.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.493 0.664 . . . . 0.0 110.096 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -35.56 26.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.449 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.788 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.9 OUTLIER -71.58 -57.12 4.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.388 0.614 . . . . 0.0 110.774 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.788 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 5.2 ttt-85 -70.22 -32.5 70.4 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.73 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.184 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.2 m -83.78 -50.44 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.725 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 33.8 t80 -36.23 -49.73 1.71 Allowed Pre-proline 0 CA--C 1.509 -0.625 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.293 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.86 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 39.1 Cg_endo -54.02 -46.86 30.5 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 N-CA-C 106.532 -2.142 . . . . 0.0 106.532 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.86 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 48.6 t80 -94.54 -17.04 22.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.928 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.184 ' N ' ' O ' ' B' ' 28' ' ' VAL . 27.6 p -155.81 90.39 2.81 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.41 ' HB3' ' HZ1' ' B' ' 37' ' ' LYS . 51.0 Cg_exo -55.01 -42.98 63.93 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.883 2.389 . . . . 0.0 113.792 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -66.44 -53.9 30.23 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.548 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 9.0 mt -52.52 -56.73 13.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 120.951 0.405 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.44 -29.78 26.25 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.054 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.41 ' HZ1' ' HB3' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.7 -47.84 51.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.726 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.767 ' NH1' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.48 -35.55 81.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' B' ' 35' ' ' LEU . 3.5 m-85 -71.15 -44.43 65.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.957 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -45.51 -38.93 2.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.719 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.9 -42.37 81.25 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.548 ' O ' HG23 ' B' ' 46' ' ' VAL . 48.3 mt -64.26 -47.75 78.4 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.601 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.53 -31.3 61.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.434 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 0.8 OUTLIER -64.08 -54.39 34.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 4.1 pp -61.61 -27.48 68.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.365 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.663 ' CG2' ' HE ' ' B' ' 17' ' ' ARG . 63.8 t -64.41 -47.24 90.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.32 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -66.5 -57.09 8.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.61 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 12.8 pt20 -81.96 -49.58 10.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.77 -33.48 75.97 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -92.64 5.83 49.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 mttm 54.01 75.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.502 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.89 134.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.306 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -123.71 109.52 13.8 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' PRO . 31.0 mt -135.68 137.25 25.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.638 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' B' ' 54' ' ' ILE . 52.2 Cg_exo -33.53 100.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.245 1.963 . . . . 0.0 111.467 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -86.32 77.0 9.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.664 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' B' ' 59' ' ' LYS . 50.1 pttt -72.55 -14.92 61.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.623 ' NE1' ' CE1' ' B' ' 22' ' ' PHE . 14.2 m0 -58.22 -2.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.537 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' B' ' 57' ' ' LYS . 32.4 pttt -68.18 -3.62 11.18 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' B' ' 58' ' ' TRP . 5.9 ptm180 -83.67 -30.74 26.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.888 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.712 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -130.45 21.78 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.938 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 81.9 t80 -118.95 155.76 30.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.334 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 3.5 t -127.17 126.08 42.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.266 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -87.91 6.54 35.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 109.908 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.59 ' HZ1' ' CE1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -107.26 -22.97 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.381 -178.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.582 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.5 p -150.84 17.11 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.335 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.582 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.9 OUTLIER 35.21 106.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 111.443 179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -164.75 -175.04 3.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' B' ' 61' ' ' ARG . 9.4 t80 -118.17 102.93 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.712 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.4 OUTLIER -110.77 120.72 43.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.857 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.6 t -92.78 117.42 67.56 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.061 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.24 119.38 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.307 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.73 -41.96 1.86 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.538 HG22 ' H ' ' B' ' 75' ' ' ASN . 3.8 tt -102.95 -65.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 117.219 0.51 . . . . 0.0 111.293 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.538 ' H ' HG22 ' B' ' 74' ' ' ILE . 5.8 t-20 -112.26 12.97 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.748 0.309 . . . . 0.0 110.856 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.85 164.4 37.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.273 0.559 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 77' ' ' ARG . 41.0 mtp180 -150.45 134.23 16.7 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.048 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 12.9 m -139.0 132.25 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.783 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' B' ' 79' ' ' ARG . 29.7 ttm-85 -146.7 150.61 35.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.918 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 1.2 pp -123.73 131.74 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' B' ' 83' ' ' LYS . 17.6 mmt180 -137.98 166.48 23.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' B' ' 84' ' ' ARG . 2.5 mt-30 -76.58 20.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.724 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' B' ' 85' ' ' MET . 31.2 mtpt -52.4 89.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' B' ' 85' ' ' MET . 20.9 ttt180 72.24 -13.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.383 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.503 ' CG ' ' O ' ' B' ' 84' ' ' ARG . 1.3 mtt 159.49 153.57 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -46.07 105.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.11 1.873 . . . . 0.0 111.325 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . 0.554 ' O ' ' ND1' ' B' ' 87' ' ' HIS . 1.4 p-80 -138.86 131.63 29.18 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.83 130.88 40.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.0 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 7.3 p -98.2 121.06 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 1.1 m -112.2 127.07 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -141.32 136.14 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.295 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.531 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.1 OUTLIER -80.53 132.51 35.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.688 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 95.5 mt -93.83 -4.84 49.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.31 -54.56 4.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.869 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 5.2 p -113.22 75.45 0.92 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.54 92.75 0.01 OUTLIER Glycine 0 C--N 1.324 -0.138 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.597 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -129.47 124.85 35.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.672 -1.264 . . . . 0.0 110.15 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . 0.501 ' H ' HD13 ' B' ' 98' ' ' ILE . 2.3 mp -92.36 120.3 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.615 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 36.7 mmm -128.17 163.83 23.81 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.893 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -126.31 141.86 51.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.634 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.534 ' OH ' ' NZ ' ' B' ' 59' ' ' LYS . 48.5 t80 -138.1 91.75 12.84 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.378 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -52.5 165.64 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.386 2.057 . . . . 0.0 112.203 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -142.82 105.39 4.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.928 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.16 127.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.185 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.272 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.508 ' O ' ' C ' ' A' ' 18' ' ' GLY . 36.3 mt-30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 17' ' ' GLN . . . 24.28 93.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.781 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLU . 80.3 p -54.01 -35.06 61.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.459 . . . . 0.0 110.076 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.402 ' C ' ' H ' ' A' ' 22' ' ' GLU . 52.8 m-85 -40.45 -61.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.384 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.06 -8.79 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 19' ' ' SER . 42.5 tp10 -103.95 -40.72 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.263 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.449 ' HA ' ' CE2' ' B' ' 31' ' ' TYR . 3.5 mm -95.19 32.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 111.09 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 24' ' ' ILE . 0.3 OUTLIER -81.2 127.34 39.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.704 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 82.15 -18.1 14.93 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.81 27.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.826 1.313 . . . . 0.0 110.793 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.704 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -42.03 -15.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 33.6 t-105 -57.17 -53.81 53.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.46 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 16.8 pt -69.31 -11.86 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.609 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' B' ' 24' ' ' LEU . 33.7 m-85 -91.15 -26.37 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -70.07 -64.59 0.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.173 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.86 48.65 3.31 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 29' ' ' ILE . . . -162.38 -38.35 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.628 ' CD2' ' H ' ' A' ' 50' ' ' GLY . 38.9 t-80 -110.71 100.37 9.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.613 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -150.75 10.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' H ' HG12 ' B' ' 20' ' ' ILE . . . -41.77 164.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.646 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 33.9 ttp180 -66.59 133.02 49.44 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.709 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 63.2 t -113.26 135.66 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.666 ' O ' ' N ' ' A' ' 42' ' ' ASN . 6.0 m120 -166.3 149.07 7.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.831 -1.532 . . . . 0.0 108.016 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 42' ' ' ASN . 56.1 tttp -46.04 -53.79 9.58 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.197 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 13.4 pttp -60.84 -4.63 1.04 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.072 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.736 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 88.9 m-20 -125.13 0.23 7.83 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.082 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.602 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.45 -39.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.06 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -91.06 5.25 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.829 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -119.92 -6.18 10.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.869 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.736 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -98.74 151.64 20.54 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.735 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.676 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -72.73 110.83 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.555 ' O ' ' CD1' ' A' ' 49' ' ' ILE . 12.5 mt -74.21 116.1 14.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.641 HG22 ' CE1' ' B' ' 39' ' ' TYR . 1.1 mm -155.28 -31.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.596 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.628 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -134.5 -22.23 0.71 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.912 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -44.82 153.25 0.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HZ2' ' HB3' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -100.49 128.49 46.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.845 HG22 ' H ' ' A' ' 54' ' ' ARG . 12.9 p -149.16 171.52 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.399 0.618 . . . . 0.0 111.572 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.845 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.51 152.28 51.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 65' ' ' GLY . 59.9 t -96.22 98.95 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.31 -51.86 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.415 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -128.53 118.35 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.707 ' HG ' ' HD1' ' A' ' 60' ' ' HIS . 47.9 t -149.07 173.53 13.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.184 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 33.7 p -102.98 78.6 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.724 ' CD2' ' O ' ' A' ' 59' ' ' THR . 21.6 m80 -166.57 96.15 0.72 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.251 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.11 -4.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.535 2.157 . . . . 0.0 114.015 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -132.0 23.32 4.16 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.638 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -141.11 -14.1 0.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.793 1.296 . . . . 0.0 111.615 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.62 138.89 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.9 6.71 88.74 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.35 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.796 HG22 ' NE1' ' A' ' 87' ' ' TRP . 2.3 tt -108.32 146.92 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 117.712 0.756 . . . . 0.0 112.243 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 6.9 tm-20 -116.15 131.87 56.82 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.428 ' O ' ' CG2' ' A' ' 80' ' ' ILE . . . -147.24 174.95 26.85 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.487 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.55 115.72 28.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.584 ' N ' HG21 ' A' ' 80' ' ' ILE . 1.9 t -45.19 145.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.015 0.436 . . . . 0.0 111.457 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 79' ' ' VAL . 15.8 mt -136.48 -61.51 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 19.9 t0 -94.89 148.01 22.76 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.833 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 10.7 tt0 -156.52 105.11 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 75' ' ' ARG . 14.6 t -162.49 176.68 10.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 111.798 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.709 ' H ' ' HG1' ' A' ' 74' ' ' THR . 54.5 ttt85 -58.72 -1.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.864 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' THR . 7.6 t-20 -133.47 -11.58 2.77 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -166.66 156.21 11.25 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.669 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.48 ' CD2' ' CZ ' ' A' ' 96' ' ' PHE . 5.3 tp -139.33 110.94 7.11 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.675 ' O ' ' N ' ' A' ' 71' ' ' ILE . 61.3 t -119.95 145.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.673 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -117.88 152.25 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.142 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -125.12 136.44 53.63 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.108 0.48 . . . . 0.0 111.963 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -149.91 155.78 26.42 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 82' ' ' GLY . 6.1 pt-20 31.83 -115.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.561 0.219 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -121.24 33.31 5.59 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.917 0.389 . . . . 0.0 110.176 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 30.4 tttp -133.52 158.84 42.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.631 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 16.1 m -123.62 155.54 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 110.688 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.796 ' NE1' HG22 ' A' ' 66' ' ' ILE . 2.5 m-90 -100.35 145.49 28.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.325 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -128.22 94.13 3.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.36 99.17 4.21 Favored Pre-proline 0 C--N 1.342 0.266 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.253 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.33 146.03 84.63 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.483 1.455 . . . . 0.0 110.231 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 27.2 mttm -54.17 -22.13 10.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -90.63 -6.38 54.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.574 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -128.52 35.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.644 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -166.95 155.72 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.027 179.142 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 77.2 mt -111.14 116.11 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.644 ' CZ ' ' SG ' ' A' ' 94' ' ' CYS . 88.1 m-85 -98.53 127.11 44.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.536 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 24.3 tt0 -110.12 94.74 5.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.652 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 4.8 m-85 -87.55 145.66 26.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -90.2 127.39 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.804 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -62.8 142.88 58.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.389 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.709 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.19 0.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.605 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.552 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 75.6 m-20 -106.85 13.39 27.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.36 21.64 66.71 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 100' ' ' THR . 16.7 m -106.74 150.0 26.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.477 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -91.16 134.28 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 7.7 mt -110.59 132.62 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -118.55 102.9 9.24 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.65 139.41 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.974 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 m -88.55 148.49 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.994 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.47 -0.59 4.9 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.018 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.65 -22.72 60.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -80.11 -47.55 14.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.362 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 28.13 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.1 p -59.32 106.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.512 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.84 -40.89 0.32 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.496 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 116' ' ' ARG . 1.0 OUTLIER -101.18 87.63 0.92 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -176.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.542 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.1 Cg_endo -67.34 -29.16 38.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.25 1.3 . . . . 0.0 108.828 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 119' ' ' MET . 8.1 pt-20 -56.66 -49.51 74.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.915 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 123' ' ' LYS . 9.7 ttm -34.67 -64.83 0.24 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.821 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -59.17 -44.93 92.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.843 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -60.27 -40.32 89.95 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -102.02 18.79 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.752 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.558 ' C ' ' O ' ' A' ' 122' ' ' LYS . 87.9 tttt -15.86 104.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.612 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 126' ' ' ARG . 13.7 ttp180 -148.99 -97.92 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.338 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.486 ' CD1' ' C ' ' A' ' 124' ' ' ARG . 41.8 p-90 32.32 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.958 0.408 . . . . 0.0 111.051 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 124' ' ' ARG . 45.4 mtt180 -61.8 -50.94 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' OXT' ' O ' ' A' ' 126' ' ' ARG . 28.1 ttmt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.588 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . 0.627 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.63 -30.47 46.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.747 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.0 OUTLIER -73.72 -34.25 64.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.799 1.285 . . . . 0.0 108.301 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.916 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -61.85 -51.26 68.94 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 112.126 -2.306 . . . . 0.0 111.667 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -71.32 -34.92 55.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.87 91.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.049 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.481 ' O ' HG23 ' B' ' 18' ' ' ILE . 6.8 tptm -58.85 -51.0 71.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.233 0.539 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.63 -37.14 70.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.882 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.542 HH22 ' HB2' ' A' ' 117' ' ' PRO . 9.7 ttt180 -60.56 -51.02 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.593 0.711 . . . . 0.0 110.668 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.499 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -60.53 -38.33 77.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.17 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 13.2 m-20 -68.23 -30.44 69.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.492 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.455 HD12 ' N ' ' B' ' 20' ' ' ILE . 1.1 mp -71.53 -57.68 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.638 ' CD2' ' C ' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.2 -35.06 76.16 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.596 ' N ' ' CD1' ' B' ' 21' ' ' LEU . 5.4 t80 -53.75 -39.36 65.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.047 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -67.77 -40.8 83.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.383 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.464 ' CD1' ' CG1' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -56.25 -58.02 9.76 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.731 0.777 . . . . 0.0 109.396 179.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' B' ' 29' ' ' PHE . . . -49.23 -37.52 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.562 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.84 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -68.97 -59.27 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.313 0.577 . . . . 0.0 110.087 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.784 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 7.2 ttm-85 -66.6 -36.91 83.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.809 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 1.199 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -82.99 -50.69 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.321 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.748 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 41.1 t80 -36.75 -50.26 1.99 Allowed Pre-proline 0 CA--C 1.509 -0.63 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' PRO . . . . . 0.854 ' HG2' ' H ' ' B' ' 31' ' ' TYR . 37.4 Cg_endo -54.01 -46.84 30.62 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 106.576 -2.124 . . . . 0.0 106.576 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.854 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 49.4 t80 -94.42 -13.24 26.46 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.335 -2.211 . . . . 0.0 112.708 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 1.199 ' N ' ' O ' ' B' ' 28' ' ' VAL . 57.4 p -160.51 92.87 1.6 Allowed Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.439 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 47.3 Cg_exo -55.67 -41.59 76.06 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.736 2.291 . . . . 0.0 113.673 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.59 -54.41 23.81 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' LEU . . . . . 0.522 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 7.7 mt -52.22 -55.04 23.73 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.205 0.526 . . . . 0.0 110.604 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.529 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.77 -30.24 60.95 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.076 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.63 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.77 -48.93 43.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.543 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.95 -38.7 89.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.77 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.641 ' CE1' HG22 ' A' ' 49' ' ' ILE . 3.5 m-85 -64.43 -44.71 90.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 118.627 -1.229 . . . . 0.0 108.327 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.155 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.95 -41.5 77.94 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.1 mt -65.48 -44.71 86.26 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.41 -30.66 63.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.946 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.72 -54.34 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.588 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.781 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.6 pp -57.25 -27.32 61.95 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.747 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . 0.781 ' N ' HD12 ' B' ' 45' ' ' LEU . 86.0 t -68.27 -46.38 81.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.017 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -57.1 8.3 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.818 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 8.4 pt20 -81.32 -47.35 13.43 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 7.4 tptt -70.04 -32.74 71.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -88.22 -3.98 58.79 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.419 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mttp 62.59 73.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.691 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -133.29 138.05 52.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.734 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -45.45 153.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.663 ' H ' ' CD1' ' B' ' 54' ' ' ILE . 0.1 OUTLIER -114.56 115.14 44.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.685 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' B' ' 57' ' ' LYS . 87.8 Cg_endo -81.91 -1.62 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 112.414 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.12 18.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.503 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' B' ' 55' ' ' PRO . 0.0 OUTLIER -65.96 -37.72 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 110.077 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.568 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 5.2 m-90 -62.04 7.25 0.06 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.778 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' B' ' 57' ' ' LYS . 33.1 pttt -65.89 -6.87 13.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' B' ' 58' ' ' TRP . 12.1 ptp180 -81.35 -25.44 36.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.808 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -141.25 22.97 2.2 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.418 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.416 ' CZ ' ' HA ' ' B' ' 67' ' ' HIS . 51.8 t80 -116.15 148.6 40.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.019 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' CYS . . . . . 0.581 ' C ' ' H ' ' B' ' 65' ' ' LYS . 8.2 t -126.54 107.79 10.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.633 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' B' ' 64' ' ' LYS . 1.1 mptp? -66.21 5.47 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.664 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.588 ' HD3' ' ND1' ' B' ' 97' ' ' HIS . 0.2 OUTLIER -105.96 -17.66 14.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.609 -178.061 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' B' ' 95' ' ' CYS . 14.5 p -150.81 6.75 0.53 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' B' ' 63' ' ' CYS . 2.0 m80 42.74 78.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.679 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.16 -172.14 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.303 0.573 . . . . 0.0 111.268 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' PHE . . . . . 0.63 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 4.7 t80 -117.73 105.09 11.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.808 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.6 OUTLIER -109.35 126.29 53.24 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -103.17 121.92 47.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.886 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.63 127.2 15.81 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.981 1.787 . . . . 0.0 111.733 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.67 -34.01 6.02 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.539 ' CG2' HD21 ' B' ' 75' ' ' ASN . 96.6 mt -93.89 -79.99 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.539 HD21 ' CG2' ' B' ' 74' ' ' ILE . 1.9 m-80 -110.86 15.94 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.11 161.53 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -143.45 138.71 29.48 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.606 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' B' ' 78' ' ' VAL . 10.5 m -139.1 110.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -129.49 143.01 50.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 0.4 OUTLIER -107.92 128.17 54.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.023 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' B' ' 82' ' ' GLN . 16.3 mmt85 -139.23 176.42 8.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' B' ' 83' ' ' LYS . 8.9 tm0? 81.21 136.81 0.06 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.544 ' C ' ' H ' ' B' ' 85' ' ' MET . 24.2 mmtp -103.05 155.57 18.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' B' ' 84' ' ' ARG . 45.0 mtt-85 66.16 -8.62 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' MET . . . . . 0.544 ' H ' ' C ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -149.31 66.22 8.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -44.2 115.49 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.637 2.225 . . . . 0.0 112.108 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -132.2 131.05 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.162 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.513 ' CG1' ' HB3' ' B' ' 80' ' ' LEU . 2.7 mt -115.5 146.31 20.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 2.6 t -109.22 119.86 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.899 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . 0.612 ' HZ2' ' C ' ' B' ' 96' ' ' GLY . 6.4 tttp -145.04 151.19 38.16 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 118.719 -1.193 . . . . 0.0 113.728 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' CYS . . . . . 0.621 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.6 OUTLIER -86.5 136.64 33.01 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.518 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.2 1.76 47.7 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.95 -32.03 12.81 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' B' ' 66' ' ' CYS . 0.0 OUTLIER -144.72 77.66 1.54 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 112.231 -2.259 . . . . 0.0 106.764 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -38.12 92.73 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.6 ' N ' ' O ' ' B' ' 95' ' ' CYS . 66.5 t60 -122.99 134.93 54.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.397 -1.402 . . . . 0.0 109.524 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mm -99.67 120.88 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.638 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 5.9 mmm -116.33 172.29 7.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -121.12 147.75 45.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' B' ' 101' ' ' TYR . 1.8 t80 -157.37 90.66 2.4 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.238 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -83.96 164.37 13.57 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.692 2.262 . . . . 0.0 112.723 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -137.88 101.81 4.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.921 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.24 118.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.542 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' GLU . 77.9 p . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.948 0.404 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 79' ' ' VAL . 58.2 m-85 -38.93 -58.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.69 -8.81 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' SER . 47.0 tp10 -104.03 -37.98 7.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.156 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.68 HG23 ' CE2' ' B' ' 31' ' ' TYR . 4.3 mm -95.66 22.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.482 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 ' H ' ' A' ' 24' ' ' ILE . 1.3 tp -80.76 117.43 26.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 105.12 -29.74 11.14 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 121.022 -0.609 . . . . 0.0 114.43 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.66 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -63.28 29.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.967 . . . . 0.0 110.882 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.66 ' H ' ' C ' ' A' ' 25' ' ' GLY . 3.3 p -44.5 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.66 ' N ' ' O ' ' A' ' 26' ' ' ARG . 27.9 t-105 -57.86 -52.52 65.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.407 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.834 ' CD1' HG12 ' B' ' 28' ' ' VAL . 10.4 pt -69.73 -12.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.977 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' B' ' 24' ' ' LEU . 40.5 m-85 -93.53 -11.07 32.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.06 -68.3 0.8 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.41 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.03 46.42 1.5 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . . . -161.88 -34.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.739 ' HA ' HG23 ' B' ' 20' ' ' ILE . 19.6 t-80 -103.55 108.19 19.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.822 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.701 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -149.56 9.51 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.783 ' O ' ' CD1' ' A' ' 101' ' ' TRP . . . -49.04 148.15 5.26 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -64.25 111.13 2.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 118.486 -1.285 . . . . 0.0 108.947 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 100' ' ' THR . 92.6 t -83.08 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.903 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.756 ' O ' ' N ' ' A' ' 43' ' ' ILE . 4.1 t-20 -163.81 150.5 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.563 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 69.5 tttt -48.29 -56.67 7.44 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.753 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 54.2 pttt -61.63 -5.3 1.79 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 70.2 m-20 -126.0 3.54 7.27 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.783 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.756 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.53 -42.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.072 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.713 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -94.48 -0.46 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.23 14.65 16.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.458 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -120.37 176.47 5.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.764 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.733 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -90.81 112.26 24.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.983 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.767 ' O ' HD13 ' A' ' 49' ' ' ILE . 55.5 mt -74.39 114.14 12.42 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm -155.79 -40.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.761 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.604 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -131.84 -20.05 1.1 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.744 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -44.44 142.31 1.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.813 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.2 ttpm? -92.13 131.54 37.3 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.972 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.8 p -150.04 170.74 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.191 0.52 . . . . 0.0 111.282 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.67 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.42 152.44 51.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.898 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 65' ' ' GLY . 48.1 t -97.5 99.17 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.87 -50.89 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.841 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -128.47 120.75 27.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 94' ' ' CYS . 3.2 t -147.06 173.28 12.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.44 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -109.95 78.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' GLY . 3.0 m-70 -168.72 102.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.328 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.73 -4.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.478 2.119 . . . . 0.0 113.822 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -130.2 22.46 4.75 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.193 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 66' ' ' ILE . 20.8 m-85 -141.0 -11.76 0.97 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.533 1.167 . . . . 0.0 111.513 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 64' ' ' VAL . 2.2 m -72.98 131.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.02 5.21 90.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.664 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.047 HG23 ' NE1' ' A' ' 87' ' ' TRP . 9.0 tt -100.38 151.24 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 117.758 0.779 . . . . 0.0 112.345 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.687 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 2.7 tm-20 -118.0 132.71 56.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.57 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.25 173.22 27.47 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.853 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -96.5 114.93 26.63 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.8 t -48.77 146.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.012 HD11 ' HB2' ' A' ' 81' ' ' ALA . 36.2 mt -140.02 -60.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.127 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -104.14 144.71 31.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.62 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 43.8 tp10 -148.18 106.17 3.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.986 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.471 ' HA ' HH21 ' B' ' 38' ' ' ARG . 1.8 p -137.04 179.9 6.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.726 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' CA ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -55.44 -17.01 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.144 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HA ' ' HZ3' ' A' ' 91' ' ' LYS . 41.1 t30 -137.54 13.52 2.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.85 159.02 39.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 118.728 -1.189 . . . . 0.0 113.957 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.731 HD23 ' CE1' ' A' ' 96' ' ' PHE . 7.2 tp -150.46 110.55 4.14 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' ILE . 91.1 t -112.1 146.37 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.57 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -129.1 147.44 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.972 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.012 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -123.08 137.59 54.89 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.577 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.76 152.06 23.79 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 84' ' ' ASN . 8.9 pt-20 38.06 -136.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.699 -0.295 . . . . 0.0 110.937 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 87.3 m-20 -99.67 34.08 2.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.052 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 21.5 tptt -145.18 165.93 26.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.707 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.508 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 24.7 m -119.65 155.57 22.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.469 0.652 . . . . 0.0 110.693 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 1.047 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.4 m-90 -97.54 92.7 6.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.708 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -86.97 100.01 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 55' ' ' VAL . 3.9 t -147.27 109.16 3.93 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.448 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.01 164.35 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.323 1.348 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.749 ' H ' ' CD ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -72.03 -31.43 66.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 16.9 p-10 -90.28 -5.69 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -97.5 0.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.286 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -166.27 174.42 9.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.926 -1.11 . . . . 0.0 113.654 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.22 124.01 65.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.702 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.731 ' CE1' HD23 ' A' ' 78' ' ' LEU . 59.7 m-85 -99.04 131.19 45.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.972 ' C ' HG23 ' A' ' 53' ' ' VAL . 18.5 tt0 -111.29 95.48 5.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.751 ' CD1' HD11 ' A' ' 43' ' ' ILE . 16.4 m-85 -89.58 146.01 24.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.16 132.4 36.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.729 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 104' ' ' THR . 16.9 m -65.85 142.41 57.94 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -62.43 -1.66 0.84 Allowed 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.919 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 100' ' ' THR . 86.9 m-20 -106.92 19.45 20.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.751 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.03 23.49 77.07 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.57 137.21 44.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.423 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -81.28 129.56 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 44.7 mt -104.41 134.7 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.578 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -117.86 102.04 8.78 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.3 138.06 45.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.691 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.7 p -78.26 123.22 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.487 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -53.2 -2.44 0.1 OUTLIER Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -81.77 -22.86 36.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.167 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -66.69 -46.34 75.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.17 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -92.68 28.68 1.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 114' ' ' VAL . 3.6 p -55.28 105.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 75' ' ' ARG . . . 67.73 -40.64 0.24 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 114.462 -1.245 . . . . 0.0 114.47 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.8 91.66 1.98 Allowed Pre-proline 0 N--CA 1.466 0.328 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HB2' HH22 ' B' ' 17' ' ' ARG . 29.2 Cg_endo -69.76 -27.97 25.84 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.462 1.442 . . . . 0.0 108.752 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.818 ' HB3' HD22 ' B' ' 45' ' ' LEU . 13.0 pt-20 -61.08 -52.27 65.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.222 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.556 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 31.3 ttp -36.16 -38.38 0.14 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.596 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.617 ' NH2' ' CZ2' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -81.57 -50.03 9.84 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.145 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.55 -33.29 73.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.054 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.299 . . . . 0.0 111.054 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.734 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.587 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -79.3 -29.6 42.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.886 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -72.31 -33.58 67.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.723 1.249 . . . . 0.0 107.844 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.959 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.2 OUTLIER -62.94 -51.8 65.51 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.736 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.4 pt -65.73 -27.84 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.082 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -66.48 -42.35 87.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.725 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.495 ' O ' HG22 ' B' ' 18' ' ' ILE . 18.6 mmtt -53.93 -50.97 65.24 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 109.514 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.717 ' O ' HG12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -73.17 -38.15 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.6 HH22 ' HB2' ' A' ' 117' ' ' PRO . 31.1 ttt180 -65.06 -52.91 53.06 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.521 0.676 . . . . 0.0 110.895 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.589 HG23 ' N ' ' B' ' 19' ' ' ASP . 8.0 tp -56.74 -43.99 80.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.236 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.589 ' N ' HG23 ' B' ' 18' ' ' ILE . 11.1 m-20 -67.29 -29.2 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 34' ' ' HIS . 26.4 mm -74.99 -58.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.094 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.45 -34.18 74.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.094 ' N ' HD13 ' B' ' 21' ' ' LEU . 5.0 t80 -54.51 -50.32 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -71.44 -32.59 68.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.484 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.83 HD12 HG13 ' B' ' 28' ' ' VAL . 0.2 OUTLIER -66.29 -56.65 10.15 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.186 0.517 . . . . 0.0 109.641 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -50.32 -38.25 40.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.205 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.841 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 62.2 mt-10 -69.07 -46.14 68.57 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.192 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 3.0 ttt-85 -70.97 -33.37 70.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.897 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.232 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.9 m -84.5 -49.36 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.552 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.758 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 24.6 t80 -36.48 -49.98 1.84 Allowed Pre-proline 0 C--N 1.351 0.632 0 CA-C-N 119.531 1.06 . . . . 0.0 109.439 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.6 Cg_endo -54.85 -47.41 26.8 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.509 -2.151 . . . . 0.0 106.509 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.791 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.7 t80 -94.44 -13.65 26.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.397 -2.183 . . . . 0.0 112.752 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.232 ' N ' ' O ' ' B' ' 28' ' ' VAL . 52.5 p -159.1 90.84 1.99 Allowed Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 51.5 Cg_exo -53.46 -45.0 44.24 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.711 2.274 . . . . 0.0 113.81 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' B' ' 38' ' ' ARG . 79.5 tt0 -64.37 -53.96 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 21.8 mt -51.73 -59.61 4.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.004 0.431 . . . . 0.0 111.155 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.722 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.45 -35.4 52.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.196 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.824 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.57 -36.06 73.41 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.001 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.714 ' HD3' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -65.47 -54.68 24.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.824 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.86 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.2 m-85 -59.58 -39.94 85.76 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.1 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.9 t -45.32 -41.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -64.43 -43.24 94.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.805 ' O ' HG23 ' B' ' 46' ' ' VAL . 14.5 mt -64.55 -43.61 93.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.728 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -66.39 -31.51 72.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.243 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.609 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.9 -53.86 52.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -64.68 -41.01 96.36 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.743 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.893 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 97.3 t -53.51 -42.46 49.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.266 0.555 . . . . 0.0 109.99 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.84 -55.28 17.92 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.301 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.7 pt20 -80.71 -53.08 6.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 26.6 mmtt -56.53 -41.19 76.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -90.23 -9.06 49.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 0.0 110.348 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.54 66.84 1.01 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.349 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.455 ' O ' ' HD2' ' B' ' 61' ' ' ARG . 10.1 m0 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -8.5 45.39 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -80.59 -18.69 47.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -142.97 11.88 1.81 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.511 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 92.0 t80 -119.98 158.64 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 2.0 t -126.28 120.64 30.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -85.97 5.28 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.249 0.547 . . . . 0.0 109.639 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 2.5 mmmm -97.75 -39.73 8.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.86 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 5.2 p -136.07 1.98 2.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.7 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 66' ' ' CYS . 3.8 m-70 57.44 121.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.764 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 176.17 -172.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.766 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.824 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.4 OUTLIER -121.35 104.7 9.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.783 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -109.81 145.7 36.28 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.348 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.506 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 92.3 t -128.44 117.76 20.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' PRO . . . . . 0.428 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 77.9 Cg_exo -45.95 125.34 8.21 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.029 1.819 . . . . 0.0 111.85 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.76 -29.82 11.7 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.41 -80.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.003 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.529 ' C ' HD12 ' B' ' 93' ' ' LEU . 90.3 m-20 -116.97 17.38 14.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.082 0.468 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.529 HD12 ' C ' ' B' ' 75' ' ' ASN . 96.0 mt . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 121.221 0.534 . . . . 0.0 109.674 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 95.7 p . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.983 0.421 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 19' ' ' SER . 59.9 m-85 -33.7 -62.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.894 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.84 -22.08 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.325 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.2 tp10 -97.37 -34.59 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 ' CE2' ' B' ' 31' ' ' TYR . 1.8 mm -98.78 15.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.696 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -79.49 117.49 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.137 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 112.77 -35.5 4.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.889 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -61.07 25.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.958 0.879 . . . . 0.0 110.895 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.703 ' H ' ' C ' ' A' ' 25' ' ' GLY . 29.2 p -37.66 -17.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.513 0.673 . . . . 0.0 109.899 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' ARG . 17.7 t-105 -56.99 -56.34 22.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.689 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.873 ' CD1' HG12 ' B' ' 28' ' ' VAL . 13.5 pt -63.6 -17.91 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.269 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 18.1 m-85 -89.44 -16.89 29.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.1 mmt85 -90.91 -61.56 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.171 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' B' ' 27' ' ' ARG . . . -71.43 45.34 0.79 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -153.53 -36.15 0.1 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CG ' HD12 ' B' ' 20' ' ' ILE . 2.0 t-80 -90.56 106.78 18.73 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.029 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.66 0.83 3.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.434 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.507 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -54.28 146.41 24.66 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.537 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 2.1 ttm-85 -66.81 125.14 24.94 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.861 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -101.42 136.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.909 0.861 . . . . 0.0 113.301 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.632 ' O ' ' N ' ' A' ' 43' ' ' ILE . 11.0 m120 -166.11 152.17 9.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.323 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 42' ' ' ASN . 20.8 ttmt -49.96 -51.93 37.53 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.91 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -60.22 -4.81 0.89 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 77.7 m-20 -122.53 -10.25 8.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.33 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.656 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -80.12 -41.06 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.616 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.889 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.1 9.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.87 1.319 . . . . 0.0 107.57 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.889 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.24 -25.37 4.49 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.81 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -79.0 146.28 33.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.788 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -70.89 111.48 6.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 49' ' ' ILE . 13.5 mt -68.73 115.87 8.58 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.9 mm -157.42 -27.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.865 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -152.11 30.95 0.89 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.283 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.951 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -98.38 156.13 16.89 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.791 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.4 tmtt? -98.04 127.0 43.73 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.427 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.987 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.8 p -149.4 171.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.269 0.557 . . . . 0.0 111.871 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.92 152.62 49.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.799 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 65' ' ' GLY . 89.0 t -96.33 99.52 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.79 -51.97 13.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -129.03 118.61 22.83 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.331 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 5.2 t -149.36 173.35 13.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.331 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 59' ' ' THR . 10.8 t -108.32 75.46 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.294 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.4 m-70 -168.59 93.08 0.59 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.745 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.2 -5.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.349 2.033 . . . . 0.0 113.263 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -109.55 9.06 32.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.366 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 66' ' ' ILE . 39.6 m-85 -140.74 -12.95 0.98 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.234 1.017 . . . . 0.0 112.255 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.2 m -72.0 132.66 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.129 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.5 6.39 88.66 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.335 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.049 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.0 tt -100.87 148.48 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.701 0.75 . . . . 0.0 112.055 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.664 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 4.8 tm-20 -119.7 129.98 54.79 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.583 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -145.69 174.24 25.74 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 116.412 -0.358 . . . . 0.0 112.509 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.1 t80 -96.25 115.2 27.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.571 0.348 . . . . 0.0 110.093 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -48.21 142.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.727 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.2 mt -141.76 -39.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -121.82 143.43 49.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.212 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' N ' ' CZ ' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -157.21 106.48 2.18 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 -171.33 2.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.28 0.562 . . . . 0.0 111.084 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -53.24 -24.7 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.125 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -138.43 30.93 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.473 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -164.68 169.6 16.69 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.687 -1.205 . . . . 0.0 113.91 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.4 tp -165.83 110.21 0.83 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' ILE . 98.0 t -116.41 146.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.637 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -126.89 145.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.229 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.18 136.13 53.96 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.532 . . . . 0.0 111.828 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.92 132.88 3.82 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 64.33 -123.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.808 -0.231 . . . . 0.0 110.643 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -116.31 33.22 5.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 110.618 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.549 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 6.1 tptp -145.25 170.75 15.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.549 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 7.8 m -124.28 156.11 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.701 0.762 . . . . 0.0 110.85 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 1.049 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.2 m-90 -99.11 119.73 38.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.623 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -107.98 104.47 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.28 96.26 3.97 Favored Pre-proline 0 N--CA 1.457 -0.115 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.92 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 92' ' ' ASP . 38.3 Cg_exo -54.16 126.76 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.095 1.197 . . . . 0.0 110.295 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.78 -19.84 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.431 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' PRO . 5.3 p-10 -87.6 -6.92 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 59' ' ' THR . 2.2 t -133.72 33.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.714 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -167.09 158.06 11.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.712 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.487 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 73.1 mt -106.45 118.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 78' ' ' LEU . 66.6 m-85 -99.08 131.12 45.35 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.987 ' C ' HG23 ' A' ' 53' ' ' VAL . 11.2 tt0 -115.49 94.87 4.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.84 143.58 26.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.85 ' OE2' ' N ' ' A' ' 104' ' ' THR . 2.5 tm-20 -90.99 127.52 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.485 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.921 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -58.98 143.27 48.7 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.817 -178.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.861 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -54.83 0.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.284 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' THR . 31.8 t70 -106.66 10.64 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.16 14.42 76.91 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.921 ' O ' ' OG1' ' A' ' 100' ' ' THR . 19.3 m -106.54 127.6 53.45 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.806 ' CD ' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -76.47 135.98 39.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.431 0.634 . . . . 0.0 111.581 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.756 HD11 HG23 ' A' ' 100' ' ' THR . 70.2 mt -102.88 135.5 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.525 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -107.9 101.92 11.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.07 139.19 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.353 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 2.5 m -79.29 145.49 33.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.773 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -70.88 -1.91 42.54 Favored Glycine 0 CA--C 1.507 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.087 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.94 -21.61 34.05 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.352 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -64.82 -47.08 79.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.419 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -94.29 28.58 2.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.776 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 114' ' ' VAL . 12.6 p -60.81 106.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.98 -40.2 0.25 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.104 -0.953 . . . . 0.0 114.162 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -101.43 78.55 0.22 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.528 ' HB2' HH22 ' B' ' 17' ' ' ARG . 19.5 Cg_endo -66.59 -24.25 48.72 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.392 1.394 . . . . 0.0 108.984 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 119' ' ' MET . 9.3 pt-20 -62.94 -52.63 62.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.482 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.4 mmt -35.01 -55.56 0.59 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.667 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' CE3' ' A' ' 45' ' ' TRP . 4.2 tpt180 -68.28 -40.69 81.76 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.963 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -62.1 -39.15 91.52 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.689 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -79.62 -33.45 41.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.764 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 8.9 tttp -73.45 -35.06 65.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.664 1.221 . . . . 0.0 108.485 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 1.008 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -61.1 -51.51 68.84 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.088 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.706 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.9 mt -69.59 -35.56 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.9 -53.6 56.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.514 ' O ' HG22 ' B' ' 18' ' ' ILE . 12.9 mmmt -53.33 -50.96 63.9 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.734 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 7.7 pt-20 -71.53 -38.22 71.09 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.246 0.546 . . . . 0.0 110.755 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.727 ' HD3' HD11 ' A' ' 121' ' ' LEU . 7.0 ttt180 -58.84 -53.6 56.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.897 0.856 . . . . 0.0 109.844 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.685 ' HA ' HD12 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -59.36 -32.01 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.35 -50.13 73.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.663 HD12 ' CG ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -74.31 -49.61 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.12 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -56.0 -37.41 69.08 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.12 ' N ' HD13 ' B' ' 21' ' ' LEU . 6.2 t80 -59.76 -51.99 67.41 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.425 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 64.6 p -69.68 -34.95 74.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.856 HD12 HG13 ' B' ' 28' ' ' VAL . 0.1 OUTLIER -63.79 -56.26 16.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.181 0.515 . . . . 0.0 109.913 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -51.87 -34.51 41.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.832 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 1.7 tm-20 -74.19 -40.07 62.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.856 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 53.9 mtt180 -72.53 -34.74 67.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.215 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.7 m -85.83 -49.39 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.723 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 23.2 t80 -36.19 -49.85 1.69 Allowed Pre-proline 0 C--N 1.353 0.741 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.304 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.856 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 38.3 Cg_endo -54.58 -48.28 22.25 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.802 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.1 t80 -94.3 -10.8 31.62 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 112.473 -2.149 . . . . 0.0 112.773 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.215 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.0 p -165.03 95.13 0.88 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' B' ' 37' ' ' LYS . 33.2 Cg_exo -56.5 -39.12 93.5 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.503 2.135 . . . . 0.0 113.319 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -53.37 35.3 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.56 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 13.5 mt -54.36 -57.85 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.587 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -51.66 -31.24 24.81 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.185 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' O ' ' B' ' 69' ' ' PHE . 2.2 mptt -70.97 -41.17 71.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.761 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.848 HH11 HD11 ' B' ' 42' ' ' LEU . 2.5 tmm_? -60.07 -54.34 47.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.951 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.895 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -61.66 -39.29 90.85 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.718 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.1 t -45.64 -43.23 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.596 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.72 -43.64 98.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.848 HD11 HH11 ' B' ' 38' ' ' ARG . 63.1 mt -64.8 -43.94 91.55 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.361 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.802 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.81 -30.86 64.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.682 HD11 ' OH ' ' B' ' 62' ' ' TYR . 7.3 mt -67.66 -54.83 16.34 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.47 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.552 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.3 pp -57.74 -28.25 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.745 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.978 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 83.5 t -69.1 -48.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.153 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -66.08 -56.84 9.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 8.9 pt20 -80.75 -48.33 12.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -69.51 -33.85 73.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -89.38 -8.38 53.27 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? 64.82 71.15 0.46 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.834 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.646 ' O ' ' N ' ' B' ' 62' ' ' TYR . 2.0 m0 . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.52 -8.75 15.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.9 ptm180 -88.19 -26.4 22.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.264 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.742 ' NH1' ' CE2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -134.54 15.15 3.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.754 -177.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.682 ' OH ' HD11 ' B' ' 44' ' ' LEU . 23.5 t80 -111.82 151.13 29.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.773 ' CB ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -118.82 105.16 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.156 -178.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -92.86 -4.77 52.32 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.599 ' HB2' ' SG ' ' B' ' 66' ' ' CYS . 20.9 mmmt -78.57 -37.93 41.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.659 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 17.7 1.72 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.879 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.58 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.7 m80 53.96 95.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.902 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.402 ' N ' HG11 ' B' ' 40' ' ' VAL . . . -166.4 -173.92 2.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.8 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.781 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -125.44 102.51 7.44 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 1.061 HD22 ' H ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -99.97 154.4 18.42 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.814 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 42.9 t -131.12 115.15 16.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.424 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' PRO . . . . . 0.401 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 73.6 Cg_exo -45.0 122.49 4.33 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.224 1.949 . . . . 0.0 111.848 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.74 -26.77 23.25 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.446 HD12 HG11 ' B' ' 71' ' ' VAL . 56.1 mt -105.05 -80.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -115.55 22.36 13.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.958 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 70' ' ' LEU . . . . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.274 0.559 . . . . 0.0 111.972 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' B' ' 93' ' ' LEU . 92.9 mt . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.342 0.591 . . . . 0.0 109.432 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 54.7 p . . . . . 0 C--O 1.226 -0.164 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.623 ' HB3' HG11 ' A' ' 86' ' ' VAL . 37.0 m-85 -42.44 -58.52 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -43.72 -15.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' TYR . 38.2 tp10 -99.82 -32.62 10.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.327 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.704 HD12 ' OG ' ' B' ' 32' ' ' SER . 3.8 mm -109.11 19.15 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -80.35 117.13 25.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.543 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.26 -37.48 3.6 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.204 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 28' ' ' TRP . 1.9 mtt180 -62.26 30.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.552 0.676 . . . . 0.0 110.875 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.666 ' H ' ' C ' ' A' ' 25' ' ' GLY . 2.9 p -43.74 -12.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.747 0.784 . . . . 0.0 109.022 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.684 ' N ' ' O ' ' A' ' 26' ' ' ARG . 24.1 t-105 -58.24 -55.77 30.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.169 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.764 ' CD1' HG12 ' B' ' 28' ' ' VAL . 7.2 pt -64.66 -13.59 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 71' ' ' ILE . 60.5 m-85 -93.42 -16.5 24.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.9 mmm180 -89.13 -56.68 3.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.736 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' NE ' ' B' ' 27' ' ' ARG . . . -78.58 46.42 2.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ILE . . . -153.12 -40.98 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -75.68 126.96 32.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.536 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -154.78 -35.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.553 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' ARG . . . -32.29 144.77 0.02 OUTLIER Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 24.4 ttm105 -66.42 119.5 11.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -92.71 136.62 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.767 0.794 . . . . 0.0 113.115 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 43' ' ' ILE . 39.3 t30 -165.82 155.52 12.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 42' ' ' ASN . 86.3 tttt -52.21 -52.77 50.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.76 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.565 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 8.7 pttm -60.15 -4.24 0.76 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.748 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 72.3 m-20 -123.95 -3.41 8.13 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.228 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -86.41 -39.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 117.876 0.307 . . . . 0.0 111.466 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.882 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -88.43 3.12 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.238 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.882 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -114.65 -37.88 4.14 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.617 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.748 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -67.29 140.38 57.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.787 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -66.25 110.09 2.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.826 ' O ' HG12 ' A' ' 49' ' ' ILE . 5.0 mt -72.9 114.5 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.407 -1.317 . . . . 0.0 108.013 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.865 HD11 HD12 ' B' ' 42' ' ' LEU . 4.7 mt -168.42 51.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 O-C-N 123.803 0.689 . . . . 0.0 109.491 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 150.16 -35.26 0.99 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.591 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.969 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.6 tt -44.59 146.05 0.79 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.882 ' H ' HD23 ' A' ' 51' ' ' LEU . 13.0 tmtt? -85.46 125.31 32.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.348 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.977 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.0 p -149.1 171.02 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.434 0.635 . . . . 0.0 111.954 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.89 152.81 49.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.001 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 65' ' ' GLY . 31.6 t -100.44 99.46 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.58 -51.98 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.56 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HB3' HD12 ' A' ' 95' ' ' ILE . 15.1 t-20 -128.48 117.42 21.31 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.553 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.1 t -150.18 173.53 13.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.466 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.619 ' O ' ' OG1' ' A' ' 59' ' ' THR . 0.1 OUTLIER -101.36 79.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.507 ' O ' ' N ' ' A' ' 62' ' ' GLY . 62.6 m80 -161.14 94.92 1.4 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.614 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.7 -5.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.177 1.918 . . . . 0.0 113.219 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -134.79 22.57 3.64 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.193 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' ILE . 27.2 m-85 -140.69 -10.85 1.03 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.628 1.214 . . . . 0.0 111.834 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.4 m -72.14 134.07 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 83.27 5.87 88.44 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.291 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.083 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.4 tt -104.54 153.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.66 0.73 . . . . 0.0 112.204 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.614 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.3 tm-20 -120.26 131.49 54.95 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.31 173.29 27.49 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 116.341 -0.39 . . . . 0.0 112.502 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -96.45 117.89 31.83 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -51.9 145.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.962 0.41 . . . . 0.0 111.654 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.6 mt -140.32 -33.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.485 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.666 ' OD2' ' NH1' ' B' ' 38' ' ' ARG . 37.6 t0 -123.56 149.29 45.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.662 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 tm-20 -161.71 106.05 1.26 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.959 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.536 HG23 ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -148.45 -175.23 4.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.194 0.521 . . . . 0.0 110.964 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.493 HH12 HH21 ' A' ' 116' ' ' ARG . 37.1 ttt85 -53.17 -23.25 7.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.094 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -138.83 29.16 2.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -166.29 164.53 17.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 118.358 -1.337 . . . . 0.0 114.267 179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.645 HD23 ' CE1' ' A' ' 96' ' ' PHE . 10.5 tp -163.43 109.79 1.13 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 112.975 -1.92 . . . . 0.0 105.937 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 71' ' ' ILE . 83.3 t -118.24 146.3 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 112.474 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.622 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -127.6 147.09 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.357 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -122.69 137.47 54.9 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.597 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -155.52 124.96 1.57 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 64.8 -130.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 110.552 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.24 32.06 5.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.544 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 13.7 tttp -139.12 166.75 23.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.607 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 20' ' ' TYR . 7.5 m -123.45 155.44 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.421 0.629 . . . . 0.0 110.611 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 1.083 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.6 m-90 -102.17 93.14 5.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.437 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' HG13 ' A' ' 89' ' ' VAL . 20.9 ttmt -91.3 104.84 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.928 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 88' ' ' LYS . 2.5 m -157.24 95.85 2.1 Favored Pre-proline 0 N--CA 1.457 -0.123 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.563 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 32.0 Cg_exo -54.28 126.82 23.45 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.973 1.782 . . . . 0.0 111.687 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.823 ' HZ3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -38.81 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.204 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 90' ' ' PRO . 4.0 p-10 -82.24 -6.11 58.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -137.06 33.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.271 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 90' ' ' PRO . 3.2 p -167.37 154.82 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.354 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 57' ' ' ASN . 23.7 mt -105.37 146.13 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.271 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.761 ' HB3' HG21 ' A' ' 53' ' ' VAL . 50.3 m-85 -130.42 137.65 49.94 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.977 ' C ' HG23 ' A' ' 53' ' ' VAL . 7.8 tt0 -119.65 94.0 4.26 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' ILE . 1.4 m-85 -87.69 144.82 26.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.612 ' O ' HD21 ' A' ' 51' ' ' LEU . 82.6 tt0 -90.01 131.6 35.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.317 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.67 143.39 57.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.693 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.45 -0.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.296 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 20.2 t0 -107.37 12.98 27.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.8 22.65 68.75 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.06 149.47 26.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.417 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.46 133.41 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.42 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 100' ' ' THR . 22.2 mt -107.16 134.9 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -115.65 102.63 9.93 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -151.38 139.92 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.933 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 111' ' ' GLU . 37.4 m -89.74 148.35 23.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.275 0.559 . . . . 0.0 111.449 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.34 -1.0 0.94 Allowed Glycine 0 CA--C 1.506 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.174 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -76.44 -23.75 53.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.287 -178.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -74.63 -47.56 31.4 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.303 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -90.81 28.41 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.1 p -59.64 105.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.823 ' N ' ' HZ3' ' A' ' 91' ' ' LYS . . . 67.49 -41.02 0.23 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.792 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.493 HH21 HH12 ' A' ' 75' ' ' ARG . 7.0 mmt180 -100.79 79.72 0.23 Allowed Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HB2' HH22 ' B' ' 17' ' ' ARG . 18.3 Cg_endo -64.83 -24.48 61.3 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.608 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -64.72 -57.31 9.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.446 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.463 ' C ' ' O ' ' A' ' 118' ' ' GLU . 2.6 tpt -31.81 -45.4 0.1 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.741 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.626 ' NE ' ' CZ3' ' A' ' 45' ' ' TRP . 6.8 tpm_? -70.9 -46.77 61.96 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.46 -41.35 97.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.97 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.618 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.55 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 2.6 pt-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' B' ' 11' ' ' LYS . 16.9 pttp -79.85 -41.49 26.21 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.965 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.847 ' H ' HH11 ' B' ' 12' ' ' ARG . 16.8 ttpt -72.85 -33.62 66.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 122.742 1.258 . . . . 0.0 108.431 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.98 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.5 mpt_? -61.8 -51.07 69.78 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.418 -2.173 . . . . 0.0 110.98 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 45' ' ' TRP . 15.1 mt -68.33 -27.55 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -61.95 -53.09 60.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.904 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.468 ' O ' HG22 ' B' ' 18' ' ' ILE . 29.5 mttp -54.16 -50.25 67.43 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.79 -37.49 70.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.302 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.506 HH22 ' HB2' ' A' ' 117' ' ' PRO . 17.6 ttt180 -61.79 -53.66 52.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.842 0.83 . . . . 0.0 110.163 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -57.35 -34.83 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.118 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -67.07 -31.28 71.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.143 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.572 HG21 ' OE2' ' A' ' 47' ' ' GLU . 31.3 mt -71.33 -56.88 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.023 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -65.14 -34.0 77.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.908 0.861 . . . . 0.0 109.087 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.023 ' N ' HD13 ' B' ' 21' ' ' LEU . 14.0 t80 -53.09 -49.33 66.64 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.305 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.4 p -68.27 -37.21 80.48 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.123 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -60.4 -56.78 17.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.708 0.766 . . . . 0.0 110.032 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.57 -33.99 34.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.159 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.813 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 7.9 mm-40 -75.15 -43.51 52.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.583 0.706 . . . . 0.0 109.79 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.84 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 83.6 mtt-85 -72.69 -34.56 67.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.4 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.256 ' O ' ' N ' ' B' ' 32' ' ' SER . 3.6 m -85.19 -50.9 14.22 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.642 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.727 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 14.1 t80 -36.42 -49.73 1.81 Allowed Pre-proline 0 C--N 1.35 0.599 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.525 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.84 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 41.5 Cg_endo -55.39 -47.91 23.42 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 N-CA-C 106.893 -2.003 . . . . 0.0 106.893 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.807 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.2 t80 -94.47 -15.25 24.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.536 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.256 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -161.2 93.62 1.44 Allowed Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.524 ' HB3' ' HZ1' ' B' ' 37' ' ' LYS . 50.5 Cg_exo -53.7 -43.47 57.57 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.03 2.487 . . . . 0.0 114.158 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.08 -52.17 60.58 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.645 ' CD2' HH21 ' B' ' 38' ' ' ARG . 11.4 mt -51.3 -58.15 6.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.758 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -53.68 -34.04 57.37 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.354 0.597 . . . . 0.0 109.649 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.783 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -70.8 -41.06 72.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.391 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.666 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 3.6 ttm-85 -62.75 -51.54 66.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.406 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.876 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.5 m-30 -60.48 -41.19 93.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.097 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 36' ' ' ALA . 3.1 t -45.27 -36.47 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.381 -1.281 . . . . 0.0 107.948 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 67.5 tt0 -67.87 -44.03 78.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.865 HD12 HD11 ' A' ' 49' ' ' ILE . 26.8 mt -66.17 -40.02 90.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.323 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -68.27 -31.1 70.32 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 4.5 mt -63.16 -54.64 34.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.601 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.665 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.9 pp -60.2 -38.17 82.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.13 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.945 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.0 t -54.42 -44.37 66.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.451 0.643 . . . . 0.0 109.702 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.4 -55.16 17.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.761 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 13.3 pt20 -80.32 -52.27 7.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 13.9 mptt -61.7 -39.96 93.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.313 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.56 -11.65 45.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.07 67.63 0.84 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.112 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.899 178.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.424 ' HA ' ' HE ' ' B' ' 61' ' ' ARG . 7.7 m0 . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -69.04 -16.65 63.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.472 HH11 ' HD2' ' B' ' 60' ' ' ARG . 7.6 ptm85 -78.73 -20.37 50.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.558 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -140.71 17.87 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.138 -177.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' B' ' 58' ' ' TRP . 85.9 t80 -119.48 156.79 29.56 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.558 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.5 OUTLIER -127.22 124.08 38.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.043 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.51 4.48 49.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.515 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -97.53 -38.6 9.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.196 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.3 p -136.71 10.72 3.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.473 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' B' ' 66' ' ' CYS . 5.4 m-70 49.63 109.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.7 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.96 -170.04 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.783 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -122.85 105.06 9.68 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -109.47 141.69 41.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.814 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.7 t -119.71 121.01 30.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.09 122.92 6.87 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.017 1.811 . . . . 0.0 111.991 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 76' ' ' ALA . . . 101.78 -33.08 6.79 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.473 HG22 ' OD1' ' B' ' 75' ' ' ASN . 89.3 mt -99.37 -77.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.773 0.321 . . . . 0.0 110.975 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.473 ' OD1' HG22 ' B' ' 74' ' ' ILE . 73.6 m-20 -109.27 14.65 23.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.71 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 121.368 0.604 . . . . 0.0 109.391 178.859 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.59 0.233 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.3 m-85 -49.85 -48.79 50.95 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.12 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -40.84 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 110.45 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -101.77 -35.56 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.616 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.698 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.6 mm -94.96 22.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -80.45 117.89 27.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.69 0.281 . . . . 0.0 111.712 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 107.07 -33.15 6.6 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.154 -0.546 . . . . 0.0 114.078 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.8 28.47 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.988 0.894 . . . . 0.0 111.038 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' GLY . 16.5 p -42.76 -14.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.565 0.698 . . . . 0.0 109.397 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.653 ' N ' ' O ' ' A' ' 26' ' ' ARG . 18.9 t-105 -58.84 -59.53 5.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.263 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.795 ' CD1' HG12 ' B' ' 28' ' ' VAL . 11.9 pt -56.97 -12.97 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.576 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.639 ' CD2' HD21 ' B' ' 24' ' ' LEU . 27.4 m-85 -94.25 -29.62 14.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -74.65 -41.59 60.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.46 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.18 26.15 10.76 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.75 15.43 1.09 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -127.81 100.49 5.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.997 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.567 ' H ' HG13 ' B' ' 20' ' ' ILE . 5.3 mmt85 -138.87 -9.64 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.82 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.693 ' H ' ' CG1' ' B' ' 20' ' ' ILE . . . -45.52 145.05 2.9 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.571 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 28.7 ttt180 -66.87 118.26 10.12 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 61.8 t -93.64 136.5 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 43' ' ' ILE . 10.7 t-20 -165.86 150.93 8.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.279 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.542 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 88.0 tttt -48.45 -55.5 10.73 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.357 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.3 pttp -59.31 -5.28 0.71 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.626 ' O ' ' CG ' ' A' ' 46' ' ' HIS . 2.2 m120 -125.12 0.5 7.86 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.231 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.9 -38.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.907 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -97.63 9.85 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.575 1.179 . . . . 0.0 108.015 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.797 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -125.82 6.44 7.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.535 -1.666 . . . . 0.0 107.664 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.731 ' C ' ' HE ' ' B' ' 17' ' ' ARG . 0.1 OUTLIER -107.97 176.16 5.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.687 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.789 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -94.57 111.75 23.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.794 ' O ' HD13 ' A' ' 49' ' ' ILE . 45.9 mt -75.21 115.39 14.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.801 ' HB ' HD23 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -161.02 -40.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -136.1 20.44 3.59 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.885 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -86.72 137.78 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.71 ' H ' HD23 ' A' ' 51' ' ' LEU . 76.2 tttt -71.1 135.89 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.669 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 54' ' ' ARG . 1.8 p -149.48 171.89 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.442 0.639 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -146.98 140.27 25.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.901 178.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 65' ' ' GLY . 42.9 t -91.25 99.53 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.43 -50.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.457 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.33 117.9 13.89 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 4.5 t -150.27 174.02 13.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.758 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.601 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 1.4 p -97.14 78.84 2.79 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.716 ' O ' HG13 ' A' ' 64' ' ' VAL . 73.9 m80 -166.56 111.71 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.696 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.05 -6.03 17.23 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.88 1.72 . . . . 0.0 112.654 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.08 13.72 9.03 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.763 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 87' ' ' TRP . 30.5 m-85 -138.82 -22.74 0.95 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.345 1.072 . . . . 0.0 111.589 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 60' ' ' HIS . 8.8 m -71.82 145.63 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.52 6.4 89.2 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.365 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.962 HG21 ' CZ2' ' A' ' 87' ' ' TRP . 26.1 mt -111.9 158.4 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 66' ' ' ILE . 4.5 tt0 -115.13 120.54 40.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.88 171.37 26.86 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.145 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -91.03 129.91 36.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.3 t -68.13 153.84 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.369 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.693 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 85.2 mt -141.59 -55.96 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.671 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 0.8 OUTLIER -106.41 150.21 26.26 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.676 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -156.68 107.05 2.33 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.477 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.73 -173.13 3.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 110.759 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -52.21 -29.5 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.581 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.593 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -137.98 31.37 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.678 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -157.13 161.46 39.38 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 118.992 -1.083 . . . . 0.0 113.358 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.715 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.3 tp -161.93 109.23 1.37 Allowed 'General case' 0 C--O 1.243 0.748 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 72' ' ' ASP . 80.4 t -107.86 147.29 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -131.11 143.86 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.002 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.07 136.19 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.945 0.403 . . . . 0.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.86 136.89 5.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 51.77 -133.93 1.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.517 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -102.23 33.75 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 22.1 tptm -145.46 160.34 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.092 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 14.0 m -120.57 156.69 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.588 0.709 . . . . 0.0 110.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.962 ' CZ2' HG21 ' A' ' 66' ' ' ILE . 2.6 m-90 -107.35 128.62 54.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.209 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' C ' ' CG2' ' A' ' 89' ' ' VAL . 83.0 tttt -118.64 106.54 12.71 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -152.31 99.58 2.85 Favored Pre-proline 0 CA--C 1.528 0.112 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.565 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 50.8 Cg_exo -50.66 137.9 41.16 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.812 1.675 . . . . 0.0 110.795 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.611 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -49.98 -19.9 0.81 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.787 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.611 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 1.2 p-10 -84.8 -6.17 59.34 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -125.12 5.89 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -142.34 139.41 31.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.117 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mt -85.71 116.99 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.727 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 53.1 m-85 -98.12 130.31 44.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 106' ' ' ILE . 38.3 tt0 -113.5 97.28 6.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.727 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 47.2 m-85 -90.28 145.14 25.21 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -90.62 127.04 36.15 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.773 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.662 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -63.01 143.62 57.62 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.765 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.831 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.43 -0.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.402 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.7 t0 -106.85 13.38 27.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.23 21.92 69.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.662 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.58 149.77 26.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.625 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.495 ' HG3' HH21 ' A' ' 54' ' ' ARG . 0.1 OUTLIER -91.05 132.4 36.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 20.6 mt -105.52 134.07 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.281 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -112.54 101.03 9.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -138.11 136.18 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.431 -177.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' GLU . 3.8 m -81.32 134.66 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.668 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' LYS . . . -59.33 -2.19 1.4 Allowed Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.829 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 pt-20 -86.19 -21.06 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.916 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -63.45 -44.33 94.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.92 27.72 3.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.216 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.3 p -48.1 103.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.471 0.653 . . . . 0.0 112.333 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' A' ' 91' ' ' LYS . . . 67.05 -41.44 0.2 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.725 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 119' ' ' MET . 12.4 mtt85 -100.52 97.4 6.48 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HB2' ' NH2' ' B' ' 17' ' ' ARG . 24.7 Cg_endo -69.32 -30.16 24.78 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 N-CA-C 107.1 -1.923 . . . . 0.0 107.1 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.593 ' HB3' HD13 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -64.79 -53.3 49.13 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.703 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 118' ' ' GLU . 0.8 OUTLIER -29.37 -36.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.056 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.631 ' CZ ' ' CH2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -82.39 -53.32 6.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.017 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.42 -31.25 54.81 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.463 179.856 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.654 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -78.45 -37.88 42.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.576 -0.45 . . . . 0.0 112.161 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.862 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.3 OUTLIER -72.12 -33.24 67.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 122.958 1.361 . . . . 0.0 108.237 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.969 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -59.85 -51.01 71.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 112.013 -2.358 . . . . 0.0 111.216 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.477 ' HA ' ' OE2' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -69.68 -29.34 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.23 -48.57 64.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.503 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.425 ' O ' HG22 ' B' ' 18' ' ' ILE . 10.1 tptt -50.75 -51.15 53.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' HD13 ' B' ' 20' ' ' ILE . 17.5 pt-20 -72.74 -36.7 67.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.206 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 46' ' ' HIS . 34.5 ttt-85 -60.92 -52.53 64.65 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.857 0.837 . . . . 0.0 110.606 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -35.91 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.422 -177.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.75 -32.15 72.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.693 ' CG1' ' H ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -73.78 -55.05 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.996 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.59 -34.45 75.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.996 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -54.43 -51.29 65.41 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.017 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -69.1 -31.53 70.3 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.501 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.818 HD12 HG13 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -69.11 -54.4 15.17 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.19 -34.3 31.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.614 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.837 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 49.6 mt-10 -73.89 -43.08 59.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.44 0.638 . . . . 0.0 110.437 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.86 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 86.0 mtt-85 -71.4 -35.42 71.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.384 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.205 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.4 m -82.33 -50.7 15.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 O-C-N 121.336 -0.853 . . . . 0.0 110.485 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.703 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 2.1 t80 -36.42 -51.2 1.84 Allowed Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.616 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.86 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.2 Cg_endo -53.66 -46.72 31.65 Favored 'Trans proline' 0 C--N 1.296 -2.188 0 N-CA-C 106.129 -2.297 . . . . 0.0 106.129 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' B' ' 28' ' ' VAL . 41.9 t80 -95.0 -14.32 24.46 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.139 -2.301 . . . . 0.0 113.269 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.205 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.6 p -157.91 96.24 1.95 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 52.7 Cg_exo -55.09 -47.4 26.62 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.967 2.445 . . . . 0.0 114.347 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.21 -53.2 56.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.548 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 62.0 mt -51.74 -60.25 3.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.984 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.8 -32.95 60.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.812 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.29 -38.46 75.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.702 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.854 ' NH1' HD11 ' B' ' 42' ' ' LEU . 3.8 tmm_? -60.72 -50.35 73.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.027 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.8 OUTLIER -64.26 -40.46 96.04 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.8 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.02 -37.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -66.97 -45.45 77.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.854 HD11 ' NH1' ' B' ' 38' ' ' ARG . 11.6 mt -63.37 -50.7 68.88 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.454 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.14 -30.29 68.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.805 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 10.4 mt -65.33 -54.43 29.13 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 118' ' ' GLU . 3.5 pp -59.6 -35.03 73.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.673 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.712 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.4 t -64.94 -49.89 77.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.435 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.11 -51.13 70.91 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.022 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 7.0 pt20 -78.85 -39.64 34.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.77 ' HD3' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -83.06 -42.21 17.72 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.089 -177.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -67.06 -14.87 63.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 mttm 72.54 52.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.021 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.995 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.623 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 36.2 m0 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.624 0.25 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -66.26 -17.06 64.52 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' B' ' 60' ' ' ARG . 9.6 ptp180 -76.17 -18.86 58.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.84 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.802 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -147.53 15.34 1.12 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.417 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 32.4 t80 -113.54 154.08 27.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.584 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 5.8 t -123.66 114.51 20.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.896 0.379 . . . . 0.0 111.448 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.36 3.89 12.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.921 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -98.27 -43.49 6.94 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.482 ' C ' ' CG ' ' B' ' 67' ' ' HIS . 6.1 p -134.14 -2.64 2.84 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.599 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER 61.94 134.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.513 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 164.97 -170.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.098 0.475 . . . . 0.0 110.783 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.825 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -117.96 103.92 10.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.802 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -110.23 117.35 33.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.45 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.688 HG23 ' CE2' ' B' ' 29' ' ' PHE . 1.5 t -101.59 121.06 52.63 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.939 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.15 124.79 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.792 1.662 . . . . 0.0 111.38 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.98 -33.93 6.18 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.488 HD12 HG11 ' B' ' 71' ' ' VAL . 96.6 mt -96.78 -80.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.854 0.359 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.43 18.6 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.115 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 N--CA 1.465 0.315 0 O-C-N 123.502 0.501 . . . . 0.0 109.785 178.938 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 22' ' ' GLU . 8.6 m-85 -43.23 -57.23 3.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -38.62 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.902 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 20' ' ' TYR . 47.0 tp10 -104.13 -32.6 9.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.728 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.1 mm -102.05 15.58 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 25' ' ' GLY . 1.2 tp -79.51 117.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.373 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.41 -36.42 4.06 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.328 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.676 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.32 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.631 0.716 . . . . 0.0 110.793 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.693 ' H ' ' C ' ' A' ' 25' ' ' GLY . 14.2 p -41.9 -14.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 109.601 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.676 ' N ' ' O ' ' A' ' 26' ' ' ARG . 23.2 t-105 -57.31 -53.74 54.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.212 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' B' ' 28' ' ' VAL . 8.6 pt -67.67 -13.11 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.082 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 49' ' ' ILE . 41.3 m-85 -92.8 -9.88 38.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.5 ttp180 -95.04 -64.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.77 31.74 0.38 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -146.63 -36.51 0.24 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -90.84 112.29 24.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.785 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.6 OUTLIER -148.47 2.13 0.63 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.943 -179.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA3' HH22 ' B' ' 17' ' ' ARG . . . -45.91 153.56 0.8 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 9.2 ttm180 -67.69 117.73 10.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 47.0 t -95.25 134.2 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 43' ' ' ILE . 5.7 t-20 -166.1 149.94 7.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.276 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' ASN . 11.3 tttm -48.26 -55.14 11.3 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.576 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 44.2 pttt -59.91 -4.86 0.81 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 90.2 m-20 -123.77 -0.35 8.56 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.229 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.54 -39.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.849 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.3 9.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.833 1.301 . . . . 0.0 107.578 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -126.55 -6.44 6.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.849 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.751 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -93.35 147.1 23.23 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.866 ' OE1' ' NE ' ' B' ' 17' ' ' ARG . 0.4 OUTLIER -74.48 110.64 8.93 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 49' ' ' ILE . 15.8 mt -73.24 117.94 15.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.4 mm -152.69 -30.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.763 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -146.76 0.03 0.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.541 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -58.32 162.35 3.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.665 0.732 . . . . 0.0 109.488 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.843 ' H ' HD23 ' A' ' 51' ' ' LEU . 11.9 tttt -106.73 125.16 50.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.472 0.177 . . . . 0.0 111.171 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.003 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.5 p -148.97 170.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.443 0.639 . . . . 0.0 111.513 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.708 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -132.27 145.43 51.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.439 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' GLY . 23.7 t -100.83 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.34 -47.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.937 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -127.77 119.43 25.72 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.133 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.9 p -148.61 135.95 20.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.052 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.629 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -71.26 77.1 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.281 -1.368 . . . . 0.0 108.948 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.629 ' CG ' ' C ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -169.29 97.89 0.5 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.027 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.89 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.469 2.113 . . . . 0.0 113.774 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -124.0 24.43 6.33 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 120.402 -0.904 . . . . 0.0 114.407 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -141.05 -21.98 0.78 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.804 1.302 . . . . 0.0 111.694 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 58' ' ' SER . 3.1 m -72.96 145.08 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.75 5.31 89.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.919 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.615 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.1 mt -104.64 148.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 118.259 1.03 . . . . 0.0 111.538 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -114.71 126.97 55.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.81 173.37 27.9 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.981 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -95.85 120.21 35.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.7 t -53.12 141.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.117 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.729 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.6 mt -135.39 -36.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.971 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 1.7 t70 -121.83 141.68 50.99 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.639 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 5.0 tt0 -153.19 106.23 2.97 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -140.42 -176.77 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.125 0.488 . . . . 0.0 110.725 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 72.6 ttt-85 -57.96 -16.46 12.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.816 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -138.77 27.29 2.46 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.551 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 2.4 ptp -165.96 170.02 14.12 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 118.7 -1.2 . . . . 0.0 114.066 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 96' ' ' PHE . 1.4 tp -166.13 110.24 0.8 Allowed 'General case' 0 C--O 1.252 1.233 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.907 ' C ' HD13 ' A' ' 80' ' ' ILE . 66.0 t -120.01 136.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.975 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -114.84 151.96 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -128.13 135.93 50.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.122 0.486 . . . . 0.0 111.82 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.442 ' N ' ' HZ3' ' A' ' 87' ' ' TRP . . . -157.53 122.64 1.19 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 66.73 -130.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -108.69 18.17 21.12 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.947 0.403 . . . . 0.0 110.101 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -119.56 144.51 47.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.425 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.73 155.47 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.512 0.673 . . . . 0.0 110.959 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.618 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 3.2 m-90 -99.39 137.69 37.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.294 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -128.95 93.74 3.67 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.14 107.35 2.63 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.366 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.29 165.0 2.42 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.794 1.662 . . . . 0.0 110.563 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.699 ' HD2' ' H ' ' A' ' 115' ' ' GLY . 1.7 mttm -72.79 -21.42 60.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.68 -5.73 59.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.0 15.36 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 15.1 p -161.32 174.29 13.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.015 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.09 139.72 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.807 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.849 ' CE2' HD23 ' A' ' 78' ' ' LEU . 88.1 m-85 -121.66 131.31 54.03 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 1.003 ' C ' HG23 ' A' ' 53' ' ' VAL . 43.9 tt0 -114.69 94.48 4.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' ILE . 3.1 m-85 -86.74 145.24 26.73 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -89.78 129.4 36.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.659 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.06 143.36 57.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.729 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.37 0.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.55 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 84.8 m-20 -107.26 13.42 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.01 21.93 66.94 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.87 150.05 26.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.635 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 133.3 36.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 111.121 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 100' ' ' THR . 16.0 mt -106.49 134.03 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -115.93 102.98 10.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -147.8 140.93 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.34 -178.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -88.38 150.71 23.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.435 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.34 -1.77 4.73 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.604 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 -21.55 47.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.658 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -73.66 -47.5 39.35 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.297 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.75 28.04 2.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.0 p -55.42 106.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.699 ' H ' ' HD2' ' A' ' 91' ' ' LYS . . . 68.2 -41.08 0.28 Allowed Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.476 -1.238 . . . . 0.0 114.464 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -101.92 87.87 1.13 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -69.47 -26.41 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.632 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.99 -57.69 7.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.685 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.424 ' C ' ' O ' ' A' ' 118' ' ' GLU . 5.3 ttp -31.43 -54.35 0.24 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.767 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -45.21 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.298 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -48.06 -30.98 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.251 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.413 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.758 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 28.9 mt-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -78.76 -29.07 44.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.951 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -33.93 64.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.68 1.229 . . . . 0.0 108.526 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.963 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -63.6 -51.7 64.14 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 112.322 -2.217 . . . . 0.0 111.722 -178.086 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.541 ' O ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -71.07 -27.12 28.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -68.74 -39.95 80.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.418 ' O ' HG22 ' B' ' 18' ' ' ILE . 47.1 mttt -63.17 -49.56 73.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.962 0.411 . . . . 0.0 110.488 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.521 ' C ' ' NH1' ' B' ' 17' ' ' ARG . 1.0 OUTLIER -69.34 -35.36 75.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.866 ' NE ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -62.16 -52.04 65.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.512 0.672 . . . . 0.0 111.342 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.99 -41.65 91.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.594 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 5.3 m-20 -69.78 -26.74 64.43 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.692 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.785 HD12 ' H ' ' A' ' 35' ' ' ARG . 5.7 mm -74.16 -57.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.67 -34.26 76.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.0 ' H ' HD13 ' B' ' 21' ' ' LEU . 11.6 t80 -53.72 -47.89 70.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.381 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 37.7 m -70.95 -34.11 71.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.449 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -67.86 -55.18 13.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.552 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.545 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -50.62 -38.44 46.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.735 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.823 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 23.7 mt-10 -65.84 -46.79 77.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.15 0.5 . . . . 0.0 111.263 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.889 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 1.7 ttt-85 -72.17 -33.47 67.72 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.354 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.171 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.7 m -82.6 -50.71 15.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.424 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.73 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 1.6 t80 -36.39 -50.63 1.82 Allowed Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.889 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.3 Cg_endo -53.64 -46.36 34.27 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 N-CA-C 106.21 -2.265 . . . . 0.0 106.21 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.8 ' N ' ' O ' ' B' ' 28' ' ' VAL . 39.8 t80 -94.92 -12.66 26.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.028 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.171 ' N ' ' O ' ' B' ' 28' ' ' VAL . 60.5 p -160.34 96.67 1.48 Allowed Pre-proline 0 N--CA 1.472 0.654 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.64 -44.75 45.02 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.261 2.641 . . . . 0.0 114.439 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.34 -53.0 55.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.035 0.445 . . . . 0.0 112.133 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.521 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 24.3 mt -53.81 -61.14 2.5 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.093 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.55 -32.72 42.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.725 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -70.46 -41.05 73.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.079 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.864 HH11 HD11 ' B' ' 42' ' ' LEU . 2.8 tmm_? -59.68 -53.58 56.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.555 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.91 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.1 m-30 -58.88 -43.17 90.86 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 110.049 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.513 HG23 ' CD2' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -46.32 -40.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.902 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.95 -42.21 99.75 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.864 HD11 HH11 ' B' ' 38' ' ' ARG . 63.2 mt -67.39 -51.36 52.83 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.477 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -52.23 -31.03 30.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.987 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 23.8 mt -65.33 -54.44 28.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.305 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.673 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.4 pp -62.02 -28.3 69.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.832 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.905 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 95.1 t -64.34 -48.87 83.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.602 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLN . . . . . 0.434 ' NE2' ' CD1' ' B' ' 18' ' ' ILE . 1.8 tp-100 -65.74 -57.41 8.09 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.8 pt20 -81.62 -52.16 7.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 5.4 tptt -62.96 -37.71 88.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.889 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -81.45 -0.71 42.9 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.725 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 63.61 69.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.744 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.743 179.012 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.626 ' O ' ' N ' ' B' ' 62' ' ' TYR . 6.0 m-90 . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.543 0.211 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -61.65 -19.66 62.55 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.81 -17.79 64.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.818 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -150.74 8.3 0.57 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.64 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' B' ' 58' ' ' TRP . 92.6 t80 -117.72 157.5 26.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.988 0.423 . . . . 0.0 110.551 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' B' ' 62' ' ' TYR . 22.6 t -126.99 129.99 49.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.042 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -87.33 3.13 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.79 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -108.16 -31.44 7.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.796 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' B' ' 67' ' ' HIS . 11.5 p -138.96 10.44 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.209 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.0 OUTLIER 37.12 103.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.985 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.781 ' HB1' ' NZ ' ' B' ' 37' ' ' LYS . . . -162.25 -173.05 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.122 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.618 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -113.97 103.18 10.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -105.57 147.56 28.26 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.632 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.511 HG11 HD12 ' B' ' 74' ' ' ILE . 2.5 t -125.95 120.72 24.11 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.86 123.64 6.29 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.859 1.706 . . . . 0.0 111.654 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.13 -33.26 6.67 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.511 HD12 HG11 ' B' ' 71' ' ' VAL . 94.8 mt -94.44 -80.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.615 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.86 22.64 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.225 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.51 -0.592 0 CA-C-O 120.516 0.198 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 76' ' ' ALA . 14.1 mt . . . . . 0 C--N 1.329 -0.326 0 O-C-N 124.597 1.186 . . . . 0.0 108.279 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.951 0.405 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' A' ' 72' ' ' ASP . 54.0 m-85 -38.32 -62.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.915 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.39 -7.92 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.414 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.3 tp10 -97.9 -36.93 10.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' B' ' 31' ' ' TYR . 2.5 mm -104.51 14.16 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.3 tp -79.98 118.8 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.413 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 120.07 -38.85 2.63 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -66.87 27.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.676 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -41.94 -14.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.739 0.78 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 28.1 t-105 -58.71 -54.44 47.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.329 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.755 ' CD1' HG12 ' B' ' 28' ' ' VAL . 4.7 pt -66.2 -14.25 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -89.71 -34.35 16.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.98 -32.61 19.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.765 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' NH1' ' B' ' 27' ' ' ARG . . . -85.48 28.81 4.64 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -156.13 20.72 0.37 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -127.15 101.91 6.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.671 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.472 ' H ' ' CG1' ' B' ' 20' ' ' ILE . 23.0 mmt-85 -145.85 12.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.938 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.644 ' HA3' HH21 ' B' ' 17' ' ' ARG . . . -62.32 152.45 44.3 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 14.9 ttm180 -67.31 132.84 48.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.805 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 55.1 t -116.8 136.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.707 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.691 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -166.23 153.81 10.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.617 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' ASN . 28.8 tttm -49.83 -55.8 12.81 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.837 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.623 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 42.9 pttt -60.64 -3.51 0.72 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.746 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 31.6 m-20 -124.72 1.12 8.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.26 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.98 -42.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.876 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.853 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.7 0.79 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.853 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -117.23 18.04 14.59 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.008 -1.906 . . . . 0.0 107.68 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.23 126.58 45.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.925 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -59.28 113.42 2.15 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 98' ' ' PHE . 2.6 mt -78.13 122.18 25.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.759 0.314 . . . . 0.0 111.001 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.784 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.0 mm -151.22 -46.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.936 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -127.57 -3.06 6.15 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.181 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -60.35 140.87 56.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.248 0.524 . . . . 0.0 110.358 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.651 ' H ' HD23 ' A' ' 51' ' ' LEU . 64.1 tttt -75.38 135.56 40.8 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 2.7 p -148.75 170.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.546 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -150.33 140.52 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.855 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.4 t -88.19 100.79 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.5 -51.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 O-C-N 123.374 0.421 . . . . 0.0 110.512 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.7 118.75 15.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.182 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.65 ' HB3' HG12 ' A' ' 64' ' ' VAL . 23.3 t -148.74 174.23 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.96 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.703 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 5.9 t -103.11 78.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 59' ' ' THR . 19.2 m80 -167.62 118.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.17 -5.29 15.48 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 121.73 1.62 . . . . 0.0 112.975 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.14 20.94 7.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.187 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.21 -23.09 0.75 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.905 1.352 . . . . 0.0 112.098 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 58' ' ' SER . 3.3 m -71.57 145.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.64 7.31 87.6 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.257 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.845 ' CD1' ' HE1' ' A' ' 87' ' ' TRP . 19.8 mt -108.05 159.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' N ' HG22 ' A' ' 66' ' ' ILE . 5.7 tm-20 -126.76 121.82 33.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.459 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -148.09 172.38 28.38 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.073 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 1.6 m-85 -87.32 123.56 32.42 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.9 t -56.43 157.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.9 mt -143.73 -60.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 62.0 t0 -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.828 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -153.72 106.56 2.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 178.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -157.97 177.59 11.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.225 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.505 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 44.8 ttm-85 -53.69 -5.12 0.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.274 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.783 ' H ' HG23 ' A' ' 74' ' ' THR . 78.3 m-20 -137.98 0.79 2.21 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 74' ' ' THR . 4.8 ptp -165.78 167.89 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.895 HD23 ' CE2' ' A' ' 96' ' ' PHE . 4.5 tp -151.16 109.72 3.81 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.1 t -113.71 147.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -127.99 141.57 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.999 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -110.46 136.48 49.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -151.56 119.0 0.94 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 3.5 tp10 65.07 -123.14 0.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.404 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 56.5 m-20 -111.57 21.01 16.61 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.973 0.416 . . . . 0.0 110.475 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.542 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.0 tttp -130.66 164.46 24.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.481 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.469 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 29.2 m -120.67 156.28 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 110.637 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.845 ' HE1' ' CD1' ' A' ' 66' ' ' ILE . 2.5 m-90 -105.62 104.49 14.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.182 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.93 110.26 22.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.98 96.35 3.31 Favored Pre-proline 0 C--N 1.334 -0.097 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.224 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -55.75 146.31 66.99 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.882 1.721 . . . . 0.0 111.308 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.562 ' H ' ' CD ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.68 -29.11 37.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.613 -178.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -6.96 59.55 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -126.13 22.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.509 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.662 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 24.6 p -165.27 158.3 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.457 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 109' ' ' SER . 57.5 mt -112.58 124.62 69.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.627 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.895 ' CE2' HD23 ' A' ' 78' ' ' LEU . 72.4 m-85 -100.92 144.53 29.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 18.6 tt0 -125.75 97.59 5.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 48' ' ' LEU . 8.1 m-85 -90.45 145.72 24.7 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -89.46 130.76 35.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.068 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.66 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -65.48 142.46 58.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.483 0.659 . . . . 0.0 110.265 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.805 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.24 0.19 0.11 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.678 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.1 t0 -107.15 4.43 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.77 23.2 36.64 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -107.05 150.16 26.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 110.35 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -90.52 128.8 36.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 111.359 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 100' ' ' THR . 14.1 mt -104.03 135.07 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -120.35 101.82 8.05 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.497 HG21 HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -142.25 132.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.063 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.2 m -74.34 145.34 43.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.153 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -63.86 -2.52 6.48 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.546 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -81.46 -22.79 37.87 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.62 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -69.22 -44.56 71.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.022 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -99.0 29.38 3.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.9 p -54.36 105.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.82 -40.49 0.31 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.685 -1.143 . . . . 0.0 114.735 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 119' ' ' MET . 21.2 mtm-85 -100.49 85.75 0.57 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.68 -23.45 76.32 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.9 OUTLIER -68.59 -57.25 6.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.489 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 118' ' ' GLU . 26.4 ttp -24.8 -48.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.572 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' GLU . 2.9 tpm_? -82.58 -49.18 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.852 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -52.15 -39.11 59.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.495 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 118' ' ' GLU . 1.3 ptmt . . . . . 0 N--CA 1.462 0.163 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.917 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.524 ' O ' HG12 ' B' ' 13' ' ' ILE . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.58 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -53.73 -37.28 63.19 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.009 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.539 ' HG2' ' HD2' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -65.41 -46.64 79.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.276 1.036 . . . . 0.0 109.38 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.624 ' O ' ' CD ' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -64.92 -51.05 63.99 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.314 -1.767 . . . . 0.0 112.433 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.524 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.8 pt -62.61 -27.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.5 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -70.57 -38.14 74.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.418 ' HD3' HH21 ' B' ' 12' ' ' ARG . 37.1 mttt -60.85 -47.2 87.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.702 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.635 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -67.31 -38.43 84.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.366 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.678 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 2.6 mmp_? -67.39 -52.31 41.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.499 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -57.48 -42.53 81.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 6.9 m-20 -71.71 -32.42 67.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -71.33 -53.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.951 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.1 -33.54 76.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.951 ' N ' HD13 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -52.1 -44.33 64.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.943 178.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 18.7 p -73.86 -31.9 63.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.331 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -68.46 -58.21 4.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.26 -42.41 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.82 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -60.03 -50.65 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.529 0.68 . . . . 0.0 110.031 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.875 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 2.9 ttm180 -67.9 -37.74 82.12 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.958 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.213 ' O ' ' N ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -86.75 -42.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.363 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.787 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 25.2 t80 -39.17 -49.11 4.44 Favored Pre-proline 0 CA--C 1.509 -0.624 0 CA-C-N 119.982 1.265 . . . . 0.0 108.689 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.875 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.3 Cg_endo -54.45 -46.85 30.35 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.389 2.06 . . . . 0.0 106.747 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 34.8 t80 -93.53 -14.51 26.52 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.534 -2.121 . . . . 0.0 112.37 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.213 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -163.49 95.98 1.05 Allowed Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' B' ' 29' ' ' PHE . 52.3 Cg_exo -54.63 -45.09 43.57 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.197 2.598 . . . . 0.0 114.684 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.77 -53.65 53.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.745 ' CD2' HH21 ' B' ' 38' ' ' ARG . 32.4 mt -51.78 -58.39 6.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.7 -30.92 34.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.398 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.653 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.02 -41.75 70.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.612 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.745 HH21 ' CD2' ' B' ' 35' ' ' LEU . 2.4 ttm-85 -63.26 -46.98 84.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.897 ' CB ' HD23 ' B' ' 21' ' ' LEU . 2.2 m-85 -67.91 -40.06 83.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.942 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.4 t -46.63 -40.96 4.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.901 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.57 -38.73 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.821 HD11 ' OE1' ' A' ' 73' ' ' GLU . 17.9 mt -66.91 -45.43 77.96 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.718 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' B' ' 21' ' ' LEU . . . -58.0 -30.54 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.364 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.823 HD11 ' OH ' ' B' ' 62' ' ' TYR . 60.6 mt -69.02 -54.77 13.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.071 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' A' ' 118' ' ' GLU . 3.1 pp -57.4 -30.85 65.27 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.958 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 58.0 t -62.05 -47.13 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.525 0.679 . . . . 0.0 109.479 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -67.66 -56.12 10.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.384 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 5.7 pt20 -80.21 -46.74 15.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.21 -38.31 69.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.593 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -86.03 -9.63 56.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 63.02 74.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.307 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.221 178.42 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.496 ' C ' ' H ' ' B' ' 60' ' ' ARG . 5.0 m0 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -61.37 -6.84 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' B' ' 58' ' ' TRP . 11.8 ptp180 -93.08 -21.9 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.973 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.851 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -145.76 29.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.373 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.823 ' OH ' HD11 ' B' ' 44' ' ' LEU . 24.2 t80 -122.4 151.6 41.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.567 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 1.5 t -123.04 114.3 20.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.524 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -83.83 9.13 12.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 109.567 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.437 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 9.1 mmmt -99.34 -40.4 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.01 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.4 p -136.79 9.29 3.07 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.271 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.547 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.4 m80 54.84 122.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 172.22 -171.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.163 0.506 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.653 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 1.8 t80 -123.6 105.4 9.7 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.937 HD22 ' N ' ' B' ' 70' ' ' LEU . 0.2 OUTLIER -111.42 124.97 53.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.507 -177.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.55 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 66.5 t -106.23 127.21 28.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.9 125.98 12.28 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.174 1.916 . . . . 0.0 112.372 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.24 -35.93 4.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.5 -76.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.425 ' ND2' HD12 ' B' ' 70' ' ' LEU . 57.4 t30 -118.22 19.29 13.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.047 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 37.4 mt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.039 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 22' ' ' GLU . 96.4 p . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.751 0.31 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.674 ' HB3' HG11 ' A' ' 86' ' ' VAL . 8.1 m-85 -40.19 -58.85 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -49.57 -15.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.749 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' SER . 49.0 tp10 -104.49 -33.13 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.6 mm -100.83 18.7 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.0 tp -79.66 117.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.421 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.66 -38.1 3.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.537 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.7 32.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.738 0.769 . . . . 0.0 111.32 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.648 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -44.82 -11.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.642 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.9 t-105 -59.74 -59.85 4.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.858 HD12 HG12 ' B' ' 28' ' ' VAL . 17.8 pt -60.93 -10.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.216 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CD2' HD11 ' B' ' 24' ' ' LEU . 39.3 m-85 -94.19 -19.26 20.92 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 33' ' ' ALA . 6.5 mmm-85 -80.7 -69.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.528 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.33 44.16 1.11 Allowed Glycine 0 CA--C 1.518 0.276 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -158.09 -38.87 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' H ' ' A' ' 49' ' ' ILE . 44.7 t-80 -109.49 100.05 9.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.776 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -154.03 13.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.788 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.51 163.55 0.04 OUTLIER Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.636 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 7.8 ttt180 -67.84 112.34 4.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.369 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.813 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 54.5 t -90.19 136.37 24.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -165.6 145.95 6.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.048 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 59.9 tttm -47.14 -54.4 10.66 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.421 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 47.1 pttt -62.82 -4.46 2.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.645 ' N ' ' O ' ' A' ' 39' ' ' ASN . 73.3 m-20 -121.68 -4.61 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.439 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.87 -40.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.745 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.899 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -87.38 10.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.993 1.378 . . . . 0.0 107.394 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.899 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.98 -38.4 2.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.975 -1.92 . . . . 0.0 107.636 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HD1' ' CG2' ' B' ' 13' ' ' ILE . 0.0 OUTLIER -58.4 174.48 0.3 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.755 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' OE2' ' CZ ' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -100.76 109.05 21.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 176.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.873 ' O ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -76.54 117.05 17.79 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 117.585 -1.646 . . . . 0.0 108.055 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -162.56 40.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.93 -29.17 0.59 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.504 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -45.54 137.62 4.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.492 ' H ' HD23 ' A' ' 51' ' ' LEU . 4.4 ttpt -77.79 128.9 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.785 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HG21 ' A' ' 80' ' ' ILE . 5.2 p -148.4 169.37 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.39 0.614 . . . . 0.0 111.211 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.733 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -139.26 146.98 41.08 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.994 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 89' ' ' VAL . 66.2 t -98.15 98.88 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -91.17 -51.57 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.996 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -126.06 118.32 25.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 64' ' ' VAL . 4.0 p -148.72 159.97 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.454 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.64 80.43 7.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -167.62 116.27 0.66 Allowed Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.77 -4.85 14.11 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.817 1.678 . . . . 0.0 113.961 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.43 32.88 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.686 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -141.26 -21.32 0.77 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.032 0.916 . . . . 0.0 111.645 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG12 ' OG ' ' A' ' 58' ' ' SER . 3.5 m -72.38 138.41 21.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.262 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 99.14 5.8 56.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.053 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.674 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.23 157.81 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.356 1.078 . . . . 0.0 112.047 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 tm-20 -123.9 126.83 47.07 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.694 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.28 174.19 27.15 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.862 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ALA . 6.4 m-85 -95.09 120.34 35.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -48.77 151.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 111.55 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 81' ' ' ALA . 48.4 mt -142.64 -58.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.8 t0 -107.91 143.65 36.24 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 3.3 mp0 -146.38 106.92 4.07 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.955 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.599 HG22 ' NH1' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -138.41 -175.01 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 9.4 ttp180 -50.76 -31.85 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.124 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 75' ' ' ARG . 94.0 m-20 -138.11 31.66 2.41 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.517 ' HG3' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -155.12 158.97 39.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.784 -1.167 . . . . 0.0 113.713 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -156.6 110.01 2.65 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 71' ' ' ILE . 73.3 t -111.49 145.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.222 0.534 . . . . 0.0 112.319 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -133.82 140.25 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.261 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.025 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -113.37 135.57 53.72 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.95 0.405 . . . . 0.0 111.48 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -145.77 159.2 27.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 82' ' ' GLY . 5.1 pt-20 32.72 -109.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 110.847 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -127.28 33.72 4.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.88 0.372 . . . . 0.0 110.46 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 23.9 tttp -143.1 160.49 40.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.398 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 20' ' ' TYR . 4.2 m -114.07 155.4 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.721 0.772 . . . . 0.0 110.903 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.822 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.2 m-90 -97.71 135.29 39.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -125.97 96.04 4.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.41 101.61 3.78 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.429 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.512 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.6 Cg_exo -55.66 145.19 72.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.696 1.597 . . . . 0.0 111.064 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.898 ' HZ2' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -53.28 -37.71 62.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.078 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.04 -6.38 56.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 93' ' ' VAL . 3.3 t -125.22 29.81 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.41 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 31.6 p -168.02 165.32 13.6 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 118.931 -1.108 . . . . 0.0 113.926 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -114.46 133.97 58.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.157 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.743 ' CE2' HD23 ' A' ' 78' ' ' LEU . 50.0 m-85 -117.06 130.79 56.89 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 53' ' ' VAL . 6.4 tt0 -116.96 94.84 4.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.72 ' CE2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -89.81 146.48 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 105' ' ' LYS . 45.9 tt0 -88.49 127.77 35.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.85 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.621 HG23 HD11 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -63.91 142.36 58.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.219 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.813 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.66 -0.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.668 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 101' ' ' TRP . 1.1 m-20 -107.19 16.51 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.95 23.72 73.9 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.63 149.7 26.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.646 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 99' ' ' GLU . 58.9 mmtt -92.15 131.86 37.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.731 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' THR . 27.5 mt -107.17 135.25 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.912 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -118.04 101.31 8.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -139.13 139.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.212 -177.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 17.4 p -78.49 149.0 33.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.089 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -71.43 -1.87 46.13 Favored Glycine 0 CA--C 1.508 -0.368 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -86.9 -22.44 25.69 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.597 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -63.03 -47.69 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.221 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.601 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -95.2 28.43 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.6 p -52.17 104.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.898 ' H ' ' HZ2' ' A' ' 91' ' ' LYS . . . 68.14 -41.48 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.376 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 24.5 mmt180 -101.86 88.03 1.16 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.53 -25.49 34.97 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 N-CA-C 108.106 -1.536 . . . . 0.0 108.106 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.796 ' HB3' HD22 ' B' ' 45' ' ' LEU . 12.8 pt-20 -66.21 -55.24 17.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.163 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 23.9 mmm -34.2 -41.74 0.12 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.128 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.697 ' HE ' ' CA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.93 -43.91 42.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.887 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.871 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -61.78 -41.09 97.27 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.146 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HZ1' ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.831 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.839 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 7.4 pt-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -79.77 -45.89 18.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' B' ' 14' ' ' ALA . 20.2 ttpt -72.44 -33.48 67.09 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.726 1.251 . . . . 0.0 108.617 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 1.041 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER -62.6 -51.86 65.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.658 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.721 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 33.5 mt -64.94 -27.51 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -65.27 -48.5 73.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.244 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -52.18 -48.71 64.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.937 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -70.12 -38.03 75.47 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.965 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.633 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -65.82 -52.03 53.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.366 0.603 . . . . 0.0 110.451 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.55 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.85 -42.76 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.19 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 1.5 m-20 -71.82 -22.18 61.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.937 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -75.49 -56.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.998 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.98 -34.43 77.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.998 ' H ' HD13 ' B' ' 21' ' ' LEU . 2.8 t80 -53.12 -44.06 67.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.921 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -64.66 -40.16 94.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.922 ' O ' HG13 ' B' ' 28' ' ' VAL . 1.9 mm? -56.9 -57.55 12.03 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.776 0.798 . . . . 0.0 109.297 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.04 -33.35 17.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.392 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.811 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 57.5 mt-10 -77.12 -55.82 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.914 0.864 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.852 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 79.9 mtt-85 -67.95 -35.88 79.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.474 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.182 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -85.48 -50.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.673 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.754 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 27.8 t80 -36.3 -49.34 1.73 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.173 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.852 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 36.5 Cg_endo -53.26 -47.86 25.17 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 N-CA-C 106.506 -2.151 . . . . 0.0 106.506 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 62.2 t80 -94.5 -15.17 24.41 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.289 -2.232 . . . . 0.0 113.08 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.182 ' N ' ' O ' ' B' ' 28' ' ' VAL . 43.0 p -158.04 91.19 2.21 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.84 -41.9 73.91 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.977 2.451 . . . . 0.0 113.88 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 55.8 mp0 -66.67 -54.25 25.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 25.9 mt -52.09 -55.38 21.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.985 0.422 . . . . 0.0 110.155 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.35 -30.24 50.96 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.331 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.704 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.48 -47.11 57.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.884 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.701 ' C ' ' CD ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -60.54 -53.3 59.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.799 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.956 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.2 m-85 -59.69 -42.57 93.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' B' ' 39' ' ' TYR . 1.1 t -45.05 -34.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.568 ' CD ' HH21 ' B' ' 38' ' ' ARG . 0.0 OUTLIER -70.65 -44.86 66.25 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' TYR . 49.4 mt -65.45 -47.89 74.59 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.961 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.72 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -57.17 -31.16 65.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.535 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.73 -50.94 69.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.383 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -61.95 -39.29 91.62 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.015 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.736 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 40.2 t -61.22 -49.23 85.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 111.49 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -49.6 72.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.714 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.84 -55.96 4.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.986 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.62 ' N ' ' O ' ' B' ' 45' ' ' LEU . 6.6 mmpt? -59.0 -43.29 91.46 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -79.07 -16.21 57.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 26.1 mttt 70.75 43.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.748 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.316 -0.885 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.745 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' NH1' ' B' ' 60' ' ' ARG . 5.4 m-90 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.75 -3.79 7.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' B' ' 58' ' ' TRP . 18.6 ptt-85 -82.28 -35.34 28.14 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.302 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -124.94 21.6 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.515 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -118.43 154.6 32.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 1.7 t -126.39 113.62 17.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.656 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -78.85 4.35 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.976 0.417 . . . . 0.0 109.986 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.449 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.4 OUTLIER -95.86 -38.23 10.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.538 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.0 p -138.72 -0.2 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.734 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.5 m80 61.52 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . 169.81 -171.41 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.065 0.46 . . . . 0.0 111.123 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.574 ' O ' ' CE2' ' B' ' 29' ' ' PHE . 13.2 t80 -121.19 103.02 8.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.842 HD22 ' N ' ' B' ' 70' ' ' LEU . 0.4 OUTLIER -113.58 119.26 36.89 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.411 0.624 . . . . 0.0 112.441 -177.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.602 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 61.1 t -96.16 136.13 22.24 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.046 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.92 118.55 5.59 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.719 1.613 . . . . 0.0 111.531 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.64 -33.42 4.64 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.57 -78.09 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' B' ' 93' ' ' LEU . 19.3 m-20 -116.77 19.76 14.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.929 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' B' ' 75' ' ' ASN . 84.0 mt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 22' ' ' GLU . 79.0 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' HG11 ' A' ' 79' ' ' VAL . 89.2 m-85 -37.45 -45.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.131 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -58.28 -21.58 49.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 19' ' ' SER . 4.5 tt0 -104.79 -38.0 6.83 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.458 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.818 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.61 24.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.462 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.651 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -80.01 118.98 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.712 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.687 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 83.68 -7.0 71.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.656 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.708 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -64.09 21.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.516 0.658 . . . . 0.0 109.887 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.687 ' H ' ' C ' ' A' ' 25' ' ' GLY . 7.0 p -38.13 -16.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.387 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.708 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.0 t-105 -58.67 -57.0 14.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.763 ' CD1' HG12 ' B' ' 28' ' ' VAL . 6.1 pt -65.68 -11.27 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.609 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' B' ' 24' ' ' LEU . 88.7 m-85 -96.32 -37.37 10.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.8 mmt180 -61.0 -68.43 0.31 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.144 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.81 52.02 1.59 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -150.43 -40.19 0.13 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.793 ' CE1' ' H ' ' A' ' 51' ' ' LEU . 1.9 m-70 -91.1 100.15 13.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.218 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -125.71 -20.54 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.984 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -40.67 146.6 0.34 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.9 ttm180 -67.11 118.96 11.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.808 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.1 t -92.8 136.69 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 1.5 t-20 -164.98 150.74 9.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.124 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 42' ' ' ASN . 43.8 tttm -50.04 -55.68 13.8 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.217 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.61 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 52.2 pttt -58.85 -4.09 0.41 Allowed 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 5.6 m120 -126.06 0.48 7.21 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.27 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.801 HD11 ' CG ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.41 -38.14 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.261 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.809 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.7 0.75 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.814 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.81 6.9 14.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.829 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -115.41 139.13 50.29 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.775 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.804 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -59.95 111.77 1.61 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.924 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -74.09 116.34 14.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 177.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 48' ' ' LEU . 3.7 mm -153.64 -29.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.289 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.663 ' H ' ' CE1' ' A' ' 34' ' ' HIS . . . -138.22 -25.38 0.35 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.922 HD23 ' H ' ' A' ' 52' ' ' LYS . 1.5 tt -44.2 150.03 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.922 ' H ' HD23 ' A' ' 51' ' ' LEU . 82.8 tttt -93.62 131.41 38.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.057 0.456 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.952 HG23 ' C ' ' A' ' 97' ' ' GLU . 7.9 p -148.77 166.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.0 t -94.61 98.87 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.18 -48.09 17.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.451 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -132.94 120.77 21.88 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.956 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.561 ' OG ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -147.25 172.71 13.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.093 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.623 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 4.4 t -104.14 77.08 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.062 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -169.28 96.87 0.51 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.72 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 -4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.324 2.016 . . . . 0.0 113.237 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -122.74 19.28 7.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.507 -0.854 . . . . 0.0 114.474 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' ' N ' ' A' ' 88' ' ' LYS . 54.8 m-85 -142.34 -23.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.181 1.491 . . . . 0.0 112.28 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.561 HG12 ' OG ' ' A' ' 58' ' ' SER . 1.5 m -74.04 144.36 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 85.86 5.61 83.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.51 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.605 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.2 mt -107.53 153.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.924 0.862 . . . . 0.0 111.59 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' C ' ' CZ2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.58 126.46 53.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.472 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.3 173.78 27.31 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.93 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -96.73 117.69 31.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.634 0.374 . . . . 0.0 110.098 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -50.15 148.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.693 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.709 ' N ' ' O ' ' A' ' 79' ' ' VAL . 95.0 mt -143.87 -60.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -108.01 134.79 50.41 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.606 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -144.69 107.14 4.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.869 HG22 ' NH2' ' B' ' 38' ' ' ARG . 2.6 p -132.96 -169.6 2.29 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -52.76 -27.44 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -138.71 31.59 2.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.887 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 2.0 ptp -153.75 160.82 42.41 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.934 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.002 HD23 ' CE2' ' A' ' 96' ' ' PHE . 7.3 tp -163.86 110.15 1.09 Allowed 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.889 ' C ' HD13 ' A' ' 80' ' ' ILE . 74.5 t -117.25 129.75 73.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.018 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -111.55 152.36 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.027 178.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -129.02 136.89 50.91 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.351 0.596 . . . . 0.0 112.417 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -152.32 158.74 28.0 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' GLY . 14.0 pt-20 33.89 -128.52 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.749 0.275 . . . . 0.0 110.622 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -110.17 33.68 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 110.526 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 3.1 tppt? -138.09 151.9 48.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 31.1 m -118.31 156.17 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.351 0.596 . . . . 0.0 110.709 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.621 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 2.0 m-90 -97.96 140.52 32.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.732 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' N ' ' CE1' ' A' ' 63' ' ' TYR . 72.3 tttt -127.92 92.76 3.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.46 107.05 3.12 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.757 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.64 164.27 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.74 1.626 . . . . 0.0 111.31 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HD3' HD22 ' A' ' 78' ' ' LEU . 10.1 mttt -67.84 -27.17 66.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -90.55 -5.29 56.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 9.86 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.966 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -161.23 173.99 14.25 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.916 -1.114 . . . . 0.0 113.077 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.2 mt -111.97 130.73 65.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.71 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 1.002 ' CE2' HD23 ' A' ' 78' ' ' LEU . 97.1 m-85 -108.96 126.1 52.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.952 ' C ' HG23 ' A' ' 53' ' ' VAL . 26.8 tt0 -107.97 93.97 4.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.924 ' CZ ' HD22 ' A' ' 48' ' ' LEU . 37.1 m-85 -80.0 143.66 33.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.85 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.649 ' O ' HD21 ' A' ' 51' ' ' LEU . 75.6 tt0 -93.47 129.61 39.59 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.687 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -72.68 143.32 48.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.123 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.808 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.35 -0.93 0.28 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.621 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.511 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 27.5 t70 -107.14 20.18 19.36 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.33 22.62 78.56 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.578 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.29 149.76 26.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.475 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -93.48 131.0 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.153 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 10.4 mt -103.81 133.83 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -114.56 100.83 8.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.09 132.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.059 -178.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 111' ' ' GLU . 13.8 p -79.57 144.95 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.213 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.35 4.01 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -80.42 -22.59 41.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.4 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -69.89 -47.3 63.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -95.88 28.67 3.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.2 p -45.77 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.617 0.723 . . . . 0.0 112.876 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' LYS . . . 66.83 -42.29 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.674 175.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HB3' ' H ' ' A' ' 119' ' ' MET . 71.1 mtm180 -101.89 99.17 11.38 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.469 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.7 Cg_endo -70.12 -26.54 25.75 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 N-CA-C 107.294 -1.849 . . . . 0.0 107.294 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.1 pt-20 -65.45 -45.87 82.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.516 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.9 tpt -39.74 -33.71 0.21 Allowed 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -78.75 -56.74 4.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.652 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.736 HD12 HG13 ' B' ' 46' ' ' VAL . 0.1 OUTLIER -58.56 -42.32 87.67 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 118.313 -1.355 . . . . 0.0 107.836 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.501 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.636 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -78.72 -31.45 46.4 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.241 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.733 ' H ' HH11 ' B' ' 12' ' ' ARG . 8.7 ttpt -73.86 -34.18 64.38 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.809 1.29 . . . . 0.0 108.122 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.924 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 4.7 mpt_? -60.96 -51.33 69.72 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.777 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -72.97 -29.06 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.543 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.409 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -70.56 -51.77 26.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.49 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' B' ' 16' ' ' GLU . 0.6 OUTLIER -55.28 -46.81 76.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.519 ' N ' ' HD3' ' B' ' 15' ' ' LYS . 9.3 pt-20 -72.08 -38.08 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.603 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 39.3 ttt180 -62.63 -54.19 43.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.703 0.763 . . . . 0.0 110.387 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -56.73 -34.28 42.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.519 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.42 -33.28 72.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.707 HD11 ' HA3' ' A' ' 36' ' ' GLY . 94.7 mt -69.61 -58.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.019 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.05 -35.4 76.81 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.019 ' N ' HD13 ' B' ' 21' ' ' LEU . 4.1 t80 -53.79 -38.94 65.03 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.05 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.7 m -66.9 -40.27 87.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.431 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.836 HD12 HG11 ' B' ' 28' ' ' VAL . 2.3 mm? -61.23 -58.79 6.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.524 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.404 ' HA ' ' CB ' ' B' ' 36' ' ' ALA . . . -49.46 -36.48 22.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.527 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.805 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -71.73 -60.26 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.407 0.623 . . . . 0.0 109.875 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.843 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 6.8 ttm-85 -64.43 -37.4 87.39 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.992 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.144 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.3 m -84.12 -50.86 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.275 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.719 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 29.7 t80 -36.37 -49.9 1.79 Allowed Pre-proline 0 CA--C 1.51 -0.572 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.359 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.843 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 35.7 Cg_endo -51.93 -46.13 34.23 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.816 ' N ' ' O ' ' B' ' 28' ' ' VAL . 10.2 t80 -92.87 -32.21 14.69 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.101 -2.318 . . . . 0.0 112.678 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.144 ' N ' ' O ' ' B' ' 28' ' ' VAL . 61.7 p -144.2 96.91 5.29 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.682 ' C ' ' HZ3' ' B' ' 37' ' ' LYS . 32.1 Cg_exo -55.88 -42.13 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.791 2.327 . . . . 0.0 114.019 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.96 -53.77 28.44 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.527 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 10.6 mt -51.05 -53.21 35.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.262 0.554 . . . . 0.0 110.281 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.74 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -55.59 -34.14 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.11 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.682 ' HZ3' ' C ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.45 -41.78 69.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.869 ' NH2' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -58.79 -53.96 52.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.306 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.932 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.3 m-85 -60.68 -39.04 86.98 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.94 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.769 ' O ' HD23 ' B' ' 44' ' ' LEU . 3.7 t -45.87 -34.96 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 50.7 tt0 -72.21 -43.92 63.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.6 mt -63.78 -46.63 84.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.88 -34.03 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.796 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 40' ' ' VAL . 1.6 mm? -64.43 -45.02 89.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.592 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -63.91 -34.56 78.23 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.521 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.736 HG13 HD12 ' A' ' 121' ' ' LEU . 51.0 t -70.88 -56.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.16 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.447 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 17.0 pt20 -71.86 -51.06 24.21 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.332 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 121' ' ' LEU . 5.0 tmtt? -82.27 -35.64 27.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.375 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -65.4 -12.41 51.94 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.21 30.48 15.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.046 179.373 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.677 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 17.4 m0 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.767 0.318 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -62.63 -7.86 5.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' B' ' 58' ' ' TRP . 18.1 ptt180 -87.85 -21.66 24.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.442 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.824 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -146.88 20.23 1.27 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.094 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' B' ' 58' ' ' TRP . 50.1 t80 -114.78 154.42 28.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.7 OUTLIER -126.41 116.97 21.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.135 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -87.02 16.28 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.498 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.0 OUTLIER -116.59 -22.06 8.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.741 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.669 ' O ' ' O ' ' B' ' 67' ' ' HIS . 0.8 OUTLIER -153.73 21.59 0.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.869 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.669 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.2 OUTLIER 34.37 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 111.877 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.481 ' HB3' HD11 ' B' ' 70' ' ' LEU . . . -177.45 -176.99 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' NH1' ' B' ' 61' ' ' ARG . 0.5 OUTLIER -115.37 104.61 11.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.272 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.824 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -106.62 129.46 54.53 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.75 -177.042 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 48.7 t -113.38 124.16 31.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.053 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -46.89 126.1 10.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.886 1.724 . . . . 0.0 112.119 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.98 -36.54 3.97 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.5 -77.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.66 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.23 19.65 16.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.266 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.732 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 22' ' ' GLU . 93.1 p . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.718 ' HB3' HG11 ' A' ' 86' ' ' VAL . 83.1 m-85 -35.49 -63.41 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.094 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -16.37 39.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.194 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 19' ' ' SER . 41.8 tp10 -92.06 -30.4 16.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.2 mm -106.7 13.55 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -79.34 126.87 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.853 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.783 ' N ' HD13 ' A' ' 24' ' ' ILE . . . 106.78 -35.17 5.21 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.38 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -64.15 27.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.975 0.388 . . . . 0.0 110.736 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.642 ' H ' ' C ' ' A' ' 25' ' ' GLY . 13.9 p -43.75 -14.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.884 0.849 . . . . 0.0 108.745 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.741 ' HE1' HH12 ' B' ' 27' ' ' ARG . 38.1 t-105 -57.85 -52.52 65.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.294 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.861 ' CD1' HG12 ' B' ' 28' ' ' VAL . 12.7 pt -71.88 -11.8 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.587 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' B' ' 24' ' ' LEU . 58.5 m-85 -89.87 -23.46 21.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.4 tpp85 -80.88 -68.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.56 35.67 0.17 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.701 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -145.41 -39.02 0.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -95.95 105.93 18.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.92 1.33 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.45 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -47.25 156.95 0.68 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.611 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 6.1 ttm-85 -67.98 118.49 11.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 42.2 t -97.48 139.31 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.677 ' O ' ' N ' ' A' ' 43' ' ' ILE . 2.0 t-20 -166.66 154.65 9.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.435 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . 75.9 tttt -51.72 -55.94 16.69 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' CD2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -59.15 -3.79 0.43 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.698 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 55.0 m-20 -125.41 2.61 7.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.815 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.76 -39.75 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.563 0.221 . . . . 0.0 110.935 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.838 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.81 4.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 108.084 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.877 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.46 -21.92 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.04 -179.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.8 146.92 29.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.655 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -64.26 108.74 1.67 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.862 ' O ' HG12 ' A' ' 49' ' ' ILE . 8.2 mt -76.21 110.45 10.72 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.881 HD13 ' CD1' ' B' ' 39' ' ' TYR . 3.9 mt -170.78 55.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 124.032 0.832 . . . . 0.0 109.496 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 143.95 -27.82 2.02 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.935 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.2 tt -53.14 133.5 39.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' N ' HD23 ' A' ' 51' ' ' LEU . 1.7 tmtp? -69.61 124.38 23.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.097 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 97' ' ' GLU . 13.8 p -149.19 169.7 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.108 0.48 . . . . 0.0 110.654 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.688 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.65 149.62 46.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.138 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 89' ' ' VAL . 92.2 t -99.4 100.23 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.28 -36.98 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.433 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -135.1 120.19 18.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 110.476 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.83 166.35 27.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.665 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.587 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 1.7 t -103.52 75.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -169.82 105.34 0.45 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.545 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.18 -4.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 122.178 1.919 . . . . 0.0 113.909 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -129.4 31.13 3.49 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.645 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -141.31 -21.59 0.76 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.876 1.338 . . . . 0.0 111.794 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.0 144.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 84.02 6.52 86.55 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.152 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.63 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 118.447 1.124 . . . . 0.0 111.79 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 tt0 -120.1 125.88 49.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.665 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -146.44 172.88 26.89 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.527 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m-85 -99.57 121.73 41.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.6 t -48.76 148.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.903 0.383 . . . . 0.0 111.572 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 81' ' ' ALA . 79.2 mt -138.51 -60.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.962 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.779 ' CG ' ' HE ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -101.99 140.25 36.54 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.767 ' O ' ' NH1' ' B' ' 38' ' ' ARG . 70.6 tt0 -149.62 105.05 3.4 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.187 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.756 HG22 HH22 ' B' ' 38' ' ' ARG . 6.8 t -152.01 -178.92 7.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.543 0.687 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.705 ' HE ' HH22 ' A' ' 116' ' ' ARG . 32.5 ttm180 -55.07 -6.79 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.227 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 74' ' ' THR . 46.9 m-80 -138.52 0.0 2.01 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.888 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 2.4 ptp -165.44 149.99 8.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 117.952 -1.499 . . . . 0.0 114.794 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.9 tp -135.09 110.71 9.2 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.6 t -114.41 147.2 18.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 121.441 0.638 . . . . 0.0 112.553 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -131.4 142.18 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.278 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.04 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -114.83 135.29 54.35 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.864 -0.523 . . . . 0.0 111.746 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -153.4 125.66 1.81 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 69.09 -115.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -124.62 19.98 8.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.415 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 17.8 tttp -126.19 167.33 15.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.344 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 20' ' ' TYR . 5.7 m -121.55 153.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 110.596 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.4 m-90 -99.14 110.8 23.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.475 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -108.03 96.7 6.56 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.079 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 55' ' ' VAL . 2.7 m -148.87 95.7 3.88 Favored Pre-proline 0 CA--C 1.518 -0.264 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.073 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 93' ' ' VAL . 65.0 Cg_exo -43.23 161.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 120.942 1.095 . . . . 0.0 110.518 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.888 ' HZ1' ' C ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -63.53 -30.31 71.45 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -89.17 -4.95 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 90' ' ' PRO . 2.5 m -112.41 11.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.72 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -167.19 169.23 12.82 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.856 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.38 140.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.343 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.72 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 87.0 m-85 -117.61 131.67 56.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.92 ' C ' HG23 ' A' ' 53' ' ' VAL . 21.3 tt0 -115.04 95.07 5.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -90.89 145.49 24.7 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.743 ' O ' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -89.68 133.17 34.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.243 0.544 . . . . 0.0 111.604 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.605 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -70.87 144.05 50.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.849 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.879 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.1 0.12 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.221 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.574 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 74.4 m-20 -107.52 15.17 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.12 22.9 72.83 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.17 146.56 30.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.756 0.312 . . . . 0.0 110.358 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -90.74 132.82 35.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 11.3 mt -105.72 134.42 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -120.27 106.49 11.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.61 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.216 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.6 p -94.99 145.68 24.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.22 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.62 -1.65 0.36 Allowed Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.43 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 109' ' ' SER . 21.0 pt-20 -68.26 -31.5 71.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.678 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -75.13 -47.44 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.493 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 29.1 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 114' ' ' VAL . 9.9 p -63.71 106.06 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.7 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.46 -40.47 0.29 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 114.551 -1.204 . . . . 0.0 114.034 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.705 HH22 ' HE ' ' A' ' 75' ' ' ARG . 5.6 mmp_? -100.59 85.06 0.51 Allowed Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.449 ' HB2' HH22 ' B' ' 17' ' ' ARG . 26.9 Cg_endo -66.74 -26.01 45.78 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.629 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.0 pt-20 -67.99 -48.46 65.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.545 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 37.6 tpp -36.37 -47.1 0.58 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.724 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -71.61 -47.91 51.54 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.368 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.793 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -62.29 -31.87 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 118' ' ' GLU . 3.8 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.869 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.609 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 4.3 mm-40 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.418 ' H ' ' HG2' ' B' ' 10' ' ' LYS . 2.3 mmtp -79.35 -32.05 43.14 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.911 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.719 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.6 OUTLIER -73.2 -33.96 65.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.708 1.242 . . . . 0.0 108.159 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.931 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 5.0 mpt_? -60.99 -51.38 69.5 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.392 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.769 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.3 mt -70.44 -26.72 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.124 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.19 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.584 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.443 ' O ' HG22 ' B' ' 18' ' ' ILE . 4.1 ptmm? -57.54 -48.42 79.36 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.546 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 3.1 pt-20 -68.94 -37.35 78.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.342 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.811 ' HE ' HG22 ' B' ' 46' ' ' VAL . 3.0 ttt180 -62.72 -52.07 64.71 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.542 0.686 . . . . 0.0 110.673 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.73 -35.55 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.098 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.41 -27.04 63.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.42 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 36' ' ' GLY . 8.6 mt -69.15 -58.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.039 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.08 -33.34 75.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.894 0.854 . . . . 0.0 108.832 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.039 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -52.92 -46.51 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.073 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 11.6 p -64.8 -42.04 95.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.967 HD12 HG11 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -56.1 -58.42 7.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.493 0.664 . . . . 0.0 110.096 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -35.56 26.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.449 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.788 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.9 OUTLIER -71.58 -57.12 4.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.388 0.614 . . . . 0.0 110.774 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.888 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 5.2 ttt-85 -70.22 -32.5 70.4 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.73 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.184 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.2 m -83.78 -50.44 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.733 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 33.8 t80 -36.23 -49.73 1.71 Allowed Pre-proline 0 CA--C 1.509 -0.625 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.293 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.888 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 39.1 Cg_endo -54.02 -46.86 30.5 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 N-CA-C 106.532 -2.142 . . . . 0.0 106.532 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.81 ' N ' ' O ' ' B' ' 28' ' ' VAL . 48.6 t80 -94.54 -17.04 22.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.928 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.184 ' N ' ' O ' ' B' ' 28' ' ' VAL . 27.6 p -155.81 90.39 2.81 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.01 -42.98 63.93 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.883 2.389 . . . . 0.0 113.792 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -66.44 -53.9 30.23 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 9.0 mt -52.52 -56.73 13.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 120.951 0.405 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.44 -29.78 26.25 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.054 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.675 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.7 -47.84 51.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.726 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.779 ' HE ' ' CG ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -64.48 -35.55 81.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.914 ' HB3' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -71.15 -44.43 65.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.957 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.546 ' O ' HD23 ' B' ' 44' ' ' LEU . 2.1 t -45.51 -38.93 2.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.719 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.9 -42.37 81.25 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.739 HD12 HD11 ' A' ' 49' ' ' ILE . 48.3 mt -64.26 -47.75 78.4 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.601 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -55.53 -31.3 61.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.434 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -64.08 -54.39 34.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 118' ' ' GLU . 4.1 pp -61.61 -27.48 68.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.365 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.935 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 63.8 t -64.41 -47.24 90.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.32 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -66.5 -57.09 8.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.61 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 12.8 pt20 -81.96 -49.58 10.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.77 -33.48 75.97 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -92.64 5.83 49.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 mttm 54.01 75.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.502 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.306 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.623 ' NE1' ' CE1' ' B' ' 22' ' ' PHE . 14.2 m0 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.914 0.388 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -68.18 -3.62 11.18 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.476 ' H ' ' C ' ' B' ' 58' ' ' TRP . 5.9 ptm180 -83.67 -30.74 26.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.888 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -130.45 21.78 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.938 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 81.9 t80 -118.95 155.76 30.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.334 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 3.5 t -127.17 126.08 42.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.266 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -87.91 6.54 35.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 109.908 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.439 ' HB3' ' NZ ' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -107.26 -22.97 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.381 -178.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 66' ' ' CYS . . . . . 0.582 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.5 p -150.84 17.11 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.335 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.582 ' O ' ' O ' ' B' ' 66' ' ' CYS . 1.9 m-70 35.21 106.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . -164.75 -175.04 3.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' B' ' 61' ' ' ARG . 9.4 t80 -118.17 102.93 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.838 HD22 ' N ' ' B' ' 70' ' ' LEU . 0.4 OUTLIER -110.77 120.72 43.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.857 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.6 t -92.78 117.42 67.56 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.061 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.24 119.38 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.307 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.73 -41.96 1.86 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.768 HG23 ' H ' ' B' ' 75' ' ' ASN . 3.8 tt -102.95 -65.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 117.219 0.51 . . . . 0.0 111.293 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.768 ' H ' HG23 ' B' ' 74' ' ' ILE . 5.8 t-20 -112.26 12.97 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.748 0.309 . . . . 0.0 110.856 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.819 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.273 0.559 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 110.688 -0.115 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 93' ' ' LEU . 95.5 mt . . . . . 0 C--O 1.232 0.151 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLU . 80.3 p . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 121.065 0.459 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.639 ' HB3' HG11 ' A' ' 86' ' ' VAL . 52.8 m-85 -40.45 -61.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.384 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.06 -8.79 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 19' ' ' SER . 42.5 tp10 -103.95 -40.72 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.263 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.5 mm -95.19 32.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 111.09 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -81.2 127.34 39.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.678 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 82.15 -18.1 14.93 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.81 27.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.826 1.313 . . . . 0.0 110.793 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.678 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -42.03 -15.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 33.6 t-105 -57.17 -53.81 53.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.46 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' B' ' 28' ' ' VAL . 16.8 pt -69.31 -11.86 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.609 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.791 ' CD2' HD11 ' B' ' 24' ' ' LEU . 33.7 m-85 -91.15 -26.37 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -70.07 -64.59 0.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.173 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.86 48.65 3.31 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 29' ' ' ILE . . . -162.38 -38.35 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 50' ' ' GLY . 38.9 t-80 -110.71 100.37 9.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.613 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -150.75 10.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.54 ' H ' HG12 ' B' ' 20' ' ' ILE . . . -41.77 164.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.646 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 33.9 ttp180 -66.59 133.02 49.44 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.802 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 63.2 t -113.26 135.66 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.666 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.5 m-20 -166.3 149.07 7.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.831 -1.532 . . . . 0.0 108.016 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 42' ' ' ASN . 56.1 tttp -46.04 -53.79 9.58 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.197 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 13.4 pttp -60.84 -4.63 1.04 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.072 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 7.3 m120 -125.13 0.23 7.83 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.082 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.45 -39.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.06 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.856 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.06 5.25 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.856 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -119.92 -6.18 10.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.869 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -98.74 151.64 20.54 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.735 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.676 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -72.73 110.83 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.043 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 49' ' ' ILE . 12.5 mt -74.21 116.1 14.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.1 mm -155.28 -31.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.596 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.674 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -134.5 -22.23 0.71 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.912 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.939 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -44.82 153.25 0.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.783 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -100.49 128.49 46.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.988 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.9 p -149.16 171.52 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.399 0.618 . . . . 0.0 111.572 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.722 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.51 152.28 51.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 65' ' ' GLY . 59.9 t -96.22 98.95 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.31 -51.86 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.415 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -128.53 118.35 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.557 ' OG ' ' ND1' ' A' ' 60' ' ' HIS . 47.9 t -149.07 173.53 13.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.184 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 33.7 p -102.98 78.6 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.724 ' CD2' ' O ' ' A' ' 59' ' ' THR . 21.6 m80 -166.57 96.15 0.72 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.251 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.11 -4.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.535 2.157 . . . . 0.0 114.015 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -132.0 23.32 4.16 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.638 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.639 ' O ' HG22 ' A' ' 66' ' ' ILE . 29.2 m-85 -141.11 -14.1 0.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.793 1.296 . . . . 0.0 111.615 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.3 m -71.62 138.89 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.9 6.71 88.74 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.35 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.142 HG23 ' NE1' ' A' ' 87' ' ' TRP . 2.3 tt -108.32 146.92 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 117.712 0.756 . . . . 0.0 112.243 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 6.9 tm-20 -116.15 131.87 56.82 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 80' ' ' ILE . . . -147.24 174.95 26.85 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.487 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.55 115.72 28.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -45.19 145.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.015 0.436 . . . . 0.0 111.457 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 81' ' ' ALA . 15.8 mt -136.48 -61.51 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 19.9 t0 -94.89 148.01 22.76 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.833 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.78 ' O ' HD11 ' B' ' 42' ' ' LEU . 10.7 tt0 -156.52 105.11 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.844 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -162.49 176.68 10.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 111.798 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 54.5 ttt85 -58.72 -1.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.864 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.844 ' H ' HG23 ' A' ' 74' ' ' THR . 7.6 t-20 -133.47 -11.58 2.77 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -166.66 156.21 11.25 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.669 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.3 tp -139.33 110.94 7.11 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.908 ' C ' HD13 ' A' ' 80' ' ' ILE . 61.3 t -119.95 145.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.939 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -117.88 152.25 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.142 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.92 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -125.12 136.44 53.63 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.108 0.48 . . . . 0.0 111.963 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -149.91 155.78 26.42 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 24' ' ' ILE . 6.1 pt-20 31.83 -115.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.561 0.219 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -121.24 33.31 5.59 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.917 0.389 . . . . 0.0 110.176 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 30.4 tttp -133.52 158.84 42.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.631 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 20' ' ' TYR . 16.1 m -123.62 155.54 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 110.688 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 1.142 ' NE1' HG23 ' A' ' 66' ' ' ILE . 2.5 m-90 -100.35 145.49 28.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.325 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -128.22 94.13 3.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.36 99.17 4.21 Favored Pre-proline 0 C--N 1.342 0.266 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.253 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.33 146.03 84.63 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.483 1.455 . . . . 0.0 110.231 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.602 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 27.2 mttm -54.17 -22.13 10.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -90.63 -6.38 54.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.502 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -128.52 35.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.64 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -166.95 155.72 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.027 179.142 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 77.2 mt -111.14 116.11 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.833 ' HB3' HG21 ' A' ' 53' ' ' VAL . 88.1 m-85 -98.53 127.11 44.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.988 ' C ' HG23 ' A' ' 53' ' ' VAL . 24.3 tt0 -110.12 94.74 5.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 43' ' ' ILE . 4.8 m-85 -87.55 145.66 26.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -90.2 127.39 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.804 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -62.8 142.88 58.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.389 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.802 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.19 0.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.605 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.552 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 75.6 m-20 -106.85 13.39 27.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.36 21.64 66.71 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 100' ' ' THR . 16.7 m -106.74 150.0 26.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.477 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -91.16 134.28 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 7.7 mt -110.59 132.62 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -118.55 102.9 9.24 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.65 139.41 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.974 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 m -88.55 148.49 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.994 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.47 -0.59 4.9 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.018 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.65 -22.72 60.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -80.11 -47.55 14.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.362 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -95.69 28.13 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.1 p -59.32 106.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.602 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.84 -40.89 0.32 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.496 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 116' ' ' ARG . 1.0 OUTLIER -101.18 87.63 0.92 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -176.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.584 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.1 Cg_endo -67.34 -29.16 38.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.25 1.3 . . . . 0.0 108.828 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HB3' HD22 ' B' ' 45' ' ' LEU . 8.1 pt-20 -56.66 -49.51 74.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.915 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 9.7 ttm -34.67 -64.83 0.24 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.821 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -59.17 -44.93 92.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.843 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -60.27 -40.32 89.95 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.752 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLU . . . . . 0.627 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.63 -30.47 46.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.797 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.0 OUTLIER -73.72 -34.25 64.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.799 1.285 . . . . 0.0 108.301 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.953 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -61.85 -51.26 68.94 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 112.126 -2.306 . . . . 0.0 111.667 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -71.32 -34.92 55.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.87 91.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.049 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.563 ' O ' HG22 ' B' ' 18' ' ' ILE . 6.8 tptm -58.85 -51.0 71.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.233 0.539 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' HD13 ' B' ' 20' ' ' ILE . 10.8 pt-20 -71.63 -37.14 70.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.882 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 121' ' ' LEU . 9.7 ttt180 -60.56 -51.02 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.593 0.711 . . . . 0.0 110.668 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.563 HG22 ' O ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -60.53 -38.33 77.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.17 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 13.2 m-20 -68.23 -30.44 69.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.492 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.554 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.1 mp -71.53 -57.68 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 1.065 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.2 -35.06 76.16 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.065 ' H ' HD13 ' B' ' 21' ' ' LEU . 5.4 t80 -53.75 -39.36 65.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.047 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -67.77 -40.8 83.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.383 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.939 HD12 HG11 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -56.25 -58.02 9.76 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.731 0.777 . . . . 0.0 109.396 179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' B' ' 29' ' ' PHE . . . -49.23 -37.52 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.562 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.84 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -68.97 -59.27 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.313 0.577 . . . . 0.0 110.087 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 7.2 ttm-85 -66.6 -36.91 83.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.809 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 1.199 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -82.99 -50.69 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.321 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.752 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 41.1 t80 -36.75 -50.26 1.99 Allowed Pre-proline 0 CA--C 1.509 -0.63 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.4 Cg_endo -54.01 -46.84 30.62 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 106.576 -2.124 . . . . 0.0 106.576 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.777 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 49.4 t80 -94.42 -13.24 26.46 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.335 -2.211 . . . . 0.0 112.708 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . 1.199 ' N ' ' O ' ' B' ' 28' ' ' VAL . 57.4 p -160.51 92.87 1.6 Allowed Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.67 -41.59 76.06 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.736 2.291 . . . . 0.0 113.673 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.59 -54.41 23.81 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 7.7 mt -52.22 -55.04 23.73 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.205 0.526 . . . . 0.0 110.604 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.544 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.77 -30.24 60.95 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.076 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.77 -48.93 43.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.543 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.95 -38.7 89.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.77 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -64.43 -44.71 90.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 118.627 -1.229 . . . . 0.0 108.327 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.3 t -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.155 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.95 -41.5 77.94 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 73' ' ' GLU . 28.1 mt -65.48 -44.71 86.26 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.41 -30.66 63.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 14.2 mt -66.72 -54.34 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.588 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.6 pp -57.25 -27.32 61.95 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.747 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' VAL . . . . . 0.963 ' N ' HD12 ' B' ' 45' ' ' LEU . 86.0 t -68.27 -46.38 81.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.017 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -57.1 8.3 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.818 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 8.4 pt20 -81.32 -47.35 13.43 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 7.4 tptt -70.04 -32.74 71.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.22 -3.98 58.79 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.419 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mttp 62.59 73.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.691 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HZ1' ' B' ' 11' ' ' LYS . 11.7 t . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.734 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.568 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 5.2 m-90 . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -65.89 -6.87 13.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' B' ' 58' ' ' TRP . 12.1 ptp180 -81.35 -25.44 36.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.833 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -141.25 22.97 2.2 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.418 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' B' ' 67' ' ' HIS . 51.8 t80 -116.15 148.6 40.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.019 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' CYS . . . . . 0.558 ' C ' ' H ' ' B' ' 65' ' ' LYS . 8.2 t -126.54 107.79 10.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.633 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.496 ' H ' ' HD2' ' B' ' 64' ' ' LYS . 1.1 mptp? -66.21 5.47 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.664 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -105.96 -17.66 14.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.609 -178.061 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 14.5 p -150.81 6.75 0.53 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' B' ' 63' ' ' CYS . 2.0 m80 42.74 78.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.679 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.493 ' HB1' ' CE ' ' B' ' 37' ' ' LYS . . . -140.16 -172.14 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.303 0.573 . . . . 0.0 111.268 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 4.7 t80 -117.73 105.09 11.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.833 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.6 OUTLIER -109.35 126.29 53.24 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -103.17 121.92 47.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.886 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.63 127.2 15.81 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.981 1.787 . . . . 0.0 111.733 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.67 -34.01 6.02 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.599 HG22 ' OD1' ' B' ' 75' ' ' ASN . 96.6 mt -93.89 -79.99 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' B' ' 74' ' ' ILE . 3.4 m120 -110.86 15.94 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.975 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.85 149.4 16.89 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' GLU . 77.9 p -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.948 0.404 . . . . 0.0 110.464 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 79' ' ' VAL . 58.2 m-85 -38.93 -58.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.69 -8.81 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' SER . 47.0 tp10 -104.03 -37.98 7.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.156 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.68 HG23 ' CE2' ' B' ' 31' ' ' TYR . 4.3 mm -95.66 22.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.482 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 ' H ' ' A' ' 24' ' ' ILE . 1.3 tp -80.76 117.43 26.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 105.12 -29.74 11.14 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 121.022 -0.609 . . . . 0.0 114.43 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.66 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -63.28 29.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.967 . . . . 0.0 110.882 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.66 ' H ' ' C ' ' A' ' 25' ' ' GLY . 3.3 p -44.5 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.66 ' N ' ' O ' ' A' ' 26' ' ' ARG . 27.9 t-105 -57.86 -52.52 65.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.407 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.834 ' CD1' HG12 ' B' ' 28' ' ' VAL . 10.4 pt -69.73 -12.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.977 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' B' ' 24' ' ' LEU . 40.5 m-85 -93.53 -11.07 32.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.06 -68.3 0.8 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.41 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.03 46.42 1.5 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . . . -161.88 -34.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.739 ' HA ' HG23 ' B' ' 20' ' ' ILE . 19.6 t-80 -103.55 108.19 19.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.822 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.701 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -149.56 9.51 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.783 ' O ' ' CD1' ' A' ' 101' ' ' TRP . . . -49.04 148.15 5.26 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -64.25 111.13 2.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 118.486 -1.285 . . . . 0.0 108.947 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 100' ' ' THR . 92.6 t -83.08 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.903 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.756 ' O ' ' N ' ' A' ' 43' ' ' ILE . 4.1 t-20 -163.81 150.5 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.563 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 69.5 tttt -48.29 -56.67 7.44 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.753 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 54.2 pttt -61.63 -5.3 1.79 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 70.2 m-20 -126.0 3.54 7.27 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.783 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.756 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.53 -42.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.072 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.713 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -94.48 -0.46 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.23 14.65 16.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.458 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -120.37 176.47 5.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.764 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.733 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -90.81 112.26 24.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.983 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.767 ' O ' HD13 ' A' ' 49' ' ' ILE . 55.5 mt -74.39 114.14 12.42 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm -155.79 -40.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.761 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.604 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -131.84 -20.05 1.1 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.744 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -44.44 142.31 1.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.813 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.2 ttpm? -92.13 131.54 37.3 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.972 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.8 p -150.04 170.74 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.191 0.52 . . . . 0.0 111.282 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.67 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.42 152.44 51.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.898 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 65' ' ' GLY . 48.1 t -97.5 99.17 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.87 -50.89 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.841 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -128.47 120.75 27.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 94' ' ' CYS . 3.2 t -147.06 173.28 12.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.44 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -109.95 78.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 62' ' ' GLY . 3.0 m-70 -168.72 102.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.328 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.73 -4.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.478 2.119 . . . . 0.0 113.822 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -130.2 22.46 4.75 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.193 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 66' ' ' ILE . 20.8 m-85 -141.0 -11.76 0.97 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.533 1.167 . . . . 0.0 111.513 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 64' ' ' VAL . 2.2 m -72.98 131.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.02 5.21 90.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.664 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.047 HG23 ' NE1' ' A' ' 87' ' ' TRP . 9.0 tt -100.38 151.24 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 117.758 0.779 . . . . 0.0 112.345 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.687 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 2.7 tm-20 -118.0 132.71 56.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.57 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.25 173.22 27.47 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.853 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -96.5 114.93 26.63 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.8 t -48.77 146.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.012 HD11 ' HB2' ' A' ' 81' ' ' ALA . 36.2 mt -140.02 -60.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.127 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -104.14 144.71 31.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.62 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 43.8 tp10 -148.18 106.17 3.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.986 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.471 ' HA ' HH21 ' B' ' 38' ' ' ARG . 1.8 p -137.04 179.9 6.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.726 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' CA ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -55.44 -17.01 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.144 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HA ' ' HZ3' ' A' ' 91' ' ' LYS . 41.1 t30 -137.54 13.52 2.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.85 159.02 39.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 118.728 -1.189 . . . . 0.0 113.957 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.731 HD23 ' CE1' ' A' ' 96' ' ' PHE . 7.2 tp -150.46 110.55 4.14 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' ILE . 91.1 t -112.1 146.37 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.57 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -129.1 147.44 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.972 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.012 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -123.08 137.59 54.89 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.577 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.76 152.06 23.79 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 84' ' ' ASN . 8.9 pt-20 38.06 -136.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.699 -0.295 . . . . 0.0 110.937 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 87.3 m-20 -99.67 34.08 2.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.052 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 21.5 tptt -145.18 165.93 26.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.707 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 24.7 m -119.65 155.57 22.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.469 0.652 . . . . 0.0 110.693 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 1.047 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.4 m-90 -97.54 92.7 6.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.708 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -86.97 100.01 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 55' ' ' VAL . 3.9 t -147.27 109.16 3.93 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.448 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.01 164.35 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.323 1.348 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.749 ' H ' ' CD ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -72.03 -31.43 66.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 16.9 p-10 -90.28 -5.69 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -97.5 0.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.286 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -166.27 174.42 9.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.926 -1.11 . . . . 0.0 113.654 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.22 124.01 65.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.702 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.731 ' CE1' HD23 ' A' ' 78' ' ' LEU . 59.7 m-85 -99.04 131.19 45.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.972 ' C ' HG23 ' A' ' 53' ' ' VAL . 18.5 tt0 -111.29 95.48 5.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.751 ' CD1' HD11 ' A' ' 43' ' ' ILE . 16.4 m-85 -89.58 146.01 24.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.16 132.4 36.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.729 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 104' ' ' THR . 16.9 m -65.85 142.41 57.94 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -62.43 -1.66 0.84 Allowed 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.919 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 100' ' ' THR . 86.9 m-20 -106.92 19.45 20.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.751 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.03 23.49 77.07 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.57 137.21 44.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.423 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -81.28 129.56 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 44.7 mt -104.41 134.7 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.578 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -117.86 102.04 8.78 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.3 138.06 45.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.691 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.7 p -78.26 123.22 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.487 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -53.2 -2.44 0.1 OUTLIER Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -81.77 -22.86 36.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.167 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -66.69 -46.34 75.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.17 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -92.68 28.68 1.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 114' ' ' VAL . 3.6 p -55.28 105.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 75' ' ' ARG . . . 67.73 -40.64 0.24 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 114.462 -1.245 . . . . 0.0 114.47 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.8 91.66 1.98 Allowed Pre-proline 0 N--CA 1.466 0.328 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HB2' HH22 ' B' ' 17' ' ' ARG . 29.2 Cg_endo -69.76 -27.97 25.84 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.462 1.442 . . . . 0.0 108.752 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.818 ' HB3' HD22 ' B' ' 45' ' ' LEU . 13.0 pt-20 -61.08 -52.27 65.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.222 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.556 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 31.3 ttp -36.16 -38.38 0.14 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.596 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.617 ' NH2' ' CZ2' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -81.57 -50.03 9.84 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.145 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.55 -33.29 73.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.054 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -103.87 18.39 22.08 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.299 . . . . 0.0 111.054 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 57.34 168.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 123' ' ' LYS . 2.7 mtp180 -43.93 168.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -43.83 147.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.529 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -90.72 112.76 24.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.676 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.481 179.799 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.734 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.587 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -79.3 -29.6 42.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.886 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -72.31 -33.58 67.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.723 1.249 . . . . 0.0 107.844 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.959 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.2 OUTLIER -62.94 -51.8 65.51 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.736 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.4 pt -65.73 -27.84 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.082 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -66.48 -42.35 87.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.725 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.495 ' O ' HG22 ' B' ' 18' ' ' ILE . 18.6 mmtt -53.93 -50.97 65.24 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 109.514 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.717 ' O ' HG12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -73.17 -38.15 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.6 HH22 ' HB2' ' A' ' 117' ' ' PRO . 31.1 ttt180 -65.06 -52.91 53.06 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.521 0.676 . . . . 0.0 110.895 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.589 HG23 ' N ' ' B' ' 19' ' ' ASP . 8.0 tp -56.74 -43.99 80.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.236 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.589 ' N ' HG23 ' B' ' 18' ' ' ILE . 11.1 m-20 -67.29 -29.2 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 34' ' ' HIS . 26.4 mm -74.99 -58.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.094 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.45 -34.18 74.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.094 ' N ' HD13 ' B' ' 21' ' ' LEU . 5.0 t80 -54.51 -50.32 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -71.44 -32.59 68.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.484 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.83 HD12 HG13 ' B' ' 28' ' ' VAL . 0.2 OUTLIER -66.29 -56.65 10.15 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.186 0.517 . . . . 0.0 109.641 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -50.32 -38.25 40.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.205 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.841 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 62.2 mt-10 -69.07 -46.14 68.57 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.192 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 3.0 ttt-85 -70.97 -33.37 70.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.897 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.232 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.9 m -84.5 -49.36 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.552 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.758 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 24.6 t80 -36.48 -49.98 1.84 Allowed Pre-proline 0 C--N 1.351 0.632 0 CA-C-N 119.531 1.06 . . . . 0.0 109.439 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.6 Cg_endo -54.85 -47.41 26.8 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.509 -2.151 . . . . 0.0 106.509 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.791 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.7 t80 -94.44 -13.65 26.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.397 -2.183 . . . . 0.0 112.752 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.232 ' N ' ' O ' ' B' ' 28' ' ' VAL . 52.5 p -159.1 90.84 1.99 Allowed Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 51.5 Cg_exo -53.46 -45.0 44.24 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.711 2.274 . . . . 0.0 113.81 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' B' ' 38' ' ' ARG . 79.5 tt0 -64.37 -53.96 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 21.8 mt -51.73 -59.61 4.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.004 0.431 . . . . 0.0 111.155 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.722 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.45 -35.4 52.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.196 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.824 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.57 -36.06 73.41 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.001 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.714 ' HD3' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -65.47 -54.68 24.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.824 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.86 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.2 m-85 -59.58 -39.94 85.76 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.1 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.9 t -45.32 -41.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -64.43 -43.24 94.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.805 ' O ' HG23 ' B' ' 46' ' ' VAL . 14.5 mt -64.55 -43.61 93.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.728 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -66.39 -31.51 72.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.243 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.609 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.9 -53.86 52.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -64.68 -41.01 96.36 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.743 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.893 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 97.3 t -53.51 -42.46 49.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.266 0.555 . . . . 0.0 109.99 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.84 -55.28 17.92 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.301 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.7 pt20 -80.71 -53.08 6.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 26.6 mmtt -56.53 -41.19 76.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -90.23 -9.06 49.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 0.0 110.348 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.54 66.84 1.01 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.672 HG12 ' H ' ' B' ' 53' ' ' LYS . 1.6 t -109.56 -147.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.349 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.672 ' H ' HG12 ' B' ' 52' ' ' VAL . 92.9 mttt -63.24 143.85 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.049 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 mm -88.94 134.68 33.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.812 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.07 142.34 87.07 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.856 1.704 . . . . 0.0 111.571 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' B' ' 59' ' ' LYS . 5.5 ptp180 -142.13 -61.25 0.45 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' LYS . 58.8 pttt -87.09 -38.23 16.68 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.696 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.455 ' O ' ' HD2' ' B' ' 61' ' ' ARG . 10.1 m0 -47.05 -8.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LYS . 0.0 OUTLIER -68.99 -8.5 45.39 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -80.59 -18.69 47.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -142.97 11.88 1.81 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.511 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 92.0 t80 -119.98 158.64 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 2.0 t -126.28 120.64 30.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -85.97 5.28 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.249 0.547 . . . . 0.0 109.639 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.483 ' HB2' ' SG ' ' B' ' 95' ' ' CYS . 2.5 mmmm -97.75 -39.73 8.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.86 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 5.2 p -136.07 1.98 2.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.7 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 66' ' ' CYS . 3.8 m-70 57.44 121.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.764 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 176.17 -172.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.766 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.824 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.4 OUTLIER -121.35 104.7 9.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.783 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -109.81 145.7 36.28 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.348 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.506 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 92.3 t -128.44 117.76 20.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' PRO . . . . . 0.428 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 77.9 Cg_exo -45.95 125.34 8.21 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.029 1.819 . . . . 0.0 111.85 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.76 -29.82 11.7 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.41 -80.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.003 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.529 ' C ' HD12 ' B' ' 93' ' ' LEU . 90.3 m-20 -116.97 17.38 14.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.082 0.468 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -141.23 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.624 ' HG3' HD11 ' B' ' 93' ' ' LEU . 96.6 mtt180 -142.49 130.6 21.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 18.2 m -134.08 132.55 55.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.893 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -140.17 130.78 25.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 110.623 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 1.3 pp -126.55 132.28 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.656 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mtp85 -138.01 140.31 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 83' ' ' LYS . 2.0 pt20 -88.09 -165.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' B' ' 82' ' ' GLN . 66.5 tttt 98.88 77.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.314 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 73.27 85.07 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.751 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.523 ' O ' ' CD2' ' B' ' 87' ' ' HIS . 0.0 OUTLIER 61.79 87.08 0.14 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.03 145.47 91.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.589 2.193 . . . . 0.0 111.991 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 85' ' ' MET . 89.7 m-70 -133.13 136.92 46.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.52 HG13 ' HB3' ' B' ' 80' ' ' LEU . 0.0 OUTLIER -99.11 139.51 20.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.906 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 17.6 t -109.04 122.11 63.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.8 140.35 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -153.54 143.63 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.949 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.678 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.5 OUTLIER -82.73 125.1 30.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.096 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.624 HD11 ' HG3' ' B' ' 77' ' ' ARG . 96.0 mt -85.03 -8.77 58.56 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.221 0.534 . . . . 0.0 109.674 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.18 -54.75 4.42 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.852 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 5.2 p -115.81 75.07 0.92 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.39 93.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 122.254 0.919 . . . . 0.0 110.948 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.6 OUTLIER -124.67 134.38 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.337 -1.431 . . . . 0.0 109.355 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 2.1 mt -92.68 123.2 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.903 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 55.6 mmm -132.78 159.64 39.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -134.11 155.04 50.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.33 96.49 2.65 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.7 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.78 170.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.38 2.054 . . . . 0.0 112.12 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -125.42 119.74 29.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.899 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.37 128.4 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 66.7 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.398 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.19 -144.25 1.46 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 95.7 p -58.17 -41.11 83.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.421 . . . . 0.0 110.256 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 19' ' ' SER . 59.9 m-85 -33.7 -62.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.894 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.84 -22.08 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.325 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.2 tp10 -97.37 -34.59 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 ' CE2' ' B' ' 31' ' ' TYR . 1.8 mm -98.78 15.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.696 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -79.49 117.49 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.137 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 112.77 -35.5 4.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.889 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -61.07 25.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.958 0.879 . . . . 0.0 110.895 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.703 ' H ' ' C ' ' A' ' 25' ' ' GLY . 29.2 p -37.66 -17.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.513 0.673 . . . . 0.0 109.899 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' ARG . 17.7 t-105 -56.99 -56.34 22.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.689 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.873 ' CD1' HG12 ' B' ' 28' ' ' VAL . 13.5 pt -63.6 -17.91 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.269 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 18.1 m-85 -89.44 -16.89 29.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.1 mmt85 -90.91 -61.56 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.171 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' B' ' 27' ' ' ARG . . . -71.43 45.34 0.79 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -153.53 -36.15 0.1 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CG ' HD12 ' B' ' 20' ' ' ILE . 2.0 t-80 -90.56 106.78 18.73 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.029 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.66 0.83 3.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.434 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.507 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -54.28 146.41 24.66 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.537 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 2.1 ttm-85 -66.81 125.14 24.94 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.861 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -101.42 136.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.909 0.861 . . . . 0.0 113.301 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.632 ' O ' ' N ' ' A' ' 43' ' ' ILE . 11.0 m120 -166.11 152.17 9.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.323 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 42' ' ' ASN . 20.8 ttmt -49.96 -51.93 37.53 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.91 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -60.22 -4.81 0.89 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 77.7 m-20 -122.53 -10.25 8.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.33 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.656 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -80.12 -41.06 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.616 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.889 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.1 9.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.87 1.319 . . . . 0.0 107.57 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.889 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.24 -25.37 4.49 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.81 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -79.0 146.28 33.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.788 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -70.89 111.48 6.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 49' ' ' ILE . 13.5 mt -68.73 115.87 8.58 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.9 mm -157.42 -27.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.865 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -152.11 30.95 0.89 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.283 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.951 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -98.38 156.13 16.89 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.791 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.4 tmtt? -98.04 127.0 43.73 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.427 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.987 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.8 p -149.4 171.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.269 0.557 . . . . 0.0 111.871 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.92 152.62 49.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.799 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 65' ' ' GLY . 89.0 t -96.33 99.52 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.79 -51.97 13.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -129.03 118.61 22.83 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.331 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 5.2 t -149.36 173.35 13.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.331 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 59' ' ' THR . 10.8 t -108.32 75.46 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.294 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.4 m-70 -168.59 93.08 0.59 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.745 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.2 -5.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.349 2.033 . . . . 0.0 113.263 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -109.55 9.06 32.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.366 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 66' ' ' ILE . 39.6 m-85 -140.74 -12.95 0.98 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.234 1.017 . . . . 0.0 112.255 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.2 m -72.0 132.66 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.129 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.5 6.39 88.66 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.335 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.049 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.0 tt -100.87 148.48 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.701 0.75 . . . . 0.0 112.055 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.664 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 4.8 tm-20 -119.7 129.98 54.79 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.583 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -145.69 174.24 25.74 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 116.412 -0.358 . . . . 0.0 112.509 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.1 t80 -96.25 115.2 27.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.571 0.348 . . . . 0.0 110.093 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -48.21 142.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.727 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.2 mt -141.76 -39.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -121.82 143.43 49.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.212 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' N ' ' CZ ' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -157.21 106.48 2.18 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 -171.33 2.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.28 0.562 . . . . 0.0 111.084 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -53.24 -24.7 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.125 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -138.43 30.93 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.473 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -164.68 169.6 16.69 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.687 -1.205 . . . . 0.0 113.91 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.4 tp -165.83 110.21 0.83 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' ILE . 98.0 t -116.41 146.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.637 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -126.89 145.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.229 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.18 136.13 53.96 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.532 . . . . 0.0 111.828 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.92 132.88 3.82 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 64.33 -123.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.808 -0.231 . . . . 0.0 110.643 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -116.31 33.22 5.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 110.618 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.549 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 6.1 tptp -145.25 170.75 15.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.549 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 7.8 m -124.28 156.11 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.701 0.762 . . . . 0.0 110.85 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 1.049 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.2 m-90 -99.11 119.73 38.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.623 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -107.98 104.47 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.28 96.26 3.97 Favored Pre-proline 0 N--CA 1.457 -0.115 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.92 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 92' ' ' ASP . 38.3 Cg_exo -54.16 126.76 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.095 1.197 . . . . 0.0 110.295 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.78 -19.84 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.431 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' PRO . 5.3 p-10 -87.6 -6.92 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 59' ' ' THR . 2.2 t -133.72 33.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.714 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -167.09 158.06 11.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.712 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.487 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 73.1 mt -106.45 118.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 78' ' ' LEU . 66.6 m-85 -99.08 131.12 45.35 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.987 ' C ' HG23 ' A' ' 53' ' ' VAL . 11.2 tt0 -115.49 94.87 4.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.84 143.58 26.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.85 ' OE2' ' N ' ' A' ' 104' ' ' THR . 2.5 tm-20 -90.99 127.52 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.485 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.921 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -58.98 143.27 48.7 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.817 -178.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.861 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -54.83 0.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.284 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' THR . 31.8 t70 -106.66 10.64 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.16 14.42 76.91 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.921 ' O ' ' OG1' ' A' ' 100' ' ' THR . 19.3 m -106.54 127.6 53.45 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.806 ' CD ' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -76.47 135.98 39.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.431 0.634 . . . . 0.0 111.581 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.756 HD11 HG23 ' A' ' 100' ' ' THR . 70.2 mt -102.88 135.5 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.525 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -107.9 101.92 11.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.07 139.19 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.353 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 2.5 m -79.29 145.49 33.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.773 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -70.88 -1.91 42.54 Favored Glycine 0 CA--C 1.507 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.087 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.94 -21.61 34.05 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.352 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -64.82 -47.08 79.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.419 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -94.29 28.58 2.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.776 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 114' ' ' VAL . 12.6 p -60.81 106.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.98 -40.2 0.25 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.104 -0.953 . . . . 0.0 114.162 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -101.43 78.55 0.22 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.528 ' HB2' HH22 ' B' ' 17' ' ' ARG . 19.5 Cg_endo -66.59 -24.25 48.72 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.392 1.394 . . . . 0.0 108.984 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 119' ' ' MET . 9.3 pt-20 -62.94 -52.63 62.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.482 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.4 mmt -35.01 -55.56 0.59 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.667 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' CE3' ' A' ' 45' ' ' TRP . 4.2 tpt180 -68.28 -40.69 81.76 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.963 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -62.1 -39.15 91.52 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -96.48 6.02 49.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.6 tttm 64.33 149.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.769 0.319 . . . . 0.0 110.799 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -69.18 -39.09 78.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.747 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -86.24 142.0 28.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' LYS . 75.8 ttt-85 -129.24 103.31 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.732 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 126' ' ' ARG . 23.4 tttm . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.576 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.689 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -79.62 -33.45 41.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.764 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 8.9 tttp -73.45 -35.06 65.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.664 1.221 . . . . 0.0 108.485 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 1.008 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -61.1 -51.51 68.84 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.088 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.706 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.9 mt -69.59 -35.56 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.9 -53.6 56.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.514 ' O ' HG22 ' B' ' 18' ' ' ILE . 12.9 mmmt -53.33 -50.96 63.9 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.734 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 7.7 pt-20 -71.53 -38.22 71.09 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.246 0.546 . . . . 0.0 110.755 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.727 ' HD3' HD11 ' A' ' 121' ' ' LEU . 7.0 ttt180 -58.84 -53.6 56.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.897 0.856 . . . . 0.0 109.844 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.685 ' HA ' HD12 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -59.36 -32.01 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.35 -50.13 73.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.663 HD12 ' CG ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -74.31 -49.61 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.12 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -56.0 -37.41 69.08 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.12 ' N ' HD13 ' B' ' 21' ' ' LEU . 6.2 t80 -59.76 -51.99 67.41 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.425 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 64.6 p -69.68 -34.95 74.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.856 HD12 HG13 ' B' ' 28' ' ' VAL . 0.1 OUTLIER -63.79 -56.26 16.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.181 0.515 . . . . 0.0 109.913 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -51.87 -34.51 41.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.832 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 1.7 tm-20 -74.19 -40.07 62.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.856 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 53.9 mtt180 -72.53 -34.74 67.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.215 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.7 m -85.83 -49.39 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.723 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 23.2 t80 -36.19 -49.85 1.69 Allowed Pre-proline 0 C--N 1.353 0.741 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.304 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.856 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 38.3 Cg_endo -54.58 -48.28 22.25 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.802 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.1 t80 -94.3 -10.8 31.62 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 112.473 -2.149 . . . . 0.0 112.773 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.215 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.0 p -165.03 95.13 0.88 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' B' ' 37' ' ' LYS . 33.2 Cg_exo -56.5 -39.12 93.5 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.503 2.135 . . . . 0.0 113.319 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -53.37 35.3 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.56 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 13.5 mt -54.36 -57.85 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.587 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -51.66 -31.24 24.81 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.185 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' O ' ' B' ' 69' ' ' PHE . 2.2 mptt -70.97 -41.17 71.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.761 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.848 HH11 HD11 ' B' ' 42' ' ' LEU . 2.5 tmm_? -60.07 -54.34 47.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.951 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.895 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -61.66 -39.29 90.85 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.718 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.1 t -45.64 -43.23 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.596 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.72 -43.64 98.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.848 HD11 HH11 ' B' ' 38' ' ' ARG . 63.1 mt -64.8 -43.94 91.55 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.361 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.802 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.81 -30.86 64.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.682 HD11 ' OH ' ' B' ' 62' ' ' TYR . 7.3 mt -67.66 -54.83 16.34 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.47 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.552 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.3 pp -57.74 -28.25 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.745 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.978 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 83.5 t -69.1 -48.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.153 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.552 ' CD ' ' HE ' ' B' ' 56' ' ' ARG . 7.5 tt0 -66.08 -56.84 9.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 8.9 pt20 -80.75 -48.33 12.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -69.51 -33.85 73.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -89.38 -8.38 53.27 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? 64.82 71.15 0.46 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.66 133.64 64.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.99 109.52 14.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.067 0.461 . . . . 0.0 110.943 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' B' ' 55' ' ' PRO . 7.3 mm -135.33 134.85 21.59 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.357 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 54' ' ' ILE . 94.8 Cg_exo -37.82 117.16 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.942 1.761 . . . . 0.0 111.409 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.552 ' HE ' ' CD ' ' B' ' 47' ' ' GLN . 48.8 mtt85 -95.34 77.81 3.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.866 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' B' ' 59' ' ' LYS . 57.2 pttt -74.13 -24.17 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.646 ' O ' ' N ' ' B' ' 62' ' ' TYR . 2.0 m0 -55.48 -2.89 0.05 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' B' ' 57' ' ' LYS . 15.9 pttp -64.52 -8.75 15.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.9 ptm180 -88.19 -26.4 22.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.264 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.742 ' NH1' ' CE2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -134.54 15.15 3.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.754 -177.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.682 ' OH ' HD11 ' B' ' 44' ' ' LEU . 23.5 t80 -111.82 151.13 29.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.773 ' CB ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -118.82 105.16 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.156 -178.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -92.86 -4.77 52.32 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.632 ' HZ3' ' CG ' ' B' ' 99' ' ' MET . 20.9 mmmt -78.57 -37.93 41.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.659 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 17.7 1.72 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.879 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.58 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.7 m80 53.96 95.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.902 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.402 ' N ' HG11 ' B' ' 40' ' ' VAL . . . -166.4 -173.92 2.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.8 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.781 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -125.44 102.51 7.44 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 1.061 HD22 ' H ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -99.97 154.4 18.42 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.814 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 42.9 t -131.12 115.15 16.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.424 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' PRO . . . . . 0.401 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 73.6 Cg_exo -45.0 122.49 4.33 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.224 1.949 . . . . 0.0 111.848 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.74 -26.77 23.25 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.446 HD12 HG11 ' B' ' 71' ' ' VAL . 56.1 mt -105.05 -80.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -115.55 22.36 13.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.958 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 70' ' ' LEU . . . -150.75 161.75 42.04 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.274 0.559 . . . . 0.0 111.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.445 ' HG3' HD11 ' B' ' 93' ' ' LEU . 75.9 mtt-85 -149.94 127.16 11.33 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.144 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 78' ' ' VAL . 19.5 m -139.27 118.34 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.529 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' B' ' 88' ' ' ILE . 9.8 mtt85 -131.73 145.08 51.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 110.378 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 2.0 pp -114.62 117.77 31.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.362 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -137.72 147.51 44.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -64.96 -120.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.814 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' B' ' 84' ' ' ARG . 29.3 mtpt 60.35 103.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' B' ' 83' ' ' LYS . 38.4 ttt85 41.96 100.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.952 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.446 ' O ' ' O ' ' B' ' 84' ' ' ARG . 12.7 ttm 48.94 99.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.95 140.57 31.17 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.192 1.928 . . . . 0.0 112.16 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -154.77 145.57 22.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -96.54 123.98 49.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 2.5 p -84.62 118.66 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.164 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.415 HG12 HG12 ' B' ' 78' ' ' VAL . 14.6 m -121.82 134.17 65.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -146.89 134.35 20.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.463 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.571 ' HB2' ' O ' ' B' ' 95' ' ' CYS . 8.3 m -68.52 109.76 3.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.245 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.445 HD11 ' HG3' ' B' ' 77' ' ' ARG . 92.9 mt -87.34 -6.81 58.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.342 0.591 . . . . 0.0 109.432 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -99.44 -18.09 17.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -143.8 72.01 1.34 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.022 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.71 91.12 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.458 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.579 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.6 OUTLIER -131.31 124.57 30.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.177 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 79.8 mt -87.9 121.91 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.033 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.632 ' CG ' ' HZ3' ' B' ' 65' ' ' LYS . 17.7 mmm -136.02 165.67 25.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.292 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -141.73 135.87 30.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.403 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.49 96.05 48.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.388 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.53 161.53 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.862 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -142.95 103.88 4.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.615 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.74 125.49 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.343 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.72 177.89 29.54 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 54.7 p -81.05 -22.86 38.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.623 ' HB3' HG11 ' A' ' 86' ' ' VAL . 37.0 m-85 -42.44 -58.52 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -43.72 -15.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' TYR . 38.2 tp10 -99.82 -32.62 10.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.327 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.704 HD12 ' OG ' ' B' ' 32' ' ' SER . 3.8 mm -109.11 19.15 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -80.35 117.13 25.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.543 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.26 -37.48 3.6 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.204 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 28' ' ' TRP . 1.9 mtt180 -62.26 30.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.552 0.676 . . . . 0.0 110.875 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.666 ' H ' ' C ' ' A' ' 25' ' ' GLY . 2.9 p -43.74 -12.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.747 0.784 . . . . 0.0 109.022 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.684 ' N ' ' O ' ' A' ' 26' ' ' ARG . 24.1 t-105 -58.24 -55.77 30.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.169 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.764 ' CD1' HG12 ' B' ' 28' ' ' VAL . 7.2 pt -64.66 -13.59 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 71' ' ' ILE . 60.5 m-85 -93.42 -16.5 24.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.9 mmm180 -89.13 -56.68 3.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.736 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' NE ' ' B' ' 27' ' ' ARG . . . -78.58 46.42 2.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ILE . . . -153.12 -40.98 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -75.68 126.96 32.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.536 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -154.78 -35.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.553 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' ARG . . . -32.29 144.77 0.02 OUTLIER Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 24.4 ttm105 -66.42 119.5 11.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -92.71 136.62 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.767 0.794 . . . . 0.0 113.115 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 43' ' ' ILE . 39.3 t30 -165.82 155.52 12.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 42' ' ' ASN . 86.3 tttt -52.21 -52.77 50.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.76 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.565 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 8.7 pttm -60.15 -4.24 0.76 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.748 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 72.3 m-20 -123.95 -3.41 8.13 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.228 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -86.41 -39.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 117.876 0.307 . . . . 0.0 111.466 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.882 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -88.43 3.12 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.882 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -114.65 -37.88 4.14 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.617 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.748 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -67.29 140.38 57.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.787 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -66.25 110.09 2.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.826 ' O ' HG12 ' A' ' 49' ' ' ILE . 5.0 mt -72.9 114.5 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.407 -1.317 . . . . 0.0 108.013 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.865 HD11 HD12 ' B' ' 42' ' ' LEU . 4.7 mt -168.42 51.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 O-C-N 123.803 0.689 . . . . 0.0 109.491 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 150.16 -35.26 0.99 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.591 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.969 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.6 tt -44.59 146.05 0.79 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.882 ' H ' HD23 ' A' ' 51' ' ' LEU . 13.0 tmtt? -85.46 125.31 32.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.348 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.977 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.0 p -149.1 171.02 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.434 0.635 . . . . 0.0 111.954 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.89 152.81 49.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.001 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 65' ' ' GLY . 31.6 t -100.44 99.46 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.58 -51.98 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.56 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HB3' HD12 ' A' ' 95' ' ' ILE . 15.1 t-20 -128.48 117.42 21.31 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.553 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.1 t -150.18 173.53 13.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.466 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.619 ' O ' ' OG1' ' A' ' 59' ' ' THR . 0.1 OUTLIER -101.36 79.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.507 ' O ' ' N ' ' A' ' 62' ' ' GLY . 62.6 m80 -161.14 94.92 1.4 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.614 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.7 -5.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.177 1.918 . . . . 0.0 113.219 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -134.79 22.57 3.64 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.193 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' ILE . 27.2 m-85 -140.69 -10.85 1.03 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.628 1.214 . . . . 0.0 111.834 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.4 m -72.14 134.07 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 83.27 5.87 88.44 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.291 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.083 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.4 tt -104.54 153.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.66 0.73 . . . . 0.0 112.204 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.614 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.3 tm-20 -120.26 131.49 54.95 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.31 173.29 27.49 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 116.341 -0.39 . . . . 0.0 112.502 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -96.45 117.89 31.83 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -51.9 145.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.962 0.41 . . . . 0.0 111.654 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.6 mt -140.32 -33.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.485 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.666 ' OD2' ' NH1' ' B' ' 38' ' ' ARG . 37.6 t0 -123.56 149.29 45.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.662 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 tm-20 -161.71 106.05 1.26 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.959 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.536 HG23 ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -148.45 -175.23 4.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.194 0.521 . . . . 0.0 110.964 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.493 HH12 HH21 ' A' ' 116' ' ' ARG . 37.1 ttt85 -53.17 -23.25 7.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.094 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -138.83 29.16 2.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -166.29 164.53 17.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 118.358 -1.337 . . . . 0.0 114.267 179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.645 HD23 ' CE1' ' A' ' 96' ' ' PHE . 10.5 tp -163.43 109.79 1.13 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 112.975 -1.92 . . . . 0.0 105.937 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 71' ' ' ILE . 83.3 t -118.24 146.3 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 112.474 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.622 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -127.6 147.09 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.357 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -122.69 137.47 54.9 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.597 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -155.52 124.96 1.57 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 64.8 -130.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 110.552 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.24 32.06 5.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.544 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 13.7 tttp -139.12 166.75 23.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.607 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 20' ' ' TYR . 7.5 m -123.45 155.44 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.421 0.629 . . . . 0.0 110.611 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 1.083 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.6 m-90 -102.17 93.14 5.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.437 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' HG13 ' A' ' 89' ' ' VAL . 20.9 ttmt -91.3 104.84 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.928 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 88' ' ' LYS . 2.5 m -157.24 95.85 2.1 Favored Pre-proline 0 N--CA 1.457 -0.123 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.563 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 32.0 Cg_exo -54.28 126.82 23.45 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.973 1.782 . . . . 0.0 111.687 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.823 ' HZ3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -38.81 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.204 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 90' ' ' PRO . 4.0 p-10 -82.24 -6.11 58.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -137.06 33.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.271 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 90' ' ' PRO . 3.2 p -167.37 154.82 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.354 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 57' ' ' ASN . 23.7 mt -105.37 146.13 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.271 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.761 ' HB3' HG21 ' A' ' 53' ' ' VAL . 50.3 m-85 -130.42 137.65 49.94 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.977 ' C ' HG23 ' A' ' 53' ' ' VAL . 7.8 tt0 -119.65 94.0 4.26 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' ILE . 1.4 m-85 -87.69 144.82 26.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.612 ' O ' HD21 ' A' ' 51' ' ' LEU . 82.6 tt0 -90.01 131.6 35.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.317 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.67 143.39 57.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.693 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.45 -0.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.296 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 20.2 t0 -107.37 12.98 27.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.8 22.65 68.75 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.06 149.47 26.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.417 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.46 133.41 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.42 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 100' ' ' THR . 22.2 mt -107.16 134.9 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -115.65 102.63 9.93 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -151.38 139.92 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.933 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 111' ' ' GLU . 37.4 m -89.74 148.35 23.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.275 0.559 . . . . 0.0 111.449 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.34 -1.0 0.94 Allowed Glycine 0 CA--C 1.506 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.174 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -76.44 -23.75 53.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.287 -178.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -74.63 -47.56 31.4 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.303 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -90.81 28.41 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.1 p -59.64 105.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.823 ' N ' ' HZ3' ' A' ' 91' ' ' LYS . . . 67.49 -41.02 0.23 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.792 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.493 HH21 HH12 ' A' ' 75' ' ' ARG . 7.0 mmt180 -100.79 79.72 0.23 Allowed Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HB2' HH22 ' B' ' 17' ' ' ARG . 18.3 Cg_endo -64.83 -24.48 61.3 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.608 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -64.72 -57.31 9.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.446 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 123' ' ' LYS . 2.6 tpt -31.81 -45.4 0.1 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.741 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.626 ' NE ' ' CZ3' ' A' ' 45' ' ' TRP . 6.8 tpm_? -70.9 -46.77 61.96 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.46 -41.35 97.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.97 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.45 17.94 22.95 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.618 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 119' ' ' MET . 42.4 mtmt 47.12 -145.42 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.876 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -100.13 167.13 10.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -105.05 -5.14 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.586 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 126' ' ' ARG . 40.2 mtp-105 -58.51 131.94 52.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.671 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.578 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.55 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 2.6 pt-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' B' ' 11' ' ' LYS . 16.9 pttp -79.85 -41.49 26.21 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.965 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.847 ' H ' HH11 ' B' ' 12' ' ' ARG . 16.8 ttpt -72.85 -33.62 66.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 122.742 1.258 . . . . 0.0 108.431 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.98 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.5 mpt_? -61.8 -51.07 69.78 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.418 -2.173 . . . . 0.0 110.98 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 45' ' ' TRP . 15.1 mt -68.33 -27.55 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -61.95 -53.09 60.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.904 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.468 ' O ' HG22 ' B' ' 18' ' ' ILE . 29.5 mttp -54.16 -50.25 67.43 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.79 -37.49 70.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.302 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.506 HH22 ' HB2' ' A' ' 117' ' ' PRO . 17.6 ttt180 -61.79 -53.66 52.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.842 0.83 . . . . 0.0 110.163 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -57.35 -34.83 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.118 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -67.07 -31.28 71.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.143 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.572 HG21 ' OE2' ' A' ' 47' ' ' GLU . 31.3 mt -71.33 -56.88 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.023 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -65.14 -34.0 77.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.908 0.861 . . . . 0.0 109.087 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.023 ' N ' HD13 ' B' ' 21' ' ' LEU . 14.0 t80 -53.09 -49.33 66.64 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.305 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.4 p -68.27 -37.21 80.48 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.123 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -60.4 -56.78 17.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.708 0.766 . . . . 0.0 110.032 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.57 -33.99 34.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.159 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.813 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 7.9 mm-40 -75.15 -43.51 52.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.583 0.706 . . . . 0.0 109.79 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.84 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 83.6 mtt-85 -72.69 -34.56 67.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.4 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.256 ' O ' ' N ' ' B' ' 32' ' ' SER . 3.6 m -85.19 -50.9 14.22 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.642 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.727 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 14.1 t80 -36.42 -49.73 1.81 Allowed Pre-proline 0 C--N 1.35 0.599 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.525 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.84 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 41.5 Cg_endo -55.39 -47.91 23.42 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 N-CA-C 106.893 -2.003 . . . . 0.0 106.893 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.807 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.2 t80 -94.47 -15.25 24.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.536 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.256 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -161.2 93.62 1.44 Allowed Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.524 ' HB3' ' HZ1' ' B' ' 37' ' ' LYS . 50.5 Cg_exo -53.7 -43.47 57.57 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.03 2.487 . . . . 0.0 114.158 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.08 -52.17 60.58 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.645 ' CD2' HH21 ' B' ' 38' ' ' ARG . 11.4 mt -51.3 -58.15 6.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.758 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -53.68 -34.04 57.37 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.354 0.597 . . . . 0.0 109.649 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.783 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -70.8 -41.06 72.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.391 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.666 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 3.6 ttm-85 -62.75 -51.54 66.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.406 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.876 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.5 m-30 -60.48 -41.19 93.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.097 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 36' ' ' ALA . 3.1 t -45.27 -36.47 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.381 -1.281 . . . . 0.0 107.948 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 67.5 tt0 -67.87 -44.03 78.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.865 HD12 HD11 ' A' ' 49' ' ' ILE . 26.8 mt -66.17 -40.02 90.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.323 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -68.27 -31.1 70.32 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 4.5 mt -63.16 -54.64 34.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.601 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.665 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.9 pp -60.2 -38.17 82.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.13 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.945 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.0 t -54.42 -44.37 66.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.451 0.643 . . . . 0.0 109.702 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.4 -55.16 17.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.761 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 13.3 pt20 -80.32 -52.27 7.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 13.9 mptt -61.7 -39.96 93.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.313 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.56 -11.65 45.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.07 67.63 0.84 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.112 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.93 137.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.899 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -44.54 141.41 1.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.145 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' B' ' 55' ' ' PRO . 6.7 tt -107.61 102.79 46.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' B' ' 54' ' ' ILE . 52.1 Cg_exo -51.24 -134.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.532 2.154 . . . . 0.0 112.235 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.484 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 0.8 OUTLIER -166.67 -16.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.628 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.411 ' H ' ' H ' ' B' ' 56' ' ' ARG . 27.3 tttt -58.68 -40.33 83.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.424 ' HA ' ' HE ' ' B' ' 61' ' ' ARG . 7.7 m0 -67.17 -3.51 7.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' B' ' 56' ' ' ARG . 2.7 pttt -69.04 -16.65 63.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.472 HH11 ' HD2' ' B' ' 60' ' ' ARG . 7.6 ptm85 -78.73 -20.37 50.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.558 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -140.71 17.87 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.138 -177.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' B' ' 58' ' ' TRP . 85.9 t80 -119.48 156.79 29.56 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.558 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.5 OUTLIER -127.22 124.08 38.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.043 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.51 4.48 49.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.515 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -97.53 -38.6 9.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.196 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.3 p -136.71 10.72 3.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.473 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' B' ' 66' ' ' CYS . 5.4 m-70 49.63 109.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.7 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.96 -170.04 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.783 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -122.85 105.06 9.68 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -109.47 141.69 41.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.814 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.7 t -119.71 121.01 30.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.09 122.92 6.87 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.017 1.811 . . . . 0.0 111.991 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 76' ' ' ALA . . . 101.78 -33.08 6.79 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.473 HG22 ' OD1' ' B' ' 75' ' ' ASN . 89.3 mt -99.37 -77.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.773 0.321 . . . . 0.0 110.975 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.473 ' OD1' HG22 ' B' ' 74' ' ' ILE . 73.6 m-20 -109.27 14.65 23.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -152.87 161.87 42.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -142.0 136.5 30.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.732 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.744 HG23 ' O ' ' B' ' 78' ' ' VAL . 33.1 m -130.79 100.3 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 O-C-N 123.36 0.413 . . . . 0.0 111.489 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.535 ' HA ' HD13 ' B' ' 88' ' ' ILE . 44.0 ttt85 -165.41 120.06 1.27 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.196 0.522 . . . . 0.0 111.02 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' B' ' 87' ' ' HIS . 21.7 tp -136.3 141.36 43.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.005 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ARG . . . . . 0.668 ' H ' HD12 ' B' ' 80' ' ' LEU . 16.3 ptt180 -61.57 -179.61 0.19 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.02 0.438 . . . . 0.0 111.214 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.593 ' CB ' ' O ' ' B' ' 81' ' ' ARG . 30.3 mm-40 132.12 143.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.995 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -103.31 -73.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.402 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -85.83 -5.91 59.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.383 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.541 ' O ' ' CE1' ' B' ' 87' ' ' HIS . 13.0 mtm -135.92 57.96 21.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.23 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' B' ' 82' ' ' GLN . 86.9 Cg_exo -41.4 119.05 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.918 2.412 . . . . 0.0 112.852 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' HIS . . . . . 0.759 ' HB3' HD23 ' B' ' 80' ' ' LEU . 3.7 m-70 -114.6 -179.19 3.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.555 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.661 ' CA ' ' HB3' ' B' ' 80' ' ' LEU . 1.2 mm -144.14 134.37 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.602 ' N ' ' HB2' ' B' ' 80' ' ' LEU . 53.3 t -95.67 116.41 37.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.631 ' CG1' HG12 ' B' ' 78' ' ' VAL . 0.0 OUTLIER -108.62 118.86 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -136.02 145.98 46.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.583 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.2 OUTLIER -82.35 127.19 32.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.737 178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.67 -3.85 58.69 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.368 0.604 . . . . 0.0 109.391 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.36 -51.42 5.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.842 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 4.7 p -118.42 76.26 1.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.73 93.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -128.04 126.41 41.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.651 -1.275 . . . . 0.0 109.984 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 tt -90.19 121.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.464 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 4.2 mtt -124.82 173.01 8.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.975 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 100' ' ' ARG . 33.4 mtm180 -128.05 155.3 44.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.438 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 3.7 t80 -157.93 91.52 2.22 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.181 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.82 164.61 9.5 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.147 1.898 . . . . 0.0 111.962 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -141.61 109.42 5.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.914 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.53 127.87 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.344 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.46 160.93 24.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.7 t -85.34 -10.83 55.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.674 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.3 m-85 -49.85 -48.79 50.95 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.12 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -40.84 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 110.45 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -101.77 -35.56 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.616 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.698 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.6 mm -94.96 22.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -80.45 117.89 27.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.69 0.281 . . . . 0.0 111.712 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 107.07 -33.15 6.6 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.154 -0.546 . . . . 0.0 114.078 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.8 28.47 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.988 0.894 . . . . 0.0 111.038 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' GLY . 16.5 p -42.76 -14.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.565 0.698 . . . . 0.0 109.397 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.653 ' N ' ' O ' ' A' ' 26' ' ' ARG . 18.9 t-105 -58.84 -59.53 5.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.263 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.795 ' CD1' HG12 ' B' ' 28' ' ' VAL . 11.9 pt -56.97 -12.97 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.576 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.639 ' CD2' HD21 ' B' ' 24' ' ' LEU . 27.4 m-85 -94.25 -29.62 14.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -74.65 -41.59 60.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.46 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.18 26.15 10.76 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.75 15.43 1.09 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -127.81 100.49 5.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.997 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.567 ' H ' HG13 ' B' ' 20' ' ' ILE . 5.3 mmt85 -138.87 -9.64 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.82 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.693 ' H ' ' CG1' ' B' ' 20' ' ' ILE . . . -45.52 145.05 2.9 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.571 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 28.7 ttt180 -66.87 118.26 10.12 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 61.8 t -93.64 136.5 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 43' ' ' ILE . 10.7 t-20 -165.86 150.93 8.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.279 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.542 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 88.0 tttt -48.45 -55.5 10.73 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.357 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.587 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 6.3 pttp -59.31 -5.28 0.71 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.626 ' O ' ' CG ' ' A' ' 46' ' ' HIS . 2.2 m120 -125.12 0.5 7.86 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.231 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.9 -38.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.907 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -97.63 9.85 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.575 1.179 . . . . 0.0 108.015 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.797 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -125.82 6.44 7.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.535 -1.666 . . . . 0.0 107.664 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.731 ' C ' ' HE ' ' B' ' 17' ' ' ARG . 0.1 OUTLIER -107.97 176.16 5.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.687 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.789 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -94.57 111.75 23.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.794 ' O ' HD13 ' A' ' 49' ' ' ILE . 45.9 mt -75.21 115.39 14.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.801 ' HB ' HD23 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -161.02 -40.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -136.1 20.44 3.59 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.885 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -86.72 137.78 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.71 ' H ' HD23 ' A' ' 51' ' ' LEU . 76.2 tttt -71.1 135.89 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.669 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 54' ' ' ARG . 1.8 p -149.48 171.89 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.442 0.639 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -146.98 140.27 25.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.901 178.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 65' ' ' GLY . 42.9 t -91.25 99.53 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.43 -50.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.457 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.33 117.9 13.89 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 4.5 t -150.27 174.02 13.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.758 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.601 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 1.4 p -97.14 78.84 2.79 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.716 ' O ' HG13 ' A' ' 64' ' ' VAL . 73.9 m80 -166.56 111.71 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.696 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.05 -6.03 17.23 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.88 1.72 . . . . 0.0 112.654 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.08 13.72 9.03 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.763 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 87' ' ' TRP . 30.5 m-85 -138.82 -22.74 0.95 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.345 1.072 . . . . 0.0 111.589 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 60' ' ' HIS . 8.8 m -71.82 145.63 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.52 6.4 89.2 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.365 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.962 HG21 ' CZ2' ' A' ' 87' ' ' TRP . 26.1 mt -111.9 158.4 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 66' ' ' ILE . 4.5 tt0 -115.13 120.54 40.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.88 171.37 26.86 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.145 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -91.03 129.91 36.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.3 t -68.13 153.84 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.369 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.693 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 85.2 mt -141.59 -55.96 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.671 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 0.8 OUTLIER -106.41 150.21 26.26 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.676 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -156.68 107.05 2.33 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.477 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.73 -173.13 3.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 110.759 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -52.21 -29.5 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.581 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.593 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -137.98 31.37 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.678 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -157.13 161.46 39.38 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 118.992 -1.083 . . . . 0.0 113.358 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.715 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.3 tp -161.93 109.23 1.37 Allowed 'General case' 0 C--O 1.243 0.748 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 72' ' ' ASP . 80.4 t -107.86 147.29 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -131.11 143.86 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.002 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.07 136.19 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.945 0.403 . . . . 0.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.86 136.89 5.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 51.77 -133.93 1.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.517 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -102.23 33.75 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 22.1 tptm -145.46 160.34 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.092 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 14.0 m -120.57 156.69 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.588 0.709 . . . . 0.0 110.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.962 ' CZ2' HG21 ' A' ' 66' ' ' ILE . 2.6 m-90 -107.35 128.62 54.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.209 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' C ' ' CG2' ' A' ' 89' ' ' VAL . 83.0 tttt -118.64 106.54 12.71 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -152.31 99.58 2.85 Favored Pre-proline 0 CA--C 1.528 0.112 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.565 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 50.8 Cg_exo -50.66 137.9 41.16 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.812 1.675 . . . . 0.0 110.795 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.611 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -49.98 -19.9 0.81 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.787 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.611 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 1.2 p-10 -84.8 -6.17 59.34 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -125.12 5.89 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -142.34 139.41 31.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.117 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mt -85.71 116.99 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.727 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 53.1 m-85 -98.12 130.31 44.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 106' ' ' ILE . 38.3 tt0 -113.5 97.28 6.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.727 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 47.2 m-85 -90.28 145.14 25.21 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -90.62 127.04 36.15 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.773 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.662 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -63.01 143.62 57.62 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.765 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.831 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.43 -0.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.402 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.7 t0 -106.85 13.38 27.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.23 21.92 69.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.662 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.58 149.77 26.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.625 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.495 ' HG3' HH21 ' A' ' 54' ' ' ARG . 0.1 OUTLIER -91.05 132.4 36.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 20.6 mt -105.52 134.07 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.281 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -112.54 101.03 9.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -138.11 136.18 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.431 -177.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' GLU . 3.8 m -81.32 134.66 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.668 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' LYS . . . -59.33 -2.19 1.4 Allowed Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.829 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 pt-20 -86.19 -21.06 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.916 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -63.45 -44.33 94.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.92 27.72 3.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.216 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.3 p -48.1 103.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.471 0.653 . . . . 0.0 112.333 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' A' ' 91' ' ' LYS . . . 67.05 -41.44 0.2 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.725 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 119' ' ' MET . 12.4 mtt85 -100.52 97.4 6.48 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HB2' ' NH2' ' B' ' 17' ' ' ARG . 24.7 Cg_endo -69.32 -30.16 24.78 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 N-CA-C 107.1 -1.923 . . . . 0.0 107.1 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.593 ' HB3' HD13 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -64.79 -53.3 49.13 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.703 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 118' ' ' GLU . 0.8 OUTLIER -29.37 -36.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.056 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.631 ' CZ ' ' CH2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -82.39 -53.32 6.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.017 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.42 -31.25 54.81 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.613 ' O ' ' C ' ' A' ' 123' ' ' LYS . 6.8 mtpp -84.71 -8.53 58.81 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.463 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.613 ' C ' ' O ' ' A' ' 122' ' ' LYS . 61.7 tttt -5.04 115.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.8 0.333 . . . . 0.0 111.833 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.491 ' C ' ' H ' ' A' ' 126' ' ' ARG . 6.2 ttm-85 -55.26 -96.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.293 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 67.76 -40.15 0.4 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.491 ' H ' ' C ' ' A' ' 124' ' ' ARG . 53.8 ttt85 -58.93 133.2 55.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.377 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.488 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.654 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -78.45 -37.88 42.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.576 -0.45 . . . . 0.0 112.161 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.862 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.3 OUTLIER -72.12 -33.24 67.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 122.958 1.361 . . . . 0.0 108.237 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.969 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -59.85 -51.01 71.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 112.013 -2.358 . . . . 0.0 111.216 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.477 ' HA ' ' OE2' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -69.68 -29.34 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.23 -48.57 64.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.503 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.425 ' O ' HG22 ' B' ' 18' ' ' ILE . 10.1 tptt -50.75 -51.15 53.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' HD13 ' B' ' 20' ' ' ILE . 17.5 pt-20 -72.74 -36.7 67.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.206 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 46' ' ' HIS . 34.5 ttt-85 -60.92 -52.53 64.65 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.857 0.837 . . . . 0.0 110.606 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -35.91 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.422 -177.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.75 -32.15 72.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.693 ' CG1' ' H ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -73.78 -55.05 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.996 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.59 -34.45 75.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.996 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -54.43 -51.29 65.41 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.017 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -69.1 -31.53 70.3 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.501 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.818 HD12 HG13 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -69.11 -54.4 15.17 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.19 -34.3 31.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.614 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.837 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 49.6 mt-10 -73.89 -43.08 59.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.44 0.638 . . . . 0.0 110.437 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.86 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 86.0 mtt-85 -71.4 -35.42 71.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.384 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.205 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.4 m -82.33 -50.7 15.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 O-C-N 121.336 -0.853 . . . . 0.0 110.485 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.703 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 2.1 t80 -36.42 -51.2 1.84 Allowed Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.616 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.86 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.2 Cg_endo -53.66 -46.72 31.65 Favored 'Trans proline' 0 C--N 1.296 -2.188 0 N-CA-C 106.129 -2.297 . . . . 0.0 106.129 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' B' ' 28' ' ' VAL . 41.9 t80 -95.0 -14.32 24.46 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.139 -2.301 . . . . 0.0 113.269 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.205 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.6 p -157.91 96.24 1.95 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 52.7 Cg_exo -55.09 -47.4 26.62 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.967 2.445 . . . . 0.0 114.347 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.21 -53.2 56.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.548 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 62.0 mt -51.74 -60.25 3.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.984 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.8 -32.95 60.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.812 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.29 -38.46 75.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.702 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.854 ' NH1' HD11 ' B' ' 42' ' ' LEU . 3.8 tmm_? -60.72 -50.35 73.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.027 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.8 OUTLIER -64.26 -40.46 96.04 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.8 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.02 -37.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -66.97 -45.45 77.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.854 HD11 ' NH1' ' B' ' 38' ' ' ARG . 11.6 mt -63.37 -50.7 68.88 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.454 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.14 -30.29 68.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.805 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 10.4 mt -65.33 -54.43 29.13 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 118' ' ' GLU . 3.5 pp -59.6 -35.03 73.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.673 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.712 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.4 t -64.94 -49.89 77.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.435 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.11 -51.13 70.91 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.022 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 7.0 pt20 -78.85 -39.64 34.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.77 ' HD3' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -83.06 -42.21 17.72 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.089 -177.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -67.06 -14.87 63.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 mttm 72.54 52.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.021 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.472 HG12 ' H ' ' B' ' 53' ' ' LYS . 0.2 OUTLIER -101.45 -178.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.995 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.472 ' H ' HG12 ' B' ' 52' ' ' VAL . 12.4 mtmm -71.16 162.47 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.56 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.45 ' H ' ' CD1' ' B' ' 54' ' ' ILE . 0.1 OUTLIER -78.06 148.29 74.78 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.69 -69.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.592 2.195 . . . . 0.0 112.342 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 77.32 -83.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.362 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.617 ' O ' ' NE ' ' B' ' 60' ' ' ARG . 11.3 pttm -55.96 -39.69 72.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.623 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 36.2 m0 -61.89 1.5 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' B' ' 57' ' ' LYS . 7.5 pttp -66.26 -17.06 64.52 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' B' ' 57' ' ' LYS . 9.6 ptp180 -76.17 -18.86 58.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.84 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.802 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -147.53 15.34 1.12 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.417 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 32.4 t80 -113.54 154.08 27.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.584 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 5.8 t -123.66 114.51 20.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.896 0.379 . . . . 0.0 111.448 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.36 3.89 12.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.921 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.568 ' HB2' ' SG ' ' B' ' 95' ' ' CYS . 1.8 mmmt -98.27 -43.49 6.94 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.482 ' C ' ' CG ' ' B' ' 67' ' ' HIS . 6.1 p -134.14 -2.64 2.84 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.599 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER 61.94 134.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.513 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 164.97 -170.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.098 0.475 . . . . 0.0 110.783 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.825 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -117.96 103.92 10.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.802 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -110.23 117.35 33.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.45 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.688 HG23 ' CE2' ' B' ' 29' ' ' PHE . 1.5 t -101.59 121.06 52.63 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.939 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' PRO . . . . . 0.53 ' HB3' HG22 ' B' ' 78' ' ' VAL . 71.0 Cg_exo -46.15 124.79 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.792 1.662 . . . . 0.0 111.38 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.98 -33.93 6.18 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.488 HD12 HG11 ' B' ' 71' ' ' VAL . 96.6 mt -96.78 -80.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.854 0.359 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.43 18.6 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.115 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -148.0 164.44 33.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.857 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.649 ' HG3' HD11 ' B' ' 93' ' ' LEU . 79.7 mtp180 -144.17 129.64 18.99 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.478 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.737 HG23 ' O ' ' B' ' 78' ' ' VAL . 15.5 m -138.07 104.67 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.603 ' NH1' HH21 ' B' ' 77' ' ' ARG . 18.7 mtm-85 -128.08 145.2 51.07 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.256 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 1.5 pp -125.39 124.22 41.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.668 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -137.65 155.07 49.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.599 ' C ' ' H ' ' B' ' 84' ' ' ARG . 12.7 mp0 -85.6 -97.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.466 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 23.4 tttt 67.9 -13.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.076 0.465 . . . . 0.0 109.988 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' B' ' 82' ' ' GLN . 5.5 ptp180 179.53 -24.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.499 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' MET . . . . . . . . . . . . . 1.2 mtt 177.56 136.8 0.22 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.061 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.52 103.4 1.42 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.105 1.87 . . . . 0.0 112.16 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -127.41 132.16 50.16 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.472 HG13 ' HB3' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -84.26 135.89 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.588 ' O ' HG13 ' B' ' 89' ' ' VAL . 7.1 p -106.09 119.42 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -112.32 129.55 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.415 ' HA ' ' CE1' ' B' ' 97' ' ' HIS . 40.9 tttt -147.87 144.74 28.33 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.638 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.618 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 1.1 t -81.33 131.98 35.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.224 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.649 HD11 ' HG3' ' B' ' 77' ' ' ARG . 78.9 mt -95.78 0.34 52.21 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.502 0.501 . . . . 0.0 109.785 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -44.9 7.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.856 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 4.6 p -129.95 79.5 1.91 Allowed 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.066 -1.879 . . . . 0.0 106.235 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.2 94.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 122.197 0.887 . . . . 0.0 111.936 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.554 ' CG ' ' O ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -118.76 120.71 38.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.412 -1.394 . . . . 0.0 108.931 178.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 79.3 mt -91.51 120.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.839 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.418 ' HG3' ' HE2' ' B' ' 97' ' ' HIS . 16.6 mmm -132.25 165.15 24.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.99 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -129.5 154.64 46.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -155.95 106.63 2.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.258 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -47.44 170.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.362 2.042 . . . . 0.0 112.478 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -115.94 75.87 0.98 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.926 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.78 115.17 45.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.341 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 59.1 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.41 179.819 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.72 145.09 12.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -92.0 -4.29 54.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.298 . . . . 0.0 110.644 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 22' ' ' GLU . 8.6 m-85 -43.23 -57.23 3.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -38.62 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.902 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 20' ' ' TYR . 47.0 tp10 -104.13 -32.6 9.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.728 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.1 mm -102.05 15.58 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 25' ' ' GLY . 1.2 tp -79.51 117.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.373 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.41 -36.42 4.06 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.328 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.676 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.32 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.631 0.716 . . . . 0.0 110.793 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.693 ' H ' ' C ' ' A' ' 25' ' ' GLY . 14.2 p -41.9 -14.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 109.601 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.676 ' N ' ' O ' ' A' ' 26' ' ' ARG . 23.2 t-105 -57.31 -53.74 54.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.212 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' B' ' 28' ' ' VAL . 8.6 pt -67.67 -13.11 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.082 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 49' ' ' ILE . 41.3 m-85 -92.8 -9.88 38.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.5 ttp180 -95.04 -64.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.77 31.74 0.38 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -146.63 -36.51 0.24 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -90.84 112.29 24.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.785 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.6 OUTLIER -148.47 2.13 0.63 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.943 -179.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA3' HH22 ' B' ' 17' ' ' ARG . . . -45.91 153.56 0.8 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 9.2 ttm180 -67.69 117.73 10.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 47.0 t -95.25 134.2 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 43' ' ' ILE . 5.7 t-20 -166.1 149.94 7.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.276 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' ASN . 11.3 tttm -48.26 -55.14 11.3 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 44.2 pttt -59.91 -4.86 0.81 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 90.2 m-20 -123.77 -0.35 8.56 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.229 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.54 -39.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.849 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.3 9.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.833 1.301 . . . . 0.0 107.578 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -126.55 -6.44 6.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.849 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.751 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -93.35 147.1 23.23 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.866 ' OE1' ' NE ' ' B' ' 17' ' ' ARG . 0.4 OUTLIER -74.48 110.64 8.93 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 49' ' ' ILE . 15.8 mt -73.24 117.94 15.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.4 mm -152.69 -30.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.763 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -146.76 0.03 0.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.541 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -58.32 162.35 3.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.665 0.732 . . . . 0.0 109.488 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.843 ' H ' HD23 ' A' ' 51' ' ' LEU . 11.9 tttt -106.73 125.16 50.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.472 0.177 . . . . 0.0 111.171 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.003 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.5 p -148.97 170.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.443 0.639 . . . . 0.0 111.513 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.708 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -132.27 145.43 51.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.439 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' GLY . 23.7 t -100.83 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.34 -47.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.937 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -127.77 119.43 25.72 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.133 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.9 p -148.61 135.95 20.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.052 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.629 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -71.26 77.1 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.281 -1.368 . . . . 0.0 108.948 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.629 ' CG ' ' C ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -169.29 97.89 0.5 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.027 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.89 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.469 2.113 . . . . 0.0 113.774 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -124.0 24.43 6.33 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 120.402 -0.904 . . . . 0.0 114.407 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -141.05 -21.98 0.78 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.804 1.302 . . . . 0.0 111.694 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 58' ' ' SER . 3.1 m -72.96 145.08 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.75 5.31 89.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.919 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.615 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.1 mt -104.64 148.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 118.259 1.03 . . . . 0.0 111.538 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -114.71 126.97 55.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.81 173.37 27.9 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.981 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -95.85 120.21 35.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.7 t -53.12 141.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.117 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.729 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.6 mt -135.39 -36.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.971 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 1.7 t70 -121.83 141.68 50.99 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.639 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 5.0 tt0 -153.19 106.23 2.97 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -140.42 -176.77 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.125 0.488 . . . . 0.0 110.725 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 72.6 ttt-85 -57.96 -16.46 12.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.816 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -138.77 27.29 2.46 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.551 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 2.4 ptp -165.96 170.02 14.12 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 118.7 -1.2 . . . . 0.0 114.066 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 96' ' ' PHE . 1.4 tp -166.13 110.24 0.8 Allowed 'General case' 0 C--O 1.252 1.233 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.907 ' C ' HD13 ' A' ' 80' ' ' ILE . 66.0 t -120.01 136.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.975 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -114.84 151.96 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -128.13 135.93 50.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.122 0.486 . . . . 0.0 111.82 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.442 ' N ' ' HZ3' ' A' ' 87' ' ' TRP . . . -157.53 122.64 1.19 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 66.73 -130.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -108.69 18.17 21.12 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.947 0.403 . . . . 0.0 110.101 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -119.56 144.51 47.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.425 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.73 155.47 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.512 0.673 . . . . 0.0 110.959 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.618 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 3.2 m-90 -99.39 137.69 37.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.294 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -128.95 93.74 3.67 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.14 107.35 2.63 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.366 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.29 165.0 2.42 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.794 1.662 . . . . 0.0 110.563 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.699 ' HD2' ' H ' ' A' ' 115' ' ' GLY . 1.7 mttm -72.79 -21.42 60.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.68 -5.73 59.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.0 15.36 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 15.1 p -161.32 174.29 13.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.015 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.09 139.72 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.807 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.849 ' CE2' HD23 ' A' ' 78' ' ' LEU . 88.1 m-85 -121.66 131.31 54.03 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 1.003 ' C ' HG23 ' A' ' 53' ' ' VAL . 43.9 tt0 -114.69 94.48 4.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' ILE . 3.1 m-85 -86.74 145.24 26.73 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -89.78 129.4 36.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.659 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.06 143.36 57.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.729 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.37 0.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.55 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 84.8 m-20 -107.26 13.42 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.01 21.93 66.94 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.87 150.05 26.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.635 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 133.3 36.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 111.121 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 100' ' ' THR . 16.0 mt -106.49 134.03 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -115.93 102.98 10.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -147.8 140.93 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.34 -178.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -88.38 150.71 23.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.435 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.34 -1.77 4.73 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.604 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 -21.55 47.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.658 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -73.66 -47.5 39.35 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.297 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.75 28.04 2.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.0 p -55.42 106.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.699 ' H ' ' HD2' ' A' ' 91' ' ' LYS . . . 68.2 -41.08 0.28 Allowed Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.476 -1.238 . . . . 0.0 114.464 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -101.92 87.87 1.13 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -69.47 -26.41 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.632 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.99 -57.69 7.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.685 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.424 ' C ' ' O ' ' A' ' 118' ' ' GLU . 5.3 ttp -31.43 -54.35 0.24 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.767 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -45.21 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.298 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -48.06 -30.98 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.251 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -103.54 -18.59 14.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.413 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 122' ' ' LYS . 37.6 ttmt 58.86 145.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt85 -93.8 133.63 36.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.609 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -170.34 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.18 148.81 27.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.361 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.572 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.758 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 28.9 mt-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -78.76 -29.07 44.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.951 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -33.93 64.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.68 1.229 . . . . 0.0 108.526 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.963 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -63.6 -51.7 64.14 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 112.322 -2.217 . . . . 0.0 111.722 -178.086 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.541 ' O ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -71.07 -27.12 28.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -68.74 -39.95 80.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.418 ' O ' HG22 ' B' ' 18' ' ' ILE . 47.1 mttt -63.17 -49.56 73.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.962 0.411 . . . . 0.0 110.488 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.521 ' C ' ' NH1' ' B' ' 17' ' ' ARG . 1.0 OUTLIER -69.34 -35.36 75.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.866 ' NE ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -62.16 -52.04 65.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.512 0.672 . . . . 0.0 111.342 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.99 -41.65 91.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.594 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 5.3 m-20 -69.78 -26.74 64.43 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.692 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.785 HD12 ' H ' ' A' ' 35' ' ' ARG . 5.7 mm -74.16 -57.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.67 -34.26 76.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.0 ' H ' HD13 ' B' ' 21' ' ' LEU . 11.6 t80 -53.72 -47.89 70.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.381 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 37.7 m -70.95 -34.11 71.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.449 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -67.86 -55.18 13.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.552 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.545 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -50.62 -38.44 46.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.735 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.823 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 23.7 mt-10 -65.84 -46.79 77.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.15 0.5 . . . . 0.0 111.263 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.889 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 1.7 ttt-85 -72.17 -33.47 67.72 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.354 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.171 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.7 m -82.6 -50.71 15.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.424 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.73 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 1.6 t80 -36.39 -50.63 1.82 Allowed Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.889 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.3 Cg_endo -53.64 -46.36 34.27 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 N-CA-C 106.21 -2.265 . . . . 0.0 106.21 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.8 ' N ' ' O ' ' B' ' 28' ' ' VAL . 39.8 t80 -94.92 -12.66 26.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.028 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.171 ' N ' ' O ' ' B' ' 28' ' ' VAL . 60.5 p -160.34 96.67 1.48 Allowed Pre-proline 0 N--CA 1.472 0.654 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.64 -44.75 45.02 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.261 2.641 . . . . 0.0 114.439 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.34 -53.0 55.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.035 0.445 . . . . 0.0 112.133 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.521 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 24.3 mt -53.81 -61.14 2.5 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.093 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.55 -32.72 42.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.725 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -70.46 -41.05 73.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.079 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.864 HH11 HD11 ' B' ' 42' ' ' LEU . 2.8 tmm_? -59.68 -53.58 56.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.555 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.91 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.1 m-30 -58.88 -43.17 90.86 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 110.049 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.513 HG23 ' CD2' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -46.32 -40.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.902 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.95 -42.21 99.75 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.864 HD11 HH11 ' B' ' 38' ' ' ARG . 63.2 mt -67.39 -51.36 52.83 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.477 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -52.23 -31.03 30.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.987 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 23.8 mt -65.33 -54.44 28.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.305 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.673 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.4 pp -62.02 -28.3 69.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.832 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.905 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 95.1 t -64.34 -48.87 83.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.602 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.446 HE21 ' HD2' ' B' ' 55' ' ' PRO . 1.8 tp-100 -65.74 -57.41 8.09 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.8 pt20 -81.62 -52.16 7.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 5.4 tptt -62.96 -37.71 88.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.889 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -81.45 -0.71 42.9 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.725 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 63.61 69.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.744 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -132.06 156.88 42.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.743 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.9 145.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.559 HG23 ' O ' ' B' ' 54' ' ' ILE . 8.4 tt -112.25 94.28 25.75 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.747 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PRO . . . . . 0.446 ' HD2' HE21 ' B' ' 47' ' ' GLN . 22.2 Cg_exo -60.66 177.74 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.451 2.101 . . . . 0.0 110.997 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.444 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 77.4 mtp180 -149.25 24.37 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.907 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' B' ' 59' ' ' LYS . 17.3 ptmt -86.97 -38.38 16.68 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.626 ' O ' ' N ' ' B' ' 62' ' ' TYR . 6.0 m-90 -49.5 -2.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' B' ' 57' ' ' LYS . 24.4 mtpp -61.65 -19.66 62.55 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.81 -17.79 64.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.818 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -150.74 8.3 0.57 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.64 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' B' ' 58' ' ' TRP . 92.6 t80 -117.72 157.5 26.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.988 0.423 . . . . 0.0 110.551 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' B' ' 62' ' ' TYR . 22.6 t -126.99 129.99 49.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.042 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -87.33 3.13 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.79 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' B' ' 97' ' ' HIS . 1.1 mmpt? -108.16 -31.44 7.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.796 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' B' ' 67' ' ' HIS . 11.5 p -138.96 10.44 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.209 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.0 OUTLIER 37.12 103.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.985 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.781 ' HB1' ' NZ ' ' B' ' 37' ' ' LYS . . . -162.25 -173.05 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.122 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.618 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -113.97 103.18 10.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -105.57 147.56 28.26 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.632 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.511 HG11 HD12 ' B' ' 74' ' ' ILE . 2.5 t -125.95 120.72 24.11 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.86 123.64 6.29 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.859 1.706 . . . . 0.0 111.654 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.13 -33.26 6.67 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.511 HD12 HG11 ' B' ' 71' ' ' VAL . 94.8 mt -94.44 -80.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.615 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.86 22.64 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -151.29 157.76 42.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.12 138.42 23.98 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.745 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 78' ' ' VAL . 20.8 m -138.82 119.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -130.66 146.21 52.1 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.555 ' HB3' HG13 ' B' ' 88' ' ' ILE . 1.5 pp -125.97 126.93 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.937 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.74 158.54 44.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.44 . . . . 0.0 111.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' B' ' 83' ' ' LYS . 4.1 pt20 -76.72 -130.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.3 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 82' ' ' GLN . 14.4 tptm 83.7 70.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.013 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' B' ' 85' ' ' MET . 0.9 OUTLIER 45.07 93.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.768 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' B' ' 84' ' ' ARG . 1.7 tmm? 85.75 110.24 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.798 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.05 136.18 19.96 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.175 1.917 . . . . 0.0 112.149 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -144.19 146.26 32.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.044 0.45 . . . . 0.0 111.248 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' B' ' 80' ' ' LEU . 0.0 OUTLIER -102.02 137.1 31.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.933 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 8.3 t -103.42 110.89 31.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.279 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 99' ' ' MET . 3.2 p -121.09 135.81 60.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' B' ' 97' ' ' HIS . 5.9 tttp -154.22 153.73 32.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.479 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.611 ' H ' ' HB3' ' B' ' 97' ' ' HIS . 12.1 t -81.26 130.79 35.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 76' ' ' ALA . 14.1 mt -108.79 17.26 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.597 1.186 . . . . 0.0 108.279 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.539 ' OE2' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -95.41 -30.46 13.88 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.881 ' SG ' ' N ' ' B' ' 96' ' ' GLY . 21.5 p -144.21 -104.17 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.407 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.881 ' N ' ' SG ' ' B' ' 95' ' ' CYS . . . -159.88 98.21 0.17 Allowed Glycine 0 C--N 1.315 -0.631 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.621 ' O ' ' HA ' ' B' ' 91' ' ' LYS . 20.0 t-160 -122.34 113.47 19.44 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.888 0.844 . . . . 0.0 111.05 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mt -94.33 119.67 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.495 ' HB2' HG13 ' B' ' 90' ' ' VAL . 6.2 mmt -141.54 159.9 41.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.472 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -141.71 141.21 33.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.002 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -136.32 103.64 9.55 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.008 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.25 166.05 3.66 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.253 1.969 . . . . 0.0 112.495 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -142.37 74.5 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.32 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 76.8 mt -100.5 135.07 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.511 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.11 129.86 21.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -90.76 -21.29 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' A' ' 72' ' ' ASP . 54.0 m-85 -38.32 -62.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.915 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.39 -7.92 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.414 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.3 tp10 -97.9 -36.93 10.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' B' ' 31' ' ' TYR . 2.5 mm -104.51 14.16 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.3 tp -79.98 118.8 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.413 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 120.07 -38.85 2.63 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -66.87 27.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.676 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -41.94 -14.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.739 0.78 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 28.1 t-105 -58.71 -54.44 47.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.329 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.755 ' CD1' HG12 ' B' ' 28' ' ' VAL . 4.7 pt -66.2 -14.25 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -89.71 -34.35 16.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.98 -32.61 19.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.765 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' NH1' ' B' ' 27' ' ' ARG . . . -85.48 28.81 4.64 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -156.13 20.72 0.37 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -127.15 101.91 6.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.671 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.472 ' H ' ' CG1' ' B' ' 20' ' ' ILE . 23.0 mmt-85 -145.85 12.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.938 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.644 ' HA3' HH21 ' B' ' 17' ' ' ARG . . . -62.32 152.45 44.3 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 14.9 ttm180 -67.31 132.84 48.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.805 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 55.1 t -116.8 136.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.707 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.691 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -166.23 153.81 10.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.617 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' ASN . 28.8 tttm -49.83 -55.8 12.81 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.837 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.623 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 42.9 pttt -60.64 -3.51 0.72 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.746 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 31.6 m-20 -124.72 1.12 8.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.26 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.98 -42.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.876 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.853 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.7 0.79 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.853 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -117.23 18.04 14.59 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.008 -1.906 . . . . 0.0 107.68 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.23 126.58 45.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.925 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -59.28 113.42 2.15 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 98' ' ' PHE . 2.6 mt -78.13 122.18 25.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.759 0.314 . . . . 0.0 111.001 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.784 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.0 mm -151.22 -46.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.936 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -127.57 -3.06 6.15 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.181 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -60.35 140.87 56.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.248 0.524 . . . . 0.0 110.358 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.651 ' H ' HD23 ' A' ' 51' ' ' LEU . 64.1 tttt -75.38 135.56 40.8 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 2.7 p -148.75 170.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.546 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -150.33 140.52 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.855 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.4 t -88.19 100.79 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.5 -51.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 O-C-N 123.374 0.421 . . . . 0.0 110.512 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.7 118.75 15.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.182 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.65 ' HB3' HG12 ' A' ' 64' ' ' VAL . 23.3 t -148.74 174.23 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.96 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.703 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 5.9 t -103.11 78.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 59' ' ' THR . 19.2 m80 -167.62 118.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.17 -5.29 15.48 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 121.73 1.62 . . . . 0.0 112.975 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.14 20.94 7.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.187 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.21 -23.09 0.75 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.905 1.352 . . . . 0.0 112.098 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 58' ' ' SER . 3.3 m -71.57 145.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.64 7.31 87.6 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.257 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.845 ' CD1' ' HE1' ' A' ' 87' ' ' TRP . 19.8 mt -108.05 159.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' N ' HG22 ' A' ' 66' ' ' ILE . 5.7 tm-20 -126.76 121.82 33.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.459 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -148.09 172.38 28.38 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.073 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 1.6 m-85 -87.32 123.56 32.42 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.9 t -56.43 157.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.9 mt -143.73 -60.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 62.0 t0 -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.828 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -153.72 106.56 2.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 178.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -157.97 177.59 11.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.225 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 44.8 ttm-85 -53.69 -5.12 0.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.274 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.783 ' H ' HG23 ' A' ' 74' ' ' THR . 78.3 m-20 -137.98 0.79 2.21 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 74' ' ' THR . 4.8 ptp -165.78 167.89 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.895 HD23 ' CE2' ' A' ' 96' ' ' PHE . 4.5 tp -151.16 109.72 3.81 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.1 t -113.71 147.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -127.99 141.57 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.999 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -110.46 136.48 49.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -151.56 119.0 0.94 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 3.5 tp10 65.07 -123.14 0.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.404 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 56.5 m-20 -111.57 21.01 16.61 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.973 0.416 . . . . 0.0 110.475 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.542 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.0 tttp -130.66 164.46 24.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.481 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.469 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 29.2 m -120.67 156.28 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 110.637 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.845 ' HE1' ' CD1' ' A' ' 66' ' ' ILE . 2.5 m-90 -105.62 104.49 14.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.182 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.93 110.26 22.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.98 96.35 3.31 Favored Pre-proline 0 C--N 1.334 -0.097 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.224 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -55.75 146.31 66.99 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.882 1.721 . . . . 0.0 111.308 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.562 ' H ' ' CD ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.68 -29.11 37.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.613 -178.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -6.96 59.55 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -126.13 22.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.509 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.662 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 24.6 p -165.27 158.3 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.457 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 109' ' ' SER . 57.5 mt -112.58 124.62 69.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.627 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.895 ' CE2' HD23 ' A' ' 78' ' ' LEU . 72.4 m-85 -100.92 144.53 29.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 18.6 tt0 -125.75 97.59 5.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 48' ' ' LEU . 8.1 m-85 -90.45 145.72 24.7 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -89.46 130.76 35.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.068 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.66 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -65.48 142.46 58.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.483 0.659 . . . . 0.0 110.265 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.805 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.24 0.19 0.11 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.678 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.1 t0 -107.15 4.43 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.77 23.2 36.64 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -107.05 150.16 26.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 110.35 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -90.52 128.8 36.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 111.359 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 100' ' ' THR . 14.1 mt -104.03 135.07 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -120.35 101.82 8.05 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.497 HG21 HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -142.25 132.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.063 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.2 m -74.34 145.34 43.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.153 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -63.86 -2.52 6.48 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.546 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -81.46 -22.79 37.87 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.62 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -69.22 -44.56 71.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.022 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -99.0 29.38 3.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.9 p -54.36 105.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.82 -40.49 0.31 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.685 -1.143 . . . . 0.0 114.735 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 119' ' ' MET . 21.2 mtm-85 -100.49 85.75 0.57 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.68 -23.45 76.32 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.9 OUTLIER -68.59 -57.25 6.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.489 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 118' ' ' GLU . 26.4 ttp -24.8 -48.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.572 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' GLU . 2.9 tpm_? -82.58 -49.18 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.852 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -52.15 -39.11 59.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.495 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 123' ' ' LYS . 1.3 ptmt -88.22 -34.92 17.6 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.917 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 122' ' ' LYS . 87.7 tttt 56.57 146.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.149 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.31 150.32 51.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.46 ' CD2' ' N ' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -95.35 -52.5 4.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 46.2 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.572 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.2 mttm . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.286 179.728 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.524 ' O ' HG12 ' B' ' 13' ' ' ILE . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.58 ' CD ' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -53.73 -37.28 63.19 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.009 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.539 ' HG2' ' HD2' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -65.41 -46.64 79.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.276 1.036 . . . . 0.0 109.38 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.624 ' O ' ' CD ' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -64.92 -51.05 63.99 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.314 -1.767 . . . . 0.0 112.433 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.524 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.8 pt -62.61 -27.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.5 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -70.57 -38.14 74.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.418 ' HD3' HH21 ' B' ' 12' ' ' ARG . 37.1 mttt -60.85 -47.2 87.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.702 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.635 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -67.31 -38.43 84.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.366 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.678 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 2.6 mmp_? -67.39 -52.31 41.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.499 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -57.48 -42.53 81.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 6.9 m-20 -71.71 -32.42 67.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -71.33 -53.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.951 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.1 -33.54 76.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.951 ' N ' HD13 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -52.1 -44.33 64.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.943 178.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 18.7 p -73.86 -31.9 63.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.331 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -68.46 -58.21 4.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.26 -42.41 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.82 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -60.03 -50.65 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.529 0.68 . . . . 0.0 110.031 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.875 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 2.9 ttm180 -67.9 -37.74 82.12 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.958 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.213 ' O ' ' N ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -86.75 -42.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.363 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.787 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 25.2 t80 -39.17 -49.11 4.44 Favored Pre-proline 0 CA--C 1.509 -0.624 0 CA-C-N 119.982 1.265 . . . . 0.0 108.689 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.875 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.3 Cg_endo -54.45 -46.85 30.35 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.389 2.06 . . . . 0.0 106.747 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 34.8 t80 -93.53 -14.51 26.52 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.534 -2.121 . . . . 0.0 112.37 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.213 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -163.49 95.98 1.05 Allowed Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' B' ' 29' ' ' PHE . 52.3 Cg_exo -54.63 -45.09 43.57 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.197 2.598 . . . . 0.0 114.684 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.77 -53.65 53.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.745 ' CD2' HH21 ' B' ' 38' ' ' ARG . 32.4 mt -51.78 -58.39 6.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.7 -30.92 34.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.398 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.653 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.02 -41.75 70.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.612 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.745 HH21 ' CD2' ' B' ' 35' ' ' LEU . 2.4 ttm-85 -63.26 -46.98 84.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.897 ' CB ' HD23 ' B' ' 21' ' ' LEU . 2.2 m-85 -67.91 -40.06 83.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.942 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.4 t -46.63 -40.96 4.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.901 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.57 -38.73 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.821 HD11 ' OE1' ' A' ' 73' ' ' GLU . 17.9 mt -66.91 -45.43 77.96 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.718 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' B' ' 21' ' ' LEU . . . -58.0 -30.54 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.364 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.823 HD11 ' OH ' ' B' ' 62' ' ' TYR . 60.6 mt -69.02 -54.77 13.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.071 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' A' ' 118' ' ' GLU . 3.1 pp -57.4 -30.85 65.27 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.958 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 58.0 t -62.05 -47.13 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.525 0.679 . . . . 0.0 109.479 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -67.66 -56.12 10.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.384 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 5.7 pt20 -80.21 -46.74 15.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.21 -38.31 69.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.593 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -86.03 -9.63 56.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 63.02 74.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.307 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.35 154.84 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.221 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -113.63 117.09 30.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.776 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.465 HD12 HD12 ' B' ' 18' ' ' ILE . 0.4 OUTLIER -135.61 142.99 43.08 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.962 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PRO . . . . . 0.408 ' O ' ' CB ' ' B' ' 56' ' ' ARG . 19.7 Cg_endo -59.47 -32.26 96.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.123 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.462 ' H ' HG23 ' B' ' 54' ' ' ILE . 48.8 ttm-85 78.37 81.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' B' ' 59' ' ' LYS . 0.5 OUTLIER -79.7 -22.94 42.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.82 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.496 ' C ' ' H ' ' B' ' 60' ' ' ARG . 5.0 m0 -58.51 -0.15 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' B' ' 57' ' ' LYS . 25.6 pttt -61.37 -6.84 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' B' ' 58' ' ' TRP . 11.8 ptp180 -93.08 -21.9 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.973 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.851 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -145.76 29.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.373 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.823 ' OH ' HD11 ' B' ' 44' ' ' LEU . 24.2 t80 -122.4 151.6 41.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.567 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 1.5 t -123.04 114.3 20.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.524 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -83.83 9.13 12.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 109.567 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.504 ' HB2' ' SG ' ' B' ' 95' ' ' CYS . 9.1 mmmt -99.34 -40.4 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.01 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.4 p -136.79 9.29 3.07 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.271 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.547 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.4 m80 54.84 122.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 172.22 -171.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.163 0.506 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.653 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 1.8 t80 -123.6 105.4 9.7 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.937 HD22 ' N ' ' B' ' 70' ' ' LEU . 0.2 OUTLIER -111.42 124.97 53.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.507 -177.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.55 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 66.5 t -106.23 127.21 28.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' PRO . . . . . 0.495 ' HB3' HG22 ' B' ' 78' ' ' VAL . 50.2 Cg_exo -47.9 125.98 12.28 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.174 1.916 . . . . 0.0 112.372 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.24 -35.93 4.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.5 -76.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.22 19.29 13.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -150.31 166.78 28.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.047 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -147.43 134.73 20.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.886 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.608 HG23 ' O ' ' B' ' 78' ' ' VAL . 34.5 m -133.15 111.89 17.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.093 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -142.66 149.74 39.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.468 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.832 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.3 OUTLIER -123.09 142.46 50.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.653 0.739 . . . . 0.0 112.187 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -88.3 136.27 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.56 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.28 98.93 10.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.6 ' O ' ' O ' ' B' ' 84' ' ' ARG . 4.3 tptp -166.89 98.72 0.55 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.599 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.6 ' O ' ' O ' ' B' ' 83' ' ' LYS . 52.1 mtt-85 41.15 105.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 110.328 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.541 ' O ' ' CE1' ' B' ' 87' ' ' HIS . 5.7 mtt 58.15 61.86 5.25 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -37.68 159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.321 2.68 . . . . 0.0 112.607 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' B' ' 85' ' ' MET . 1.2 m80 -142.03 131.6 23.94 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.4 OUTLIER -84.05 148.07 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.816 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.584 HG13 ' O ' ' B' ' 99' ' ' MET . 23.4 t -120.35 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.105 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' B' ' 99' ' ' MET . 1.6 p -118.9 131.34 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -144.33 148.73 35.13 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.054 -1.059 . . . . 0.0 113.462 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.572 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.3 OUTLIER -85.33 129.0 34.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.499 179.428 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 37.4 mt -93.18 0.35 57.12 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -92.16 -51.68 5.06 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.848 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 6.2 p -121.18 78.48 1.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.48 94.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.41 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -127.94 132.88 49.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.69 -1.255 . . . . 0.0 109.77 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.85 122.89 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.712 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.584 ' O ' HG13 ' B' ' 89' ' ' VAL . 18.7 mtt -121.8 148.46 44.64 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.092 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -109.05 148.2 31.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.672 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' B' ' 88' ' ' ILE . 0.3 OUTLIER -145.11 95.98 5.04 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.453 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.06 168.51 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.214 1.943 . . . . 0.0 112.316 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -140.89 86.15 2.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.042 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 mt -109.64 129.55 64.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.78 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.319 179.698 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.84 0.44 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 22' ' ' GLU . 96.4 p -62.66 -24.99 67.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.751 0.31 . . . . 0.0 110.682 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.674 ' HB3' HG11 ' A' ' 86' ' ' VAL . 8.1 m-85 -40.19 -58.85 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -49.57 -15.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.749 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' SER . 49.0 tp10 -104.49 -33.13 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.6 mm -100.83 18.7 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.0 tp -79.66 117.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.421 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.66 -38.1 3.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.537 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.7 32.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.738 0.769 . . . . 0.0 111.32 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.648 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -44.82 -11.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.642 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.9 t-105 -59.74 -59.85 4.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.858 HD12 HG12 ' B' ' 28' ' ' VAL . 17.8 pt -60.93 -10.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.216 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CD2' HD11 ' B' ' 24' ' ' LEU . 39.3 m-85 -94.19 -19.26 20.92 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 33' ' ' ALA . 6.5 mmm-85 -80.7 -69.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.528 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.33 44.16 1.11 Allowed Glycine 0 CA--C 1.518 0.276 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -158.09 -38.87 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' H ' ' A' ' 49' ' ' ILE . 44.7 t-80 -109.49 100.05 9.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.776 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -154.03 13.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.788 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.51 163.55 0.04 OUTLIER Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.636 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 7.8 ttt180 -67.84 112.34 4.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.369 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.813 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 54.5 t -90.19 136.37 24.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -165.6 145.95 6.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.048 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 59.9 tttm -47.14 -54.4 10.66 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.421 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 47.1 pttt -62.82 -4.46 2.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.645 ' N ' ' O ' ' A' ' 39' ' ' ASN . 73.3 m-20 -121.68 -4.61 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.439 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.87 -40.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.745 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.899 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -87.38 10.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.993 1.378 . . . . 0.0 107.394 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.899 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.98 -38.4 2.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.975 -1.92 . . . . 0.0 107.636 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HD1' ' CG2' ' B' ' 13' ' ' ILE . 0.0 OUTLIER -58.4 174.48 0.3 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.755 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' OE2' ' CZ ' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -100.76 109.05 21.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 176.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.873 ' O ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -76.54 117.05 17.79 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 117.585 -1.646 . . . . 0.0 108.055 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -162.56 40.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.93 -29.17 0.59 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.504 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -45.54 137.62 4.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.492 ' H ' HD23 ' A' ' 51' ' ' LEU . 4.4 ttpt -77.79 128.9 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.785 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HG21 ' A' ' 80' ' ' ILE . 5.2 p -148.4 169.37 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.39 0.614 . . . . 0.0 111.211 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.733 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -139.26 146.98 41.08 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.994 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 89' ' ' VAL . 66.2 t -98.15 98.88 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -91.17 -51.57 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.996 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -126.06 118.32 25.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 64' ' ' VAL . 4.0 p -148.72 159.97 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.454 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.64 80.43 7.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -167.62 116.27 0.66 Allowed Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.77 -4.85 14.11 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.817 1.678 . . . . 0.0 113.961 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.43 32.88 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.686 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -141.26 -21.32 0.77 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.032 0.916 . . . . 0.0 111.645 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG12 ' OG ' ' A' ' 58' ' ' SER . 3.5 m -72.38 138.41 21.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.262 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 99.14 5.8 56.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.053 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.674 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.23 157.81 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.356 1.078 . . . . 0.0 112.047 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 tm-20 -123.9 126.83 47.07 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.694 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.28 174.19 27.15 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.862 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ALA . 6.4 m-85 -95.09 120.34 35.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -48.77 151.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 111.55 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 81' ' ' ALA . 48.4 mt -142.64 -58.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.8 t0 -107.91 143.65 36.24 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 3.3 mp0 -146.38 106.92 4.07 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.955 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.599 HG22 ' NH1' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -138.41 -175.01 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 9.4 ttp180 -50.76 -31.85 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.124 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 75' ' ' ARG . 94.0 m-20 -138.11 31.66 2.41 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.517 ' HG3' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -155.12 158.97 39.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.784 -1.167 . . . . 0.0 113.713 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -156.6 110.01 2.65 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 71' ' ' ILE . 73.3 t -111.49 145.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.222 0.534 . . . . 0.0 112.319 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -133.82 140.25 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.261 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.025 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -113.37 135.57 53.72 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.95 0.405 . . . . 0.0 111.48 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -145.77 159.2 27.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 82' ' ' GLY . 5.1 pt-20 32.72 -109.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 110.847 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -127.28 33.72 4.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.88 0.372 . . . . 0.0 110.46 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 23.9 tttp -143.1 160.49 40.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.398 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 20' ' ' TYR . 4.2 m -114.07 155.4 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.721 0.772 . . . . 0.0 110.903 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.822 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.2 m-90 -97.71 135.29 39.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -125.97 96.04 4.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.41 101.61 3.78 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.429 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.512 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.6 Cg_exo -55.66 145.19 72.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.696 1.597 . . . . 0.0 111.064 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.898 ' HZ2' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -53.28 -37.71 62.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.078 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.04 -6.38 56.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 93' ' ' VAL . 3.3 t -125.22 29.81 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.41 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 31.6 p -168.02 165.32 13.6 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 118.931 -1.108 . . . . 0.0 113.926 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -114.46 133.97 58.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.157 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.743 ' CE2' HD23 ' A' ' 78' ' ' LEU . 50.0 m-85 -117.06 130.79 56.89 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 53' ' ' VAL . 6.4 tt0 -116.96 94.84 4.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.72 ' CE2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -89.81 146.48 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 105' ' ' LYS . 45.9 tt0 -88.49 127.77 35.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.85 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.621 HG23 HD11 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -63.91 142.36 58.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.219 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.813 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.66 -0.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.668 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 101' ' ' TRP . 1.1 m-20 -107.19 16.51 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.95 23.72 73.9 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.63 149.7 26.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.646 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 99' ' ' GLU . 58.9 mmtt -92.15 131.86 37.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.731 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' THR . 27.5 mt -107.17 135.25 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.912 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -118.04 101.31 8.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -139.13 139.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.212 -177.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 17.4 p -78.49 149.0 33.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.089 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -71.43 -1.87 46.13 Favored Glycine 0 CA--C 1.508 -0.368 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -86.9 -22.44 25.69 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.597 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -63.03 -47.69 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.221 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.601 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -95.2 28.43 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.6 p -52.17 104.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.898 ' H ' ' HZ2' ' A' ' 91' ' ' LYS . . . 68.14 -41.48 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.376 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 24.5 mmt180 -101.86 88.03 1.16 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.53 -25.49 34.97 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 N-CA-C 108.106 -1.536 . . . . 0.0 108.106 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.796 ' HB3' HD22 ' B' ' 45' ' ' LEU . 12.8 pt-20 -66.21 -55.24 17.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.163 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 23.9 mmm -34.2 -41.74 0.12 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.128 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.697 ' HE ' ' CA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.93 -43.91 42.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.887 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.871 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -61.78 -41.09 97.27 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.146 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HZ1' ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -85.21 -25.16 27.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.831 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 122' ' ' LYS . 21.2 ttpp 35.5 82.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.036 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -139.31 124.82 19.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.119 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -40.9 156.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.161 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 126' ' ' ARG . 4.7 mtt180 -37.78 89.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 125' ' ' TRP . 35.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.48 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.839 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 7.4 pt-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -79.77 -45.89 18.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' B' ' 14' ' ' ALA . 20.2 ttpt -72.44 -33.48 67.09 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.726 1.251 . . . . 0.0 108.617 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 1.041 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER -62.6 -51.86 65.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.658 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.721 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 33.5 mt -64.94 -27.51 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -65.27 -48.5 73.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.244 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -52.18 -48.71 64.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.937 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -70.12 -38.03 75.47 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.965 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.633 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -65.82 -52.03 53.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.366 0.603 . . . . 0.0 110.451 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.55 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.85 -42.76 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.19 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 1.5 m-20 -71.82 -22.18 61.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.937 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -75.49 -56.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.998 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.98 -34.43 77.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.998 ' H ' HD13 ' B' ' 21' ' ' LEU . 2.8 t80 -53.12 -44.06 67.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.921 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -64.66 -40.16 94.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.922 ' O ' HG13 ' B' ' 28' ' ' VAL . 1.9 mm? -56.9 -57.55 12.03 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.776 0.798 . . . . 0.0 109.297 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.04 -33.35 17.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.392 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.811 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 57.5 mt-10 -77.12 -55.82 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.914 0.864 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.852 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 79.9 mtt-85 -67.95 -35.88 79.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.474 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.182 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -85.48 -50.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.673 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.754 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 27.8 t80 -36.3 -49.34 1.73 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.173 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.852 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 36.5 Cg_endo -53.26 -47.86 25.17 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 N-CA-C 106.506 -2.151 . . . . 0.0 106.506 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 62.2 t80 -94.5 -15.17 24.41 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.289 -2.232 . . . . 0.0 113.08 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.182 ' N ' ' O ' ' B' ' 28' ' ' VAL . 43.0 p -158.04 91.19 2.21 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.84 -41.9 73.91 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.977 2.451 . . . . 0.0 113.88 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 55.8 mp0 -66.67 -54.25 25.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 25.9 mt -52.09 -55.38 21.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.985 0.422 . . . . 0.0 110.155 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.35 -30.24 50.96 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.331 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.704 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.48 -47.11 57.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.884 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.701 ' C ' ' CD ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -60.54 -53.3 59.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.799 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.956 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.2 m-85 -59.69 -42.57 93.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' B' ' 39' ' ' TYR . 1.1 t -45.05 -34.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.568 ' CD ' HH21 ' B' ' 38' ' ' ARG . 0.0 OUTLIER -70.65 -44.86 66.25 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' TYR . 49.4 mt -65.45 -47.89 74.59 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.961 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.72 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -57.17 -31.16 65.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.535 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.73 -50.94 69.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.383 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -61.95 -39.29 91.62 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.015 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.736 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 40.2 t -61.22 -49.23 85.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 111.49 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -49.6 72.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.714 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.84 -55.96 4.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.986 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.62 ' N ' ' O ' ' B' ' 45' ' ' LEU . 6.6 mmpt? -59.0 -43.29 91.46 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -79.07 -16.21 57.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 26.1 mttt 70.75 43.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.748 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.74 124.77 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -108.87 108.06 18.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.15 0.5 . . . . 0.0 110.664 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' B' ' 55' ' ' PRO . 5.7 tt -137.4 128.56 16.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.442 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PRO . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' ILE . 67.9 Cg_exo -33.84 116.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.201 1.934 . . . . 0.0 111.976 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.429 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 1.5 mpp_? -92.16 83.08 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.698 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.609 ' C ' ' H ' ' B' ' 59' ' ' LYS . 55.0 pttt -86.47 -11.76 50.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' NH1' ' B' ' 60' ' ' ARG . 5.4 m-90 -51.2 4.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.225 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' B' ' 57' ' ' LYS . 3.1 mptp? -66.75 -3.79 7.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' B' ' 58' ' ' TRP . 18.6 ptt-85 -82.28 -35.34 28.14 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.302 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -124.94 21.6 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.515 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -118.43 154.6 32.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 1.7 t -126.39 113.62 17.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.656 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -78.85 4.35 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.976 0.417 . . . . 0.0 109.986 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.558 ' HG3' ' CG ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -95.86 -38.23 10.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.538 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.0 p -138.72 -0.2 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.734 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.5 m80 61.52 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . 169.81 -171.41 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.065 0.46 . . . . 0.0 111.123 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.574 ' O ' ' CE2' ' B' ' 29' ' ' PHE . 13.2 t80 -121.19 103.02 8.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.842 HD22 ' N ' ' B' ' 70' ' ' LEU . 0.4 OUTLIER -113.58 119.26 36.89 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.411 0.624 . . . . 0.0 112.441 -177.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.602 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 61.1 t -96.16 136.13 22.24 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.046 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.92 118.55 5.59 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.719 1.613 . . . . 0.0 111.531 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.64 -33.42 4.64 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.57 -78.09 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' B' ' 93' ' ' LEU . 19.3 m-20 -116.77 19.76 14.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -145.3 158.8 43.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.929 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -148.46 130.12 15.02 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.441 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.676 HG23 ' O ' ' B' ' 78' ' ' VAL . 35.1 m -131.23 103.86 8.14 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.306 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.814 ' O ' HG22 ' B' ' 89' ' ' VAL . 66.7 mtt85 -132.45 140.47 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.133 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.869 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.2 OUTLIER -126.28 143.93 50.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.797 0.808 . . . . 0.0 111.939 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 86' ' ' PRO . 0.2 OUTLIER -109.13 164.91 12.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 74.67 172.19 0.28 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.116 0.885 . . . . 0.0 111.477 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.654 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 97.2 mttt -150.16 116.46 5.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.593 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.654 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 73.4 ttt180 119.07 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.556 ' N ' ' HD3' ' B' ' 86' ' ' PRO . 9.7 ttt -157.38 54.14 0.78 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.451 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' B' ' 85' ' ' MET . 62.6 Cg_endo -83.87 179.85 4.52 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.358 2.705 . . . . 0.0 113.88 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' HIS . . . . . 0.442 ' CG ' ' C ' ' B' ' 86' ' ' PRO . 1.1 m80 -150.32 130.88 13.92 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.647 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' B' ' 101' ' ' TYR . 0.9 OUTLIER -88.96 150.49 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.28 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.814 HG22 ' O ' ' B' ' 79' ' ' ARG . 3.6 m -114.35 120.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.18 131.81 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' B' ' 97' ' ' HIS . 40.3 tttt -146.37 148.56 32.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.957 -1.097 . . . . 0.0 113.008 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.634 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.5 OUTLIER -88.45 127.31 35.51 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.88 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' B' ' 75' ' ' ASN . 84.0 mt -88.5 -2.63 58.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.79 -55.56 3.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.854 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 5.1 p -115.79 76.72 1.03 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.5 94.16 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.977 -175.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' B' ' 97' ' ' HIS . 0.2 OUTLIER -119.69 128.72 54.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.833 -1.184 . . . . 0.0 109.043 177.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 37.9 mt -99.28 119.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.929 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.434 ' HB2' ' HE2' ' B' ' 97' ' ' HIS . 3.6 mmt -128.71 164.36 23.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 100' ' ' ARG . 0.4 OUTLIER -120.95 155.82 33.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.553 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' B' ' 88' ' ' ILE . 0.8 OUTLIER -146.41 91.47 5.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.817 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.31 166.13 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.297 1.998 . . . . 0.0 111.743 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -99.7 84.03 2.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.767 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.19 116.94 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.491 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 tttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.559 -179.805 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.58 97.24 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 22' ' ' GLU . 79.0 p -59.99 -49.59 77.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' HG11 ' A' ' 79' ' ' VAL . 89.2 m-85 -37.45 -45.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.131 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -58.28 -21.58 49.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 19' ' ' SER . 4.5 tt0 -104.79 -38.0 6.83 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.458 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.818 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.61 24.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.462 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.651 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -80.01 118.98 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.712 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.687 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 83.68 -7.0 71.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.656 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.708 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -64.09 21.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.516 0.658 . . . . 0.0 109.887 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.687 ' H ' ' C ' ' A' ' 25' ' ' GLY . 7.0 p -38.13 -16.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.387 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.708 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.0 t-105 -58.67 -57.0 14.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.763 ' CD1' HG12 ' B' ' 28' ' ' VAL . 6.1 pt -65.68 -11.27 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.609 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' B' ' 24' ' ' LEU . 88.7 m-85 -96.32 -37.37 10.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.8 mmt180 -61.0 -68.43 0.31 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.144 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.81 52.02 1.59 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -150.43 -40.19 0.13 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.793 ' CE1' ' H ' ' A' ' 51' ' ' LEU . 1.9 m-70 -91.1 100.15 13.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.218 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -125.71 -20.54 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.984 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -40.67 146.6 0.34 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.9 ttm180 -67.11 118.96 11.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.808 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.1 t -92.8 136.69 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 1.5 t-20 -164.98 150.74 9.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.124 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 42' ' ' ASN . 43.8 tttm -50.04 -55.68 13.8 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.217 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.61 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 52.2 pttt -58.85 -4.09 0.41 Allowed 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 5.6 m120 -126.06 0.48 7.21 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.27 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.801 HD11 ' CG ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.41 -38.14 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.261 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.809 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.7 0.75 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.814 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.81 6.9 14.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.829 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -115.41 139.13 50.29 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.775 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.804 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -59.95 111.77 1.61 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.924 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -74.09 116.34 14.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 177.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 48' ' ' LEU . 3.7 mm -153.64 -29.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.289 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.663 ' H ' ' CE1' ' A' ' 34' ' ' HIS . . . -138.22 -25.38 0.35 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.922 HD23 ' H ' ' A' ' 52' ' ' LYS . 1.5 tt -44.2 150.03 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.922 ' H ' HD23 ' A' ' 51' ' ' LEU . 82.8 tttt -93.62 131.41 38.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.057 0.456 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.952 HG23 ' C ' ' A' ' 97' ' ' GLU . 7.9 p -148.77 166.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.0 t -94.61 98.87 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.18 -48.09 17.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.451 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -132.94 120.77 21.88 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.956 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.561 ' OG ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -147.25 172.71 13.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.093 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.623 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 4.4 t -104.14 77.08 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.062 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -169.28 96.87 0.51 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.72 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 -4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.324 2.016 . . . . 0.0 113.237 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -122.74 19.28 7.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.507 -0.854 . . . . 0.0 114.474 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' ' N ' ' A' ' 88' ' ' LYS . 54.8 m-85 -142.34 -23.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.181 1.491 . . . . 0.0 112.28 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.561 HG12 ' OG ' ' A' ' 58' ' ' SER . 1.5 m -74.04 144.36 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 85.86 5.61 83.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.51 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.605 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.2 mt -107.53 153.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.924 0.862 . . . . 0.0 111.59 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' C ' ' CZ2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.58 126.46 53.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.472 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.3 173.78 27.31 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.93 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -96.73 117.69 31.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.634 0.374 . . . . 0.0 110.098 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -50.15 148.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.693 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.709 ' N ' ' O ' ' A' ' 79' ' ' VAL . 95.0 mt -143.87 -60.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -108.01 134.79 50.41 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.606 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -144.69 107.14 4.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.869 HG22 ' NH2' ' B' ' 38' ' ' ARG . 2.6 p -132.96 -169.6 2.29 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -52.76 -27.44 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -138.71 31.59 2.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.887 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 2.0 ptp -153.75 160.82 42.41 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.934 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.002 HD23 ' CE2' ' A' ' 96' ' ' PHE . 7.3 tp -163.86 110.15 1.09 Allowed 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.889 ' C ' HD13 ' A' ' 80' ' ' ILE . 74.5 t -117.25 129.75 73.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.018 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -111.55 152.36 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.027 178.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -129.02 136.89 50.91 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.351 0.596 . . . . 0.0 112.417 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -152.32 158.74 28.0 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' GLY . 14.0 pt-20 33.89 -128.52 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.749 0.275 . . . . 0.0 110.622 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -110.17 33.68 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 110.526 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 3.1 tppt? -138.09 151.9 48.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 31.1 m -118.31 156.17 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.351 0.596 . . . . 0.0 110.709 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.621 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 2.0 m-90 -97.96 140.52 32.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.732 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' N ' ' CE1' ' A' ' 63' ' ' TYR . 72.3 tttt -127.92 92.76 3.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.46 107.05 3.12 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.757 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.64 164.27 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.74 1.626 . . . . 0.0 111.31 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HD3' HD22 ' A' ' 78' ' ' LEU . 10.1 mttt -67.84 -27.17 66.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -90.55 -5.29 56.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 9.86 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.966 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -161.23 173.99 14.25 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.916 -1.114 . . . . 0.0 113.077 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.2 mt -111.97 130.73 65.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.71 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.002 ' CE2' HD23 ' A' ' 78' ' ' LEU . 97.1 m-85 -108.96 126.1 52.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.952 ' C ' HG23 ' A' ' 53' ' ' VAL . 26.8 tt0 -107.97 93.97 4.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.924 ' CZ ' HD22 ' A' ' 48' ' ' LEU . 37.1 m-85 -80.0 143.66 33.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.85 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.649 ' O ' HD21 ' A' ' 51' ' ' LEU . 75.6 tt0 -93.47 129.61 39.59 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.687 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -72.68 143.32 48.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.123 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.808 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.35 -0.93 0.28 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.621 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.511 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 27.5 t70 -107.14 20.18 19.36 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.33 22.62 78.56 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.578 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.29 149.76 26.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.475 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -93.48 131.0 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.153 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 10.4 mt -103.81 133.83 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -114.56 100.83 8.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.09 132.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.059 -178.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 111' ' ' GLU . 13.8 p -79.57 144.95 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.213 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.35 4.01 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' O ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -80.42 -22.59 41.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.4 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -69.89 -47.3 63.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -95.88 28.67 3.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.2 p -45.77 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.617 0.723 . . . . 0.0 112.876 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' LYS . . . 66.83 -42.29 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.674 175.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HB3' ' H ' ' A' ' 119' ' ' MET . 71.1 mtm180 -101.89 99.17 11.38 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.469 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.7 Cg_endo -70.12 -26.54 25.75 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 N-CA-C 107.294 -1.849 . . . . 0.0 107.294 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.1 pt-20 -65.45 -45.87 82.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.516 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.9 tpt -39.74 -33.71 0.21 Allowed 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -78.75 -56.74 4.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.652 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.736 HD12 HG13 ' B' ' 46' ' ' VAL . 0.1 OUTLIER -58.56 -42.32 87.67 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 118.313 -1.355 . . . . 0.0 107.836 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -84.91 1.02 49.11 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.501 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' CA ' ' O ' ' A' ' 119' ' ' MET . 10.3 mtpm? 46.48 -175.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -66.3 127.03 30.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 126' ' ' ARG . 26.3 t-105 -137.34 -140.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.915 0.388 . . . . 0.0 110.763 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.434 ' N ' ' CG ' ' A' ' 125' ' ' TRP . 11.8 mtp180 -92.68 -107.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.759 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.542 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.636 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -78.72 -31.45 46.4 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.241 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.733 ' H ' HH11 ' B' ' 12' ' ' ARG . 8.7 ttpt -73.86 -34.18 64.38 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.809 1.29 . . . . 0.0 108.122 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.924 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 4.7 mpt_? -60.96 -51.33 69.72 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.777 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -72.97 -29.06 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.543 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.409 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -70.56 -51.77 26.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.49 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' B' ' 16' ' ' GLU . 0.6 OUTLIER -55.28 -46.81 76.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.519 ' N ' ' HD3' ' B' ' 15' ' ' LYS . 9.3 pt-20 -72.08 -38.08 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.603 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 39.3 ttt180 -62.63 -54.19 43.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.703 0.763 . . . . 0.0 110.387 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -56.73 -34.28 42.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.519 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.42 -33.28 72.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.707 HD11 ' HA3' ' A' ' 36' ' ' GLY . 94.7 mt -69.61 -58.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.019 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.05 -35.4 76.81 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.019 ' N ' HD13 ' B' ' 21' ' ' LEU . 4.1 t80 -53.79 -38.94 65.03 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.05 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.7 m -66.9 -40.27 87.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.431 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.836 HD12 HG11 ' B' ' 28' ' ' VAL . 2.3 mm? -61.23 -58.79 6.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.524 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.404 ' HA ' ' CB ' ' B' ' 36' ' ' ALA . . . -49.46 -36.48 22.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.527 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.805 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -71.73 -60.26 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.407 0.623 . . . . 0.0 109.875 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.843 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 6.8 ttm-85 -64.43 -37.4 87.39 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.992 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.144 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.3 m -84.12 -50.86 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.275 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.719 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 29.7 t80 -36.37 -49.9 1.79 Allowed Pre-proline 0 CA--C 1.51 -0.572 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.359 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.843 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 35.7 Cg_endo -51.93 -46.13 34.23 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.816 ' N ' ' O ' ' B' ' 28' ' ' VAL . 10.2 t80 -92.87 -32.21 14.69 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.101 -2.318 . . . . 0.0 112.678 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.144 ' N ' ' O ' ' B' ' 28' ' ' VAL . 61.7 p -144.2 96.91 5.29 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.682 ' C ' ' HZ3' ' B' ' 37' ' ' LYS . 32.1 Cg_exo -55.88 -42.13 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.791 2.327 . . . . 0.0 114.019 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.96 -53.77 28.44 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.527 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 10.6 mt -51.05 -53.21 35.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.262 0.554 . . . . 0.0 110.281 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.74 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -55.59 -34.14 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.11 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.682 ' HZ3' ' C ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.45 -41.78 69.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.869 ' NH2' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -58.79 -53.96 52.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.306 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.932 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.3 m-85 -60.68 -39.04 86.98 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.94 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.769 ' O ' HD23 ' B' ' 44' ' ' LEU . 3.7 t -45.87 -34.96 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 50.7 tt0 -72.21 -43.92 63.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.6 mt -63.78 -46.63 84.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.88 -34.03 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.796 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 40' ' ' VAL . 1.6 mm? -64.43 -45.02 89.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.592 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -63.91 -34.56 78.23 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.521 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.736 HG13 HD12 ' A' ' 121' ' ' LEU . 51.0 t -70.88 -56.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.16 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.447 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 17.0 pt20 -71.86 -51.06 24.21 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.332 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 121' ' ' LEU . 5.0 tmtt? -82.27 -35.64 27.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.375 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -65.4 -12.41 51.94 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.21 30.48 15.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 t -96.56 92.54 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.046 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -84.18 117.95 23.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.588 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.87 151.1 75.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.011 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.2 127.48 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.116 1.878 . . . . 0.0 111.574 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' B' ' 58' ' ' TRP . 89.3 mtt-85 -87.89 45.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -45.57 -25.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.677 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 17.4 m0 -55.65 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.398 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' B' ' 57' ' ' LYS . 37.3 mtpt -62.63 -7.86 5.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' B' ' 58' ' ' TRP . 18.1 ptt180 -87.85 -21.66 24.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.442 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.824 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -146.88 20.23 1.27 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.094 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' B' ' 58' ' ' TRP . 50.1 t80 -114.78 154.42 28.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.7 OUTLIER -126.41 116.97 21.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.135 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -87.02 16.28 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.498 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.0 OUTLIER -116.59 -22.06 8.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.741 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.669 ' O ' ' O ' ' B' ' 67' ' ' HIS . 0.8 OUTLIER -153.73 21.59 0.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.869 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.669 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.2 OUTLIER 34.37 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 111.877 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.481 ' HB3' HD11 ' B' ' 70' ' ' LEU . . . -177.45 -176.99 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' NH1' ' B' ' 61' ' ' ARG . 0.5 OUTLIER -115.37 104.61 11.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.272 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.824 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -106.62 129.46 54.53 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.75 -177.042 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 48.7 t -113.38 124.16 31.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.053 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' PRO . . . . . 0.584 ' HB3' HG22 ' B' ' 78' ' ' VAL . 50.5 Cg_exo -46.89 126.1 10.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.886 1.724 . . . . 0.0 112.119 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.98 -36.54 3.97 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.5 -77.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.66 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.23 19.65 16.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -155.65 171.53 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.266 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -147.08 132.61 18.71 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.027 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.584 HG22 ' HB3' ' B' ' 72' ' ' PRO . 15.5 m -138.89 120.75 16.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.643 ' O ' HG12 ' B' ' 89' ' ' VAL . 0.7 OUTLIER -153.8 147.23 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.896 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -126.07 141.61 51.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.536 0.684 . . . . 0.0 111.927 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ARG . . . . . 0.764 ' HE ' ' N ' ' B' ' 81' ' ' ARG . 0.0 OUTLIER -94.58 136.25 35.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.536 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -100.26 -7.23 24.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -42.52 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.935 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -81.04 -78.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.729 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.75 126.28 23.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.228 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.97 101.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.435 2.09 . . . . 0.0 112.709 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' B' ' 80' ' ' LEU . 25.6 m-70 -129.41 129.58 44.88 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.749 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.7 151.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.267 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.643 HG12 ' O ' ' B' ' 79' ' ' ARG . 1.4 p -126.71 126.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.979 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.71 132.81 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -148.51 147.08 28.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.049 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.499 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.1 OUTLIER -86.52 128.51 34.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.962 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -89.79 0.43 57.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -91.49 -52.87 4.57 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.797 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 14.1 p -120.86 79.05 1.45 Allowed 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 112.9 -1.954 . . . . 0.0 105.877 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.33 93.71 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.117 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.597 ' CD2' ' C ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -124.1 134.53 53.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.843 -1.178 . . . . 0.0 109.569 179.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.04 121.94 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.993 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 2.9 mmt -129.14 160.69 32.05 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.935 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.82 154.5 42.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.129 0.49 . . . . 0.0 111.247 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -152.04 91.1 3.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.632 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.13 164.79 9.81 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.41 2.073 . . . . 0.0 112.771 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -142.87 97.11 3.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.497 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ILE . . . . . 0.425 ' N ' HD13 ' B' ' 104' ' ' ILE . 0.0 OUTLIER -131.01 145.08 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.45 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tptm . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.429 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 18' ' ' GLY . 31.7 tt0 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 17' ' ' GLN . . . -19.96 107.06 0.01 OUTLIER Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.896 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 22' ' ' GLU . 93.1 p -60.36 -29.42 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.718 ' HB3' HG11 ' A' ' 86' ' ' VAL . 83.1 m-85 -35.49 -63.41 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.094 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -16.37 39.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.194 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 19' ' ' SER . 41.8 tp10 -92.06 -30.4 16.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.2 mm -106.7 13.55 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -79.34 126.87 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.853 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.783 ' N ' HD13 ' A' ' 24' ' ' ILE . . . 106.78 -35.17 5.21 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.38 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -64.15 27.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.975 0.388 . . . . 0.0 110.736 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.642 ' H ' ' C ' ' A' ' 25' ' ' GLY . 13.9 p -43.75 -14.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.884 0.849 . . . . 0.0 108.745 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.741 ' HE1' HH12 ' B' ' 27' ' ' ARG . 38.1 t-105 -57.85 -52.52 65.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.294 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.861 ' CD1' HG12 ' B' ' 28' ' ' VAL . 12.7 pt -71.88 -11.8 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.587 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' B' ' 24' ' ' LEU . 58.5 m-85 -89.87 -23.46 21.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.4 tpp85 -80.88 -68.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.56 35.67 0.17 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.701 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -145.41 -39.02 0.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -95.95 105.93 18.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.92 1.33 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.45 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -47.25 156.95 0.68 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.611 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 6.1 ttm-85 -67.98 118.49 11.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 42.2 t -97.48 139.31 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.677 ' O ' ' N ' ' A' ' 43' ' ' ILE . 2.0 t-20 -166.66 154.65 9.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.435 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . 75.9 tttt -51.72 -55.94 16.69 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' CD2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -59.15 -3.79 0.43 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.698 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 55.0 m-20 -125.41 2.61 7.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.815 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.76 -39.75 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.563 0.221 . . . . 0.0 110.935 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.838 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.81 4.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 108.084 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.877 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.46 -21.92 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.04 -179.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.8 146.92 29.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.655 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -64.26 108.74 1.67 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.862 ' O ' HG12 ' A' ' 49' ' ' ILE . 8.2 mt -76.21 110.45 10.72 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.881 HD13 ' CD1' ' B' ' 39' ' ' TYR . 3.9 mt -170.78 55.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 124.032 0.832 . . . . 0.0 109.496 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 143.95 -27.82 2.02 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.935 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.2 tt -53.14 133.5 39.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' N ' HD23 ' A' ' 51' ' ' LEU . 1.7 tmtp? -69.61 124.38 23.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.097 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 97' ' ' GLU . 13.8 p -149.19 169.7 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.108 0.48 . . . . 0.0 110.654 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.688 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.65 149.62 46.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.138 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 89' ' ' VAL . 92.2 t -99.4 100.23 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.28 -36.98 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.433 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -135.1 120.19 18.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 110.476 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.83 166.35 27.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.665 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.587 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 1.7 t -103.52 75.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -169.82 105.34 0.45 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.545 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.18 -4.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 122.178 1.919 . . . . 0.0 113.909 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -129.4 31.13 3.49 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.645 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -141.31 -21.59 0.76 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.876 1.338 . . . . 0.0 111.794 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.0 144.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 84.02 6.52 86.55 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.152 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.63 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 118.447 1.124 . . . . 0.0 111.79 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 tt0 -120.1 125.88 49.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.665 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -146.44 172.88 26.89 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.527 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m-85 -99.57 121.73 41.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.6 t -48.76 148.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.903 0.383 . . . . 0.0 111.572 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 81' ' ' ALA . 79.2 mt -138.51 -60.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.962 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.779 ' CG ' ' HE ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -101.99 140.25 36.54 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.767 ' O ' ' NH1' ' B' ' 38' ' ' ARG . 70.6 tt0 -149.62 105.05 3.4 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.187 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.756 HG22 HH22 ' B' ' 38' ' ' ARG . 6.8 t -152.01 -178.92 7.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.543 0.687 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.705 ' HE ' HH22 ' A' ' 116' ' ' ARG . 32.5 ttm180 -55.07 -6.79 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.227 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 74' ' ' THR . 46.9 m-80 -138.52 0.0 2.01 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.888 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 2.4 ptp -165.44 149.99 8.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 117.952 -1.499 . . . . 0.0 114.794 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.9 tp -135.09 110.71 9.2 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.6 t -114.41 147.2 18.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 121.441 0.638 . . . . 0.0 112.553 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -131.4 142.18 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.278 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.04 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -114.83 135.29 54.35 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.864 -0.523 . . . . 0.0 111.746 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -153.4 125.66 1.81 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 69.09 -115.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -124.62 19.98 8.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.415 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 17.8 tttp -126.19 167.33 15.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.344 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 20' ' ' TYR . 5.7 m -121.55 153.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 110.596 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.4 m-90 -99.14 110.8 23.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.475 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -108.03 96.7 6.56 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.079 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 55' ' ' VAL . 2.7 m -148.87 95.7 3.88 Favored Pre-proline 0 CA--C 1.518 -0.264 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.073 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 93' ' ' VAL . 65.0 Cg_exo -43.23 161.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 120.942 1.095 . . . . 0.0 110.518 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.888 ' HZ1' ' C ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -63.53 -30.31 71.45 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -89.17 -4.95 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 90' ' ' PRO . 2.5 m -112.41 11.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.72 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -167.19 169.23 12.82 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.856 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.38 140.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.343 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.72 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 87.0 m-85 -117.61 131.67 56.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.92 ' C ' HG23 ' A' ' 53' ' ' VAL . 21.3 tt0 -115.04 95.07 5.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -90.89 145.49 24.7 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.743 ' O ' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -89.68 133.17 34.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.243 0.544 . . . . 0.0 111.604 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.605 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -70.87 144.05 50.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.849 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.879 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.1 0.12 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.221 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.574 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 74.4 m-20 -107.52 15.17 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.12 22.9 72.83 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.17 146.56 30.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.756 0.312 . . . . 0.0 110.358 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -90.74 132.82 35.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 11.3 mt -105.72 134.42 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -120.27 106.49 11.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.61 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.216 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.6 p -94.99 145.68 24.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.22 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.62 -1.65 0.36 Allowed Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.43 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 109' ' ' SER . 21.0 pt-20 -68.26 -31.5 71.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.678 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -75.13 -47.44 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.493 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 29.1 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 114' ' ' VAL . 9.9 p -63.71 106.06 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.7 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.46 -40.47 0.29 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 114.551 -1.204 . . . . 0.0 114.034 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.705 HH22 ' HE ' ' A' ' 75' ' ' ARG . 5.6 mmp_? -100.59 85.06 0.51 Allowed Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.449 ' HB2' HH22 ' B' ' 17' ' ' ARG . 26.9 Cg_endo -66.74 -26.01 45.78 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.629 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.0 pt-20 -67.99 -48.46 65.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' LYS . 37.6 tpp -36.37 -47.1 0.58 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.724 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -71.61 -47.91 51.54 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.368 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.793 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -62.29 -31.87 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 118' ' ' GLU . 3.8 mmtt -85.26 -33.8 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.869 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 25.13 99.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -57.3 138.31 54.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.217 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.15 52.6 2.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.884 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 40.86 66.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.623 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.609 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 4.3 mm-40 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.418 ' H ' ' HG2' ' B' ' 10' ' ' LYS . 2.3 mmtp -79.35 -32.05 43.14 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.911 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.719 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.6 OUTLIER -73.2 -33.96 65.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.708 1.242 . . . . 0.0 108.159 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.931 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 5.0 mpt_? -60.99 -51.38 69.5 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.392 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.769 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.3 mt -70.44 -26.72 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.124 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.19 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.584 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.443 ' O ' HG22 ' B' ' 18' ' ' ILE . 4.1 ptmm? -57.54 -48.42 79.36 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.546 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 3.1 pt-20 -68.94 -37.35 78.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.342 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.811 ' HE ' HG22 ' B' ' 46' ' ' VAL . 3.0 ttt180 -62.72 -52.07 64.71 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.542 0.686 . . . . 0.0 110.673 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.73 -35.55 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.098 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.41 -27.04 63.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.42 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 36' ' ' GLY . 8.6 mt -69.15 -58.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.039 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.08 -33.34 75.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.894 0.854 . . . . 0.0 108.832 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.039 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -52.92 -46.51 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.073 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 11.6 p -64.8 -42.04 95.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.967 HD12 HG11 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -56.1 -58.42 7.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.493 0.664 . . . . 0.0 110.096 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -35.56 26.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.449 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.788 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.9 OUTLIER -71.58 -57.12 4.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.388 0.614 . . . . 0.0 110.774 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.888 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 5.2 ttt-85 -70.22 -32.5 70.4 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.73 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.184 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.2 m -83.78 -50.44 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.733 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 33.8 t80 -36.23 -49.73 1.71 Allowed Pre-proline 0 CA--C 1.509 -0.625 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.293 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.888 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 39.1 Cg_endo -54.02 -46.86 30.5 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 N-CA-C 106.532 -2.142 . . . . 0.0 106.532 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.81 ' N ' ' O ' ' B' ' 28' ' ' VAL . 48.6 t80 -94.54 -17.04 22.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.928 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.184 ' N ' ' O ' ' B' ' 28' ' ' VAL . 27.6 p -155.81 90.39 2.81 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.01 -42.98 63.93 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.883 2.389 . . . . 0.0 113.792 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -66.44 -53.9 30.23 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 9.0 mt -52.52 -56.73 13.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 120.951 0.405 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.44 -29.78 26.25 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.054 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.675 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.7 -47.84 51.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.726 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.779 ' HE ' ' CG ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -64.48 -35.55 81.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.914 ' HB3' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -71.15 -44.43 65.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.957 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.546 ' O ' HD23 ' B' ' 44' ' ' LEU . 2.1 t -45.51 -38.93 2.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.719 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.9 -42.37 81.25 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.739 HD12 HD11 ' A' ' 49' ' ' ILE . 48.3 mt -64.26 -47.75 78.4 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.601 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -55.53 -31.3 61.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.434 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -64.08 -54.39 34.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 118' ' ' GLU . 4.1 pp -61.61 -27.48 68.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.365 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.935 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 63.8 t -64.41 -47.24 90.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.32 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -66.5 -57.09 8.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.61 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 12.8 pt20 -81.96 -49.58 10.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.77 -33.48 75.97 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -92.64 5.83 49.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 mttm 54.01 75.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.502 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.89 134.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.306 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -123.71 109.52 13.8 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' PRO . 31.0 mt -135.68 137.25 25.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.638 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' B' ' 54' ' ' ILE . 52.2 Cg_exo -33.53 100.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.245 1.963 . . . . 0.0 111.467 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -86.32 77.0 9.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.664 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' B' ' 59' ' ' LYS . 50.1 pttt -72.55 -14.92 61.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.623 ' NE1' ' CE1' ' B' ' 22' ' ' PHE . 14.2 m0 -58.22 -2.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.537 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' B' ' 57' ' ' LYS . 32.4 pttt -68.18 -3.62 11.18 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.476 ' H ' ' C ' ' B' ' 58' ' ' TRP . 5.9 ptm180 -83.67 -30.74 26.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.888 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -130.45 21.78 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.938 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 81.9 t80 -118.95 155.76 30.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.334 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 3.5 t -127.17 126.08 42.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.266 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -87.91 6.54 35.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 109.908 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.495 ' HB3' ' CD2' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -107.26 -22.97 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.381 -178.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.582 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.5 p -150.84 17.11 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.335 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.582 ' O ' ' O ' ' B' ' 66' ' ' CYS . 1.9 m-70 35.21 106.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . -164.75 -175.04 3.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' B' ' 61' ' ' ARG . 9.4 t80 -118.17 102.93 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.838 HD22 ' N ' ' B' ' 70' ' ' LEU . 0.4 OUTLIER -110.77 120.72 43.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.857 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.6 t -92.78 117.42 67.56 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.061 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.24 119.38 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.307 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.73 -41.96 1.86 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.768 HG23 ' H ' ' B' ' 75' ' ' ASN . 3.8 tt -102.95 -65.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 117.219 0.51 . . . . 0.0 111.293 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.768 ' H ' HG23 ' B' ' 74' ' ' ILE . 5.8 t-20 -112.26 12.97 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.748 0.309 . . . . 0.0 110.856 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.819 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -151.85 164.4 37.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.273 0.559 . . . . 0.0 111.306 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' B' ' 93' ' ' LEU . 41.0 mtp180 -150.45 134.23 16.7 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.048 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 12.9 m -139.0 132.25 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.783 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' B' ' 79' ' ' ARG . 29.7 ttm-85 -146.7 150.61 35.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.918 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 1.2 pp -123.73 131.74 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -137.98 166.48 23.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' B' ' 84' ' ' ARG . 8.6 mt-30 -76.58 20.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.724 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' B' ' 85' ' ' MET . 31.2 mtpt -52.4 89.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' B' ' 85' ' ' MET . 20.9 ttt180 72.24 -13.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.383 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.503 ' CG ' ' O ' ' B' ' 84' ' ' ARG . 1.3 mtt 159.49 153.57 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -46.07 105.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.11 1.873 . . . . 0.0 111.325 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' HIS . . . . . 0.554 ' O ' ' ND1' ' B' ' 87' ' ' HIS . 1.4 p-80 -138.86 131.63 29.18 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.412 HG21 HD13 ' B' ' 88' ' ' ILE . 0.6 OUTLIER -91.83 130.88 40.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.0 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.61 ' O ' HG13 ' B' ' 89' ' ' VAL . 7.3 p -98.2 121.06 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 1.1 m -112.2 127.07 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -141.32 136.14 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.295 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.533 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.1 OUTLIER -80.53 132.51 35.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.688 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.466 HD11 ' HG3' ' B' ' 77' ' ' ARG . 95.5 mt -93.83 -4.84 49.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.31 -54.56 4.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.869 ' O ' ' SG ' ' B' ' 95' ' ' CYS . 5.2 p -113.22 75.45 0.92 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.54 92.75 0.01 OUTLIER Glycine 0 C--N 1.324 -0.138 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.597 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.7 OUTLIER -129.47 124.85 35.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.672 -1.264 . . . . 0.0 110.15 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ILE . . . . . 0.671 HD12 ' H ' ' B' ' 98' ' ' ILE . 2.3 mp -92.36 120.3 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.615 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.414 ' O ' HG23 ' B' ' 89' ' ' VAL . 36.7 mmm -128.17 163.83 23.81 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.893 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -126.31 141.86 51.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.634 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -138.1 91.75 12.84 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.378 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -52.5 165.64 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.386 2.057 . . . . 0.0 112.203 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -142.82 105.39 4.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.928 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.16 127.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.185 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.272 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.508 ' O ' ' C ' ' A' ' 18' ' ' GLY . 36.3 mt-30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 17' ' ' GLN . . . 24.28 93.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.781 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLU . 80.3 p -54.01 -35.06 61.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.459 . . . . 0.0 110.076 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.639 ' HB3' HG11 ' A' ' 86' ' ' VAL . 52.8 m-85 -40.45 -61.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.384 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.06 -8.79 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 19' ' ' SER . 42.5 tp10 -103.95 -40.72 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.263 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.5 mm -95.19 32.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 111.09 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -81.2 127.34 39.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.678 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 82.15 -18.1 14.93 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.81 27.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.826 1.313 . . . . 0.0 110.793 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.678 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -42.03 -15.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 33.6 t-105 -57.17 -53.81 53.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.46 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' B' ' 28' ' ' VAL . 16.8 pt -69.31 -11.86 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.609 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.791 ' CD2' HD11 ' B' ' 24' ' ' LEU . 33.7 m-85 -91.15 -26.37 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -70.07 -64.59 0.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.173 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.86 48.65 3.31 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 29' ' ' ILE . . . -162.38 -38.35 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 50' ' ' GLY . 38.9 t-80 -110.71 100.37 9.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.613 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -150.75 10.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.54 ' H ' HG12 ' B' ' 20' ' ' ILE . . . -41.77 164.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.646 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 33.9 ttp180 -66.59 133.02 49.44 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.802 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 63.2 t -113.26 135.66 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.666 ' O ' ' N ' ' A' ' 42' ' ' ASN . 54.5 m-20 -166.3 149.07 7.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.831 -1.532 . . . . 0.0 108.016 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 42' ' ' ASN . 56.1 tttp -46.04 -53.79 9.58 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.197 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 13.4 pttp -60.84 -4.63 1.04 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.072 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 7.3 m120 -125.13 0.23 7.83 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.082 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.45 -39.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.06 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.856 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.06 5.25 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.856 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -119.92 -6.18 10.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.869 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -98.74 151.64 20.54 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.735 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.676 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -72.73 110.83 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.043 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 49' ' ' ILE . 12.5 mt -74.21 116.1 14.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.1 mm -155.28 -31.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.596 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.674 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -134.5 -22.23 0.71 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.912 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.939 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -44.82 153.25 0.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.783 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -100.49 128.49 46.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.988 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.9 p -149.16 171.52 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.399 0.618 . . . . 0.0 111.572 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.722 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.51 152.28 51.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 65' ' ' GLY . 59.9 t -96.22 98.95 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.31 -51.86 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.415 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -128.53 118.35 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.557 ' OG ' ' ND1' ' A' ' 60' ' ' HIS . 47.9 t -149.07 173.53 13.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.184 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 33.7 p -102.98 78.6 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.724 ' CD2' ' O ' ' A' ' 59' ' ' THR . 21.6 m80 -166.57 96.15 0.72 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.251 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.11 -4.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.535 2.157 . . . . 0.0 114.015 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -132.0 23.32 4.16 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.638 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.639 ' O ' HG22 ' A' ' 66' ' ' ILE . 29.2 m-85 -141.11 -14.1 0.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.793 1.296 . . . . 0.0 111.615 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.3 m -71.62 138.89 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.9 6.71 88.74 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.35 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.142 HG23 ' NE1' ' A' ' 87' ' ' TRP . 2.3 tt -108.32 146.92 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 117.712 0.756 . . . . 0.0 112.243 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 6.9 tm-20 -116.15 131.87 56.82 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 80' ' ' ILE . . . -147.24 174.95 26.85 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.487 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.55 115.72 28.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -45.19 145.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.015 0.436 . . . . 0.0 111.457 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 81' ' ' ALA . 15.8 mt -136.48 -61.51 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 19.9 t0 -94.89 148.01 22.76 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.833 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.78 ' O ' HD11 ' B' ' 42' ' ' LEU . 10.7 tt0 -156.52 105.11 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.844 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -162.49 176.68 10.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 111.798 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 54.5 ttt85 -58.72 -1.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.864 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.844 ' H ' HG23 ' A' ' 74' ' ' THR . 7.6 t-20 -133.47 -11.58 2.77 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -166.66 156.21 11.25 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.669 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.3 tp -139.33 110.94 7.11 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.908 ' C ' HD13 ' A' ' 80' ' ' ILE . 61.3 t -119.95 145.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.939 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -117.88 152.25 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.142 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.92 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -125.12 136.44 53.63 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.108 0.48 . . . . 0.0 111.963 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -149.91 155.78 26.42 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 24' ' ' ILE . 6.1 pt-20 31.83 -115.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.561 0.219 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -121.24 33.31 5.59 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.917 0.389 . . . . 0.0 110.176 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 30.4 tttp -133.52 158.84 42.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.631 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 20' ' ' TYR . 16.1 m -123.62 155.54 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 110.688 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 1.142 ' NE1' HG23 ' A' ' 66' ' ' ILE . 2.5 m-90 -100.35 145.49 28.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.325 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -128.22 94.13 3.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.36 99.17 4.21 Favored Pre-proline 0 C--N 1.342 0.266 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.253 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.33 146.03 84.63 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.483 1.455 . . . . 0.0 110.231 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.602 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 27.2 mttm -54.17 -22.13 10.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -90.63 -6.38 54.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.502 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -128.52 35.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.64 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -166.95 155.72 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.027 179.142 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 77.2 mt -111.14 116.11 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.833 ' HB3' HG21 ' A' ' 53' ' ' VAL . 88.1 m-85 -98.53 127.11 44.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.988 ' C ' HG23 ' A' ' 53' ' ' VAL . 24.3 tt0 -110.12 94.74 5.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 43' ' ' ILE . 4.8 m-85 -87.55 145.66 26.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -90.2 127.39 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.804 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -62.8 142.88 58.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.389 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.802 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.19 0.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.605 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.552 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 75.6 m-20 -106.85 13.39 27.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.36 21.64 66.71 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 100' ' ' THR . 16.7 m -106.74 150.0 26.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.477 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -91.16 134.28 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 7.7 mt -110.59 132.62 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -118.55 102.9 9.24 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.65 139.41 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.974 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 m -88.55 148.49 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.994 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.47 -0.59 4.9 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.018 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.65 -22.72 60.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -80.11 -47.55 14.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.362 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -95.69 28.13 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.1 p -59.32 106.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.602 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.84 -40.89 0.32 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.496 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 116' ' ' ARG . 1.0 OUTLIER -101.18 87.63 0.92 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -176.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.584 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.1 Cg_endo -67.34 -29.16 38.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.25 1.3 . . . . 0.0 108.828 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HB3' HD22 ' B' ' 45' ' ' LEU . 8.1 pt-20 -56.66 -49.51 74.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.915 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 123' ' ' LYS . 9.7 ttm -34.67 -64.83 0.24 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.821 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -59.17 -44.93 92.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.843 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -60.27 -40.32 89.95 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -102.02 18.79 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.752 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.558 ' C ' ' O ' ' A' ' 122' ' ' LYS . 87.9 tttt -15.86 104.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.612 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 126' ' ' ARG . 13.7 ttp180 -148.99 -97.92 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.338 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.486 ' CD1' ' C ' ' A' ' 124' ' ' ARG . 41.8 p-90 32.32 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.958 0.408 . . . . 0.0 111.051 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 124' ' ' ARG . 45.4 mtt180 -61.8 -50.94 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' OXT' ' O ' ' A' ' 126' ' ' ARG . 28.1 ttmt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.588 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLU . . . . . 0.627 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.63 -30.47 46.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.797 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.0 OUTLIER -73.72 -34.25 64.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.799 1.285 . . . . 0.0 108.301 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.953 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -61.85 -51.26 68.94 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 112.126 -2.306 . . . . 0.0 111.667 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -71.32 -34.92 55.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.87 91.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.049 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.563 ' O ' HG22 ' B' ' 18' ' ' ILE . 6.8 tptm -58.85 -51.0 71.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.233 0.539 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' HD13 ' B' ' 20' ' ' ILE . 10.8 pt-20 -71.63 -37.14 70.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.882 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 121' ' ' LEU . 9.7 ttt180 -60.56 -51.02 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.593 0.711 . . . . 0.0 110.668 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.563 HG22 ' O ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -60.53 -38.33 77.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.17 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 13.2 m-20 -68.23 -30.44 69.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.492 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.554 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.1 mp -71.53 -57.68 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 1.065 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.2 -35.06 76.16 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.065 ' H ' HD13 ' B' ' 21' ' ' LEU . 5.4 t80 -53.75 -39.36 65.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.047 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -67.77 -40.8 83.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.383 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.939 HD12 HG11 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -56.25 -58.02 9.76 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.731 0.777 . . . . 0.0 109.396 179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' B' ' 29' ' ' PHE . . . -49.23 -37.52 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.562 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.84 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -68.97 -59.27 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.313 0.577 . . . . 0.0 110.087 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 7.2 ttm-85 -66.6 -36.91 83.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.809 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 1.199 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -82.99 -50.69 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.321 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.752 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 41.1 t80 -36.75 -50.26 1.99 Allowed Pre-proline 0 CA--C 1.509 -0.63 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.4 Cg_endo -54.01 -46.84 30.62 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 106.576 -2.124 . . . . 0.0 106.576 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.777 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 49.4 t80 -94.42 -13.24 26.46 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.335 -2.211 . . . . 0.0 112.708 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . 1.199 ' N ' ' O ' ' B' ' 28' ' ' VAL . 57.4 p -160.51 92.87 1.6 Allowed Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.67 -41.59 76.06 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.736 2.291 . . . . 0.0 113.673 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.59 -54.41 23.81 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 7.7 mt -52.22 -55.04 23.73 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.205 0.526 . . . . 0.0 110.604 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.544 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.77 -30.24 60.95 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.076 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.77 -48.93 43.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.543 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.95 -38.7 89.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.77 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -64.43 -44.71 90.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 118.627 -1.229 . . . . 0.0 108.327 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.3 t -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.155 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.95 -41.5 77.94 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 73' ' ' GLU . 28.1 mt -65.48 -44.71 86.26 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.41 -30.66 63.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 14.2 mt -66.72 -54.34 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.588 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.6 pp -57.25 -27.32 61.95 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.747 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' VAL . . . . . 0.963 ' N ' HD12 ' B' ' 45' ' ' LEU . 86.0 t -68.27 -46.38 81.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.017 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' B' ' 54' ' ' ILE . 0.4 OUTLIER -66.24 -57.1 8.3 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.818 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 8.4 pt20 -81.32 -47.35 13.43 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 7.4 tptt -70.04 -32.74 71.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.22 -3.98 58.79 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.419 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mttp 62.59 73.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.691 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HZ1' ' B' ' 11' ' ' LYS . 11.7 t -133.29 138.05 52.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.734 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -45.45 153.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.936 HD13 ' H ' ' B' ' 54' ' ' ILE . 0.1 OUTLIER -114.56 115.14 44.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.685 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' B' ' 57' ' ' LYS . 87.8 Cg_endo -81.91 -1.62 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 112.414 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.12 18.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.503 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' B' ' 55' ' ' PRO . 0.0 OUTLIER -65.96 -37.72 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 110.077 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.568 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 5.2 m-90 -62.04 7.25 0.06 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.778 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' B' ' 57' ' ' LYS . 33.1 pttt -65.89 -6.87 13.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' B' ' 58' ' ' TRP . 12.1 ptp180 -81.35 -25.44 36.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.833 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -141.25 22.97 2.2 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.418 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' B' ' 67' ' ' HIS . 51.8 t80 -116.15 148.6 40.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.019 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' CYS . . . . . 0.558 ' C ' ' H ' ' B' ' 65' ' ' LYS . 8.2 t -126.54 107.79 10.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.633 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.496 ' H ' ' HD2' ' B' ' 64' ' ' LYS . 1.1 mptp? -66.21 5.47 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.664 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.611 ' HD3' ' ND1' ' B' ' 97' ' ' HIS . 0.2 OUTLIER -105.96 -17.66 14.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.609 -178.061 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 66' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' B' ' 95' ' ' CYS . 14.5 p -150.81 6.75 0.53 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' B' ' 63' ' ' CYS . 2.0 m80 42.74 78.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.679 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.493 ' HB1' ' CE ' ' B' ' 37' ' ' LYS . . . -140.16 -172.14 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.303 0.573 . . . . 0.0 111.268 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 4.7 t80 -117.73 105.09 11.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.833 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.6 OUTLIER -109.35 126.29 53.24 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -103.17 121.92 47.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.886 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.63 127.2 15.81 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.981 1.787 . . . . 0.0 111.733 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.67 -34.01 6.02 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.599 HG22 ' OD1' ' B' ' 75' ' ' ASN . 96.6 mt -93.89 -79.99 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' B' ' 74' ' ' ILE . 3.4 m120 -110.86 15.94 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -148.11 161.53 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -143.45 138.71 29.48 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.606 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.815 HG12 HG12 ' B' ' 90' ' ' VAL . 10.5 m -139.1 110.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -129.49 143.01 50.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' B' ' 80' ' ' LEU . 0.4 OUTLIER -107.92 128.17 54.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.023 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' B' ' 82' ' ' GLN . 16.3 mmt85 -139.23 176.42 8.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' B' ' 83' ' ' LYS . 8.9 tm0? 81.21 136.81 0.06 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.516 ' O ' ' NE2' ' B' ' 82' ' ' GLN . 24.2 mmtp -103.05 155.57 18.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' B' ' 84' ' ' ARG . 45.0 mtt-85 66.16 -8.62 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' MET . . . . . 0.495 ' H ' ' C ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -149.31 66.22 8.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -44.2 115.49 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.637 2.225 . . . . 0.0 112.108 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -132.2 131.05 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.162 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' B' ' 80' ' ' LEU . 2.7 mt -115.5 146.31 20.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 2.6 t -109.22 119.86 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.899 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.815 HG12 HG12 ' B' ' 78' ' ' VAL . 3.6 m -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.584 ' NZ ' ' CA ' ' B' ' 96' ' ' GLY . 6.4 tttp -145.04 151.19 38.16 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 118.719 -1.193 . . . . 0.0 113.728 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' CYS . . . . . 0.615 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.6 OUTLIER -86.5 136.64 33.01 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.518 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.2 1.76 47.7 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.95 -32.03 12.81 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' B' ' 66' ' ' CYS . 0.0 OUTLIER -144.72 77.66 1.54 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 112.231 -2.259 . . . . 0.0 106.764 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -38.12 92.73 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.611 ' ND1' ' HD3' ' B' ' 65' ' ' LYS . 66.5 t60 -122.99 134.93 54.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.397 -1.402 . . . . 0.0 109.524 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mm -99.67 120.88 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.638 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.56 ' CB ' HG23 ' B' ' 90' ' ' VAL . 5.9 mmm -116.33 172.29 7.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -121.12 147.75 45.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' B' ' 101' ' ' TYR . 1.8 t80 -157.37 90.66 2.4 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.238 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -83.96 164.37 13.57 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.692 2.262 . . . . 0.0 112.723 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -137.88 101.81 4.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.921 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.24 118.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.542 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' GLU . 77.9 p . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.948 0.404 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 79' ' ' VAL . 58.2 m-85 -38.93 -58.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.69 -8.81 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' SER . 47.0 tp10 -104.03 -37.98 7.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.156 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.68 HG23 ' CE2' ' B' ' 31' ' ' TYR . 4.3 mm -95.66 22.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.482 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 ' H ' ' A' ' 24' ' ' ILE . 1.3 tp -80.76 117.43 26.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 105.12 -29.74 11.14 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 121.022 -0.609 . . . . 0.0 114.43 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.66 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -63.28 29.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.967 . . . . 0.0 110.882 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.66 ' H ' ' C ' ' A' ' 25' ' ' GLY . 3.3 p -44.5 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.66 ' N ' ' O ' ' A' ' 26' ' ' ARG . 27.9 t-105 -57.86 -52.52 65.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.407 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.834 ' CD1' HG12 ' B' ' 28' ' ' VAL . 10.4 pt -69.73 -12.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.977 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' B' ' 24' ' ' LEU . 40.5 m-85 -93.53 -11.07 32.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.06 -68.3 0.8 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.41 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.03 46.42 1.5 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . . . -161.88 -34.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.739 ' HA ' HG23 ' B' ' 20' ' ' ILE . 19.6 t-80 -103.55 108.19 19.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.822 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.701 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -149.56 9.51 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.783 ' O ' ' CD1' ' A' ' 101' ' ' TRP . . . -49.04 148.15 5.26 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -64.25 111.13 2.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 118.486 -1.285 . . . . 0.0 108.947 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 100' ' ' THR . 92.6 t -83.08 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.903 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.756 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -163.81 150.5 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.563 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 69.5 tttt -48.29 -56.67 7.44 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.753 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 54.2 pttt -61.63 -5.3 1.79 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 9.1 m120 -126.0 3.54 7.27 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.783 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.756 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.53 -42.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.072 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.713 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -94.48 -0.46 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.23 14.65 16.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.458 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -120.37 176.47 5.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.764 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.733 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -90.81 112.26 24.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.983 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.767 ' O ' HD13 ' A' ' 49' ' ' ILE . 55.5 mt -74.39 114.14 12.42 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm -155.79 -40.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.761 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.604 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -131.84 -20.05 1.1 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.744 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -44.44 142.31 1.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.813 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.2 ttpm? -92.13 131.54 37.3 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.972 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.8 p -150.04 170.74 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.191 0.52 . . . . 0.0 111.282 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.67 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.42 152.44 51.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.898 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 65' ' ' GLY . 48.1 t -97.5 99.17 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.87 -50.89 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.841 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.47 120.75 27.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 94' ' ' CYS . 3.2 t -147.06 173.28 12.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.626 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -109.95 78.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 59' ' ' THR . 17.4 m170 -168.72 102.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.328 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.73 -4.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.478 2.119 . . . . 0.0 113.822 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -130.2 22.46 4.75 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.193 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 66' ' ' ILE . 20.8 m-85 -141.0 -11.76 0.97 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.533 1.167 . . . . 0.0 111.513 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.2 m -72.98 131.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.02 5.21 90.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.664 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.047 HG23 ' NE1' ' A' ' 87' ' ' TRP . 9.0 tt -100.38 151.24 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 117.758 0.779 . . . . 0.0 112.345 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.687 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 2.7 tm-20 -118.0 132.71 56.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.57 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.25 173.22 27.47 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.853 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -96.5 114.93 26.63 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.8 t -48.77 146.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.012 HD11 ' HB2' ' A' ' 81' ' ' ALA . 36.2 mt -140.02 -60.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.127 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -104.14 144.71 31.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.62 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 43.8 tp10 -148.18 106.17 3.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.986 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.471 ' HA ' HH21 ' B' ' 38' ' ' ARG . 1.8 p -137.04 179.9 6.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.726 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' CA ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -55.44 -17.01 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.144 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HA ' ' HZ3' ' A' ' 91' ' ' LYS . 41.1 t30 -137.54 13.52 2.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.85 159.02 39.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 118.728 -1.189 . . . . 0.0 113.957 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.731 HD23 ' CE1' ' A' ' 96' ' ' PHE . 7.2 tp -150.46 110.55 4.14 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' ILE . 91.1 t -112.1 146.37 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.57 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -129.1 147.44 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.972 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.012 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -123.08 137.59 54.89 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.577 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.76 152.06 23.79 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 84' ' ' ASN . 8.9 pt-20 38.06 -136.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.699 -0.295 . . . . 0.0 110.937 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 23.1 m120 -99.67 34.08 2.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.052 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 21.5 tptt -145.18 165.93 26.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.707 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.508 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 24.7 m -119.65 155.57 22.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.469 0.652 . . . . 0.0 110.693 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 1.047 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.4 m-90 -97.54 92.7 6.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.708 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -86.97 100.01 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 55' ' ' VAL . 3.9 t -147.27 109.16 3.93 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.448 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.01 164.35 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.323 1.348 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.749 ' CD ' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -72.03 -31.43 66.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 16.9 p-10 -90.28 -5.69 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -97.5 0.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.286 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -166.27 174.42 9.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.926 -1.11 . . . . 0.0 113.654 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.22 124.01 65.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.702 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.731 ' CE1' HD23 ' A' ' 78' ' ' LEU . 59.7 m-85 -99.04 131.19 45.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.972 ' C ' HG23 ' A' ' 53' ' ' VAL . 18.5 tt0 -111.29 95.48 5.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.751 ' CD1' HD11 ' A' ' 43' ' ' ILE . 16.4 m-85 -89.58 146.01 24.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.16 132.4 36.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.729 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 104' ' ' THR . 16.9 m -65.85 142.41 57.94 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -62.43 -1.66 0.84 Allowed 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.919 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 100' ' ' THR . 86.9 m-20 -106.92 19.45 20.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.751 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.03 23.49 77.07 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.57 137.21 44.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.423 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -81.28 129.56 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 44.7 mt -104.41 134.7 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.578 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -117.86 102.04 8.78 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.3 138.06 45.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.691 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.7 p -78.26 123.22 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.487 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -53.2 -2.44 0.1 OUTLIER Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -81.77 -22.86 36.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.167 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -66.69 -46.34 75.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.17 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -92.68 28.68 1.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 114' ' ' VAL . 3.6 p -55.28 105.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 75' ' ' ARG . . . 67.73 -40.64 0.24 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 114.462 -1.245 . . . . 0.0 114.47 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.8 91.66 1.98 Allowed Pre-proline 0 N--CA 1.466 0.328 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HB2' HH22 ' B' ' 17' ' ' ARG . 29.2 Cg_endo -69.76 -27.97 25.84 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.462 1.442 . . . . 0.0 108.752 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.818 ' HB3' HD22 ' B' ' 45' ' ' LEU . 13.0 pt-20 -61.08 -52.27 65.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.222 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.556 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 31.3 ttp -36.16 -38.38 0.14 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.596 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.617 ' NH2' ' CZ2' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -81.57 -50.03 9.84 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.145 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.55 -33.29 73.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.054 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.299 . . . . 0.0 111.054 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.734 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.587 ' H ' ' CD ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -79.3 -29.6 42.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.886 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -72.31 -33.58 67.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.723 1.249 . . . . 0.0 107.844 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.959 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.2 OUTLIER -62.94 -51.8 65.51 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.736 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.4 pt -65.73 -27.84 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.082 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -66.48 -42.35 87.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.725 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.495 ' O ' HG22 ' B' ' 18' ' ' ILE . 18.6 mmtt -53.93 -50.97 65.24 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 109.514 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.717 ' O ' HG12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -73.17 -38.15 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.6 HH22 ' HB2' ' A' ' 117' ' ' PRO . 31.1 ttt180 -65.06 -52.91 53.06 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.521 0.676 . . . . 0.0 110.895 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.589 HG23 ' N ' ' B' ' 19' ' ' ASP . 8.0 tp -56.74 -43.99 80.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.236 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.589 ' N ' HG23 ' B' ' 18' ' ' ILE . 11.1 m-20 -67.29 -29.2 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 34' ' ' HIS . 26.4 mm -74.99 -58.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.094 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.45 -34.18 74.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.094 ' N ' HD13 ' B' ' 21' ' ' LEU . 5.0 t80 -54.51 -50.32 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -71.44 -32.59 68.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.484 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.83 HD12 HG13 ' B' ' 28' ' ' VAL . 0.2 OUTLIER -66.29 -56.65 10.15 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.186 0.517 . . . . 0.0 109.641 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -50.32 -38.25 40.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.205 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.841 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 62.2 mt-10 -69.07 -46.14 68.57 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.192 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 3.0 ttt-85 -70.97 -33.37 70.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.897 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.232 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.9 m -84.5 -49.36 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.552 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.758 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 24.6 t80 -36.48 -49.98 1.84 Allowed Pre-proline 0 C--N 1.351 0.632 0 CA-C-N 119.531 1.06 . . . . 0.0 109.439 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.6 Cg_endo -54.85 -47.41 26.8 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.509 -2.151 . . . . 0.0 106.509 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.791 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.7 t80 -94.44 -13.65 26.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.397 -2.183 . . . . 0.0 112.752 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.232 ' N ' ' O ' ' B' ' 28' ' ' VAL . 52.5 p -159.1 90.84 1.99 Allowed Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 51.5 Cg_exo -53.46 -45.0 44.24 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.711 2.274 . . . . 0.0 113.81 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' B' ' 38' ' ' ARG . 79.5 tt0 -64.37 -53.96 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 21.8 mt -51.73 -59.61 4.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.004 0.431 . . . . 0.0 111.155 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.722 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.45 -35.4 52.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.196 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.824 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.57 -36.06 73.41 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.001 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.714 ' C ' ' HD3' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -65.47 -54.68 24.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.824 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.86 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.2 m-85 -59.58 -39.94 85.76 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.1 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.9 t -45.32 -41.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -64.43 -43.24 94.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.805 ' O ' HG23 ' B' ' 46' ' ' VAL . 14.5 mt -64.55 -43.61 93.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.728 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -66.39 -31.51 72.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.243 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.609 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.9 -53.86 52.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -64.68 -41.01 96.36 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.743 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.893 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 97.3 t -53.51 -42.46 49.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.266 0.555 . . . . 0.0 109.99 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.84 -55.28 17.92 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.301 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 3.0 pt20 -80.71 -53.08 6.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 26.6 mmtt -56.53 -41.19 76.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -90.23 -9.06 49.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 0.0 110.348 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.54 66.84 1.01 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.349 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.455 ' O ' ' HD2' ' B' ' 61' ' ' ARG . 10.1 m0 . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -8.5 45.39 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -80.59 -18.69 47.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -142.97 11.88 1.81 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.511 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 92.0 t80 -119.98 158.64 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 2.0 t -126.28 120.64 30.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -85.97 5.28 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.249 0.547 . . . . 0.0 109.639 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 2.5 mmmm -97.75 -39.73 8.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.86 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 5.2 p -136.07 1.98 2.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.7 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 66' ' ' CYS . 6.8 m170 57.44 121.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.764 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 176.17 -172.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.766 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.824 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.4 OUTLIER -121.35 104.7 9.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.783 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -109.81 145.7 36.28 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.348 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.506 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 92.3 t -128.44 117.76 20.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . 0.428 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 77.9 Cg_exo -45.95 125.34 8.21 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.029 1.819 . . . . 0.0 111.85 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.76 -29.82 11.7 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.41 -80.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.003 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.529 ' C ' HD12 ' B' ' 93' ' ' LEU . 90.3 m-20 -116.97 17.38 14.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.082 0.468 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.529 HD12 ' C ' ' B' ' 75' ' ' ASN . 96.0 mt . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 121.221 0.534 . . . . 0.0 109.674 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 95.7 p . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.983 0.421 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 19' ' ' SER . 59.9 m-85 -33.7 -62.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.894 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.84 -22.08 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.325 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.2 tp10 -97.37 -34.59 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 ' CE2' ' B' ' 31' ' ' TYR . 1.8 mm -98.78 15.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.696 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -79.49 117.49 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.137 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 112.77 -35.5 4.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.889 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -61.07 25.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.958 0.879 . . . . 0.0 110.895 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.703 ' H ' ' C ' ' A' ' 25' ' ' GLY . 29.2 p -37.66 -17.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.513 0.673 . . . . 0.0 109.899 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' ARG . 17.7 t-105 -56.99 -56.34 22.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.689 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.873 ' CD1' HG12 ' B' ' 28' ' ' VAL . 13.5 pt -63.6 -17.91 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.269 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 18.1 m-85 -89.44 -16.89 29.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.1 mmt85 -90.91 -61.56 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.171 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' B' ' 27' ' ' ARG . . . -71.43 45.34 0.79 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -153.53 -36.15 0.1 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CG ' HD12 ' B' ' 20' ' ' ILE . 2.0 t-80 -90.56 106.78 18.73 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.029 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.66 0.83 3.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.434 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.507 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -54.28 146.41 24.66 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.537 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 2.1 ttm-85 -66.81 125.14 24.94 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.861 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -101.42 136.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.909 0.861 . . . . 0.0 113.301 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.632 ' O ' ' N ' ' A' ' 43' ' ' ILE . 38.5 m-80 -166.11 152.17 9.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.323 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 42' ' ' ASN . 20.8 ttmt -49.96 -51.93 37.53 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.91 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -60.22 -4.81 0.89 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 77.7 m-20 -122.53 -10.25 8.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.33 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.656 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -80.12 -41.06 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.616 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.889 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.1 9.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.87 1.319 . . . . 0.0 107.57 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.889 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.24 -25.37 4.49 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.81 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -79.0 146.28 33.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.788 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -70.89 111.48 6.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 49' ' ' ILE . 13.5 mt -68.73 115.87 8.58 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.9 mm -157.42 -27.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.865 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -152.11 30.95 0.89 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.283 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.951 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -98.38 156.13 16.89 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.791 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.4 tmtt? -98.04 127.0 43.73 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.427 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.987 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.8 p -149.4 171.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.269 0.557 . . . . 0.0 111.871 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.92 152.62 49.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.799 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 65' ' ' GLY . 89.0 t -96.33 99.52 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.79 -51.97 13.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -129.03 118.61 22.83 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.331 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.556 ' OG ' ' CE1' ' A' ' 60' ' ' HIS . 5.2 t -149.36 173.35 13.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.331 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 59' ' ' THR . 10.8 t -108.32 75.46 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.294 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.738 ' CD2' ' O ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -168.59 93.08 0.59 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.745 178.035 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.2 -5.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.349 2.033 . . . . 0.0 113.263 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -109.55 9.06 32.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.366 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 66' ' ' ILE . 39.6 m-85 -140.74 -12.95 0.98 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.234 1.017 . . . . 0.0 112.255 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.2 m -72.0 132.66 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.129 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.5 6.39 88.66 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.335 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.049 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.0 tt -100.87 148.48 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.701 0.75 . . . . 0.0 112.055 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.664 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 4.8 tm-20 -119.7 129.98 54.79 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.583 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -145.69 174.24 25.74 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 116.412 -0.358 . . . . 0.0 112.509 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.1 t80 -96.25 115.2 27.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.571 0.348 . . . . 0.0 110.093 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -48.21 142.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.727 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.2 mt -141.76 -39.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -121.82 143.43 49.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.58 ' N ' ' CZ ' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -157.21 106.48 2.18 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 -171.33 2.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.28 0.562 . . . . 0.0 111.084 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -53.24 -24.7 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.125 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -138.43 30.93 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.473 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -164.68 169.6 16.69 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.687 -1.205 . . . . 0.0 113.91 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.4 tp -165.83 110.21 0.83 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' ILE . 98.0 t -116.41 146.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.637 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -126.89 145.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.229 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.18 136.13 53.96 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.532 . . . . 0.0 111.828 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.92 132.88 3.82 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 64.33 -123.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.808 -0.231 . . . . 0.0 110.643 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -116.31 33.22 5.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 110.618 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.549 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 6.1 tptp -145.25 170.75 15.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.549 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 7.8 m -124.28 156.11 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.701 0.762 . . . . 0.0 110.85 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 1.049 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.2 m-90 -99.11 119.73 38.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.623 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -107.98 104.47 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.28 96.26 3.97 Favored Pre-proline 0 N--CA 1.457 -0.115 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.92 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 92' ' ' ASP . 38.3 Cg_exo -54.16 126.76 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.095 1.197 . . . . 0.0 110.295 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.78 -19.84 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.431 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' PRO . 5.3 p-10 -87.6 -6.92 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 59' ' ' THR . 2.2 t -133.72 33.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.714 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -167.09 158.06 11.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.712 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.487 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 73.1 mt -106.45 118.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 78' ' ' LEU . 66.6 m-85 -99.08 131.12 45.35 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.987 ' C ' HG23 ' A' ' 53' ' ' VAL . 11.2 tt0 -115.49 94.87 4.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.84 143.58 26.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.85 ' OE2' ' N ' ' A' ' 104' ' ' THR . 2.5 tm-20 -90.99 127.52 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.485 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.921 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -58.98 143.27 48.7 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.817 -178.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.861 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -54.83 0.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.284 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' THR . 31.8 t70 -106.66 10.64 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.16 14.42 76.91 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.921 ' O ' ' OG1' ' A' ' 100' ' ' THR . 19.3 m -106.54 127.6 53.45 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.806 ' H ' ' CD ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -76.47 135.98 39.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.431 0.634 . . . . 0.0 111.581 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.756 HD11 HG23 ' A' ' 100' ' ' THR . 70.2 mt -102.88 135.5 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.525 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -107.9 101.92 11.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.07 139.19 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.353 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 2.5 m -79.29 145.49 33.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.773 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -70.88 -1.91 42.54 Favored Glycine 0 CA--C 1.507 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.087 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.94 -21.61 34.05 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.352 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -64.82 -47.08 79.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.419 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -94.29 28.58 2.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.776 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 114' ' ' VAL . 12.6 p -60.81 106.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.98 -40.2 0.25 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.104 -0.953 . . . . 0.0 114.162 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -101.43 78.55 0.22 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.528 ' HB2' HH22 ' B' ' 17' ' ' ARG . 19.5 Cg_endo -66.59 -24.25 48.72 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.392 1.394 . . . . 0.0 108.984 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 119' ' ' MET . 9.3 pt-20 -62.94 -52.63 62.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.482 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.4 mmt -35.01 -55.56 0.59 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.667 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' CE3' ' A' ' 45' ' ' TRP . 4.2 tpt180 -68.28 -40.69 81.76 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.963 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -62.1 -39.15 91.52 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.689 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -79.62 -33.45 41.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.764 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 8.9 tttp -73.45 -35.06 65.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.664 1.221 . . . . 0.0 108.485 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 1.008 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -61.1 -51.51 68.84 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.088 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.706 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.9 mt -69.59 -35.56 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.9 -53.6 56.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.514 ' O ' HG22 ' B' ' 18' ' ' ILE . 12.9 mmmt -53.33 -50.96 63.9 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.734 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 7.7 pt-20 -71.53 -38.22 71.09 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.246 0.546 . . . . 0.0 110.755 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.727 ' HD3' HD11 ' A' ' 121' ' ' LEU . 7.0 ttt180 -58.84 -53.6 56.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.897 0.856 . . . . 0.0 109.844 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.685 ' HA ' HD12 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -59.36 -32.01 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.35 -50.13 73.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.663 HD12 ' CG ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -74.31 -49.61 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.12 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -56.0 -37.41 69.08 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.12 ' N ' HD13 ' B' ' 21' ' ' LEU . 6.2 t80 -59.76 -51.99 67.41 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.425 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 64.6 p -69.68 -34.95 74.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.856 HD12 HG13 ' B' ' 28' ' ' VAL . 0.1 OUTLIER -63.79 -56.26 16.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.181 0.515 . . . . 0.0 109.913 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -51.87 -34.51 41.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.832 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 1.7 tm-20 -74.19 -40.07 62.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.856 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 53.9 mtt180 -72.53 -34.74 67.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.215 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.7 m -85.83 -49.39 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.723 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 23.2 t80 -36.19 -49.85 1.69 Allowed Pre-proline 0 C--N 1.353 0.741 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.304 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.856 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 38.3 Cg_endo -54.58 -48.28 22.25 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.802 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.1 t80 -94.3 -10.8 31.62 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 112.473 -2.149 . . . . 0.0 112.773 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.215 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.0 p -165.03 95.13 0.88 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' B' ' 37' ' ' LYS . 33.2 Cg_exo -56.5 -39.12 93.5 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.503 2.135 . . . . 0.0 113.319 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -53.37 35.3 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.56 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 13.5 mt -54.36 -57.85 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.587 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -51.66 -31.24 24.81 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.185 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' O ' ' B' ' 69' ' ' PHE . 2.2 mptt -70.97 -41.17 71.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.761 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.848 HH11 HD11 ' B' ' 42' ' ' LEU . 2.5 tmm_? -60.07 -54.34 47.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.951 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.895 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -61.66 -39.29 90.85 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.718 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.1 t -45.64 -43.23 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.596 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.72 -43.64 98.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.848 HD11 HH11 ' B' ' 38' ' ' ARG . 63.1 mt -64.8 -43.94 91.55 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.361 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.802 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.81 -30.86 64.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.682 HD11 ' OH ' ' B' ' 62' ' ' TYR . 7.3 mt -67.66 -54.83 16.34 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.47 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.552 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.3 pp -57.74 -28.25 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.745 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.978 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 83.5 t -69.1 -48.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.153 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.08 -56.84 9.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 8.9 pt20 -80.75 -48.33 12.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -69.51 -33.85 73.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -89.38 -8.38 53.27 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? 64.82 71.15 0.46 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.834 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.646 ' O ' ' N ' ' B' ' 62' ' ' TYR . 2.0 m0 . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -64.52 -8.75 15.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.9 ptm180 -88.19 -26.4 22.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.264 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.742 ' NH1' ' CE2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -134.54 15.15 3.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.754 -177.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.682 ' OH ' HD11 ' B' ' 44' ' ' LEU . 23.5 t80 -111.82 151.13 29.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.773 ' CB ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -118.82 105.16 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.156 -178.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -92.86 -4.77 52.32 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.599 ' HB2' ' SG ' ' B' ' 66' ' ' CYS . 20.9 mmmt -78.57 -37.93 41.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.659 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 17.7 1.72 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.879 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.58 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.7 m80 53.96 95.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.902 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.402 ' N ' HG11 ' B' ' 40' ' ' VAL . . . -166.4 -173.92 2.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.8 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.781 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -125.44 102.51 7.44 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 1.061 HD22 ' H ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -99.97 154.4 18.42 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.814 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 42.9 t -131.12 115.15 16.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.424 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . 0.401 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 73.6 Cg_exo -45.0 122.49 4.33 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.224 1.949 . . . . 0.0 111.848 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.74 -26.77 23.25 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.446 HD12 HG11 ' B' ' 71' ' ' VAL . 56.1 mt -105.05 -80.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -115.55 22.36 13.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.958 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 70' ' ' LEU . . . . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.274 0.559 . . . . 0.0 111.972 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' B' ' 93' ' ' LEU . 92.9 mt . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.342 0.591 . . . . 0.0 109.432 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 54.7 p . . . . . 0 C--O 1.226 -0.164 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.623 ' HB3' HG11 ' A' ' 86' ' ' VAL . 37.0 m-85 -42.44 -58.52 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -43.72 -15.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' TYR . 38.2 tp10 -99.82 -32.62 10.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.327 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.704 HD12 ' OG ' ' B' ' 32' ' ' SER . 3.8 mm -109.11 19.15 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -80.35 117.13 25.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.543 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.26 -37.48 3.6 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.204 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 28' ' ' TRP . 1.9 mtt180 -62.26 30.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.552 0.676 . . . . 0.0 110.875 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.666 ' H ' ' C ' ' A' ' 25' ' ' GLY . 2.9 p -43.74 -12.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.747 0.784 . . . . 0.0 109.022 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.684 ' N ' ' O ' ' A' ' 26' ' ' ARG . 24.1 t-105 -58.24 -55.77 30.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.169 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.764 ' CD1' HG12 ' B' ' 28' ' ' VAL . 7.2 pt -64.66 -13.59 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 71' ' ' ILE . 60.5 m-85 -93.42 -16.5 24.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.9 mmm180 -89.13 -56.68 3.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.736 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' NE ' ' B' ' 27' ' ' ARG . . . -78.58 46.42 2.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ILE . . . -153.12 -40.98 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -75.68 126.96 32.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.536 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -154.78 -35.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.553 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' ARG . . . -32.29 144.77 0.02 OUTLIER Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 24.4 ttm105 -66.42 119.5 11.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -92.71 136.62 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.767 0.794 . . . . 0.0 113.115 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 43' ' ' ILE . 39.3 t30 -165.82 155.52 12.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 42' ' ' ASN . 86.3 tttt -52.21 -52.77 50.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.76 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.565 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 8.7 pttm -60.15 -4.24 0.76 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.748 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 72.3 m-20 -123.95 -3.41 8.13 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.228 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -86.41 -39.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 117.876 0.307 . . . . 0.0 111.466 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.882 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -88.43 3.12 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.882 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -114.65 -37.88 4.14 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.617 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.748 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -67.29 140.38 57.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.787 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -66.25 110.09 2.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.826 ' O ' HG12 ' A' ' 49' ' ' ILE . 5.0 mt -72.9 114.5 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.407 -1.317 . . . . 0.0 108.013 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.865 HD11 HD12 ' B' ' 42' ' ' LEU . 4.7 mt -168.42 51.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 O-C-N 123.803 0.689 . . . . 0.0 109.491 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 150.16 -35.26 0.99 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.591 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.969 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.6 tt -44.59 146.05 0.79 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.882 ' H ' HD23 ' A' ' 51' ' ' LEU . 13.0 tmtt? -85.46 125.31 32.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.348 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.977 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.0 p -149.1 171.02 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.434 0.635 . . . . 0.0 111.954 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.89 152.81 49.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.001 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 65' ' ' GLY . 31.6 t -100.44 99.46 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.58 -51.98 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.56 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HB3' HD12 ' A' ' 95' ' ' ILE . 15.1 t-20 -128.48 117.42 21.31 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.553 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.1 t -150.18 173.53 13.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.466 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.68 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -101.36 79.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.68 ' CD2' ' O ' ' A' ' 59' ' ' THR . 37.3 m-70 -161.14 94.92 1.4 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.614 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.7 -5.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.177 1.918 . . . . 0.0 113.219 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -134.79 22.57 3.64 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.193 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' ILE . 27.2 m-85 -140.69 -10.85 1.03 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.628 1.214 . . . . 0.0 111.834 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.4 m -72.14 134.07 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 83.27 5.87 88.44 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.291 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.083 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.4 tt -104.54 153.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.66 0.73 . . . . 0.0 112.204 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.614 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.3 tm-20 -120.26 131.49 54.95 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.31 173.29 27.49 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 116.341 -0.39 . . . . 0.0 112.502 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -96.45 117.89 31.83 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -51.9 145.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.962 0.41 . . . . 0.0 111.654 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.6 mt -140.32 -33.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.485 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.666 ' OD2' ' NH1' ' B' ' 38' ' ' ARG . 37.6 t0 -123.56 149.29 45.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.662 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 tm-20 -161.71 106.05 1.26 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.959 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.536 HG23 ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -148.45 -175.23 4.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.194 0.521 . . . . 0.0 110.964 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.493 HH12 HH21 ' A' ' 116' ' ' ARG . 37.1 ttt85 -53.17 -23.25 7.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.094 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -138.83 29.16 2.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -166.29 164.53 17.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 118.358 -1.337 . . . . 0.0 114.267 179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.645 HD23 ' CE1' ' A' ' 96' ' ' PHE . 10.5 tp -163.43 109.79 1.13 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 112.975 -1.92 . . . . 0.0 105.937 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 71' ' ' ILE . 83.3 t -118.24 146.3 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 112.474 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.622 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -127.6 147.09 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.357 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -122.69 137.47 54.9 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.597 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -155.52 124.96 1.57 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 64.8 -130.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 110.552 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.24 32.06 5.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.544 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 13.7 tttp -139.12 166.75 23.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.607 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 20' ' ' TYR . 7.5 m -123.45 155.44 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.421 0.629 . . . . 0.0 110.611 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 1.083 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.6 m-90 -102.17 93.14 5.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.437 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' HG13 ' A' ' 89' ' ' VAL . 20.9 ttmt -91.3 104.84 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.928 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 88' ' ' LYS . 2.5 m -157.24 95.85 2.1 Favored Pre-proline 0 N--CA 1.457 -0.123 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.563 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 32.0 Cg_exo -54.28 126.82 23.45 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.973 1.782 . . . . 0.0 111.687 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.823 ' HZ3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -38.81 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.204 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 90' ' ' PRO . 4.0 p-10 -82.24 -6.11 58.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.405 HG12 ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -137.06 33.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.271 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 90' ' ' PRO . 3.2 p -167.37 154.82 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.354 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 57' ' ' ASN . 23.7 mt -105.37 146.13 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.271 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.761 ' HB3' HG21 ' A' ' 53' ' ' VAL . 50.3 m-85 -130.42 137.65 49.94 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.977 ' C ' HG23 ' A' ' 53' ' ' VAL . 7.8 tt0 -119.65 94.0 4.26 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' ILE . 1.4 m-85 -87.69 144.82 26.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.612 ' O ' HD21 ' A' ' 51' ' ' LEU . 82.6 tt0 -90.01 131.6 35.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.317 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.67 143.39 57.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.693 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.45 -0.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.296 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 20.2 t0 -107.37 12.98 27.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.8 22.65 68.75 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.06 149.47 26.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.417 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.46 133.41 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.42 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 100' ' ' THR . 22.2 mt -107.16 134.9 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -115.65 102.63 9.93 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -151.38 139.92 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.933 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 111' ' ' GLU . 37.4 m -89.74 148.35 23.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.275 0.559 . . . . 0.0 111.449 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.34 -1.0 0.94 Allowed Glycine 0 CA--C 1.506 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.174 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -76.44 -23.75 53.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.287 -178.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -74.63 -47.56 31.4 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.303 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -90.81 28.41 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.1 p -59.64 105.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.823 ' N ' ' HZ3' ' A' ' 91' ' ' LYS . . . 67.49 -41.02 0.23 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.792 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.493 HH21 HH12 ' A' ' 75' ' ' ARG . 7.0 mmt180 -100.79 79.72 0.23 Allowed Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HB2' HH22 ' B' ' 17' ' ' ARG . 18.3 Cg_endo -64.83 -24.48 61.3 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.608 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -64.72 -57.31 9.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.446 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.463 ' C ' ' O ' ' A' ' 118' ' ' GLU . 2.6 tpt -31.81 -45.4 0.1 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.741 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.626 ' NE ' ' CZ3' ' A' ' 45' ' ' TRP . 6.8 tpm_? -70.9 -46.77 61.96 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.46 -41.35 97.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.97 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.209 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.618 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.55 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 2.6 pt-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' B' ' 11' ' ' LYS . 16.9 pttp -79.85 -41.49 26.21 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.965 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.847 ' H ' HH11 ' B' ' 12' ' ' ARG . 16.8 ttpt -72.85 -33.62 66.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 122.742 1.258 . . . . 0.0 108.431 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.98 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.5 mpt_? -61.8 -51.07 69.78 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.418 -2.173 . . . . 0.0 110.98 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 45' ' ' TRP . 15.1 mt -68.33 -27.55 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -61.95 -53.09 60.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.904 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.468 ' O ' HG22 ' B' ' 18' ' ' ILE . 29.5 mttp -54.16 -50.25 67.43 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.79 -37.49 70.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.302 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.506 HH22 ' HB2' ' A' ' 117' ' ' PRO . 17.6 ttt180 -61.79 -53.66 52.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.842 0.83 . . . . 0.0 110.163 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -57.35 -34.83 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.118 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -67.07 -31.28 71.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.143 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.572 HG21 ' OE2' ' A' ' 47' ' ' GLU . 31.3 mt -71.33 -56.88 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.023 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -65.14 -34.0 77.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.908 0.861 . . . . 0.0 109.087 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.023 ' N ' HD13 ' B' ' 21' ' ' LEU . 14.0 t80 -53.09 -49.33 66.64 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.305 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.4 p -68.27 -37.21 80.48 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.123 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -60.4 -56.78 17.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.708 0.766 . . . . 0.0 110.032 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.57 -33.99 34.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.159 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.813 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 7.9 mm-40 -75.15 -43.51 52.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.583 0.706 . . . . 0.0 109.79 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.84 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 83.6 mtt-85 -72.69 -34.56 67.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.4 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.256 ' O ' ' N ' ' B' ' 32' ' ' SER . 3.6 m -85.19 -50.9 14.22 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.642 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.727 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 14.1 t80 -36.42 -49.73 1.81 Allowed Pre-proline 0 C--N 1.35 0.599 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.525 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.84 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 41.5 Cg_endo -55.39 -47.91 23.42 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 N-CA-C 106.893 -2.003 . . . . 0.0 106.893 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.807 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.2 t80 -94.47 -15.25 24.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.536 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.256 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -161.2 93.62 1.44 Allowed Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.524 ' HB3' ' HZ1' ' B' ' 37' ' ' LYS . 50.5 Cg_exo -53.7 -43.47 57.57 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.03 2.487 . . . . 0.0 114.158 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.08 -52.17 60.58 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.645 ' CD2' HH21 ' B' ' 38' ' ' ARG . 11.4 mt -51.3 -58.15 6.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.758 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -53.68 -34.04 57.37 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.354 0.597 . . . . 0.0 109.649 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.783 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -70.8 -41.06 72.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.391 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.666 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 3.6 ttm-85 -62.75 -51.54 66.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.406 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.876 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.5 m-30 -60.48 -41.19 93.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.097 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 36' ' ' ALA . 3.1 t -45.27 -36.47 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.381 -1.281 . . . . 0.0 107.948 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 67.5 tt0 -67.87 -44.03 78.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.865 HD12 HD11 ' A' ' 49' ' ' ILE . 26.8 mt -66.17 -40.02 90.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.323 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -68.27 -31.1 70.32 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 4.5 mt -63.16 -54.64 34.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.601 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.665 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.9 pp -60.2 -38.17 82.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.13 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.945 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.0 t -54.42 -44.37 66.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.451 0.643 . . . . 0.0 109.702 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.4 -55.16 17.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.761 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 13.3 pt20 -80.32 -52.27 7.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 13.9 mptt -61.7 -39.96 93.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.313 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.56 -11.65 45.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.07 67.63 0.84 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.112 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.899 178.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.424 ' HA ' ' HE ' ' B' ' 61' ' ' ARG . 7.7 m0 . . . . . 0 N--CA 1.46 0.07 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -69.04 -16.65 63.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.472 HH11 ' HD2' ' B' ' 60' ' ' ARG . 7.6 ptm85 -78.73 -20.37 50.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.558 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -140.71 17.87 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.138 -177.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' B' ' 58' ' ' TRP . 85.9 t80 -119.48 156.79 29.56 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.558 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.5 OUTLIER -127.22 124.08 38.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.043 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.51 4.48 49.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.515 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -97.53 -38.6 9.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.196 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.3 p -136.71 10.72 3.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.473 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' B' ' 66' ' ' CYS . 5.4 m-70 49.63 109.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.7 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.96 -170.04 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.783 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -122.85 105.06 9.68 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -109.47 141.69 41.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.814 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.7 t -119.71 121.01 30.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.09 122.92 6.87 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.017 1.811 . . . . 0.0 111.991 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 76' ' ' ALA . . . 101.78 -33.08 6.79 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.628 HG22 ' ND2' ' B' ' 75' ' ' ASN . 89.3 mt -99.37 -77.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.773 0.321 . . . . 0.0 110.975 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.628 ' ND2' HG22 ' B' ' 74' ' ' ILE . 5.8 m120 -109.27 14.65 23.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.71 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 121.368 0.604 . . . . 0.0 109.391 178.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.7 t . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.59 0.233 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.3 m-85 -49.85 -48.79 50.95 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.12 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -40.84 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 110.45 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -101.77 -35.56 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.616 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.698 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.6 mm -94.96 22.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -80.45 117.89 27.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.69 0.281 . . . . 0.0 111.712 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 107.07 -33.15 6.6 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.154 -0.546 . . . . 0.0 114.078 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.8 28.47 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.988 0.894 . . . . 0.0 111.038 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' GLY . 16.5 p -42.76 -14.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.565 0.698 . . . . 0.0 109.397 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.653 ' N ' ' O ' ' A' ' 26' ' ' ARG . 18.9 t-105 -58.84 -59.53 5.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.263 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.795 ' CD1' HG12 ' B' ' 28' ' ' VAL . 11.9 pt -56.97 -12.97 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.576 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.639 ' CD2' HD21 ' B' ' 24' ' ' LEU . 27.4 m-85 -94.25 -29.62 14.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -74.65 -41.59 60.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.46 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.18 26.15 10.76 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.75 15.43 1.09 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -127.81 100.49 5.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.997 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.567 ' H ' HG13 ' B' ' 20' ' ' ILE . 5.3 mmt85 -138.87 -9.64 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.82 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.693 ' H ' ' CG1' ' B' ' 20' ' ' ILE . . . -45.52 145.05 2.9 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.571 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 28.7 ttt180 -66.87 118.26 10.12 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 61.8 t -93.64 136.5 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 43' ' ' ILE . 10.7 t-20 -165.86 150.93 8.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.279 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.542 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 88.0 tttt -48.45 -55.5 10.73 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.357 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' HD22 ' A' ' 42' ' ' ASN . 6.3 pttp -59.31 -5.28 0.71 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -125.12 0.5 7.86 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.231 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.9 -38.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.907 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -97.63 9.85 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.575 1.179 . . . . 0.0 108.015 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.797 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -125.82 6.44 7.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.535 -1.666 . . . . 0.0 107.664 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.731 ' C ' ' HE ' ' B' ' 17' ' ' ARG . 0.1 OUTLIER -107.97 176.16 5.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.687 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.789 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -94.57 111.75 23.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.794 ' O ' HD13 ' A' ' 49' ' ' ILE . 45.9 mt -75.21 115.39 14.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.801 ' HB ' HD23 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -161.02 -40.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -136.1 20.44 3.59 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.885 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -86.72 137.78 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.71 ' H ' HD23 ' A' ' 51' ' ' LEU . 76.2 tttt -71.1 135.89 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.669 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 54' ' ' ARG . 1.8 p -149.48 171.89 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.442 0.639 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -146.98 140.27 25.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.901 178.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 65' ' ' GLY . 42.9 t -91.25 99.53 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.43 -50.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.457 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.33 117.9 13.89 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 4.5 t -150.27 174.02 13.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.758 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.691 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 1.4 p -97.14 78.84 2.79 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.716 ' O ' HG13 ' A' ' 64' ' ' VAL . 71.1 m-70 -166.56 111.71 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.696 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.05 -6.03 17.23 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.88 1.72 . . . . 0.0 112.654 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.08 13.72 9.03 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.763 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 87' ' ' TRP . 30.5 m-85 -138.82 -22.74 0.95 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.345 1.072 . . . . 0.0 111.589 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 60' ' ' HIS . 8.8 m -71.82 145.63 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.52 6.4 89.2 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.365 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.962 HG21 ' CZ2' ' A' ' 87' ' ' TRP . 26.1 mt -111.9 158.4 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 66' ' ' ILE . 4.5 tt0 -115.13 120.54 40.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.88 171.37 26.86 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.145 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -91.03 129.91 36.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.3 t -68.13 153.84 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.369 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.693 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 85.2 mt -141.59 -55.96 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.671 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 0.8 OUTLIER -106.41 150.21 26.26 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.676 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -156.68 107.05 2.33 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.477 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.73 -173.13 3.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 110.759 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -52.21 -29.5 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.581 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 10.3 t-20 -137.98 31.37 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.678 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -157.13 161.46 39.38 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 118.992 -1.083 . . . . 0.0 113.358 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.715 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.3 tp -161.93 109.23 1.37 Allowed 'General case' 0 C--O 1.243 0.748 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 72' ' ' ASP . 80.4 t -107.86 147.29 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -131.11 143.86 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.002 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.07 136.19 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.945 0.403 . . . . 0.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.86 136.89 5.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 51.77 -133.93 1.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.517 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -102.23 33.75 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 22.1 tptm -145.46 160.34 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.092 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 14.0 m -120.57 156.69 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.588 0.709 . . . . 0.0 110.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.962 ' CZ2' HG21 ' A' ' 66' ' ' ILE . 2.6 m-90 -107.35 128.62 54.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.209 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' C ' ' CG2' ' A' ' 89' ' ' VAL . 83.0 tttt -118.64 106.54 12.71 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -152.31 99.58 2.85 Favored Pre-proline 0 CA--C 1.528 0.112 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.565 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 50.8 Cg_exo -50.66 137.9 41.16 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.812 1.675 . . . . 0.0 110.795 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.611 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -49.98 -19.9 0.81 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.787 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.611 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 1.2 p-10 -84.8 -6.17 59.34 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -125.12 5.89 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -142.34 139.41 31.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.117 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mt -85.71 116.99 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.727 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 53.1 m-85 -98.12 130.31 44.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 106' ' ' ILE . 38.3 tt0 -113.5 97.28 6.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.727 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 47.2 m-85 -90.28 145.14 25.21 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -90.62 127.04 36.15 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.773 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.662 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -63.01 143.62 57.62 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.765 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.831 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.43 -0.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.402 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.7 t0 -106.85 13.38 27.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.23 21.92 69.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.662 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.58 149.77 26.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.625 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.495 ' HG3' HH21 ' A' ' 54' ' ' ARG . 0.1 OUTLIER -91.05 132.4 36.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 20.6 mt -105.52 134.07 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.281 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -112.54 101.03 9.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -138.11 136.18 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.431 -177.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' GLU . 3.8 m -81.32 134.66 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.668 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' LYS . . . -59.33 -2.19 1.4 Allowed Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.829 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 pt-20 -86.19 -21.06 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.916 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -63.45 -44.33 94.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.92 27.72 3.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.216 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.3 p -48.1 103.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.471 0.653 . . . . 0.0 112.333 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' A' ' 91' ' ' LYS . . . 67.05 -41.44 0.2 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.725 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 119' ' ' MET . 12.4 mtt85 -100.52 97.4 6.48 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HB2' ' NH2' ' B' ' 17' ' ' ARG . 24.7 Cg_endo -69.32 -30.16 24.78 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 N-CA-C 107.1 -1.923 . . . . 0.0 107.1 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.593 ' HB3' HD13 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -64.79 -53.3 49.13 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.703 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 118' ' ' GLU . 0.8 OUTLIER -29.37 -36.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.056 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.631 ' CZ ' ' CH2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -82.39 -53.32 6.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.017 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.42 -31.25 54.81 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp . . . . . 0 CA--C 1.531 0.232 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.463 179.856 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.654 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -78.45 -37.88 42.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.576 -0.45 . . . . 0.0 112.161 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.862 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.3 OUTLIER -72.12 -33.24 67.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 122.958 1.361 . . . . 0.0 108.237 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.969 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -59.85 -51.01 71.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 112.013 -2.358 . . . . 0.0 111.216 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.477 ' HA ' ' OE2' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -69.68 -29.34 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.23 -48.57 64.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.503 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.425 ' O ' HG22 ' B' ' 18' ' ' ILE . 10.1 tptt -50.75 -51.15 53.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' HD13 ' B' ' 20' ' ' ILE . 17.5 pt-20 -72.74 -36.7 67.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.206 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 46' ' ' HIS . 34.5 ttt-85 -60.92 -52.53 64.65 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.857 0.837 . . . . 0.0 110.606 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -35.91 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.422 -177.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.75 -32.15 72.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.693 ' CG1' ' H ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -73.78 -55.05 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.996 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.59 -34.45 75.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.996 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -54.43 -51.29 65.41 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.017 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -69.1 -31.53 70.3 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.501 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.818 HD12 HG13 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -69.11 -54.4 15.17 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.19 -34.3 31.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.614 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.837 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 49.6 mt-10 -73.89 -43.08 59.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.44 0.638 . . . . 0.0 110.437 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.86 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 86.0 mtt-85 -71.4 -35.42 71.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.384 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.205 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.4 m -82.33 -50.7 15.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 O-C-N 121.336 -0.853 . . . . 0.0 110.485 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.703 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 2.1 t80 -36.42 -51.2 1.84 Allowed Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.616 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.86 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.2 Cg_endo -53.66 -46.72 31.65 Favored 'Trans proline' 0 C--N 1.296 -2.188 0 N-CA-C 106.129 -2.297 . . . . 0.0 106.129 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' B' ' 28' ' ' VAL . 41.9 t80 -95.0 -14.32 24.46 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.139 -2.301 . . . . 0.0 113.269 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.205 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.6 p -157.91 96.24 1.95 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 52.7 Cg_exo -55.09 -47.4 26.62 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.967 2.445 . . . . 0.0 114.347 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.21 -53.2 56.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.548 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 62.0 mt -51.74 -60.25 3.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.984 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.8 -32.95 60.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.812 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.29 -38.46 75.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.702 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.854 ' NH1' HD11 ' B' ' 42' ' ' LEU . 3.8 tmm_? -60.72 -50.35 73.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.027 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.8 OUTLIER -64.26 -40.46 96.04 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.8 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.02 -37.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -66.97 -45.45 77.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.854 HD11 ' NH1' ' B' ' 38' ' ' ARG . 11.6 mt -63.37 -50.7 68.88 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.454 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.14 -30.29 68.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.805 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 10.4 mt -65.33 -54.43 29.13 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 118' ' ' GLU . 3.5 pp -59.6 -35.03 73.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.673 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.712 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.4 t -64.94 -49.89 77.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.435 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.11 -51.13 70.91 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.022 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 7.0 pt20 -78.85 -39.64 34.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.77 ' HD3' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -83.06 -42.21 17.72 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.089 -177.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -67.06 -14.87 63.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 mttm 72.54 52.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.021 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.995 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.623 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 36.2 m0 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.624 0.25 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -66.26 -17.06 64.52 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' B' ' 60' ' ' ARG . 9.6 ptp180 -76.17 -18.86 58.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.84 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.802 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -147.53 15.34 1.12 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.417 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 32.4 t80 -113.54 154.08 27.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.584 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 5.8 t -123.66 114.51 20.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.896 0.379 . . . . 0.0 111.448 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.36 3.89 12.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.921 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -98.27 -43.49 6.94 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.482 ' C ' ' CG ' ' B' ' 67' ' ' HIS . 6.1 p -134.14 -2.64 2.84 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.599 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER 61.94 134.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.513 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 164.97 -170.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.098 0.475 . . . . 0.0 110.783 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.825 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -117.96 103.92 10.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.802 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -110.23 117.35 33.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.45 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.688 HG23 ' CE2' ' B' ' 29' ' ' PHE . 1.5 t -101.59 121.06 52.63 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.939 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.15 124.79 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.792 1.662 . . . . 0.0 111.38 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.98 -33.93 6.18 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.488 HD12 HG11 ' B' ' 71' ' ' VAL . 96.6 mt -96.78 -80.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.854 0.359 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.43 18.6 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.115 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 N--CA 1.465 0.315 0 O-C-N 123.502 0.501 . . . . 0.0 109.785 178.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 22' ' ' GLU . 8.6 m-85 -43.23 -57.23 3.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -38.62 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.902 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 20' ' ' TYR . 47.0 tp10 -104.13 -32.6 9.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.728 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.1 mm -102.05 15.58 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 25' ' ' GLY . 1.2 tp -79.51 117.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.373 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.41 -36.42 4.06 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.328 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.676 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.32 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.631 0.716 . . . . 0.0 110.793 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.693 ' H ' ' C ' ' A' ' 25' ' ' GLY . 14.2 p -41.9 -14.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 109.601 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.676 ' N ' ' O ' ' A' ' 26' ' ' ARG . 23.2 t-105 -57.31 -53.74 54.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.212 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' B' ' 28' ' ' VAL . 8.6 pt -67.67 -13.11 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.082 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 49' ' ' ILE . 41.3 m-85 -92.8 -9.88 38.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.5 ttp180 -95.04 -64.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.77 31.74 0.38 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -146.63 -36.51 0.24 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -90.84 112.29 24.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.785 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.6 OUTLIER -148.47 2.13 0.63 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.943 -179.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA3' HH22 ' B' ' 17' ' ' ARG . . . -45.91 153.56 0.8 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 9.2 ttm180 -67.69 117.73 10.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 47.0 t -95.25 134.2 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 43' ' ' ILE . 5.7 t-20 -166.1 149.94 7.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.276 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' ASN . 11.3 tttm -48.26 -55.14 11.3 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.576 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 44.2 pttt -59.91 -4.86 0.81 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 10.8 m120 -123.77 -0.35 8.56 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.229 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.54 -39.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.849 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.3 9.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.833 1.301 . . . . 0.0 107.578 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -126.55 -6.44 6.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.849 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.751 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -93.35 147.1 23.23 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.866 ' OE1' ' NE ' ' B' ' 17' ' ' ARG . 0.4 OUTLIER -74.48 110.64 8.93 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 49' ' ' ILE . 15.8 mt -73.24 117.94 15.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.4 mm -152.69 -30.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.763 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -146.76 0.03 0.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.541 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -58.32 162.35 3.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.665 0.732 . . . . 0.0 109.488 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.843 ' H ' HD23 ' A' ' 51' ' ' LEU . 11.9 tttt -106.73 125.16 50.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.472 0.177 . . . . 0.0 111.171 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.003 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.5 p -148.97 170.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.443 0.639 . . . . 0.0 111.513 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.708 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -132.27 145.43 51.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.439 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' GLY . 23.7 t -100.83 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.34 -47.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.937 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -127.77 119.43 25.72 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.133 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.9 p -148.61 135.95 20.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.052 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.629 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -71.26 77.1 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.281 -1.368 . . . . 0.0 108.948 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.629 ' CG ' ' C ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -169.29 97.89 0.5 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.027 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.89 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.469 2.113 . . . . 0.0 113.774 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -124.0 24.43 6.33 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 120.402 -0.904 . . . . 0.0 114.407 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -141.05 -21.98 0.78 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.804 1.302 . . . . 0.0 111.694 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 58' ' ' SER . 3.1 m -72.96 145.08 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.75 5.31 89.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.919 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.615 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.1 mt -104.64 148.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 118.259 1.03 . . . . 0.0 111.538 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -114.71 126.97 55.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.81 173.37 27.9 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.981 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -95.85 120.21 35.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.7 t -53.12 141.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.117 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.729 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.6 mt -135.39 -36.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.971 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 1.7 t70 -121.83 141.68 50.99 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.639 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 5.0 tt0 -153.19 106.23 2.97 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -140.42 -176.77 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.125 0.488 . . . . 0.0 110.725 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 72.6 ttt-85 -57.96 -16.46 12.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.816 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -138.77 27.29 2.46 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.551 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 2.4 ptp -165.96 170.02 14.12 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 118.7 -1.2 . . . . 0.0 114.066 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 96' ' ' PHE . 1.4 tp -166.13 110.24 0.8 Allowed 'General case' 0 C--O 1.252 1.233 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.907 ' C ' HD13 ' A' ' 80' ' ' ILE . 66.0 t -120.01 136.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.975 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -114.84 151.96 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -128.13 135.93 50.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.122 0.486 . . . . 0.0 111.82 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.442 ' N ' ' HZ3' ' A' ' 87' ' ' TRP . . . -157.53 122.64 1.19 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 66.73 -130.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -108.69 18.17 21.12 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.947 0.403 . . . . 0.0 110.101 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -119.56 144.51 47.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.425 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.73 155.47 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.512 0.673 . . . . 0.0 110.959 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.618 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 3.2 m-90 -99.39 137.69 37.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.294 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -128.95 93.74 3.67 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.14 107.35 2.63 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.366 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.29 165.0 2.42 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.794 1.662 . . . . 0.0 110.563 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.699 ' HD2' ' H ' ' A' ' 115' ' ' GLY . 1.7 mttm -72.79 -21.42 60.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.68 -5.73 59.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.0 15.36 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 15.1 p -161.32 174.29 13.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.015 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.09 139.72 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.807 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.849 ' CE2' HD23 ' A' ' 78' ' ' LEU . 88.1 m-85 -121.66 131.31 54.03 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 1.003 ' C ' HG23 ' A' ' 53' ' ' VAL . 43.9 tt0 -114.69 94.48 4.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' ILE . 3.1 m-85 -86.74 145.24 26.73 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -89.78 129.4 36.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.659 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.06 143.36 57.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.729 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.37 0.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.55 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.539 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 84.8 m-20 -107.26 13.42 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.01 21.93 66.94 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.87 150.05 26.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.635 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 133.3 36.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 111.121 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 100' ' ' THR . 16.0 mt -106.49 134.03 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -115.93 102.98 10.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -147.8 140.93 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.34 -178.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -88.38 150.71 23.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.435 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.34 -1.77 4.73 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.604 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 -21.55 47.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.658 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -73.66 -47.5 39.35 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.297 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.75 28.04 2.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.0 p -55.42 106.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.699 ' H ' ' HD2' ' A' ' 91' ' ' LYS . . . 68.2 -41.08 0.28 Allowed Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.476 -1.238 . . . . 0.0 114.464 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -101.92 87.87 1.13 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -69.47 -26.41 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.632 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.99 -57.69 7.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.685 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.424 ' C ' ' O ' ' A' ' 118' ' ' GLU . 5.3 ttp -31.43 -54.35 0.24 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.767 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -45.21 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.298 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -48.06 -30.98 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.251 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.413 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.758 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 28.9 mt-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -78.76 -29.07 44.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.951 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -33.93 64.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.68 1.229 . . . . 0.0 108.526 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.963 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -63.6 -51.7 64.14 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 112.322 -2.217 . . . . 0.0 111.722 -178.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.541 ' O ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -71.07 -27.12 28.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -68.74 -39.95 80.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.418 ' O ' HG22 ' B' ' 18' ' ' ILE . 47.1 mttt -63.17 -49.56 73.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.962 0.411 . . . . 0.0 110.488 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.521 ' C ' ' NH1' ' B' ' 17' ' ' ARG . 1.0 OUTLIER -69.34 -35.36 75.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.866 ' NE ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -62.16 -52.04 65.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.512 0.672 . . . . 0.0 111.342 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.99 -41.65 91.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.594 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 5.3 m-20 -69.78 -26.74 64.43 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.692 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.785 HD12 ' H ' ' A' ' 35' ' ' ARG . 5.7 mm -74.16 -57.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.67 -34.26 76.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.0 ' H ' HD13 ' B' ' 21' ' ' LEU . 11.6 t80 -53.72 -47.89 70.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.381 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 37.7 m -70.95 -34.11 71.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.449 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -67.86 -55.18 13.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.552 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.545 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -50.62 -38.44 46.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.735 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.823 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 23.7 mt-10 -65.84 -46.79 77.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.15 0.5 . . . . 0.0 111.263 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.889 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 1.7 ttt-85 -72.17 -33.47 67.72 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.354 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.171 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.7 m -82.6 -50.71 15.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.424 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.73 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 1.6 t80 -36.39 -50.63 1.82 Allowed Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.889 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.3 Cg_endo -53.64 -46.36 34.27 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 N-CA-C 106.21 -2.265 . . . . 0.0 106.21 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.8 ' N ' ' O ' ' B' ' 28' ' ' VAL . 39.8 t80 -94.92 -12.66 26.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.028 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.171 ' N ' ' O ' ' B' ' 28' ' ' VAL . 60.5 p -160.34 96.67 1.48 Allowed Pre-proline 0 N--CA 1.472 0.654 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.64 -44.75 45.02 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.261 2.641 . . . . 0.0 114.439 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.34 -53.0 55.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.035 0.445 . . . . 0.0 112.133 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.521 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 24.3 mt -53.81 -61.14 2.5 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.093 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.55 -32.72 42.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.725 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -70.46 -41.05 73.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.079 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.864 HH11 HD11 ' B' ' 42' ' ' LEU . 2.8 tmm_? -59.68 -53.58 56.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.555 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.91 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.1 m-30 -58.88 -43.17 90.86 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 110.049 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.513 HG23 ' CD2' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -46.32 -40.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.902 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.95 -42.21 99.75 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.864 HD11 HH11 ' B' ' 38' ' ' ARG . 63.2 mt -67.39 -51.36 52.83 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.477 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -52.23 -31.03 30.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.987 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 23.8 mt -65.33 -54.44 28.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.305 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.673 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.4 pp -62.02 -28.3 69.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.832 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.905 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 95.1 t -64.34 -48.87 83.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.602 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.434 ' NE2' ' CD1' ' B' ' 18' ' ' ILE . 1.8 tp-100 -65.74 -57.41 8.09 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.8 pt20 -81.62 -52.16 7.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 5.4 tptt -62.96 -37.71 88.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.889 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -81.45 -0.71 42.9 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.725 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 63.61 69.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.744 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.743 179.012 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.626 ' O ' ' N ' ' B' ' 62' ' ' TYR . 6.0 m-90 . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.543 0.211 . . . . 0.0 111.315 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -61.65 -19.66 62.55 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.81 -17.79 64.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.818 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -150.74 8.3 0.57 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.64 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' B' ' 58' ' ' TRP . 92.6 t80 -117.72 157.5 26.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.988 0.423 . . . . 0.0 110.551 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' B' ' 62' ' ' TYR . 22.6 t -126.99 129.99 49.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.042 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -87.33 3.13 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.79 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -108.16 -31.44 7.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.796 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' B' ' 67' ' ' HIS . 11.5 p -138.96 10.44 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.209 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.0 OUTLIER 37.12 103.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.985 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.781 ' HB1' ' NZ ' ' B' ' 37' ' ' LYS . . . -162.25 -173.05 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.122 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.618 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -113.97 103.18 10.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -105.57 147.56 28.26 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.632 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.511 HG11 HD12 ' B' ' 74' ' ' ILE . 2.5 t -125.95 120.72 24.11 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.86 123.64 6.29 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.859 1.706 . . . . 0.0 111.654 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.13 -33.26 6.67 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.511 HD12 HG11 ' B' ' 71' ' ' VAL . 94.8 mt -94.44 -80.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.615 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.86 22.64 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.225 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.51 -0.592 0 CA-C-O 120.516 0.198 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 76' ' ' ALA . 14.1 mt . . . . . 0 C--N 1.329 -0.326 0 O-C-N 124.597 1.186 . . . . 0.0 108.279 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.951 0.405 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' A' ' 72' ' ' ASP . 54.0 m-85 -38.32 -62.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.915 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.39 -7.92 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.414 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.3 tp10 -97.9 -36.93 10.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' B' ' 31' ' ' TYR . 2.5 mm -104.51 14.16 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.3 tp -79.98 118.8 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.413 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 120.07 -38.85 2.63 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -66.87 27.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.676 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -41.94 -14.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.739 0.78 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 28.1 t-105 -58.71 -54.44 47.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.329 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.755 ' CD1' HG12 ' B' ' 28' ' ' VAL . 4.7 pt -66.2 -14.25 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -89.71 -34.35 16.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.98 -32.61 19.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.765 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' NH1' ' B' ' 27' ' ' ARG . . . -85.48 28.81 4.64 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -156.13 20.72 0.37 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -127.15 101.91 6.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.671 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.472 ' H ' ' CG1' ' B' ' 20' ' ' ILE . 23.0 mmt-85 -145.85 12.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.938 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.644 ' HA3' HH21 ' B' ' 17' ' ' ARG . . . -62.32 152.45 44.3 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 14.9 ttm180 -67.31 132.84 48.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.805 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 55.1 t -116.8 136.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.707 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.691 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -166.23 153.81 10.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.617 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' ASN . 28.8 tttm -49.83 -55.8 12.81 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.837 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.623 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 42.9 pttt -60.64 -3.51 0.72 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.746 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 31.6 m-20 -124.72 1.12 8.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.26 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.98 -42.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.876 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.853 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.7 0.79 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.853 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -117.23 18.04 14.59 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.008 -1.906 . . . . 0.0 107.68 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.23 126.58 45.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.925 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -59.28 113.42 2.15 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 98' ' ' PHE . 2.6 mt -78.13 122.18 25.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.759 0.314 . . . . 0.0 111.001 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.784 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.0 mm -151.22 -46.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.936 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -127.57 -3.06 6.15 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.181 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -60.35 140.87 56.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.248 0.524 . . . . 0.0 110.358 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.651 ' H ' HD23 ' A' ' 51' ' ' LEU . 64.1 tttt -75.38 135.56 40.8 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 2.7 p -148.75 170.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.546 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -150.33 140.52 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.855 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.4 t -88.19 100.79 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.5 -51.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 O-C-N 123.374 0.421 . . . . 0.0 110.512 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.7 118.75 15.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.182 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.65 ' HB3' HG12 ' A' ' 64' ' ' VAL . 23.3 t -148.74 174.23 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.96 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.703 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 5.9 t -103.11 78.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 59' ' ' THR . 19.2 m80 -167.62 118.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.17 -5.29 15.48 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 121.73 1.62 . . . . 0.0 112.975 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.14 20.94 7.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.187 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.21 -23.09 0.75 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.905 1.352 . . . . 0.0 112.098 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 58' ' ' SER . 3.3 m -71.57 145.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.64 7.31 87.6 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.257 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.845 ' CD1' ' HE1' ' A' ' 87' ' ' TRP . 19.8 mt -108.05 159.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' N ' HG22 ' A' ' 66' ' ' ILE . 5.7 tm-20 -126.76 121.82 33.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.459 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -148.09 172.38 28.38 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.073 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 1.6 m-85 -87.32 123.56 32.42 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.9 t -56.43 157.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.9 mt -143.73 -60.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 62.0 t0 -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.828 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -153.72 106.56 2.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 178.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -157.97 177.59 11.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.225 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.505 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 44.8 ttm-85 -53.69 -5.12 0.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.274 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.783 ' H ' HG23 ' A' ' 74' ' ' THR . 78.3 m-20 -137.98 0.79 2.21 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 74' ' ' THR . 4.8 ptp -165.78 167.89 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.895 HD23 ' CE2' ' A' ' 96' ' ' PHE . 4.5 tp -151.16 109.72 3.81 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.1 t -113.71 147.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -127.99 141.57 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.999 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -110.46 136.48 49.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -151.56 119.0 0.94 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 3.5 tp10 65.07 -123.14 0.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.404 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 3.3 m120 -111.57 21.01 16.61 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.973 0.416 . . . . 0.0 110.475 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.542 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.0 tttp -130.66 164.46 24.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.481 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.469 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 29.2 m -120.67 156.28 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 110.637 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.845 ' HE1' ' CD1' ' A' ' 66' ' ' ILE . 2.5 m-90 -105.62 104.49 14.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.182 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.93 110.26 22.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.98 96.35 3.31 Favored Pre-proline 0 C--N 1.334 -0.097 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.224 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -55.75 146.31 66.99 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.882 1.721 . . . . 0.0 111.308 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.562 ' CD ' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.68 -29.11 37.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.613 -178.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -6.96 59.55 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -126.13 22.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.509 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.662 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 24.6 p -165.27 158.3 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.457 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 109' ' ' SER . 57.5 mt -112.58 124.62 69.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.627 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.895 ' CE2' HD23 ' A' ' 78' ' ' LEU . 72.4 m-85 -100.92 144.53 29.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 18.6 tt0 -125.75 97.59 5.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 48' ' ' LEU . 8.1 m-85 -90.45 145.72 24.7 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -89.46 130.76 35.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.068 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.66 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -65.48 142.46 58.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.483 0.659 . . . . 0.0 110.265 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.805 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.24 0.19 0.11 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.678 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.1 t0 -107.15 4.43 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.77 23.2 36.64 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -107.05 150.16 26.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 110.35 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -90.52 128.8 36.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 111.359 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 100' ' ' THR . 14.1 mt -104.03 135.07 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -120.35 101.82 8.05 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.497 HG21 HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -142.25 132.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.063 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.2 m -74.34 145.34 43.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.153 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -63.86 -2.52 6.48 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.546 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -81.46 -22.79 37.87 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.62 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -69.22 -44.56 71.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.022 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -99.0 29.38 3.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.9 p -54.36 105.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.82 -40.49 0.31 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.685 -1.143 . . . . 0.0 114.735 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 119' ' ' MET . 21.2 mtm-85 -100.49 85.75 0.57 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.68 -23.45 76.32 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.9 OUTLIER -68.59 -57.25 6.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.489 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 118' ' ' GLU . 26.4 ttp -24.8 -48.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.572 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' GLU . 2.9 tpm_? -82.58 -49.18 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.852 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -52.15 -39.11 59.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.495 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 118' ' ' GLU . 1.3 ptmt . . . . . 0 N--CA 1.462 0.163 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.917 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.524 ' O ' HG12 ' B' ' 13' ' ' ILE . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.58 ' H ' ' CD ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -53.73 -37.28 63.19 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.009 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.539 ' HG2' ' HD2' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -65.41 -46.64 79.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.276 1.036 . . . . 0.0 109.38 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.624 ' O ' ' CD ' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -64.92 -51.05 63.99 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.314 -1.767 . . . . 0.0 112.433 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.524 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.8 pt -62.61 -27.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.5 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -70.57 -38.14 74.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.418 ' HD3' HH21 ' B' ' 12' ' ' ARG . 37.1 mttt -60.85 -47.2 87.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.702 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.635 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -67.31 -38.43 84.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.366 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.678 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 2.6 mmp_? -67.39 -52.31 41.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.499 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -57.48 -42.53 81.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 6.9 m-20 -71.71 -32.42 67.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -71.33 -53.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.951 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.1 -33.54 76.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.951 ' N ' HD13 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -52.1 -44.33 64.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.943 178.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 18.7 p -73.86 -31.9 63.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.331 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -68.46 -58.21 4.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.26 -42.41 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.82 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -60.03 -50.65 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.529 0.68 . . . . 0.0 110.031 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.875 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 2.9 ttm180 -67.9 -37.74 82.12 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.958 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.213 ' O ' ' N ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -86.75 -42.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.363 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.787 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 25.2 t80 -39.17 -49.11 4.44 Favored Pre-proline 0 CA--C 1.509 -0.624 0 CA-C-N 119.982 1.265 . . . . 0.0 108.689 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.875 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.3 Cg_endo -54.45 -46.85 30.35 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.389 2.06 . . . . 0.0 106.747 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 34.8 t80 -93.53 -14.51 26.52 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.534 -2.121 . . . . 0.0 112.37 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.213 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -163.49 95.98 1.05 Allowed Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' B' ' 29' ' ' PHE . 52.3 Cg_exo -54.63 -45.09 43.57 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.197 2.598 . . . . 0.0 114.684 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.77 -53.65 53.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.745 ' CD2' HH21 ' B' ' 38' ' ' ARG . 32.4 mt -51.78 -58.39 6.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.7 -30.92 34.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.398 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.653 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.02 -41.75 70.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.612 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.745 HH21 ' CD2' ' B' ' 35' ' ' LEU . 2.4 ttm-85 -63.26 -46.98 84.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.897 ' CB ' HD23 ' B' ' 21' ' ' LEU . 2.2 m-85 -67.91 -40.06 83.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.942 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.4 t -46.63 -40.96 4.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.901 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.57 -38.73 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.821 HD11 ' OE1' ' A' ' 73' ' ' GLU . 17.9 mt -66.91 -45.43 77.96 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.718 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' B' ' 21' ' ' LEU . . . -58.0 -30.54 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.364 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.823 HD11 ' OH ' ' B' ' 62' ' ' TYR . 60.6 mt -69.02 -54.77 13.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.071 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' A' ' 118' ' ' GLU . 3.1 pp -57.4 -30.85 65.27 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.958 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 58.0 t -62.05 -47.13 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.525 0.679 . . . . 0.0 109.479 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.66 -56.12 10.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.384 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 5.7 pt20 -80.21 -46.74 15.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.21 -38.31 69.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.593 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -86.03 -9.63 56.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 63.02 74.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.307 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.221 178.42 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.496 ' C ' ' H ' ' B' ' 60' ' ' ARG . 5.0 m0 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -61.37 -6.84 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' B' ' 58' ' ' TRP . 11.8 ptp180 -93.08 -21.9 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.973 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.851 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -145.76 29.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.373 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.823 ' OH ' HD11 ' B' ' 44' ' ' LEU . 24.2 t80 -122.4 151.6 41.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.567 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 1.5 t -123.04 114.3 20.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.524 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -83.83 9.13 12.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 109.567 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.437 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 9.1 mmmt -99.34 -40.4 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.01 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.4 p -136.79 9.29 3.07 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.271 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.547 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.4 m80 54.84 122.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 172.22 -171.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.163 0.506 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.653 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 1.8 t80 -123.6 105.4 9.7 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.937 ' N ' HD22 ' B' ' 70' ' ' LEU . 0.2 OUTLIER -111.42 124.97 53.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.507 -177.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.55 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 66.5 t -106.23 127.21 28.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -47.9 125.98 12.28 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.174 1.916 . . . . 0.0 112.372 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.24 -35.93 4.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.5 -76.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.22 19.29 13.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.047 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 37.4 mt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.039 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 22' ' ' GLU . 96.4 p . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.751 0.31 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.674 ' HB3' HG11 ' A' ' 86' ' ' VAL . 8.1 m-85 -40.19 -58.85 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -49.57 -15.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.749 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' SER . 49.0 tp10 -104.49 -33.13 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.6 mm -100.83 18.7 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.0 tp -79.66 117.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.421 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.66 -38.1 3.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.537 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.7 32.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.738 0.769 . . . . 0.0 111.32 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.648 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -44.82 -11.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.642 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.9 t-105 -59.74 -59.85 4.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.858 HD12 HG12 ' B' ' 28' ' ' VAL . 17.8 pt -60.93 -10.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.216 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CD2' HD11 ' B' ' 24' ' ' LEU . 39.3 m-85 -94.19 -19.26 20.92 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 33' ' ' ALA . 6.5 mmm-85 -80.7 -69.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.528 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.33 44.16 1.11 Allowed Glycine 0 CA--C 1.518 0.276 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -158.09 -38.87 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' H ' ' A' ' 49' ' ' ILE . 44.7 t-80 -109.49 100.05 9.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.776 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -154.03 13.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.788 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.51 163.55 0.04 OUTLIER Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.636 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 7.8 ttt180 -67.84 112.34 4.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.369 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.813 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 54.5 t -90.19 136.37 24.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -165.6 145.95 6.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.048 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 59.9 tttm -47.14 -54.4 10.66 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.421 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 47.1 pttt -62.82 -4.46 2.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.645 ' N ' ' O ' ' A' ' 39' ' ' ASN . 7.0 m120 -121.68 -4.61 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.439 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.87 -40.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.745 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.899 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -87.38 10.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.993 1.378 . . . . 0.0 107.394 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.899 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.98 -38.4 2.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.975 -1.92 . . . . 0.0 107.636 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HD1' ' CG2' ' B' ' 13' ' ' ILE . 0.0 OUTLIER -58.4 174.48 0.3 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.755 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' OE2' ' CZ ' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -100.76 109.05 21.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 176.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.873 ' O ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -76.54 117.05 17.79 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 117.585 -1.646 . . . . 0.0 108.055 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -162.56 40.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.93 -29.17 0.59 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.504 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -45.54 137.62 4.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.492 ' H ' HD23 ' A' ' 51' ' ' LEU . 4.4 ttpt -77.79 128.9 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.785 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HG21 ' A' ' 80' ' ' ILE . 5.2 p -148.4 169.37 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.39 0.614 . . . . 0.0 111.211 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.733 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -139.26 146.98 41.08 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.994 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 89' ' ' VAL . 66.2 t -98.15 98.88 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -91.17 -51.57 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.996 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -126.06 118.32 25.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 64' ' ' VAL . 4.0 p -148.72 159.97 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.454 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.591 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -88.64 80.43 7.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 59' ' ' THR . 5.7 m170 -167.62 116.27 0.66 Allowed Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.77 -4.85 14.11 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.817 1.678 . . . . 0.0 113.961 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.43 32.88 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.686 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -141.26 -21.32 0.77 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.032 0.916 . . . . 0.0 111.645 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG12 ' OG ' ' A' ' 58' ' ' SER . 3.5 m -72.38 138.41 21.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.262 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 99.14 5.8 56.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.053 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.674 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.23 157.81 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.356 1.078 . . . . 0.0 112.047 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 tm-20 -123.9 126.83 47.07 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.694 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.28 174.19 27.15 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.862 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ALA . 6.4 m-85 -95.09 120.34 35.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -48.77 151.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 111.55 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 81' ' ' ALA . 48.4 mt -142.64 -58.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.8 t0 -107.91 143.65 36.24 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 3.3 mp0 -146.38 106.92 4.07 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.955 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.599 HG22 ' NH1' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -138.41 -175.01 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 9.4 ttp180 -50.76 -31.85 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.124 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 75' ' ' ARG . 94.0 m-20 -138.11 31.66 2.41 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.517 ' HG3' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -155.12 158.97 39.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.784 -1.167 . . . . 0.0 113.713 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -156.6 110.01 2.65 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 71' ' ' ILE . 73.3 t -111.49 145.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.222 0.534 . . . . 0.0 112.319 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -133.82 140.25 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.261 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.025 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -113.37 135.57 53.72 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.95 0.405 . . . . 0.0 111.48 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -145.77 159.2 27.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 82' ' ' GLY . 5.1 pt-20 32.72 -109.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 110.847 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -127.28 33.72 4.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.88 0.372 . . . . 0.0 110.46 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 23.9 tttp -143.1 160.49 40.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.398 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 20' ' ' TYR . 4.2 m -114.07 155.4 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.721 0.772 . . . . 0.0 110.903 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.822 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.2 m-90 -97.71 135.29 39.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -125.97 96.04 4.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.41 101.61 3.78 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.429 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.512 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.6 Cg_exo -55.66 145.19 72.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.696 1.597 . . . . 0.0 111.064 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.898 ' HZ2' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -53.28 -37.71 62.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.078 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.04 -6.38 56.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 93' ' ' VAL . 3.3 t -125.22 29.81 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.41 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 31.6 p -168.02 165.32 13.6 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 118.931 -1.108 . . . . 0.0 113.926 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -114.46 133.97 58.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.157 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.743 ' CE2' HD23 ' A' ' 78' ' ' LEU . 50.0 m-85 -117.06 130.79 56.89 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 53' ' ' VAL . 6.4 tt0 -116.96 94.84 4.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.72 ' CE2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -89.81 146.48 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 105' ' ' LYS . 45.9 tt0 -88.49 127.77 35.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.85 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.621 HG23 HD11 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -63.91 142.36 58.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.219 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.813 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.66 -0.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.668 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 101' ' ' TRP . 1.1 m-20 -107.19 16.51 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.95 23.72 73.9 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.63 149.7 26.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.646 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 99' ' ' GLU . 58.9 mmtt -92.15 131.86 37.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.731 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' THR . 27.5 mt -107.17 135.25 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.912 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -118.04 101.31 8.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -139.13 139.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.212 -177.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 17.4 p -78.49 149.0 33.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.089 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -71.43 -1.87 46.13 Favored Glycine 0 CA--C 1.508 -0.368 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -86.9 -22.44 25.69 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.597 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -63.03 -47.69 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.221 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.601 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -95.2 28.43 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.6 p -52.17 104.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.898 ' H ' ' HZ2' ' A' ' 91' ' ' LYS . . . 68.14 -41.48 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.376 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 24.5 mmt180 -101.86 88.03 1.16 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.53 -25.49 34.97 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 N-CA-C 108.106 -1.536 . . . . 0.0 108.106 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.796 ' HB3' HD22 ' B' ' 45' ' ' LEU . 12.8 pt-20 -66.21 -55.24 17.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.163 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 23.9 mmm -34.2 -41.74 0.12 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.128 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.697 ' HE ' ' CA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.93 -43.91 42.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.887 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.871 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -61.78 -41.09 97.27 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.146 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HZ1' ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.831 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.839 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 7.4 pt-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -79.77 -45.89 18.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' B' ' 14' ' ' ALA . 20.2 ttpt -72.44 -33.48 67.09 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.726 1.251 . . . . 0.0 108.617 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 1.041 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER -62.6 -51.86 65.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.658 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.721 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 33.5 mt -64.94 -27.51 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -65.27 -48.5 73.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.244 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -52.18 -48.71 64.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.937 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -70.12 -38.03 75.47 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.965 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.633 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -65.82 -52.03 53.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.366 0.603 . . . . 0.0 110.451 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.55 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.85 -42.76 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.19 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 1.5 m-20 -71.82 -22.18 61.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.937 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -75.49 -56.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.998 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.98 -34.43 77.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.998 ' H ' HD13 ' B' ' 21' ' ' LEU . 2.8 t80 -53.12 -44.06 67.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.921 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -64.66 -40.16 94.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.922 ' O ' HG13 ' B' ' 28' ' ' VAL . 1.9 mm? -56.9 -57.55 12.03 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.776 0.798 . . . . 0.0 109.297 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.04 -33.35 17.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.392 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.811 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 57.5 mt-10 -77.12 -55.82 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.914 0.864 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.852 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 79.9 mtt-85 -67.95 -35.88 79.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.474 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.182 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -85.48 -50.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.673 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.754 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 27.8 t80 -36.3 -49.34 1.73 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.173 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.852 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 36.5 Cg_endo -53.26 -47.86 25.17 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 N-CA-C 106.506 -2.151 . . . . 0.0 106.506 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 62.2 t80 -94.5 -15.17 24.41 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.289 -2.232 . . . . 0.0 113.08 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.182 ' N ' ' O ' ' B' ' 28' ' ' VAL . 43.0 p -158.04 91.19 2.21 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.84 -41.9 73.91 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.977 2.451 . . . . 0.0 113.88 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 55.8 mp0 -66.67 -54.25 25.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 25.9 mt -52.09 -55.38 21.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.985 0.422 . . . . 0.0 110.155 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.35 -30.24 50.96 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.331 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.704 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.48 -47.11 57.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.884 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.701 ' CD ' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -60.54 -53.3 59.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.799 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.956 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.2 m-85 -59.69 -42.57 93.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' B' ' 39' ' ' TYR . 1.1 t -45.05 -34.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.568 ' CD ' HH21 ' B' ' 38' ' ' ARG . 0.0 OUTLIER -70.65 -44.86 66.25 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' TYR . 49.4 mt -65.45 -47.89 74.59 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.961 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.72 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -57.17 -31.16 65.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.535 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.73 -50.94 69.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.383 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -61.95 -39.29 91.62 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.015 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.736 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 40.2 t -61.22 -49.23 85.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 111.49 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -49.6 72.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.714 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.84 -55.96 4.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.986 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.62 ' N ' ' O ' ' B' ' 45' ' ' LEU . 6.6 mmpt? -59.0 -43.29 91.46 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -79.07 -16.21 57.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 26.1 mttt 70.75 43.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.748 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.316 -0.885 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.745 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' NH1' ' B' ' 60' ' ' ARG . 5.4 m-90 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -66.75 -3.79 7.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' B' ' 58' ' ' TRP . 18.6 ptt-85 -82.28 -35.34 28.14 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.302 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -124.94 21.6 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.515 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -118.43 154.6 32.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 1.7 t -126.39 113.62 17.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.656 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -78.85 4.35 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.976 0.417 . . . . 0.0 109.986 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.449 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.4 OUTLIER -95.86 -38.23 10.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.538 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.0 p -138.72 -0.2 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.734 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.5 m80 61.52 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . 169.81 -171.41 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.065 0.46 . . . . 0.0 111.123 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.574 ' O ' ' CE2' ' B' ' 29' ' ' PHE . 13.2 t80 -121.19 103.02 8.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.842 ' N ' HD22 ' B' ' 70' ' ' LEU . 0.4 OUTLIER -113.58 119.26 36.89 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.411 0.624 . . . . 0.0 112.441 -177.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.602 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 61.1 t -96.16 136.13 22.24 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.046 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.92 118.55 5.59 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.719 1.613 . . . . 0.0 111.531 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.64 -33.42 4.64 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.57 -78.09 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' B' ' 93' ' ' LEU . 19.3 m-20 -116.77 19.76 14.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.929 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' B' ' 75' ' ' ASN . 84.0 mt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 22' ' ' GLU . 79.0 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' HG11 ' A' ' 79' ' ' VAL . 89.2 m-85 -37.45 -45.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.131 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -58.28 -21.58 49.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 19' ' ' SER . 4.5 tt0 -104.79 -38.0 6.83 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.458 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.818 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.61 24.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.462 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.651 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -80.01 118.98 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.712 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.687 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 83.68 -7.0 71.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.656 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.708 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -64.09 21.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.516 0.658 . . . . 0.0 109.887 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.687 ' H ' ' C ' ' A' ' 25' ' ' GLY . 7.0 p -38.13 -16.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.387 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.708 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.0 t-105 -58.67 -57.0 14.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.763 ' CD1' HG12 ' B' ' 28' ' ' VAL . 6.1 pt -65.68 -11.27 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.609 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' B' ' 24' ' ' LEU . 88.7 m-85 -96.32 -37.37 10.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.8 mmt180 -61.0 -68.43 0.31 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.144 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.81 52.02 1.59 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -150.43 -40.19 0.13 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.793 ' CE1' ' H ' ' A' ' 51' ' ' LEU . 1.9 m-70 -91.1 100.15 13.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.218 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -125.71 -20.54 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.984 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -40.67 146.6 0.34 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.9 ttm180 -67.11 118.96 11.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.808 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.1 t -92.8 136.69 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -164.98 150.74 9.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.124 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 42' ' ' ASN . 43.8 tttm -50.04 -55.68 13.8 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.217 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.61 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 52.2 pttt -58.85 -4.09 0.41 Allowed 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 73.8 m-20 -126.06 0.48 7.21 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.27 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.801 HD11 ' CG ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.41 -38.14 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.261 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.809 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.7 0.75 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.814 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.81 6.9 14.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.829 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -115.41 139.13 50.29 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.775 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.804 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -59.95 111.77 1.61 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.924 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -74.09 116.34 14.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 177.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 48' ' ' LEU . 3.7 mm -153.64 -29.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.289 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.663 ' H ' ' CE1' ' A' ' 34' ' ' HIS . . . -138.22 -25.38 0.35 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.922 HD23 ' H ' ' A' ' 52' ' ' LYS . 1.5 tt -44.2 150.03 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.922 ' H ' HD23 ' A' ' 51' ' ' LEU . 82.8 tttt -93.62 131.41 38.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.057 0.456 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.952 HG23 ' C ' ' A' ' 97' ' ' GLU . 7.9 p -148.77 166.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.0 t -94.61 98.87 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.18 -48.09 17.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.451 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -132.94 120.77 21.88 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.956 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.561 ' OG ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -147.25 172.71 13.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.093 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.623 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 4.4 t -104.14 77.08 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.062 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -169.28 96.87 0.51 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.72 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 -4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.324 2.016 . . . . 0.0 113.237 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -122.74 19.28 7.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.507 -0.854 . . . . 0.0 114.474 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' ' N ' ' A' ' 88' ' ' LYS . 54.8 m-85 -142.34 -23.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.181 1.491 . . . . 0.0 112.28 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.561 HG12 ' OG ' ' A' ' 58' ' ' SER . 1.5 m -74.04 144.36 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 85.86 5.61 83.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.51 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.605 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.2 mt -107.53 153.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.924 0.862 . . . . 0.0 111.59 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' C ' ' CZ2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.58 126.46 53.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.472 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.3 173.78 27.31 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.93 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -96.73 117.69 31.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.634 0.374 . . . . 0.0 110.098 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -50.15 148.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.693 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.709 ' N ' ' O ' ' A' ' 79' ' ' VAL . 95.0 mt -143.87 -60.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -108.01 134.79 50.41 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.606 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -144.69 107.14 4.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.869 HG22 ' NH2' ' B' ' 38' ' ' ARG . 2.6 p -132.96 -169.6 2.29 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -52.76 -27.44 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -138.71 31.59 2.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.887 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 2.0 ptp -153.75 160.82 42.41 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.934 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.002 HD23 ' CE2' ' A' ' 96' ' ' PHE . 7.3 tp -163.86 110.15 1.09 Allowed 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.889 ' C ' HD13 ' A' ' 80' ' ' ILE . 74.5 t -117.25 129.75 73.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.018 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -111.55 152.36 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.027 178.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -129.02 136.89 50.91 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.351 0.596 . . . . 0.0 112.417 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -152.32 158.74 28.0 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' GLY . 14.0 pt-20 33.89 -128.52 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.749 0.275 . . . . 0.0 110.622 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -110.17 33.68 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 110.526 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 3.1 tppt? -138.09 151.9 48.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 31.1 m -118.31 156.17 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.351 0.596 . . . . 0.0 110.709 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.621 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 2.0 m-90 -97.96 140.52 32.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.732 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' N ' ' CE1' ' A' ' 63' ' ' TYR . 72.3 tttt -127.92 92.76 3.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.46 107.05 3.12 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.757 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.64 164.27 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.74 1.626 . . . . 0.0 111.31 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HD3' HD22 ' A' ' 78' ' ' LEU . 10.1 mttt -67.84 -27.17 66.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -90.55 -5.29 56.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 9.86 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.966 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -161.23 173.99 14.25 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.916 -1.114 . . . . 0.0 113.077 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.2 mt -111.97 130.73 65.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.71 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 1.002 ' CE2' HD23 ' A' ' 78' ' ' LEU . 97.1 m-85 -108.96 126.1 52.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.952 ' C ' HG23 ' A' ' 53' ' ' VAL . 26.8 tt0 -107.97 93.97 4.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.924 ' CZ ' HD22 ' A' ' 48' ' ' LEU . 37.1 m-85 -80.0 143.66 33.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.85 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.649 ' O ' HD21 ' A' ' 51' ' ' LEU . 75.6 tt0 -93.47 129.61 39.59 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.687 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -72.68 143.32 48.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.123 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.808 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.35 -0.93 0.28 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.621 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.511 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 27.5 t70 -107.14 20.18 19.36 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.33 22.62 78.56 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.578 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.29 149.76 26.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.475 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -93.48 131.0 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.153 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 10.4 mt -103.81 133.83 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -114.56 100.83 8.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.09 132.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.059 -178.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 111' ' ' GLU . 13.8 p -79.57 144.95 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.213 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.35 4.01 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -80.42 -22.59 41.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.4 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -69.89 -47.3 63.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -95.88 28.67 3.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.2 p -45.77 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.617 0.723 . . . . 0.0 112.876 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' LYS . . . 66.83 -42.29 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.674 175.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HB3' ' H ' ' A' ' 119' ' ' MET . 71.1 mtm180 -101.89 99.17 11.38 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.469 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.7 Cg_endo -70.12 -26.54 25.75 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 N-CA-C 107.294 -1.849 . . . . 0.0 107.294 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.1 pt-20 -65.45 -45.87 82.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.516 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.9 tpt -39.74 -33.71 0.21 Allowed 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -78.75 -56.74 4.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.652 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.736 HD12 HG13 ' B' ' 46' ' ' VAL . 0.1 OUTLIER -58.56 -42.32 87.67 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 118.313 -1.355 . . . . 0.0 107.836 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.501 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.636 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -78.72 -31.45 46.4 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.241 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.733 ' H ' HH11 ' B' ' 12' ' ' ARG . 8.7 ttpt -73.86 -34.18 64.38 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.809 1.29 . . . . 0.0 108.122 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.924 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 4.7 mpt_? -60.96 -51.33 69.72 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.777 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -72.97 -29.06 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.543 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.409 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -70.56 -51.77 26.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.49 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' B' ' 16' ' ' GLU . 0.6 OUTLIER -55.28 -46.81 76.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.519 ' N ' ' HD3' ' B' ' 15' ' ' LYS . 9.3 pt-20 -72.08 -38.08 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.603 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 39.3 ttt180 -62.63 -54.19 43.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.703 0.763 . . . . 0.0 110.387 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -56.73 -34.28 42.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.519 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.42 -33.28 72.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.707 HD11 ' HA3' ' A' ' 36' ' ' GLY . 94.7 mt -69.61 -58.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.019 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.05 -35.4 76.81 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.019 ' N ' HD13 ' B' ' 21' ' ' LEU . 4.1 t80 -53.79 -38.94 65.03 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.05 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.7 m -66.9 -40.27 87.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.431 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.836 HD12 HG11 ' B' ' 28' ' ' VAL . 2.3 mm? -61.23 -58.79 6.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.524 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.404 ' HA ' ' CB ' ' B' ' 36' ' ' ALA . . . -49.46 -36.48 22.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.527 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.805 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -71.73 -60.26 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.407 0.623 . . . . 0.0 109.875 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.843 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 6.8 ttm-85 -64.43 -37.4 87.39 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.992 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.144 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.3 m -84.12 -50.86 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.275 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.719 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 29.7 t80 -36.37 -49.9 1.79 Allowed Pre-proline 0 CA--C 1.51 -0.572 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.359 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.843 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 35.7 Cg_endo -51.93 -46.13 34.23 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.816 ' N ' ' O ' ' B' ' 28' ' ' VAL . 10.2 t80 -92.87 -32.21 14.69 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.101 -2.318 . . . . 0.0 112.678 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.144 ' N ' ' O ' ' B' ' 28' ' ' VAL . 61.7 p -144.2 96.91 5.29 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.682 ' C ' ' HZ3' ' B' ' 37' ' ' LYS . 32.1 Cg_exo -55.88 -42.13 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.791 2.327 . . . . 0.0 114.019 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.96 -53.77 28.44 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.527 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 10.6 mt -51.05 -53.21 35.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.262 0.554 . . . . 0.0 110.281 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.74 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -55.59 -34.14 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.11 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.682 ' HZ3' ' C ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.45 -41.78 69.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.869 ' NH2' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -58.79 -53.96 52.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.306 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.932 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.3 m-85 -60.68 -39.04 86.98 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.94 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.769 ' O ' HD23 ' B' ' 44' ' ' LEU . 3.7 t -45.87 -34.96 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 50.7 tt0 -72.21 -43.92 63.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.6 mt -63.78 -46.63 84.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.88 -34.03 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.796 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 40' ' ' VAL . 1.6 mm? -64.43 -45.02 89.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.592 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -63.91 -34.56 78.23 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.521 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.736 HG13 HD12 ' A' ' 121' ' ' LEU . 51.0 t -70.88 -56.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.16 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.447 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 17.0 pt20 -71.86 -51.06 24.21 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.332 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 121' ' ' LEU . 5.0 tmtt? -82.27 -35.64 27.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.375 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -65.4 -12.41 51.94 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.21 30.48 15.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.046 179.373 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.677 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 17.4 m0 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.767 0.318 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -62.63 -7.86 5.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' B' ' 58' ' ' TRP . 18.1 ptt180 -87.85 -21.66 24.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.442 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.824 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -146.88 20.23 1.27 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.094 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' B' ' 58' ' ' TRP . 50.1 t80 -114.78 154.42 28.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.7 OUTLIER -126.41 116.97 21.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.135 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -87.02 16.28 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.498 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.0 OUTLIER -116.59 -22.06 8.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.741 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.669 ' O ' ' O ' ' B' ' 67' ' ' HIS . 0.8 OUTLIER -153.73 21.59 0.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.869 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.669 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.2 OUTLIER 34.37 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 111.877 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.481 ' HB3' HD11 ' B' ' 70' ' ' LEU . . . -177.45 -176.99 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' NH1' ' B' ' 61' ' ' ARG . 0.5 OUTLIER -115.37 104.61 11.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.824 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -106.62 129.46 54.53 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.75 -177.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 48.7 t -113.38 124.16 31.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.053 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -46.89 126.1 10.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.886 1.724 . . . . 0.0 112.119 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.98 -36.54 3.97 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.5 -77.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.66 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.23 19.65 16.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.266 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 CA--C 1.521 -0.162 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.732 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 22' ' ' GLU . 93.1 p . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.718 ' HB3' HG11 ' A' ' 86' ' ' VAL . 83.1 m-85 -35.49 -63.41 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.094 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -16.37 39.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.194 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 19' ' ' SER . 41.8 tp10 -92.06 -30.4 16.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.2 mm -106.7 13.55 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -79.34 126.87 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.853 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.783 ' N ' HD13 ' A' ' 24' ' ' ILE . . . 106.78 -35.17 5.21 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.38 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -64.15 27.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.975 0.388 . . . . 0.0 110.736 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.642 ' H ' ' C ' ' A' ' 25' ' ' GLY . 13.9 p -43.75 -14.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.884 0.849 . . . . 0.0 108.745 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.741 ' HE1' HH12 ' B' ' 27' ' ' ARG . 38.1 t-105 -57.85 -52.52 65.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.294 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.861 ' CD1' HG12 ' B' ' 28' ' ' VAL . 12.7 pt -71.88 -11.8 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.587 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' B' ' 24' ' ' LEU . 58.5 m-85 -89.87 -23.46 21.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.4 tpp85 -80.88 -68.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.56 35.67 0.17 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.701 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -145.41 -39.02 0.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -95.95 105.93 18.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.92 1.33 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.45 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -47.25 156.95 0.68 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.611 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 6.1 ttm-85 -67.98 118.49 11.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 42.2 t -97.48 139.31 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.677 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -166.66 154.65 9.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.435 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . 75.9 tttt -51.72 -55.94 16.69 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' CD2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -59.15 -3.79 0.43 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.698 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 55.0 m-20 -125.41 2.61 7.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.815 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.76 -39.75 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.563 0.221 . . . . 0.0 110.935 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.838 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.81 4.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 108.084 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.877 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.46 -21.92 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.04 -179.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.8 146.92 29.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.655 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -64.26 108.74 1.67 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.862 ' O ' HG12 ' A' ' 49' ' ' ILE . 8.2 mt -76.21 110.45 10.72 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.881 HD13 ' CD1' ' B' ' 39' ' ' TYR . 3.9 mt -170.78 55.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 124.032 0.832 . . . . 0.0 109.496 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 143.95 -27.82 2.02 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.935 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.2 tt -53.14 133.5 39.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' N ' HD23 ' A' ' 51' ' ' LEU . 1.7 tmtp? -69.61 124.38 23.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.097 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 97' ' ' GLU . 13.8 p -149.19 169.7 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.108 0.48 . . . . 0.0 110.654 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.688 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.65 149.62 46.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.138 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 89' ' ' VAL . 92.2 t -99.4 100.23 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.28 -36.98 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.433 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -135.1 120.19 18.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 110.476 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.83 166.35 27.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.665 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.587 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 1.7 t -103.52 75.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -169.82 105.34 0.45 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.545 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.18 -4.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 122.178 1.919 . . . . 0.0 113.909 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -129.4 31.13 3.49 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.645 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -141.31 -21.59 0.76 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.876 1.338 . . . . 0.0 111.794 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.0 144.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 84.02 6.52 86.55 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.152 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.63 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 118.447 1.124 . . . . 0.0 111.79 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 tt0 -120.1 125.88 49.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.665 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -146.44 172.88 26.89 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.527 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m-85 -99.57 121.73 41.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.6 t -48.76 148.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.903 0.383 . . . . 0.0 111.572 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 81' ' ' ALA . 79.2 mt -138.51 -60.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.962 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.779 ' CG ' ' HE ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -101.99 140.25 36.54 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.767 ' O ' ' NH1' ' B' ' 38' ' ' ARG . 70.6 tt0 -149.62 105.05 3.4 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.187 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.756 HG22 HH22 ' B' ' 38' ' ' ARG . 6.8 t -152.01 -178.92 7.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.543 0.687 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.705 ' HE ' HH22 ' A' ' 116' ' ' ARG . 32.5 ttm180 -55.07 -6.79 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.227 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 74' ' ' THR . 46.9 m-80 -138.52 0.0 2.01 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.888 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 2.4 ptp -165.44 149.99 8.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 117.952 -1.499 . . . . 0.0 114.794 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.9 tp -135.09 110.71 9.2 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.6 t -114.41 147.2 18.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 121.441 0.638 . . . . 0.0 112.553 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -131.4 142.18 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.278 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.04 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -114.83 135.29 54.35 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.864 -0.523 . . . . 0.0 111.746 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -153.4 125.66 1.81 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 69.09 -115.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -124.62 19.98 8.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.415 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 17.8 tttp -126.19 167.33 15.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.344 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 20' ' ' TYR . 5.7 m -121.55 153.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 110.596 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.4 m-90 -99.14 110.8 23.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.475 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -108.03 96.7 6.56 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.079 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 55' ' ' VAL . 2.7 m -148.87 95.7 3.88 Favored Pre-proline 0 CA--C 1.518 -0.264 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.073 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 93' ' ' VAL . 65.0 Cg_exo -43.23 161.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 120.942 1.095 . . . . 0.0 110.518 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.888 ' HZ1' ' C ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -63.53 -30.31 71.45 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -89.17 -4.95 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 90' ' ' PRO . 2.5 m -112.41 11.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.72 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -167.19 169.23 12.82 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.856 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.38 140.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.343 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.72 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 87.0 m-85 -117.61 131.67 56.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.92 ' C ' HG23 ' A' ' 53' ' ' VAL . 21.3 tt0 -115.04 95.07 5.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -90.89 145.49 24.7 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.743 ' O ' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -89.68 133.17 34.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.243 0.544 . . . . 0.0 111.604 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.605 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -70.87 144.05 50.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.849 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.879 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.1 0.12 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.221 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.574 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 74.4 m-20 -107.52 15.17 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.12 22.9 72.83 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.17 146.56 30.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.756 0.312 . . . . 0.0 110.358 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -90.74 132.82 35.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 11.3 mt -105.72 134.42 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -120.27 106.49 11.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.61 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.216 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.6 p -94.99 145.68 24.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.22 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.62 -1.65 0.36 Allowed Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.43 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 109' ' ' SER . 21.0 pt-20 -68.26 -31.5 71.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.678 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -75.13 -47.44 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.493 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 29.1 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 114' ' ' VAL . 9.9 p -63.71 106.06 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.7 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.46 -40.47 0.29 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 114.551 -1.204 . . . . 0.0 114.034 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.705 HH22 ' HE ' ' A' ' 75' ' ' ARG . 5.6 mmp_? -100.59 85.06 0.51 Allowed Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.449 ' HB2' HH22 ' B' ' 17' ' ' ARG . 26.9 Cg_endo -66.74 -26.01 45.78 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.629 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.0 pt-20 -67.99 -48.46 65.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.545 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 37.6 tpp -36.37 -47.1 0.58 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.724 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -71.61 -47.91 51.54 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.368 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.793 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -62.29 -31.87 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 118' ' ' GLU . 3.8 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.869 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.609 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 4.3 mm-40 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.418 ' H ' ' HG2' ' B' ' 10' ' ' LYS . 2.3 mmtp -79.35 -32.05 43.14 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.911 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.719 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.6 OUTLIER -73.2 -33.96 65.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.708 1.242 . . . . 0.0 108.159 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.931 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 5.0 mpt_? -60.99 -51.38 69.5 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.392 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.769 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.3 mt -70.44 -26.72 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.124 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.19 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.584 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.443 ' O ' HG22 ' B' ' 18' ' ' ILE . 4.1 ptmm? -57.54 -48.42 79.36 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.546 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 3.1 pt-20 -68.94 -37.35 78.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.342 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.811 ' HE ' HG22 ' B' ' 46' ' ' VAL . 3.0 ttt180 -62.72 -52.07 64.71 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.542 0.686 . . . . 0.0 110.673 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.73 -35.55 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.098 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.41 -27.04 63.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.42 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 36' ' ' GLY . 8.6 mt -69.15 -58.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.039 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.08 -33.34 75.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.894 0.854 . . . . 0.0 108.832 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.039 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -52.92 -46.51 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.073 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 11.6 p -64.8 -42.04 95.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.967 HD12 HG11 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -56.1 -58.42 7.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.493 0.664 . . . . 0.0 110.096 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -35.56 26.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.449 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.788 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.9 OUTLIER -71.58 -57.12 4.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.388 0.614 . . . . 0.0 110.774 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.888 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 5.2 ttt-85 -70.22 -32.5 70.4 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.73 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.184 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.2 m -83.78 -50.44 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.733 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 33.8 t80 -36.23 -49.73 1.71 Allowed Pre-proline 0 CA--C 1.509 -0.625 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.293 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.888 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 39.1 Cg_endo -54.02 -46.86 30.5 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 N-CA-C 106.532 -2.142 . . . . 0.0 106.532 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.81 ' N ' ' O ' ' B' ' 28' ' ' VAL . 48.6 t80 -94.54 -17.04 22.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.928 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.184 ' N ' ' O ' ' B' ' 28' ' ' VAL . 27.6 p -155.81 90.39 2.81 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.01 -42.98 63.93 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.883 2.389 . . . . 0.0 113.792 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -66.44 -53.9 30.23 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 9.0 mt -52.52 -56.73 13.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 120.951 0.405 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.44 -29.78 26.25 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.054 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.675 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.7 -47.84 51.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.726 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.779 ' HE ' ' CG ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -64.48 -35.55 81.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.914 ' HB3' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -71.15 -44.43 65.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.957 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.546 ' O ' HD23 ' B' ' 44' ' ' LEU . 2.1 t -45.51 -38.93 2.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.719 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.9 -42.37 81.25 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.739 HD12 HD11 ' A' ' 49' ' ' ILE . 48.3 mt -64.26 -47.75 78.4 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.601 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -55.53 -31.3 61.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.434 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -64.08 -54.39 34.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 118' ' ' GLU . 4.1 pp -61.61 -27.48 68.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.365 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.935 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 63.8 t -64.41 -47.24 90.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.32 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -66.5 -57.09 8.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.61 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 12.8 pt20 -81.96 -49.58 10.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.77 -33.48 75.97 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -92.64 5.83 49.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 mttm 54.01 75.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.502 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.306 179.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.623 ' NE1' ' CE1' ' B' ' 22' ' ' PHE . 14.2 m0 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.914 0.388 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -68.18 -3.62 11.18 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.476 ' H ' ' C ' ' B' ' 58' ' ' TRP . 5.9 ptm180 -83.67 -30.74 26.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.888 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -130.45 21.78 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.938 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 81.9 t80 -118.95 155.76 30.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.334 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 3.5 t -127.17 126.08 42.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.266 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -87.91 6.54 35.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 109.908 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -107.26 -22.97 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.381 -178.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . 0.582 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.5 p -150.84 17.11 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.335 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.582 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.9 OUTLIER 35.21 106.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 111.443 179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . -164.75 -175.04 3.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' B' ' 61' ' ' ARG . 9.4 t80 -118.17 102.93 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.838 ' N ' HD22 ' B' ' 70' ' ' LEU . 0.4 OUTLIER -110.77 120.72 43.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.857 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.6 t -92.78 117.42 67.56 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.061 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.24 119.38 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.307 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.73 -41.96 1.86 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.768 HG23 ' H ' ' B' ' 75' ' ' ASN . 3.8 tt -102.95 -65.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 117.219 0.51 . . . . 0.0 111.293 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 0.768 ' H ' HG23 ' B' ' 74' ' ' ILE . 5.8 t-20 -112.26 12.97 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.748 0.309 . . . . 0.0 110.856 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.819 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.273 0.559 . . . . 0.0 111.306 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 110.688 -0.115 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' B' ' 93' ' ' LEU . 95.5 mt . . . . . 0 C--O 1.232 0.151 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLU . 80.3 p . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 121.065 0.459 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.639 ' HB3' HG11 ' A' ' 86' ' ' VAL . 52.8 m-85 -40.45 -61.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.384 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.06 -8.79 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 19' ' ' SER . 42.5 tp10 -103.95 -40.72 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.263 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.5 mm -95.19 32.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 111.09 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -81.2 127.34 39.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.678 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 82.15 -18.1 14.93 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.81 27.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.826 1.313 . . . . 0.0 110.793 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.678 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -42.03 -15.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 33.6 t-105 -57.17 -53.81 53.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.46 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' B' ' 28' ' ' VAL . 16.8 pt -69.31 -11.86 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.609 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.791 ' CD2' HD11 ' B' ' 24' ' ' LEU . 33.7 m-85 -91.15 -26.37 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -70.07 -64.59 0.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.173 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.86 48.65 3.31 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 29' ' ' ILE . . . -162.38 -38.35 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 50' ' ' GLY . 38.9 t-80 -110.71 100.37 9.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.613 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -150.75 10.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.54 ' H ' HG12 ' B' ' 20' ' ' ILE . . . -41.77 164.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.646 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 33.9 ttp180 -66.59 133.02 49.44 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.802 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 63.2 t -113.26 135.66 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.666 ' O ' ' N ' ' A' ' 42' ' ' ASN . 6.0 m120 -166.3 149.07 7.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.831 -1.532 . . . . 0.0 108.016 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 42' ' ' ASN . 56.1 tttp -46.04 -53.79 9.58 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.197 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 13.4 pttp -60.84 -4.63 1.04 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.072 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 88.9 m-20 -125.13 0.23 7.83 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.082 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.45 -39.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.06 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.856 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.06 5.25 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.856 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -119.92 -6.18 10.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.869 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -98.74 151.64 20.54 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.735 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.676 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -72.73 110.83 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 49' ' ' ILE . 12.5 mt -74.21 116.1 14.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.1 mm -155.28 -31.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.596 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.674 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -134.5 -22.23 0.71 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.912 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.939 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -44.82 153.25 0.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.783 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -100.49 128.49 46.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.988 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.9 p -149.16 171.52 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.399 0.618 . . . . 0.0 111.572 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.722 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.51 152.28 51.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 65' ' ' GLY . 59.9 t -96.22 98.95 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.31 -51.86 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.415 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -128.53 118.35 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.557 ' OG ' ' ND1' ' A' ' 60' ' ' HIS . 47.9 t -149.07 173.53 13.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.184 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 33.7 p -102.98 78.6 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.724 ' CD2' ' O ' ' A' ' 59' ' ' THR . 21.6 m80 -166.57 96.15 0.72 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.251 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.11 -4.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.535 2.157 . . . . 0.0 114.015 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -132.0 23.32 4.16 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.638 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.639 ' O ' HG22 ' A' ' 66' ' ' ILE . 29.2 m-85 -141.11 -14.1 0.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.793 1.296 . . . . 0.0 111.615 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.3 m -71.62 138.89 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.9 6.71 88.74 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.35 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.142 HG23 ' NE1' ' A' ' 87' ' ' TRP . 2.3 tt -108.32 146.92 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 117.712 0.756 . . . . 0.0 112.243 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 6.9 tm-20 -116.15 131.87 56.82 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 80' ' ' ILE . . . -147.24 174.95 26.85 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.487 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.55 115.72 28.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -45.19 145.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.015 0.436 . . . . 0.0 111.457 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 81' ' ' ALA . 15.8 mt -136.48 -61.51 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 19.9 t0 -94.89 148.01 22.76 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.833 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.78 ' O ' HD11 ' B' ' 42' ' ' LEU . 10.7 tt0 -156.52 105.11 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.844 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -162.49 176.68 10.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 111.798 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 54.5 ttt85 -58.72 -1.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.864 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.844 ' H ' HG23 ' A' ' 74' ' ' THR . 7.6 t-20 -133.47 -11.58 2.77 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -166.66 156.21 11.25 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.669 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.3 tp -139.33 110.94 7.11 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.908 ' C ' HD13 ' A' ' 80' ' ' ILE . 61.3 t -119.95 145.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.939 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -117.88 152.25 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.142 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.92 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -125.12 136.44 53.63 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.108 0.48 . . . . 0.0 111.963 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -149.91 155.78 26.42 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 24' ' ' ILE . 6.1 pt-20 31.83 -115.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.561 0.219 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -121.24 33.31 5.59 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.917 0.389 . . . . 0.0 110.176 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 30.4 tttp -133.52 158.84 42.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.631 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 20' ' ' TYR . 16.1 m -123.62 155.54 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 110.688 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 1.142 ' NE1' HG23 ' A' ' 66' ' ' ILE . 2.5 m-90 -100.35 145.49 28.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.325 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -128.22 94.13 3.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.36 99.17 4.21 Favored Pre-proline 0 C--N 1.342 0.266 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.253 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.33 146.03 84.63 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.483 1.455 . . . . 0.0 110.231 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.602 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 27.2 mttm -54.17 -22.13 10.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -90.63 -6.38 54.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.502 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -128.52 35.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.64 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -166.95 155.72 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.027 179.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.552 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 77.2 mt -111.14 116.11 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.833 ' HB3' HG21 ' A' ' 53' ' ' VAL . 88.1 m-85 -98.53 127.11 44.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.988 ' C ' HG23 ' A' ' 53' ' ' VAL . 24.3 tt0 -110.12 94.74 5.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 43' ' ' ILE . 4.8 m-85 -87.55 145.66 26.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -90.2 127.39 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.804 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -62.8 142.88 58.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.389 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.802 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.19 0.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.605 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.552 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 75.6 m-20 -106.85 13.39 27.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.36 21.64 66.71 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 100' ' ' THR . 16.7 m -106.74 150.0 26.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.477 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -91.16 134.28 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 7.7 mt -110.59 132.62 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -118.55 102.9 9.24 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.65 139.41 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.974 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 m -88.55 148.49 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.994 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.47 -0.59 4.9 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.018 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.65 -22.72 60.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -80.11 -47.55 14.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.362 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -95.69 28.13 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.1 p -59.32 106.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.602 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.84 -40.89 0.32 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.496 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 116' ' ' ARG . 1.0 OUTLIER -101.18 87.63 0.92 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -176.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.584 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.1 Cg_endo -67.34 -29.16 38.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.25 1.3 . . . . 0.0 108.828 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HB3' HD22 ' B' ' 45' ' ' LEU . 8.1 pt-20 -56.66 -49.51 74.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.915 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.404 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 9.7 ttm -34.67 -64.83 0.24 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.821 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -59.17 -44.93 92.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.843 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -60.27 -40.32 89.95 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.752 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLU . . . . . 0.627 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.63 -30.47 46.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.797 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.0 OUTLIER -73.72 -34.25 64.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.799 1.285 . . . . 0.0 108.301 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.953 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -61.85 -51.26 68.94 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 112.126 -2.306 . . . . 0.0 111.667 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -71.32 -34.92 55.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.87 91.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.049 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.563 ' O ' HG22 ' B' ' 18' ' ' ILE . 6.8 tptm -58.85 -51.0 71.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.233 0.539 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' HD13 ' B' ' 20' ' ' ILE . 10.8 pt-20 -71.63 -37.14 70.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.882 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 121' ' ' LEU . 9.7 ttt180 -60.56 -51.02 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.593 0.711 . . . . 0.0 110.668 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.563 HG22 ' O ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -60.53 -38.33 77.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.17 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 13.2 m-20 -68.23 -30.44 69.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.492 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.554 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.1 mp -71.53 -57.68 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 1.065 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.2 -35.06 76.16 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.065 ' H ' HD13 ' B' ' 21' ' ' LEU . 5.4 t80 -53.75 -39.36 65.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.047 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -67.77 -40.8 83.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.383 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.939 HD12 HG11 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -56.25 -58.02 9.76 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.731 0.777 . . . . 0.0 109.396 179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' B' ' 29' ' ' PHE . . . -49.23 -37.52 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.562 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.84 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -68.97 -59.27 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.313 0.577 . . . . 0.0 110.087 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 7.2 ttm-85 -66.6 -36.91 83.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.809 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 1.199 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -82.99 -50.69 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.321 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.752 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 41.1 t80 -36.75 -50.26 1.99 Allowed Pre-proline 0 CA--C 1.509 -0.63 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.4 Cg_endo -54.01 -46.84 30.62 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 106.576 -2.124 . . . . 0.0 106.576 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.777 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 49.4 t80 -94.42 -13.24 26.46 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.335 -2.211 . . . . 0.0 112.708 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . 1.199 ' N ' ' O ' ' B' ' 28' ' ' VAL . 57.4 p -160.51 92.87 1.6 Allowed Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.67 -41.59 76.06 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.736 2.291 . . . . 0.0 113.673 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.59 -54.41 23.81 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 7.7 mt -52.22 -55.04 23.73 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.205 0.526 . . . . 0.0 110.604 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.544 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.77 -30.24 60.95 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.076 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.77 -48.93 43.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.543 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.95 -38.7 89.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.77 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -64.43 -44.71 90.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 118.627 -1.229 . . . . 0.0 108.327 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.3 t -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.155 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.95 -41.5 77.94 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 73' ' ' GLU . 28.1 mt -65.48 -44.71 86.26 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.41 -30.66 63.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 14.2 mt -66.72 -54.34 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.588 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.6 pp -57.25 -27.32 61.95 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.747 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . 0.963 ' N ' HD12 ' B' ' 45' ' ' LEU . 86.0 t -68.27 -46.38 81.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.017 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -57.1 8.3 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.818 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 8.4 pt20 -81.32 -47.35 13.43 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 7.4 tptt -70.04 -32.74 71.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.22 -3.98 58.79 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.419 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mttp 62.59 73.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.691 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HZ1' ' B' ' 11' ' ' LYS . 11.7 t . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.734 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.568 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 5.2 m-90 . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -65.89 -6.87 13.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' B' ' 58' ' ' TRP . 12.1 ptp180 -81.35 -25.44 36.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.833 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -141.25 22.97 2.2 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.418 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' B' ' 67' ' ' HIS . 51.8 t80 -116.15 148.6 40.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.019 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' CYS . . . . . 0.558 ' C ' ' H ' ' B' ' 65' ' ' LYS . 8.2 t -126.54 107.79 10.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.633 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.496 ' H ' ' HD2' ' B' ' 64' ' ' LYS . 1.1 mptp? -66.21 5.47 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.664 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -105.96 -17.66 14.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.609 -178.061 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' CYS . . . . . . . . . . . . . 14.5 p -150.81 6.75 0.53 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' B' ' 63' ' ' CYS . 2.0 m80 42.74 78.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.679 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.493 ' HB1' ' CE ' ' B' ' 37' ' ' LYS . . . -140.16 -172.14 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.303 0.573 . . . . 0.0 111.268 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 4.7 t80 -117.73 105.09 11.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.833 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.6 OUTLIER -109.35 126.29 53.24 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -103.17 121.92 47.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.886 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.63 127.2 15.81 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.981 1.787 . . . . 0.0 111.733 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.67 -34.01 6.02 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 1.062 HG22 HD22 ' B' ' 75' ' ' ASN . 96.6 mt -93.89 -79.99 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASN . . . . . 1.062 HD22 HG22 ' B' ' 74' ' ' ILE . 1.9 m-80 -110.86 15.94 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.85 149.4 16.89 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 22' ' ' GLU . 77.9 p -62.99 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.948 0.404 . . . . 0.0 110.464 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 79' ' ' VAL . 58.2 m-85 -38.93 -58.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.437 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.69 -8.81 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.266 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' SER . 47.0 tp10 -104.03 -37.98 7.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.156 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.68 HG23 ' CE2' ' B' ' 31' ' ' TYR . 4.3 mm -95.66 22.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.482 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 ' H ' ' A' ' 24' ' ' ILE . 1.3 tp -80.76 117.43 26.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 105.12 -29.74 11.14 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 121.022 -0.609 . . . . 0.0 114.43 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.66 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -63.28 29.43 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.967 . . . . 0.0 110.882 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.66 ' H ' ' C ' ' A' ' 25' ' ' GLY . 3.3 p -44.5 -12.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.66 ' N ' ' O ' ' A' ' 26' ' ' ARG . 27.9 t-105 -57.86 -52.52 65.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.407 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.834 ' CD1' HG12 ' B' ' 28' ' ' VAL . 10.4 pt -69.73 -12.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.977 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' B' ' 24' ' ' LEU . 40.5 m-85 -93.53 -11.07 32.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -91.06 -68.3 0.8 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.41 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.03 46.42 1.5 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . . . -161.88 -34.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.739 ' HA ' HG23 ' B' ' 20' ' ' ILE . 19.6 t-80 -103.55 108.19 19.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.822 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.701 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -149.56 9.51 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.041 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.783 ' O ' ' CD1' ' A' ' 101' ' ' TRP . . . -49.04 148.15 5.26 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -64.25 111.13 2.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 118.486 -1.285 . . . . 0.0 108.947 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 100' ' ' THR . 92.6 t -83.08 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.903 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.756 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -163.81 150.5 11.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.563 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 69.5 tttt -48.29 -56.67 7.44 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.753 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 54.2 pttt -61.63 -5.3 1.79 Allowed 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 9.1 m120 -126.0 3.54 7.27 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.783 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.756 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.53 -42.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.072 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.713 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -94.48 -0.46 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.796 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.23 14.65 16.95 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.458 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -120.37 176.47 5.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.764 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.733 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -90.81 112.26 24.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.983 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.767 ' O ' HD13 ' A' ' 49' ' ' ILE . 55.5 mt -74.39 114.14 12.42 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.5 mm -155.79 -40.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.761 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.604 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -131.84 -20.05 1.1 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.744 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -44.44 142.31 1.63 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.813 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.2 ttpm? -92.13 131.54 37.3 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.972 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.8 p -150.04 170.74 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.191 0.52 . . . . 0.0 111.282 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.67 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.42 152.44 51.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.898 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 65' ' ' GLY . 48.1 t -97.5 99.17 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.87 -50.89 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.841 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.47 120.75 27.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.148 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 94' ' ' CYS . 3.2 t -147.06 173.28 12.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.245 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.626 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -109.95 78.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 59' ' ' THR . 17.4 m170 -168.72 102.37 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.328 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.73 -4.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.478 2.119 . . . . 0.0 113.822 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -130.2 22.46 4.75 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 120.166 -1.016 . . . . 0.0 114.193 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.51 ' O ' HG22 ' A' ' 66' ' ' ILE . 20.8 m-85 -141.0 -11.76 0.97 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.533 1.167 . . . . 0.0 111.513 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 64' ' ' VAL . 2.2 m -72.98 131.67 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.02 5.21 90.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.664 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.047 HG23 ' NE1' ' A' ' 87' ' ' TRP . 9.0 tt -100.38 151.24 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 117.758 0.779 . . . . 0.0 112.345 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.687 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 2.7 tm-20 -118.0 132.71 56.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.57 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.25 173.22 27.47 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.853 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -96.5 114.93 26.63 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.8 t -48.77 146.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.012 HD11 ' HB2' ' A' ' 81' ' ' ALA . 36.2 mt -140.02 -60.77 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.127 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -104.14 144.71 31.21 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.62 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 43.8 tp10 -148.18 106.17 3.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.986 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.471 ' HA ' HH21 ' B' ' 38' ' ' ARG . 1.8 p -137.04 179.9 6.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.726 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' CA ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -55.44 -17.01 4.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.144 -178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HA ' ' HZ3' ' A' ' 91' ' ' LYS . 41.1 t30 -137.54 13.52 2.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.85 159.02 39.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 118.728 -1.189 . . . . 0.0 113.957 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.731 HD23 ' CE1' ' A' ' 96' ' ' PHE . 7.2 tp -150.46 110.55 4.14 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 71' ' ' ILE . 91.1 t -112.1 146.37 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.57 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -129.1 147.44 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.972 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.012 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -123.08 137.59 54.89 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.577 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.76 152.06 23.79 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 84' ' ' ASN . 8.9 pt-20 38.06 -136.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.699 -0.295 . . . . 0.0 110.937 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 23.1 m120 -99.67 34.08 2.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.052 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.508 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 21.5 tptt -145.18 165.93 26.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.707 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 24.7 m -119.65 155.57 22.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.469 0.652 . . . . 0.0 110.693 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 1.047 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.4 m-90 -97.54 92.7 6.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.708 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -86.97 100.01 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.426 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 55' ' ' VAL . 3.9 t -147.27 109.16 3.93 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.448 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -53.01 164.35 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.323 1.348 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.749 ' CD ' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -72.03 -31.43 66.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 16.9 p-10 -90.28 -5.69 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -97.5 0.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.286 -178.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -166.27 174.42 9.17 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.926 -1.11 . . . . 0.0 113.654 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -109.22 124.01 65.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.702 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.731 ' CE1' HD23 ' A' ' 78' ' ' LEU . 59.7 m-85 -99.04 131.19 45.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.972 ' C ' HG23 ' A' ' 53' ' ' VAL . 18.5 tt0 -111.29 95.48 5.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.751 ' CD1' HD11 ' A' ' 43' ' ' ILE . 16.4 m-85 -89.58 146.01 24.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.16 132.4 36.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.729 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 104' ' ' THR . 16.9 m -65.85 142.41 57.94 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -62.43 -1.66 0.84 Allowed 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.919 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 100' ' ' THR . 86.9 m-20 -106.92 19.45 20.44 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.751 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.03 23.49 77.07 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.57 137.21 44.98 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.759 0.314 . . . . 0.0 110.423 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -81.28 129.56 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 44.7 mt -104.41 134.7 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.578 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -117.86 102.04 8.78 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.3 138.06 45.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.691 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.7 p -78.26 123.22 26.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.487 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -53.2 -2.44 0.1 OUTLIER Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -81.77 -22.86 36.96 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.167 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -66.69 -46.34 75.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.17 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -92.68 28.68 1.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 114' ' ' VAL . 3.6 p -55.28 105.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 75' ' ' ARG . . . 67.73 -40.64 0.24 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 114.462 -1.245 . . . . 0.0 114.47 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.8 91.66 1.98 Allowed Pre-proline 0 N--CA 1.466 0.328 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HB2' HH22 ' B' ' 17' ' ' ARG . 29.2 Cg_endo -69.76 -27.97 25.84 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.462 1.442 . . . . 0.0 108.752 175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.818 ' HB3' HD22 ' B' ' 45' ' ' LEU . 13.0 pt-20 -61.08 -52.27 65.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.222 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.556 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 31.3 ttp -36.16 -38.38 0.14 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.596 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.617 ' NH2' ' CZ2' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -81.57 -50.03 9.84 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.145 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.55 -33.29 73.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.054 178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -103.87 18.39 22.08 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.727 0.299 . . . . 0.0 111.054 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 57.34 168.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 123' ' ' LYS . 2.7 mtp180 -43.93 168.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -43.83 147.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.529 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -90.72 112.76 24.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.676 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.481 179.799 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.734 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.587 ' H ' ' CD ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -79.3 -29.6 42.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.886 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -72.31 -33.58 67.47 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.723 1.249 . . . . 0.0 107.844 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.959 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.2 OUTLIER -62.94 -51.8 65.51 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 112.145 -2.298 . . . . 0.0 111.736 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.4 pt -65.73 -27.84 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.082 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -66.48 -42.35 87.62 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.725 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.495 ' O ' HG22 ' B' ' 18' ' ' ILE . 18.6 mmtt -53.93 -50.97 65.24 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.279 0.561 . . . . 0.0 109.514 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.717 ' O ' HG12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -73.17 -38.15 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.6 HH22 ' HB2' ' A' ' 117' ' ' PRO . 31.1 ttt180 -65.06 -52.91 53.06 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.521 0.676 . . . . 0.0 110.895 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.589 HG23 ' N ' ' B' ' 19' ' ' ASP . 8.0 tp -56.74 -43.99 80.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.236 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.589 ' N ' HG23 ' B' ' 18' ' ' ILE . 11.1 m-20 -67.29 -29.2 68.73 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.739 HG23 ' HA ' ' A' ' 34' ' ' HIS . 26.4 mm -74.99 -58.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.094 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.45 -34.18 74.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.094 ' N ' HD13 ' B' ' 21' ' ' LEU . 5.0 t80 -54.51 -50.32 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.13 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -71.44 -32.59 68.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.484 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.83 HD12 HG13 ' B' ' 28' ' ' VAL . 0.2 OUTLIER -66.29 -56.65 10.15 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.186 0.517 . . . . 0.0 109.641 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -50.32 -38.25 40.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.205 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.841 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 62.2 mt-10 -69.07 -46.14 68.57 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.192 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 3.0 ttt-85 -70.97 -33.37 70.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.897 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.232 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.9 m -84.5 -49.36 16.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.552 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.758 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 24.6 t80 -36.48 -49.98 1.84 Allowed Pre-proline 0 C--N 1.351 0.632 0 CA-C-N 119.531 1.06 . . . . 0.0 109.439 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.6 Cg_endo -54.85 -47.41 26.8 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.509 -2.151 . . . . 0.0 106.509 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.791 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.7 t80 -94.44 -13.65 26.01 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 112.397 -2.183 . . . . 0.0 112.752 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.232 ' N ' ' O ' ' B' ' 28' ' ' VAL . 52.5 p -159.1 90.84 1.99 Allowed Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.532 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 51.5 Cg_exo -53.46 -45.0 44.24 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.711 2.274 . . . . 0.0 113.81 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' B' ' 38' ' ' ARG . 79.5 tt0 -64.37 -53.96 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 21.8 mt -51.73 -59.61 4.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.004 0.431 . . . . 0.0 111.155 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.722 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.45 -35.4 52.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.196 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.824 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.57 -36.06 73.41 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.001 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.714 ' C ' ' HD3' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -65.47 -54.68 24.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.824 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.86 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.2 m-85 -59.58 -39.94 85.76 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 119.549 -0.861 . . . . 0.0 109.1 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.9 t -45.32 -41.51 2.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -64.43 -43.24 94.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.805 ' O ' HG23 ' B' ' 46' ' ' VAL . 14.5 mt -64.55 -43.61 93.39 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.728 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -66.39 -31.51 72.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 0.0 110.243 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.609 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -59.9 -53.86 52.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -64.68 -41.01 96.36 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.743 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.893 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 97.3 t -53.51 -42.46 49.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.266 0.555 . . . . 0.0 109.99 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -65.84 -55.28 17.92 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.301 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 3.0 pt20 -80.71 -53.08 6.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.8 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 26.6 mmtt -56.53 -41.19 76.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -90.23 -9.06 49.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.84 0.352 . . . . 0.0 110.348 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 58.54 66.84 1.01 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.672 HG12 ' H ' ' B' ' 53' ' ' LYS . 1.6 t -109.56 -147.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.349 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.672 ' H ' HG12 ' B' ' 52' ' ' VAL . 92.9 mttt -63.24 143.85 57.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.049 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 mm -88.94 134.68 33.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.812 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.07 142.34 87.07 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.856 1.704 . . . . 0.0 111.571 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' B' ' 59' ' ' LYS . 5.5 ptp180 -142.13 -61.25 0.45 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.537 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.578 ' O ' ' N ' ' B' ' 59' ' ' LYS . 58.8 pttt -87.09 -38.23 16.68 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.696 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.455 ' O ' ' HD2' ' B' ' 61' ' ' ARG . 10.1 m0 -47.05 -8.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.899 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' B' ' 57' ' ' LYS . 0.0 OUTLIER -68.99 -8.5 45.39 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -80.59 -18.69 47.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.626 -1.624 . . . . 0.0 110.398 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.783 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -142.97 11.88 1.81 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.511 -178.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 92.0 t80 -119.98 158.64 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.546 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 2.0 t -126.28 120.64 30.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -85.97 5.28 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.249 0.547 . . . . 0.0 109.639 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.554 ' HZ2' ' CG ' ' B' ' 99' ' ' MET . 2.5 mmmm -97.75 -39.73 8.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.86 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 5.2 p -136.07 1.98 2.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.7 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 66' ' ' CYS . 6.8 m170 57.44 121.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.764 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 176.17 -172.38 0.08 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.766 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.824 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.4 OUTLIER -121.35 104.7 9.9 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.783 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -109.81 145.7 36.28 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.348 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.506 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 92.3 t -128.44 117.76 20.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.475 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . 0.428 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 77.9 Cg_exo -45.95 125.34 8.21 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.029 1.819 . . . . 0.0 111.85 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.76 -29.82 11.7 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 95.7 mt -100.41 -80.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.003 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.529 ' C ' HD12 ' B' ' 93' ' ' LEU . 90.3 m-20 -116.97 17.38 14.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.082 0.468 . . . . 0.0 109.886 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -141.23 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.624 ' HG3' HD11 ' B' ' 93' ' ' LEU . 96.6 mtt180 -142.49 130.6 21.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.756 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 18.2 m -134.08 132.55 55.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.893 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -140.17 130.78 25.63 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.337 0.589 . . . . 0.0 110.623 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.541 ' O ' ' HG ' ' B' ' 80' ' ' LEU . 1.3 pp -126.55 132.28 51.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.656 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mtp85 -138.01 140.31 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.587 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 83' ' ' LYS . 2.0 pt20 -88.09 -165.42 1.31 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.139 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.579 ' CB ' ' O ' ' B' ' 82' ' ' GLN . 66.5 tttt 98.88 77.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.314 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 73.27 85.07 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.751 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.523 ' O ' ' CD2' ' B' ' 87' ' ' HIS . 0.0 OUTLIER 61.79 87.08 0.14 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.604 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.03 145.47 91.64 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.589 2.193 . . . . 0.0 111.991 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 85' ' ' MET . 89.7 m-70 -133.13 136.92 46.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.52 HG13 ' HB3' ' B' ' 80' ' ' LEU . 0.0 OUTLIER -99.11 139.51 20.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.906 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 17.6 t -109.04 122.11 63.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 p -126.8 140.35 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -153.54 143.63 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.949 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.678 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.5 OUTLIER -82.73 125.1 30.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.096 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.624 HD11 ' HG3' ' B' ' 77' ' ' ARG . 96.0 mt -85.03 -8.77 58.56 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.221 0.534 . . . . 0.0 109.674 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.18 -54.75 4.42 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.852 ' SG ' ' O ' ' B' ' 95' ' ' CYS . 5.2 p -115.81 75.07 0.92 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.678 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.39 93.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 122.254 0.919 . . . . 0.0 110.948 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -124.67 134.38 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.337 -1.431 . . . . 0.0 109.355 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 2.1 mt -92.68 123.2 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.903 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.554 ' CG ' ' HZ2' ' B' ' 65' ' ' LYS . 55.6 mmm -132.78 159.64 39.16 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.704 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -134.11 155.04 50.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.33 96.49 2.65 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.7 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.78 170.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.38 2.054 . . . . 0.0 112.12 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -125.42 119.74 29.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.899 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.37 128.4 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.256 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 66.7 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.398 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.19 -144.25 1.46 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 95.7 p -58.17 -41.11 83.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.421 . . . . 0.0 110.256 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 19' ' ' SER . 59.9 m-85 -33.7 -62.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.894 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -49.84 -22.08 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.325 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.2 tp10 -97.37 -34.59 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 ' CE2' ' B' ' 31' ' ' TYR . 1.8 mm -98.78 15.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.546 -0.462 . . . . 0.0 112.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.696 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -79.49 117.49 25.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.137 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.703 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 112.77 -35.5 4.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.889 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -61.07 25.08 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.958 0.879 . . . . 0.0 110.895 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.703 ' H ' ' C ' ' A' ' 25' ' ' GLY . 29.2 p -37.66 -17.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.513 0.673 . . . . 0.0 109.899 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.718 ' N ' ' O ' ' A' ' 26' ' ' ARG . 17.7 t-105 -56.99 -56.34 22.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.689 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.873 ' CD1' HG12 ' B' ' 28' ' ' VAL . 13.5 pt -63.6 -17.91 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.269 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 29' ' ' ILE . 18.1 m-85 -89.44 -16.89 29.83 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.1 mmt85 -90.91 -61.56 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.171 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' B' ' 27' ' ' ARG . . . -71.43 45.34 0.79 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -153.53 -36.15 0.1 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CG ' HD12 ' B' ' 20' ' ' ILE . 2.0 t-80 -90.56 106.78 18.73 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.029 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.66 0.83 3.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.434 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.507 ' C ' ' HE2' ' A' ' 46' ' ' HIS . . . -54.28 146.41 24.66 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.537 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 2.1 ttm-85 -66.81 125.14 24.94 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.861 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -101.42 136.12 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.909 0.861 . . . . 0.0 113.301 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.632 ' O ' ' N ' ' A' ' 43' ' ' ILE . 38.5 m-80 -166.11 152.17 9.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.323 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 42' ' ' ASN . 20.8 ttmt -49.96 -51.93 37.53 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.91 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER -60.22 -4.81 0.89 Allowed 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.705 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 77.7 m-20 -122.53 -10.25 8.41 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.33 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.656 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -80.12 -41.06 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.616 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.889 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.1 9.38 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.87 1.319 . . . . 0.0 107.57 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.889 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.24 -25.37 4.49 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.81 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.705 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -79.0 146.28 33.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.788 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -70.89 111.48 6.33 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 49' ' ' ILE . 13.5 mt -68.73 115.87 8.58 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.9 mm -157.42 -27.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.865 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.529 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -152.11 30.95 0.89 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.283 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.951 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -98.38 156.13 16.89 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.791 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.4 tmtt? -98.04 127.0 43.73 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.427 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.987 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.8 p -149.4 171.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.269 0.557 . . . . 0.0 111.871 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.72 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.92 152.62 49.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.799 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 65' ' ' GLY . 89.0 t -96.33 99.52 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 t -84.79 -51.97 13.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -129.03 118.61 22.83 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.331 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.556 ' OG ' ' CE1' ' A' ' 60' ' ' HIS . 5.2 t -149.36 173.35 13.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.331 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 59' ' ' THR . 10.8 t -108.32 75.46 0.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.466 -0.893 . . . . 0.0 109.294 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.738 ' CD2' ' O ' ' A' ' 59' ' ' THR . 0.4 OUTLIER -168.59 93.08 0.59 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.745 178.035 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.2 -5.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.349 2.033 . . . . 0.0 113.263 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -109.55 9.06 32.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.366 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.511 ' O ' HG22 ' A' ' 66' ' ' ILE . 39.6 m-85 -140.74 -12.95 0.98 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.234 1.017 . . . . 0.0 112.255 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.2 m -72.0 132.66 33.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.129 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.5 6.39 88.66 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.335 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.049 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.0 tt -100.87 148.48 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.701 0.75 . . . . 0.0 112.055 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.664 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 4.8 tm-20 -119.7 129.98 54.79 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.583 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -145.69 174.24 25.74 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 116.412 -0.358 . . . . 0.0 112.509 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ALA . 2.1 t80 -96.25 115.2 27.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.571 0.348 . . . . 0.0 110.093 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -48.21 142.39 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.727 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.2 mt -141.76 -39.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.683 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -121.82 143.43 49.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.58 ' N ' ' CZ ' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -157.21 106.48 2.18 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.82 -171.33 2.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.28 0.562 . . . . 0.0 111.084 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -53.24 -24.7 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.125 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -138.43 30.93 2.36 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.473 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -164.68 169.6 16.69 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 118.687 -1.205 . . . . 0.0 113.91 179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.751 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.4 tp -165.83 110.21 0.83 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 71' ' ' ILE . 98.0 t -116.41 146.2 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.637 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.0 OUTLIER -126.89 145.3 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.229 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.18 136.13 53.96 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.532 . . . . 0.0 111.828 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -152.92 132.88 3.82 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 64.33 -123.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.808 -0.231 . . . . 0.0 110.643 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -116.31 33.22 5.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 110.618 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.549 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 6.1 tptp -145.25 170.75 15.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.549 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 7.8 m -124.28 156.11 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.701 0.762 . . . . 0.0 110.85 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 1.049 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.2 m-90 -99.11 119.73 38.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.623 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -107.98 104.47 13.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.28 96.26 3.97 Favored Pre-proline 0 N--CA 1.457 -0.115 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.92 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 92' ' ' ASP . 38.3 Cg_exo -54.16 126.76 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.095 1.197 . . . . 0.0 110.295 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.78 -19.84 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.431 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 90' ' ' PRO . 5.3 p-10 -87.6 -6.92 58.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 59' ' ' THR . 2.2 t -133.72 33.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.714 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -167.09 158.06 11.9 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.712 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.487 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 73.1 mt -106.45 118.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 78' ' ' LEU . 66.6 m-85 -99.08 131.12 45.35 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.987 ' C ' HG23 ' A' ' 53' ' ' VAL . 11.2 tt0 -115.49 94.87 4.89 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.662 ' CD2' ' HB ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.84 143.58 26.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.85 ' OE2' ' N ' ' A' ' 104' ' ' THR . 2.5 tm-20 -90.99 127.52 36.45 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.485 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.921 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -58.98 143.27 48.7 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.817 -178.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.861 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -54.83 0.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.284 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' THR . 31.8 t70 -106.66 10.64 30.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.16 14.42 76.91 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.921 ' O ' ' OG1' ' A' ' 100' ' ' THR . 19.3 m -106.54 127.6 53.45 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.806 ' H ' ' CD ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -76.47 135.98 39.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.431 0.634 . . . . 0.0 111.581 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.756 HD11 HG23 ' A' ' 100' ' ' THR . 70.2 mt -102.88 135.5 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.525 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -107.9 101.92 11.15 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.525 -0.916 . . . . 0.0 108.525 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.07 139.19 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.353 -177.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 2.5 m -79.29 145.49 33.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.773 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -70.88 -1.91 42.54 Favored Glycine 0 CA--C 1.507 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.087 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -82.94 -21.61 34.05 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.352 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -64.82 -47.08 79.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.419 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -94.29 28.58 2.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.776 179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 114' ' ' VAL . 12.6 p -60.81 106.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.98 -40.2 0.25 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.104 -0.953 . . . . 0.0 114.162 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtp180 -101.43 78.55 0.22 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.528 ' HB2' HH22 ' B' ' 17' ' ' ARG . 19.5 Cg_endo -66.59 -24.25 48.72 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.392 1.394 . . . . 0.0 108.984 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 119' ' ' MET . 9.3 pt-20 -62.94 -52.63 62.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.345 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.482 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.4 mmt -35.01 -55.56 0.59 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.667 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' CE3' ' A' ' 45' ' ' TRP . 4.2 tpt180 -68.28 -40.69 81.76 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.963 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.4 OUTLIER -62.1 -39.15 91.52 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.418 ' HE2' ' NZ ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -96.48 6.02 49.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.6 tttm 64.33 149.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.769 0.319 . . . . 0.0 110.799 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -69.18 -39.09 78.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.747 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -86.24 142.0 28.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 127' ' ' LYS . 75.8 ttt-85 -129.24 103.31 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.732 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 126' ' ' ARG . 23.4 tttm . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.576 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.689 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -79.62 -33.45 41.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.764 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 8.9 tttp -73.45 -35.06 65.69 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.664 1.221 . . . . 0.0 108.485 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 1.008 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -61.1 -51.51 68.84 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.088 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.706 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.9 mt -69.59 -35.56 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.9 -53.6 56.6 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.174 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.514 ' O ' HG22 ' B' ' 18' ' ' ILE . 12.9 mmmt -53.33 -50.96 63.9 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.734 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 7.7 pt-20 -71.53 -38.22 71.09 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.246 0.546 . . . . 0.0 110.755 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.727 ' HD3' HD11 ' A' ' 121' ' ' LEU . 7.0 ttt180 -58.84 -53.6 56.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.897 0.856 . . . . 0.0 109.844 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.685 ' HA ' HD12 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -59.36 -32.01 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.833 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.35 -50.13 73.94 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.663 HD12 ' CG ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -74.31 -49.61 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -177.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.12 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -56.0 -37.41 69.08 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.12 ' N ' HD13 ' B' ' 21' ' ' LEU . 6.2 t80 -59.76 -51.99 67.41 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.425 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 64.6 p -69.68 -34.95 74.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.138 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.856 HD12 HG13 ' B' ' 28' ' ' VAL . 0.1 OUTLIER -63.79 -56.26 16.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.181 0.515 . . . . 0.0 109.913 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' B' ' 36' ' ' ALA . . . -51.87 -34.51 41.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.726 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.832 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 1.7 tm-20 -74.19 -40.07 62.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.856 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 53.9 mtt180 -72.53 -34.74 67.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.215 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.7 m -85.83 -49.39 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.723 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 23.2 t80 -36.19 -49.85 1.69 Allowed Pre-proline 0 C--N 1.353 0.741 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.304 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.856 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 38.3 Cg_endo -54.58 -48.28 22.25 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.802 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 47.1 t80 -94.3 -10.8 31.62 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 112.473 -2.149 . . . . 0.0 112.773 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.215 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.0 p -165.03 95.13 0.88 Allowed Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' B' ' 37' ' ' LYS . 33.2 Cg_exo -56.5 -39.12 93.5 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.503 2.135 . . . . 0.0 113.319 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -53.37 35.3 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.56 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 13.5 mt -54.36 -57.85 9.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.587 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -51.66 -31.24 24.81 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.185 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' O ' ' B' ' 69' ' ' PHE . 2.2 mptt -70.97 -41.17 71.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.761 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.848 HH11 HD11 ' B' ' 42' ' ' LEU . 2.5 tmm_? -60.07 -54.34 47.13 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.951 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.895 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -61.66 -39.29 90.85 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.718 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' B' ' 69' ' ' PHE . 2.1 t -45.64 -43.23 3.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.596 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.72 -43.64 98.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.848 HD11 HH11 ' B' ' 38' ' ' ARG . 63.1 mt -64.8 -43.94 91.55 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.361 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.802 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.81 -30.86 64.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.682 HD11 ' OH ' ' B' ' 62' ' ' TYR . 7.3 mt -67.66 -54.83 16.34 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.47 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.552 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.3 pp -57.74 -28.25 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.745 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.978 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 83.5 t -69.1 -48.45 69.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.153 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.552 ' CD ' ' HE ' ' B' ' 56' ' ' ARG . 2.0 tt0 -66.08 -56.84 9.51 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 8.9 pt20 -80.75 -48.33 12.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -69.51 -33.85 73.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -89.38 -8.38 53.27 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? 64.82 71.15 0.46 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.66 133.64 64.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.99 109.52 14.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.067 0.461 . . . . 0.0 110.943 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' B' ' 55' ' ' PRO . 7.3 mm -135.33 134.85 21.59 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.357 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 54' ' ' ILE . 94.8 Cg_exo -37.82 117.16 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.942 1.761 . . . . 0.0 111.409 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.552 ' HE ' ' CD ' ' B' ' 47' ' ' GLN . 48.8 mtt85 -95.34 77.81 3.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.866 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' B' ' 59' ' ' LYS . 57.2 pttt -74.13 -24.17 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.646 ' O ' ' N ' ' B' ' 62' ' ' TYR . 2.0 m0 -55.48 -2.89 0.05 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' B' ' 57' ' ' LYS . 15.9 pttp -64.52 -8.75 15.02 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' B' ' 58' ' ' TRP . 9.9 ptm180 -88.19 -26.4 22.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.264 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.742 ' NH1' ' CE2' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -134.54 15.15 3.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.754 -177.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.682 ' OH ' HD11 ' B' ' 44' ' ' LEU . 23.5 t80 -111.82 151.13 29.42 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.773 ' CB ' HD21 ' B' ' 70' ' ' LEU . 0.0 OUTLIER -118.82 105.16 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.156 -178.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -92.86 -4.77 52.32 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.632 ' HZ3' ' CG ' ' B' ' 99' ' ' MET . 20.9 mmmt -78.57 -37.93 41.42 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.659 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 17.7 1.72 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.879 -177.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.58 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 1.7 m80 53.96 95.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.902 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.402 ' N ' HG11 ' B' ' 40' ' ' VAL . . . -166.4 -173.92 2.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.8 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.781 ' O ' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -125.44 102.51 7.44 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 1.061 HD22 ' H ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -99.97 154.4 18.42 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.814 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 42.9 t -131.12 115.15 16.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.424 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . 0.401 ' N ' ' HB3' ' B' ' 76' ' ' ALA . 73.6 Cg_exo -45.0 122.49 4.33 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.224 1.949 . . . . 0.0 111.848 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.74 -26.77 23.25 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.446 HD12 HG11 ' B' ' 71' ' ' VAL . 56.1 mt -105.05 -80.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -115.55 22.36 13.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.958 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.696 ' HB2' ' CB ' ' B' ' 70' ' ' LEU . . . -150.75 161.75 42.04 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.274 0.559 . . . . 0.0 111.972 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.445 ' HG3' HD11 ' B' ' 93' ' ' LEU . 75.9 mtt-85 -149.94 127.16 11.33 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.144 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.591 ' O ' HG23 ' B' ' 78' ' ' VAL . 19.5 m -139.27 118.34 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.529 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' B' ' 88' ' ' ILE . 9.8 mtt85 -131.73 145.08 51.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 110.378 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' B' ' 80' ' ' LEU . 2.0 pp -114.62 117.77 31.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.362 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -137.72 147.51 44.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.644 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -64.96 -120.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.814 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' B' ' 84' ' ' ARG . 29.3 mtpt 60.35 103.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' B' ' 83' ' ' LYS . 38.4 ttt85 41.96 100.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.952 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.446 ' O ' ' O ' ' B' ' 84' ' ' ARG . 12.7 ttm 48.94 99.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.282 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.95 140.57 31.17 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.192 1.928 . . . . 0.0 112.16 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -154.77 145.57 22.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.465 ' CG1' ' HB3' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -96.54 123.98 49.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 2.5 p -84.62 118.66 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.164 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.415 HG12 HG12 ' B' ' 78' ' ' VAL . 14.6 m -121.82 134.17 65.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -146.89 134.35 20.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.463 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.571 ' HB2' ' O ' ' B' ' 95' ' ' CYS . 8.3 m -68.52 109.76 3.88 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.245 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.445 HD11 ' HG3' ' B' ' 77' ' ' ARG . 92.9 mt -87.34 -6.81 58.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.342 0.591 . . . . 0.0 109.432 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -99.44 -18.09 17.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -143.8 72.01 1.34 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.367 -2.197 . . . . 0.0 107.022 178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.71 91.12 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.458 -176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.579 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.6 OUTLIER -131.31 124.57 30.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.177 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 79.8 mt -87.9 121.91 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.033 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.632 ' CG ' ' HZ3' ' B' ' 65' ' ' LYS . 17.7 mmm -136.02 165.67 25.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.292 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -141.73 135.87 30.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.403 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -120.49 96.05 48.99 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.388 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.53 161.53 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.862 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -142.95 103.88 4.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.615 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.74 125.49 66.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.343 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.72 177.89 29.54 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 54.7 p -81.05 -22.86 38.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.623 ' HB3' HG11 ' A' ' 86' ' ' VAL . 37.0 m-85 -42.44 -58.52 2.2 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.052 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -43.72 -15.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.733 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' TYR . 38.2 tp10 -99.82 -32.62 10.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.327 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.704 HD12 ' OG ' ' B' ' 32' ' ' SER . 3.8 mm -109.11 19.15 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -80.35 117.13 25.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.543 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.26 -37.48 3.6 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.204 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 28' ' ' TRP . 1.9 mtt180 -62.26 30.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.552 0.676 . . . . 0.0 110.875 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.666 ' H ' ' C ' ' A' ' 25' ' ' GLY . 2.9 p -43.74 -12.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.747 0.784 . . . . 0.0 109.022 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.684 ' N ' ' O ' ' A' ' 26' ' ' ARG . 24.1 t-105 -58.24 -55.77 30.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.169 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.764 ' CD1' HG12 ' B' ' 28' ' ' VAL . 7.2 pt -64.66 -13.59 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.945 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 71' ' ' ILE . 60.5 m-85 -93.42 -16.5 24.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 33' ' ' ALA . 5.9 mmm180 -89.13 -56.68 3.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.736 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' NE ' ' B' ' 27' ' ' ARG . . . -78.58 46.42 2.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 29' ' ' ILE . . . -153.12 -40.98 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -75.68 126.96 32.03 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.536 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -154.78 -35.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.553 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' ARG . . . -32.29 144.77 0.02 OUTLIER Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 24.4 ttm105 -66.42 119.5 11.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.7 t -92.71 136.62 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-O 121.767 0.794 . . . . 0.0 113.115 -177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.652 ' O ' ' N ' ' A' ' 43' ' ' ILE . 39.3 t30 -165.82 155.52 12.35 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 42' ' ' ASN . 86.3 tttt -52.21 -52.77 50.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.76 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.565 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 8.7 pttm -60.15 -4.24 0.76 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.748 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 72.3 m-20 -123.95 -3.41 8.13 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.228 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.787 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -86.41 -39.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 117.876 0.307 . . . . 0.0 111.466 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.882 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -88.43 3.12 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.882 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -114.65 -37.88 4.14 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.617 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.748 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -67.29 140.38 57.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.787 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -66.25 110.09 2.9 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.826 ' O ' HG12 ' A' ' 49' ' ' ILE . 5.0 mt -72.9 114.5 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.407 -1.317 . . . . 0.0 108.013 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.865 HD11 HD12 ' B' ' 42' ' ' LEU . 4.7 mt -168.42 51.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 O-C-N 123.803 0.689 . . . . 0.0 109.491 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 150.16 -35.26 0.99 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.591 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.969 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.6 tt -44.59 146.05 0.79 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.882 ' H ' HD23 ' A' ' 51' ' ' LEU . 13.0 tmtt? -85.46 125.31 32.93 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.348 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.977 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.0 p -149.1 171.02 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.434 0.635 . . . . 0.0 111.954 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.725 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.89 152.81 49.39 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.001 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 65' ' ' GLY . 31.6 t -100.44 99.46 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.58 -51.98 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.56 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HB3' HD12 ' A' ' 95' ' ' ILE . 15.1 t-20 -128.48 117.42 21.31 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.553 178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.1 t -150.18 173.53 13.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.466 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.68 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -101.36 79.2 1.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.68 ' CD2' ' O ' ' A' ' 59' ' ' THR . 37.3 m-70 -161.14 94.92 1.4 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.614 -178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.7 -5.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.177 1.918 . . . . 0.0 113.219 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -134.79 22.57 3.64 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.193 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' ILE . 27.2 m-85 -140.69 -10.85 1.03 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.628 1.214 . . . . 0.0 111.834 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.4 m -72.14 134.07 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 83.27 5.87 88.44 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.291 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.083 HG23 ' NE1' ' A' ' 87' ' ' TRP . 11.4 tt -104.54 153.5 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 117.66 0.73 . . . . 0.0 112.204 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.614 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.3 tm-20 -120.26 131.49 54.95 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.31 173.29 27.49 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 116.341 -0.39 . . . . 0.0 112.502 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -96.45 117.89 31.83 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.5 t -51.9 145.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.962 0.41 . . . . 0.0 111.654 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.6 mt -140.32 -33.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.485 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.666 ' OD2' ' NH1' ' B' ' 38' ' ' ARG . 37.6 t0 -123.56 149.29 45.46 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.662 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 1.2 tm-20 -161.71 106.05 1.26 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.959 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.536 HG23 ' OD1' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -148.45 -175.23 4.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.194 0.521 . . . . 0.0 110.964 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.493 HH12 HH21 ' A' ' 116' ' ' ARG . 37.1 ttt85 -53.17 -23.25 7.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.094 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -138.83 29.16 2.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -166.29 164.53 17.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 118.358 -1.337 . . . . 0.0 114.267 179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.645 HD23 ' CE1' ' A' ' 96' ' ' PHE . 10.5 tp -163.43 109.79 1.13 Allowed 'General case' 0 C--O 1.248 1.023 0 CA-C-N 112.975 -1.92 . . . . 0.0 105.937 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 71' ' ' ILE . 83.3 t -118.24 146.3 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.388 0.613 . . . . 0.0 112.474 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.622 HG22 ' C ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -127.6 147.09 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.357 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -122.69 137.47 54.9 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.597 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -155.52 124.96 1.57 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 64.8 -130.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 110.552 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.24 32.06 5.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.544 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 13.7 tttp -139.12 166.75 23.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.607 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 20' ' ' TYR . 7.5 m -123.45 155.44 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.421 0.629 . . . . 0.0 110.611 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 1.083 ' NE1' HG23 ' A' ' 66' ' ' ILE . 1.6 m-90 -102.17 93.14 5.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.437 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' HG13 ' A' ' 89' ' ' VAL . 20.9 ttmt -91.3 104.84 17.33 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.928 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 88' ' ' LYS . 2.5 m -157.24 95.85 2.1 Favored Pre-proline 0 N--CA 1.457 -0.123 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.563 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 32.0 Cg_exo -54.28 126.82 23.45 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.973 1.782 . . . . 0.0 111.687 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.823 ' HZ3' ' N ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -38.81 -24.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.204 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 90' ' ' PRO . 4.0 p-10 -82.24 -6.11 58.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.405 HG12 ' OG1' ' A' ' 59' ' ' THR . 0.2 OUTLIER -137.06 33.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.271 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 90' ' ' PRO . 3.2 p -167.37 154.82 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.354 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 57' ' ' ASN . 23.7 mt -105.37 146.13 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.271 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.761 ' HB3' HG21 ' A' ' 53' ' ' VAL . 50.3 m-85 -130.42 137.65 49.94 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.977 ' C ' HG23 ' A' ' 53' ' ' VAL . 7.8 tt0 -119.65 94.0 4.26 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' ILE . 1.4 m-85 -87.69 144.82 26.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.612 ' O ' HD21 ' A' ' 51' ' ' LEU . 82.6 tt0 -90.01 131.6 35.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.317 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.67 143.39 57.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.693 -179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.45 -0.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.296 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 20.2 t0 -107.37 12.98 27.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.8 22.65 68.75 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.06 149.47 26.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.417 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.46 133.41 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.42 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 100' ' ' THR . 22.2 mt -107.16 134.9 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -115.65 102.63 9.93 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -151.38 139.92 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.933 -179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 111' ' ' GLU . 37.4 m -89.74 148.35 23.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.275 0.559 . . . . 0.0 111.449 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.34 -1.0 0.94 Allowed Glycine 0 CA--C 1.506 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.174 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -76.44 -23.75 53.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.287 -178.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -74.63 -47.56 31.4 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.303 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -90.81 28.41 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.1 p -59.64 105.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.823 ' N ' ' HZ3' ' A' ' 91' ' ' LYS . . . 67.49 -41.02 0.23 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.792 175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.493 HH21 HH12 ' A' ' 75' ' ' ARG . 7.0 mmt180 -100.79 79.72 0.23 Allowed Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HB2' HH22 ' B' ' 17' ' ' ARG . 18.3 Cg_endo -64.83 -24.48 61.3 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 N-CA-C 107.677 -1.701 . . . . 0.0 107.677 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.608 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.1 OUTLIER -64.72 -57.31 9.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.446 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 123' ' ' LYS . 2.6 tpt -31.81 -45.4 0.1 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.741 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.626 ' NE ' ' CZ3' ' A' ' 45' ' ' TRP . 6.8 tpm_? -70.9 -46.77 61.96 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -61.46 -41.35 97.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.647 -0.421 . . . . 0.0 109.97 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.45 17.94 22.95 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.618 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 119' ' ' MET . 42.4 mtmt 47.12 -145.42 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.876 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -100.13 167.13 10.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -105.05 -5.14 21.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.586 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 126' ' ' ARG . 40.2 mtp-105 -58.51 131.94 52.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.671 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.578 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.55 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 2.6 pt-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' B' ' 11' ' ' LYS . 16.9 pttp -79.85 -41.49 26.21 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.965 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.847 ' H ' HH11 ' B' ' 12' ' ' ARG . 16.8 ttpt -72.85 -33.62 66.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 122.742 1.258 . . . . 0.0 108.431 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.98 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.5 mpt_? -61.8 -51.07 69.78 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 112.418 -2.173 . . . . 0.0 110.98 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 45' ' ' TRP . 15.1 mt -68.33 -27.55 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -61.95 -53.09 60.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.904 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.468 ' O ' HG22 ' B' ' 18' ' ' ILE . 29.5 mttp -54.16 -50.25 67.43 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.79 -37.49 70.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.302 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.506 HH22 ' HB2' ' A' ' 117' ' ' PRO . 17.6 ttt180 -61.79 -53.66 52.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.842 0.83 . . . . 0.0 110.163 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -57.35 -34.83 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.118 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -67.07 -31.28 71.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.143 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.572 HG21 ' OE2' ' A' ' 47' ' ' GLU . 31.3 mt -71.33 -56.88 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.023 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -65.14 -34.0 77.34 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.908 0.861 . . . . 0.0 109.087 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.023 ' N ' HD13 ' B' ' 21' ' ' LEU . 14.0 t80 -53.09 -49.33 66.64 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.305 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.4 p -68.27 -37.21 80.48 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.123 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -60.4 -56.78 17.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.708 0.766 . . . . 0.0 110.032 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.57 -33.99 34.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.159 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.813 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 7.9 mm-40 -75.15 -43.51 52.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.583 0.706 . . . . 0.0 109.79 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.84 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 83.6 mtt-85 -72.69 -34.56 67.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.4 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.256 ' O ' ' N ' ' B' ' 32' ' ' SER . 3.6 m -85.19 -50.9 14.22 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.642 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.727 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 14.1 t80 -36.42 -49.73 1.81 Allowed Pre-proline 0 C--N 1.35 0.599 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.525 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.84 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 41.5 Cg_endo -55.39 -47.91 23.42 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 N-CA-C 106.893 -2.003 . . . . 0.0 106.893 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.807 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 41.2 t80 -94.47 -15.25 24.38 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.536 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.256 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.4 OUTLIER -161.2 93.62 1.44 Allowed Pre-proline 0 N--CA 1.468 0.454 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.524 ' HB3' ' HZ1' ' B' ' 37' ' ' LYS . 50.5 Cg_exo -53.7 -43.47 57.57 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.03 2.487 . . . . 0.0 114.158 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -64.08 -52.17 60.58 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.645 ' CD2' HH21 ' B' ' 38' ' ' ARG . 11.4 mt -51.3 -58.15 6.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.928 0.394 . . . . 0.0 111.044 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.758 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -53.68 -34.04 57.37 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.354 0.597 . . . . 0.0 109.649 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.783 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.1 OUTLIER -70.8 -41.06 72.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.391 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.666 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 3.6 ttm-85 -62.75 -51.54 66.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.406 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.876 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.5 m-30 -60.48 -41.19 93.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.097 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 36' ' ' ALA . 3.1 t -45.27 -36.47 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.381 -1.281 . . . . 0.0 107.948 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 67.5 tt0 -67.87 -44.03 78.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.865 HD12 HD11 ' A' ' 49' ' ' ILE . 26.8 mt -66.17 -40.02 90.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.323 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -68.27 -31.1 70.32 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 4.5 mt -63.16 -54.64 34.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.601 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.665 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 2.9 pp -60.2 -38.17 82.47 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.13 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.945 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.0 t -54.42 -44.37 66.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.451 0.643 . . . . 0.0 109.702 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.4 -55.16 17.1 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.761 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 13.3 pt20 -80.32 -52.27 7.9 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' B' ' 45' ' ' LEU . 13.9 mptt -61.7 -39.96 93.34 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.313 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.945 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.56 -11.65 45.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.07 67.63 0.84 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.112 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.93 137.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.899 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -44.54 141.41 1.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.145 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.558 ' O ' ' O ' ' B' ' 55' ' ' PRO . 6.7 tt -107.61 102.79 46.39 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' B' ' 54' ' ' ILE . 52.1 Cg_exo -51.24 -134.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.532 2.154 . . . . 0.0 112.235 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.484 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 0.8 OUTLIER -166.67 -16.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.628 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.411 ' H ' ' H ' ' B' ' 56' ' ' ARG . 27.3 tttt -58.68 -40.33 83.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.124 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.424 ' HA ' ' HE ' ' B' ' 61' ' ' ARG . 7.7 m0 -67.17 -3.51 7.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.777 0.322 . . . . 0.0 110.941 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.484 ' CD ' ' O ' ' B' ' 56' ' ' ARG . 2.7 pttt -69.04 -16.65 63.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.472 HH11 ' HD2' ' B' ' 60' ' ' ARG . 7.6 ptm85 -78.73 -20.37 50.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.558 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -140.71 17.87 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.138 -177.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' B' ' 58' ' ' TRP . 85.9 t80 -119.48 156.79 29.56 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.558 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.5 OUTLIER -127.22 124.08 38.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.043 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.51 4.48 49.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.515 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.2 OUTLIER -97.53 -38.6 9.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.196 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.562 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.3 p -136.71 10.72 3.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.473 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' B' ' 66' ' ' CYS . 5.4 m-70 49.63 109.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.7 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -171.96 -170.04 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.694 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.783 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -122.85 105.06 9.68 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.0 OUTLIER -109.47 141.69 41.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.814 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.7 t -119.71 121.01 30.13 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.09 122.92 6.87 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.017 1.811 . . . . 0.0 111.991 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 76' ' ' ALA . . . 101.78 -33.08 6.79 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.628 HG22 ' ND2' ' B' ' 75' ' ' ASN . 89.3 mt -99.37 -77.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.773 0.321 . . . . 0.0 110.975 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.628 ' ND2' HG22 ' B' ' 74' ' ' ILE . 5.8 m120 -109.27 14.65 23.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.09 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.661 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -152.87 161.87 42.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.71 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -142.0 136.5 30.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.732 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.744 ' O ' HG23 ' B' ' 78' ' ' VAL . 33.1 m -130.79 100.3 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 O-C-N 123.36 0.413 . . . . 0.0 111.489 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.535 ' HA ' HD13 ' B' ' 88' ' ' ILE . 44.0 ttt85 -165.41 120.06 1.27 Allowed 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.196 0.522 . . . . 0.0 111.02 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.759 HD23 ' HB3' ' B' ' 87' ' ' HIS . 21.7 tp -136.3 141.36 43.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.005 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . 0.668 ' H ' HD12 ' B' ' 80' ' ' LEU . 16.3 ptt180 -61.57 -179.61 0.19 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.02 0.438 . . . . 0.0 111.214 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.593 ' CB ' ' O ' ' B' ' 81' ' ' ARG . 30.3 mm-40 132.12 143.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.995 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -103.31 -73.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.402 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 mtp-105 -85.83 -5.91 59.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.383 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.541 ' O ' ' CE1' ' B' ' 87' ' ' HIS . 13.0 mtm -135.92 57.96 21.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 0.0 110.23 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' B' ' 82' ' ' GLN . 86.9 Cg_exo -41.4 119.05 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.918 2.412 . . . . 0.0 112.852 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . 0.759 ' HB3' HD23 ' B' ' 80' ' ' LEU . 3.7 m-70 -114.6 -179.19 3.56 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.555 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.661 ' CA ' ' HB3' ' B' ' 80' ' ' LEU . 1.2 mm -144.14 134.37 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.602 ' N ' ' HB2' ' B' ' 80' ' ' LEU . 53.3 t -95.67 116.41 37.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.631 ' CG1' HG12 ' B' ' 78' ' ' VAL . 0.0 OUTLIER -108.62 118.86 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -136.02 145.98 46.66 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.583 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.2 OUTLIER -82.35 127.19 32.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.737 178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 85.8 mt -88.67 -3.85 58.69 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.368 0.604 . . . . 0.0 109.391 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.36 -51.42 5.43 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.842 ' SG ' ' O ' ' B' ' 95' ' ' CYS . 4.7 p -118.42 76.26 1.07 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.73 93.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -128.04 126.41 41.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.651 -1.275 . . . . 0.0 109.984 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 tt -90.19 121.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.464 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 4.2 mtt -124.82 173.01 8.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.975 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 100' ' ' ARG . 33.4 mtm180 -128.05 155.3 44.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.024 0.44 . . . . 0.0 111.455 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.438 ' O ' ' CG ' ' B' ' 101' ' ' TYR . 3.7 t80 -157.93 91.52 2.22 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.181 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.82 164.61 9.5 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.147 1.898 . . . . 0.0 111.962 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -141.61 109.42 5.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.914 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.53 127.87 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.344 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.46 160.93 24.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.7 t -85.34 -10.83 55.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.674 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.3 m-85 -49.85 -48.79 50.95 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.12 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -40.84 -21.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 110.45 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -101.77 -35.56 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.616 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.698 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.6 mm -94.96 22.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -80.45 117.89 27.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.69 0.281 . . . . 0.0 111.712 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 107.07 -33.15 6.6 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.154 -0.546 . . . . 0.0 114.078 177.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.8 28.47 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.988 0.894 . . . . 0.0 111.038 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.688 ' H ' ' C ' ' A' ' 25' ' ' GLY . 16.5 p -42.76 -14.72 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.565 0.698 . . . . 0.0 109.397 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.653 ' N ' ' O ' ' A' ' 26' ' ' ARG . 18.9 t-105 -58.84 -59.53 5.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.263 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.795 ' CD1' HG12 ' B' ' 28' ' ' VAL . 11.9 pt -56.97 -12.97 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.576 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.639 ' CD2' HD21 ' B' ' 24' ' ' LEU . 27.4 m-85 -94.25 -29.62 14.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -74.65 -41.59 60.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.46 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.18 26.15 10.76 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -147.75 15.43 1.09 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -127.81 100.49 5.96 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.997 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.567 ' H ' HG13 ' B' ' 20' ' ' ILE . 5.3 mmt85 -138.87 -9.64 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.82 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.693 ' H ' ' CG1' ' B' ' 20' ' ' ILE . . . -45.52 145.05 2.9 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.571 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 28.7 ttt180 -66.87 118.26 10.12 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.831 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 61.8 t -93.64 136.5 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 43' ' ' ILE . 10.7 t-20 -165.86 150.93 8.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.279 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.542 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 88.0 tttt -48.45 -55.5 10.73 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.357 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' C ' HD22 ' A' ' 42' ' ' ASN . 6.3 pttp -59.31 -5.28 0.71 Allowed 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.643 HD22 ' N ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER -125.12 0.5 7.86 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.231 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.663 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.9 -38.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.907 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.74 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -97.63 9.85 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 122.575 1.179 . . . . 0.0 108.015 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.797 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -125.82 6.44 7.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.535 -1.666 . . . . 0.0 107.664 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.731 ' C ' ' HE ' ' B' ' 17' ' ' ARG . 0.1 OUTLIER -107.97 176.16 5.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.687 178.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.789 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -94.57 111.75 23.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.794 ' O ' HD13 ' A' ' 49' ' ' ILE . 45.9 mt -75.21 115.39 14.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.801 ' HB ' HD23 ' B' ' 24' ' ' LEU . 0.2 OUTLIER -161.02 -40.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.5 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -136.1 20.44 3.59 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.525 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.885 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -86.72 137.78 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.71 ' H ' HD23 ' A' ' 51' ' ' LEU . 76.2 tttt -71.1 135.89 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.669 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 54' ' ' ARG . 1.8 p -149.48 171.89 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.442 0.639 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -146.98 140.27 25.44 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.901 178.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 65' ' ' GLY . 42.9 t -91.25 99.53 9.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.1 t -83.43 -50.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.457 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.33 117.9 13.89 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.2 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 93' ' ' VAL . 4.5 t -150.27 174.02 13.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.758 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.691 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 1.4 p -97.14 78.84 2.79 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.716 ' O ' HG13 ' A' ' 64' ' ' VAL . 71.1 m-70 -166.56 111.71 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.696 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.05 -6.03 17.23 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.88 1.72 . . . . 0.0 112.654 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.08 13.72 9.03 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.763 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 87' ' ' TRP . 30.5 m-85 -138.82 -22.74 0.95 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.345 1.072 . . . . 0.0 111.589 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 60' ' ' HIS . 8.8 m -71.82 145.63 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.52 6.4 89.2 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.365 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.962 HG21 ' CZ2' ' A' ' 87' ' ' TRP . 26.1 mt -111.9 158.4 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 66' ' ' ILE . 4.5 tt0 -115.13 120.54 40.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.137 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.88 171.37 26.86 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.145 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -91.03 129.91 36.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.3 t -68.13 153.84 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.369 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.693 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 85.2 mt -141.59 -55.96 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.671 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 0.8 OUTLIER -106.41 150.21 26.26 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -176.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.676 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -156.68 107.05 2.33 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.477 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.73 -173.13 3.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 110.759 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -52.21 -29.5 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.581 -178.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 10.3 t-20 -137.98 31.37 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.678 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -157.13 161.46 39.38 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 118.992 -1.083 . . . . 0.0 113.358 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.715 HD23 ' CE1' ' A' ' 96' ' ' PHE . 9.3 tp -161.93 109.23 1.37 Allowed 'General case' 0 C--O 1.243 0.748 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 72' ' ' ASP . 80.4 t -107.86 147.29 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.453 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -131.11 143.86 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.002 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -124.07 136.19 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.945 0.403 . . . . 0.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.86 136.89 5.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 51.77 -133.93 1.71 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.517 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -102.23 33.75 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.843 0.354 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 22.1 tptm -145.46 160.34 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.092 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 14.0 m -120.57 156.69 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.588 0.709 . . . . 0.0 110.912 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.962 ' CZ2' HG21 ' A' ' 66' ' ' ILE . 2.6 m-90 -107.35 128.62 54.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.209 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' C ' ' CG2' ' A' ' 89' ' ' VAL . 83.0 tttt -118.64 106.54 12.71 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.41 ' CG2' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -152.31 99.58 2.85 Favored Pre-proline 0 CA--C 1.528 0.112 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.565 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 91' ' ' LYS . 50.8 Cg_exo -50.66 137.9 41.16 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.812 1.675 . . . . 0.0 110.795 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.611 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -49.98 -19.9 0.81 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.787 -178.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.611 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 1.2 p-10 -84.8 -6.17 59.34 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -125.12 5.89 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -142.34 139.41 31.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.117 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.3 mt -85.71 116.99 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.727 ' HB3' ' CE1' ' A' ' 98' ' ' PHE . 53.1 m-85 -98.12 130.31 44.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 106' ' ' ILE . 38.3 tt0 -113.5 97.28 6.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.727 ' CE1' ' HB3' ' A' ' 96' ' ' PHE . 47.2 m-85 -90.28 145.14 25.21 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -90.62 127.04 36.15 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.773 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.662 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -63.01 143.62 57.62 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.765 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.831 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.43 -0.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.402 -179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.7 t0 -106.85 13.38 27.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.23 21.92 69.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.662 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.58 149.77 26.84 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.625 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.495 ' HG3' HH21 ' A' ' 54' ' ' ARG . 0.1 OUTLIER -91.05 132.4 36.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 20.6 mt -105.52 134.07 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.281 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -112.54 101.03 9.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -138.11 136.18 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.431 -177.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' GLU . 3.8 m -81.32 134.66 35.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.668 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' LYS . . . -59.33 -2.19 1.4 Allowed Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.829 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 pt-20 -86.19 -21.06 27.69 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.916 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -63.45 -44.33 94.81 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.92 27.72 3.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.216 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 114' ' ' VAL . 5.3 p -48.1 103.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.471 0.653 . . . . 0.0 112.333 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' A' ' 91' ' ' LYS . . . 67.05 -41.44 0.2 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.725 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 119' ' ' MET . 12.4 mtt85 -100.52 97.4 6.48 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HB2' ' NH2' ' B' ' 17' ' ' ARG . 24.7 Cg_endo -69.32 -30.16 24.78 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 N-CA-C 107.1 -1.923 . . . . 0.0 107.1 174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.593 ' HB3' HD13 ' B' ' 45' ' ' LEU . 0.2 OUTLIER -64.79 -53.3 49.13 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 112.486 -2.143 . . . . 0.0 109.703 179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 118' ' ' GLU . 0.8 OUTLIER -29.37 -36.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.056 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.631 ' CZ ' ' CH2' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -82.39 -53.32 6.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.017 179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.42 -31.25 54.81 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.613 ' O ' ' C ' ' A' ' 123' ' ' LYS . 6.8 mtpp -84.71 -8.53 58.81 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.463 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.613 ' C ' ' O ' ' A' ' 122' ' ' LYS . 61.7 tttt -5.04 115.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.8 0.333 . . . . 0.0 111.833 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.491 ' C ' ' H ' ' A' ' 126' ' ' ARG . 6.2 ttm-85 -55.26 -96.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.293 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 67.76 -40.15 0.4 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.491 ' H ' ' C ' ' A' ' 124' ' ' ARG . 53.8 ttt85 -58.93 133.2 55.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.377 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.488 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.654 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -78.45 -37.88 42.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.576 -0.45 . . . . 0.0 112.161 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.862 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.3 OUTLIER -72.12 -33.24 67.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 122.958 1.361 . . . . 0.0 108.237 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.969 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -59.85 -51.01 71.53 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 112.013 -2.358 . . . . 0.0 111.216 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.477 ' HA ' ' OE2' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -69.68 -29.34 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.23 -48.57 64.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.503 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.425 ' O ' HG22 ' B' ' 18' ' ' ILE . 10.1 tptt -50.75 -51.15 53.02 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.544 ' O ' HD13 ' B' ' 20' ' ' ILE . 17.5 pt-20 -72.74 -36.7 67.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.206 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.731 ' HE ' ' C ' ' A' ' 46' ' ' HIS . 34.5 ttt-85 -60.92 -52.53 64.65 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.857 0.837 . . . . 0.0 110.606 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.89 -35.91 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.422 -177.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -67.75 -32.15 72.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.693 ' CG1' ' H ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -73.78 -55.05 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.996 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.59 -34.45 75.64 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.996 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -54.43 -51.29 65.41 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.017 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -69.1 -31.53 70.3 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.501 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.818 HD12 HG13 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -69.11 -54.4 15.17 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -51.19 -34.3 31.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.614 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.837 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 49.6 mt-10 -73.89 -43.08 59.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.44 0.638 . . . . 0.0 110.437 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.86 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 86.0 mtt-85 -71.4 -35.42 71.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.384 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.205 ' O ' ' N ' ' B' ' 32' ' ' SER . 2.4 m -82.33 -50.7 15.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 O-C-N 121.336 -0.853 . . . . 0.0 110.485 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.703 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 2.1 t80 -36.42 -51.2 1.84 Allowed Pre-proline 0 CA--C 1.511 -0.543 0 C-N-CA 120.089 -0.645 . . . . 0.0 109.616 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.86 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.2 Cg_endo -53.66 -46.72 31.65 Favored 'Trans proline' 0 C--N 1.296 -2.188 0 N-CA-C 106.129 -2.297 . . . . 0.0 106.129 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' B' ' 28' ' ' VAL . 41.9 t80 -95.0 -14.32 24.46 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 112.139 -2.301 . . . . 0.0 113.269 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.205 ' N ' ' O ' ' B' ' 28' ' ' VAL . 53.6 p -157.91 96.24 1.95 Allowed Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 37' ' ' LYS . 52.7 Cg_exo -55.09 -47.4 26.62 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.967 2.445 . . . . 0.0 114.347 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.21 -53.2 56.92 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.548 ' HB2' ' OG ' ' B' ' 32' ' ' SER . 62.0 mt -51.74 -60.25 3.38 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.984 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.8 -32.95 60.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.812 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -70.29 -38.46 75.03 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.702 178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.854 ' NH1' HD11 ' B' ' 42' ' ' LEU . 3.8 tmm_? -60.72 -50.35 73.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.027 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 0.8 OUTLIER -64.26 -40.46 96.04 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.8 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -46.02 -37.57 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -66.97 -45.45 77.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.854 HD11 ' NH1' ' B' ' 38' ' ' ARG . 11.6 mt -63.37 -50.7 68.88 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.454 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.14 -30.29 68.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.805 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 10.4 mt -65.33 -54.43 29.13 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 118' ' ' GLU . 3.5 pp -59.6 -35.03 73.53 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.673 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.712 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 73.4 t -64.94 -49.89 77.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.435 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -60.11 -51.13 70.91 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.022 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 7.0 pt20 -78.85 -39.64 34.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.77 ' HD3' ' C ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -83.06 -42.21 17.72 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.089 -177.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -67.06 -14.87 63.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 57.2 mttm 72.54 52.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.021 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.472 HG12 ' H ' ' B' ' 53' ' ' LYS . 0.2 OUTLIER -101.45 -178.51 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.995 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.472 ' H ' HG12 ' B' ' 52' ' ' VAL . 12.4 mtmm -71.16 162.47 29.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.56 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.45 ' H ' ' CD1' ' B' ' 54' ' ' ILE . 0.1 OUTLIER -78.06 148.29 74.78 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.69 -69.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.592 2.195 . . . . 0.0 112.342 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 77.32 -83.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.362 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.617 ' O ' ' NE ' ' B' ' 60' ' ' ARG . 11.3 pttm -55.96 -39.69 72.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.623 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 36.2 m0 -61.89 1.5 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.621 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' B' ' 57' ' ' LYS . 7.5 pttp -66.26 -17.06 64.52 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' B' ' 57' ' ' LYS . 9.6 ptp180 -76.17 -18.86 58.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.84 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.802 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -147.53 15.34 1.12 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.417 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 63' ' ' CYS . 32.4 t80 -113.54 154.08 27.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.584 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 5.8 t -123.66 114.51 20.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.896 0.379 . . . . 0.0 111.448 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.36 3.89 12.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.921 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.568 ' HB2' ' SG ' ' B' ' 95' ' ' CYS . 1.8 mmmt -98.27 -43.49 6.94 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.482 ' C ' ' CG ' ' B' ' 67' ' ' HIS . 6.1 p -134.14 -2.64 2.84 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.599 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER 61.94 134.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.513 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 164.97 -170.87 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.098 0.475 . . . . 0.0 110.783 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.825 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -117.96 103.92 10.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.802 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -110.23 117.35 33.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.45 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.688 HG23 ' CE2' ' B' ' 29' ' ' PHE . 1.5 t -101.59 121.06 52.63 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.939 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . 0.53 ' HB3' HG22 ' B' ' 78' ' ' VAL . 71.0 Cg_exo -46.15 124.79 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.792 1.662 . . . . 0.0 111.38 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.98 -33.93 6.18 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.488 HD12 HG11 ' B' ' 71' ' ' VAL . 96.6 mt -96.78 -80.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.854 0.359 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -113.43 18.6 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.115 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -148.0 164.44 33.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.857 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.649 ' HG3' HD11 ' B' ' 93' ' ' LEU . 79.7 mtp180 -144.17 129.64 18.99 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.478 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.737 ' O ' HG23 ' B' ' 78' ' ' VAL . 15.5 m -138.07 104.67 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.603 ' NH1' HH21 ' B' ' 77' ' ' ARG . 18.7 mtm-85 -128.08 145.2 51.07 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.256 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' B' ' 80' ' ' LEU . 1.5 pp -125.39 124.22 41.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.668 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -137.65 155.07 49.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.542 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.599 ' C ' ' H ' ' B' ' 84' ' ' ARG . 12.7 mp0 -85.6 -97.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.466 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 23.4 tttt 67.9 -13.12 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.076 0.465 . . . . 0.0 109.988 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' B' ' 82' ' ' GLN . 5.5 ptp180 179.53 -24.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.499 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . . . . . . . . . 1.2 mtt 177.56 136.8 0.22 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.061 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.52 103.4 1.42 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.105 1.87 . . . . 0.0 112.16 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -127.41 132.16 50.16 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.472 HG13 ' HB3' ' B' ' 80' ' ' LEU . 1.0 OUTLIER -84.26 135.89 23.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.588 ' O ' HG13 ' B' ' 89' ' ' VAL . 7.1 p -106.09 119.42 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -112.32 129.55 67.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.415 ' HA ' ' CE1' ' B' ' 97' ' ' HIS . 40.9 tttt -147.87 144.74 28.33 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.638 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.618 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 1.1 t -81.33 131.98 35.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.224 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.649 HD11 ' HG3' ' B' ' 77' ' ' ARG . 78.9 mt -95.78 0.34 52.21 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.502 0.501 . . . . 0.0 109.785 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -44.9 7.92 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.856 ' SG ' ' O ' ' B' ' 95' ' ' CYS . 4.6 p -129.95 79.5 1.91 Allowed 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.066 -1.879 . . . . 0.0 106.235 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.618 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.2 94.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 122.197 0.887 . . . . 0.0 111.936 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.554 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -118.76 120.71 38.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.412 -1.394 . . . . 0.0 108.931 178.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 79.3 mt -91.51 120.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.839 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.418 ' HG3' ' HE2' ' B' ' 97' ' ' HIS . 16.6 mmm -132.25 165.15 24.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.99 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -129.5 154.64 46.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -155.95 106.63 2.11 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.258 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -47.44 170.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.362 2.042 . . . . 0.0 112.478 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -115.94 75.87 0.98 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.926 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 71.7 mt -122.78 115.17 45.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.341 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 59.1 mttm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.41 179.819 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.72 145.09 12.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 m -92.0 -4.29 54.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.727 0.298 . . . . 0.0 110.644 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 22' ' ' GLU . 8.6 m-85 -43.23 -57.23 3.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.143 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -38.62 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.902 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 20' ' ' TYR . 47.0 tp10 -104.13 -32.6 9.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.728 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.1 mm -102.05 15.58 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 25' ' ' GLY . 1.2 tp -79.51 117.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.373 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.41 -36.42 4.06 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.328 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.676 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -61.32 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.631 0.716 . . . . 0.0 110.793 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.693 ' H ' ' C ' ' A' ' 25' ' ' GLY . 14.2 p -41.9 -14.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.612 0.72 . . . . 0.0 109.601 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.676 ' N ' ' O ' ' A' ' 26' ' ' ARG . 23.2 t-105 -57.31 -53.74 54.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.212 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.841 ' CD1' HG12 ' B' ' 28' ' ' VAL . 8.6 pt -67.67 -13.11 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.082 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 49' ' ' ILE . 41.3 m-85 -92.8 -9.88 38.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.5 ttp180 -95.04 -64.84 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.77 31.74 0.38 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -146.63 -36.51 0.24 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -90.84 112.29 24.06 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.785 ' H ' HD12 ' B' ' 20' ' ' ILE . 0.6 OUTLIER -148.47 2.13 0.63 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.943 -179.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA3' HH22 ' B' ' 17' ' ' ARG . . . -45.91 153.56 0.8 Allowed Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 9.2 ttm180 -67.69 117.73 10.01 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.83 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 47.0 t -95.25 134.2 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 43' ' ' ILE . 5.7 t-20 -166.1 149.94 7.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.464 -1.243 . . . . 0.0 108.276 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' ASN . 11.3 tttm -48.26 -55.14 11.3 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 44.2 pttt -59.91 -4.86 0.81 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.751 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 10.8 m120 -123.77 -0.35 8.56 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.229 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.803 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.54 -39.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.849 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.3 9.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.833 1.301 . . . . 0.0 107.578 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.85 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -126.55 -6.44 6.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.101 -1.863 . . . . 0.0 108.849 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.751 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -93.35 147.1 23.23 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.866 ' OE1' ' NE ' ' B' ' 17' ' ' ARG . 0.4 OUTLIER -74.48 110.64 8.93 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 49' ' ' ILE . 15.8 mt -73.24 117.94 15.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 48' ' ' LEU . 4.4 mm -152.69 -30.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.763 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.56 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -146.76 0.03 0.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.541 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' H ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -58.32 162.35 3.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.665 0.732 . . . . 0.0 109.488 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.843 ' H ' HD23 ' A' ' 51' ' ' LEU . 11.9 tttt -106.73 125.16 50.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.472 0.177 . . . . 0.0 111.171 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.003 HG23 ' C ' ' A' ' 97' ' ' GLU . 14.5 p -148.97 170.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.443 0.639 . . . . 0.0 111.513 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.708 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -132.27 145.43 51.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.439 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' GLY . 23.7 t -100.83 99.91 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.5 t -83.34 -47.61 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.937 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -127.77 119.43 25.72 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.133 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.9 p -148.61 135.95 20.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.052 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.629 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -71.26 77.1 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 118.281 -1.368 . . . . 0.0 108.948 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.629 ' CG ' ' C ' ' A' ' 59' ' ' THR . 1.0 OUTLIER -169.29 97.89 0.5 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.027 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.89 -4.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.469 2.113 . . . . 0.0 113.774 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -124.0 24.43 6.33 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 120.402 -0.904 . . . . 0.0 114.407 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -141.05 -21.98 0.78 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.804 1.302 . . . . 0.0 111.694 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 58' ' ' SER . 3.1 m -72.96 145.08 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.75 5.31 89.93 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.119 -0.563 . . . . 0.0 113.919 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.615 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.1 mt -104.64 148.58 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 118.259 1.03 . . . . 0.0 111.538 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -114.71 126.97 55.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.471 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.81 173.37 27.9 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.981 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.56 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -95.85 120.21 35.71 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.7 t -53.12 141.44 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.117 -178.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.729 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 12.6 mt -135.39 -36.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.971 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.597 ' HA ' ' NH2' ' B' ' 38' ' ' ARG . 1.7 t70 -121.83 141.68 50.99 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.639 ' H ' ' CZ ' ' B' ' 38' ' ' ARG . 5.0 tt0 -153.19 106.23 2.97 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 p -140.42 -176.77 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.125 0.488 . . . . 0.0 110.725 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 115' ' ' GLY . 72.6 ttt-85 -57.96 -16.46 12.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.816 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -138.77 27.29 2.46 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.551 ' SD ' ' OD2' ' A' ' 72' ' ' ASP . 2.4 ptp -165.96 170.02 14.12 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 118.7 -1.2 . . . . 0.0 114.066 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 96' ' ' PHE . 1.4 tp -166.13 110.24 0.8 Allowed 'General case' 0 C--O 1.252 1.233 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.907 ' C ' HD13 ' A' ' 80' ' ' ILE . 66.0 t -120.01 136.06 58.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.975 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -114.84 151.96 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 69' ' ' TYR . . . -128.13 135.93 50.45 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.122 0.486 . . . . 0.0 111.82 -178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.442 ' N ' ' HZ3' ' A' ' 87' ' ' TRP . . . -157.53 122.64 1.19 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 66.73 -130.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -108.69 18.17 21.12 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.947 0.403 . . . . 0.0 110.101 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -119.56 144.51 47.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.425 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 m -118.73 155.47 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.512 0.673 . . . . 0.0 110.959 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.618 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 3.2 m-90 -99.39 137.69 37.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.294 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -128.95 93.74 3.67 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.14 107.35 2.63 Favored Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.366 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.29 165.0 2.42 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.794 1.662 . . . . 0.0 110.563 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.699 ' HD2' ' H ' ' A' ' 115' ' ' GLY . 1.7 mttm -72.79 -21.42 60.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.68 -5.73 59.05 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.0 15.36 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 15.1 p -161.32 174.29 13.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.038 -1.065 . . . . 0.0 113.015 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.09 139.72 45.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.807 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.849 ' CE2' HD23 ' A' ' 78' ' ' LEU . 88.1 m-85 -121.66 131.31 54.03 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 1.003 ' C ' HG23 ' A' ' 53' ' ' VAL . 43.9 tt0 -114.69 94.48 4.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' ILE . 3.1 m-85 -86.74 145.24 26.73 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -89.78 129.4 36.18 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.659 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -66.06 143.36 57.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.729 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.83 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.37 0.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.55 -179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.539 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 84.8 m-20 -107.26 13.42 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.01 21.93 66.94 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.682 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.87 150.05 26.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.635 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 133.3 36.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.014 0.435 . . . . 0.0 111.121 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 100' ' ' THR . 16.0 mt -106.49 134.03 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -115.93 102.98 10.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -147.8 140.93 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.34 -178.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -88.38 150.71 23.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.435 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.34 -1.77 4.73 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.604 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 -21.55 47.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.658 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -73.66 -47.5 39.35 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.297 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.75 28.04 2.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.0 p -55.42 106.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.699 ' H ' ' HD2' ' A' ' 91' ' ' LYS . . . 68.2 -41.08 0.28 Allowed Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.476 -1.238 . . . . 0.0 114.464 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -101.92 87.87 1.13 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -69.47 -26.41 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 N-CA-C 107.783 -1.66 . . . . 0.0 107.783 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.632 ' HB3' HD22 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.99 -57.69 7.2 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.685 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.424 ' C ' ' O ' ' A' ' 118' ' ' GLU . 5.3 ttp -31.43 -54.35 0.24 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.767 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -45.21 68.98 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.298 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -48.06 -30.98 4.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.251 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -103.54 -18.59 14.7 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.413 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 122' ' ' LYS . 37.6 ttmt 58.86 145.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.6 ptt85 -93.8 133.63 36.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.609 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -170.34 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.629 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.18 148.81 27.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.361 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.572 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.758 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 28.9 mt-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -78.76 -29.07 44.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.951 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -33.93 64.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 122.68 1.229 . . . . 0.0 108.526 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.963 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.1 OUTLIER -63.6 -51.7 64.14 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 112.322 -2.217 . . . . 0.0 111.722 -178.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.541 ' O ' ' CD ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -71.07 -27.12 28.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -68.74 -39.95 80.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.418 ' O ' HG22 ' B' ' 18' ' ' ILE . 47.1 mttt -63.17 -49.56 73.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.962 0.411 . . . . 0.0 110.488 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.521 ' C ' ' NH1' ' B' ' 17' ' ' ARG . 1.0 OUTLIER -69.34 -35.36 75.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.907 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.866 ' NE ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -62.16 -52.04 65.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.512 0.672 . . . . 0.0 111.342 -179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.505 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -61.99 -41.65 91.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.594 -177.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 5.3 m-20 -69.78 -26.74 64.43 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.692 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.785 HD12 ' H ' ' A' ' 35' ' ' ARG . 5.7 mm -74.16 -57.29 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.67 -34.26 76.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.0 ' H ' HD13 ' B' ' 21' ' ' LEU . 11.6 t80 -53.72 -47.89 70.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.381 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 37.7 m -70.95 -34.11 71.14 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.449 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.757 HD12 HG13 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -67.86 -55.18 13.87 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.552 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.545 ' HB1' ' CE2' ' B' ' 69' ' ' PHE . . . -50.62 -38.44 46.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.735 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.823 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 23.7 mt-10 -65.84 -46.79 77.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.15 0.5 . . . . 0.0 111.263 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.889 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 1.7 ttt-85 -72.17 -33.47 67.72 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.354 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.171 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.7 m -82.6 -50.71 15.63 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.424 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.73 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 1.6 t80 -36.39 -50.63 1.82 Allowed Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 120.003 -0.679 . . . . 0.0 109.376 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.889 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.3 Cg_endo -53.64 -46.36 34.27 Favored 'Trans proline' 0 C--N 1.298 -2.105 0 N-CA-C 106.21 -2.265 . . . . 0.0 106.21 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.8 ' N ' ' O ' ' B' ' 28' ' ' VAL . 39.8 t80 -94.92 -12.66 26.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 112.146 -2.297 . . . . 0.0 113.028 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.171 ' N ' ' O ' ' B' ' 28' ' ' VAL . 60.5 p -160.34 96.67 1.48 Allowed Pre-proline 0 N--CA 1.472 0.654 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.64 -44.75 45.02 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.261 2.641 . . . . 0.0 114.439 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.34 -53.0 55.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.035 0.445 . . . . 0.0 112.133 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.521 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 24.3 mt -53.81 -61.14 2.5 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.093 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.55 -32.72 42.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.725 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.781 ' NZ ' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -70.46 -41.05 73.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.079 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.864 HH11 HD11 ' B' ' 42' ' ' LEU . 2.8 tmm_? -59.68 -53.58 56.37 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.555 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.91 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.1 m-30 -58.88 -43.17 90.86 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 110.049 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.513 HG23 ' CD2' ' B' ' 69' ' ' PHE . 0.9 OUTLIER -46.32 -40.91 4.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.902 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.95 -42.21 99.75 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.864 HD11 HH11 ' B' ' 38' ' ' ARG . 63.2 mt -67.39 -51.36 52.83 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.477 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' B' ' 39' ' ' TYR . . . -52.23 -31.03 30.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.987 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 23.8 mt -65.33 -54.44 28.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.305 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.673 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.4 pp -62.02 -28.3 69.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.832 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.905 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 95.1 t -64.34 -48.87 83.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.602 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.446 HE21 ' HD2' ' B' ' 55' ' ' PRO . 1.8 tp-100 -65.74 -57.41 8.09 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 11.8 pt20 -81.62 -52.16 7.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 5.4 tptt -62.96 -37.71 88.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.889 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.905 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -81.45 -0.71 42.9 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.725 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 mttm 63.61 69.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.744 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -132.06 156.88 42.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.743 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -44.9 145.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.559 ' O ' HG23 ' B' ' 54' ' ' ILE . 8.4 tt -112.25 94.28 25.75 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.747 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . 0.446 ' HD2' HE21 ' B' ' 47' ' ' GLN . 22.2 Cg_exo -60.66 177.74 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.451 2.101 . . . . 0.0 110.997 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.444 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 77.4 mtp180 -149.25 24.37 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.907 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' B' ' 59' ' ' LYS . 17.3 ptmt -86.97 -38.38 16.68 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.626 ' O ' ' N ' ' B' ' 62' ' ' TYR . 6.0 m-90 -49.5 -2.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.315 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' B' ' 57' ' ' LYS . 24.4 mtpp -61.65 -19.66 62.55 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -68.81 -17.79 64.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.818 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -150.74 8.3 0.57 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.64 -177.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' B' ' 58' ' ' TRP . 92.6 t80 -117.72 157.5 26.38 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.988 0.423 . . . . 0.0 110.551 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' B' ' 62' ' ' TYR . 22.6 t -126.99 129.99 49.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.042 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -87.33 3.13 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.79 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' B' ' 97' ' ' HIS . 1.1 mmpt? -108.16 -31.44 7.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.796 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.569 ' O ' ' O ' ' B' ' 67' ' ' HIS . 11.5 p -138.96 10.44 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.209 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.0 OUTLIER 37.12 103.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.985 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.781 ' HB1' ' NZ ' ' B' ' 37' ' ' LYS . . . -162.25 -173.05 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.122 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.618 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 0.2 OUTLIER -113.97 103.18 10.91 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.818 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.3 OUTLIER -105.57 147.56 28.26 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.632 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.511 HG11 HD12 ' B' ' 74' ' ' ILE . 2.5 t -125.95 120.72 24.11 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.86 123.64 6.29 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.859 1.706 . . . . 0.0 111.654 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.13 -33.26 6.67 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.511 HD12 HG11 ' B' ' 71' ' ' VAL . 94.8 mt -94.44 -80.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.615 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -116.86 22.64 12.49 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -151.29 157.76 42.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.225 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.12 138.42 23.98 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.745 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 78' ' ' VAL . 20.8 m -138.82 119.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -130.66 146.21 52.1 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.555 ' HB3' HG13 ' B' ' 88' ' ' ILE . 1.5 pp -125.97 126.93 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.937 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.74 158.54 44.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.023 0.44 . . . . 0.0 111.088 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' B' ' 83' ' ' LYS . 4.1 pt20 -76.72 -130.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.3 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 82' ' ' GLN . 14.4 tptm 83.7 70.79 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.013 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' B' ' 85' ' ' MET . 0.9 OUTLIER 45.07 93.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.768 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' B' ' 84' ' ' ARG . 1.7 tmm? 85.75 110.24 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.798 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.05 136.18 19.96 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.175 1.917 . . . . 0.0 112.149 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -144.19 146.26 32.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.044 0.45 . . . . 0.0 111.248 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' B' ' 80' ' ' LEU . 0.0 OUTLIER -102.02 137.1 31.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.933 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 8.3 t -103.42 110.89 31.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.279 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 99' ' ' MET . 3.2 p -121.09 135.81 60.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' B' ' 97' ' ' HIS . 5.9 tttp -154.22 153.73 32.27 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.479 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.611 ' H ' ' HB3' ' B' ' 97' ' ' HIS . 12.1 t -81.26 130.79 35.18 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 76' ' ' ALA . 14.1 mt -108.79 17.26 22.04 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.597 1.186 . . . . 0.0 108.279 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.539 ' OE2' ' NZ ' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -95.41 -30.46 13.88 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.881 ' SG ' ' N ' ' B' ' 96' ' ' GLY . 21.5 p -144.21 -104.17 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.615 -2.539 . . . . 0.0 106.407 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.881 ' N ' ' SG ' ' B' ' 95' ' ' CYS . . . -159.88 98.21 0.17 Allowed Glycine 0 C--N 1.315 -0.631 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.621 ' O ' ' HA ' ' B' ' 91' ' ' LYS . 20.0 t-160 -122.34 113.47 19.44 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 117.888 0.844 . . . . 0.0 111.05 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mt -94.33 119.67 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.495 ' HB2' HG13 ' B' ' 90' ' ' VAL . 6.2 mmt -141.54 159.9 41.26 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.472 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -141.71 141.21 33.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.002 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -136.32 103.64 9.55 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.008 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.25 166.05 3.66 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.253 1.969 . . . . 0.0 112.495 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -142.37 74.5 1.45 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.32 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 76.8 mt -100.5 135.07 38.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.511 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.11 129.86 21.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -90.76 -21.29 21.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.85 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' A' ' 72' ' ' ASP . 54.0 m-85 -38.32 -62.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.915 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -58.39 -7.92 1.03 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.414 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' SER . 45.3 tp10 -97.9 -36.93 10.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.692 HG23 ' CD2' ' B' ' 31' ' ' TYR . 2.5 mm -104.51 14.16 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -175.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 85' ' ' LYS . 1.3 tp -79.98 118.8 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.413 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 120.07 -38.85 2.63 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -66.87 27.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.676 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -41.94 -14.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.739 0.78 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 28.1 t-105 -58.71 -54.44 47.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.329 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.755 ' CD1' HG12 ' B' ' 28' ' ' VAL . 4.7 pt -66.2 -14.25 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.238 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -89.71 -34.35 16.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.98 -32.61 19.97 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.765 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' NH1' ' B' ' 27' ' ' ARG . . . -85.48 28.81 4.64 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -156.13 20.72 0.37 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -127.15 101.91 6.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.671 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.472 ' H ' ' CG1' ' B' ' 20' ' ' ILE . 23.0 mmt-85 -145.85 12.58 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.938 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.644 ' HA3' HH21 ' B' ' 17' ' ' ARG . . . -62.32 152.45 44.3 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 14.9 ttm180 -67.31 132.84 48.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.805 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 55.1 t -116.8 136.73 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.707 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.691 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -166.23 153.81 10.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.617 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 42' ' ' ASN . 28.8 tttm -49.83 -55.8 12.81 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.837 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.623 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 42.9 pttt -60.64 -3.51 0.72 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.746 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 31.6 m-20 -124.72 1.12 8.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.26 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.73 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.98 -42.79 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.106 -0.238 . . . . 0.0 110.876 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.853 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -89.7 0.79 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.853 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -117.23 18.04 14.59 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.008 -1.906 . . . . 0.0 107.68 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.746 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -125.23 126.58 45.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.925 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -59.28 113.42 2.15 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.838 HD22 ' CE2' ' A' ' 98' ' ' PHE . 2.6 mt -78.13 122.18 25.28 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.759 0.314 . . . . 0.0 111.001 -177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.784 HD13 ' O ' ' A' ' 48' ' ' LEU . 2.0 mm -151.22 -46.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.936 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' CE2' ' A' ' 69' ' ' TYR . . . -127.57 -3.06 6.15 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.181 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -60.35 140.87 56.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.248 0.524 . . . . 0.0 110.358 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.651 ' H ' HD23 ' A' ' 51' ' ' LEU . 64.1 tttt -75.38 135.56 40.8 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HB ' ' CD2' ' A' ' 98' ' ' PHE . 2.7 p -148.75 170.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.546 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -150.33 140.52 22.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.855 178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.4 t -88.19 100.79 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t -82.5 -51.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 O-C-N 123.374 0.421 . . . . 0.0 110.512 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.7 118.75 15.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.182 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.65 ' HB3' HG12 ' A' ' 64' ' ' VAL . 23.3 t -148.74 174.23 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.96 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.703 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 5.9 t -103.11 78.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.703 ' CD2' ' O ' ' A' ' 59' ' ' THR . 19.2 m80 -167.62 118.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.17 -5.29 15.48 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 121.73 1.62 . . . . 0.0 112.975 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.14 20.94 7.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 120.478 -0.868 . . . . 0.0 114.187 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -141.21 -23.09 0.75 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.905 1.352 . . . . 0.0 112.098 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.65 HG12 ' HB3' ' A' ' 58' ' ' SER . 3.3 m -71.57 145.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 82.64 7.31 87.6 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.257 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.845 ' CD1' ' HE1' ' A' ' 87' ' ' TRP . 19.8 mt -108.05 159.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' N ' HG22 ' A' ' 66' ' ' ILE . 5.7 tm-20 -126.76 121.82 33.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.459 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -148.09 172.38 28.38 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.073 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 50' ' ' GLY . 1.6 m-85 -87.32 123.56 32.42 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 51' ' ' LEU . 2.9 t -56.43 157.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.283 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 81' ' ' ALA . 93.9 mt -143.73 -60.72 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 62.0 t0 -101.34 148.25 25.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.828 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -153.72 106.56 2.9 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 178.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -157.97 177.59 11.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.225 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 44.8 ttm-85 -53.69 -5.12 0.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.274 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.783 ' H ' HG23 ' A' ' 74' ' ' THR . 78.3 m-20 -137.98 0.79 2.21 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 74' ' ' THR . 4.8 ptp -165.78 167.89 16.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.895 HD23 ' CE2' ' A' ' 96' ' ' PHE . 4.5 tp -151.16 109.72 3.81 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.1 t -113.71 147.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -127.99 141.57 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.999 179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -110.46 136.48 49.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -151.56 119.0 0.94 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 84' ' ' ASN . 3.5 tp10 65.07 -123.14 0.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.404 ' H ' ' CG ' ' A' ' 83' ' ' GLU . 3.3 m120 -111.57 21.01 16.61 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.973 0.416 . . . . 0.0 110.475 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.542 ' O ' ' CD1' ' A' ' 24' ' ' ILE . 29.0 tttp -130.66 164.46 24.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.481 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.469 ' H ' ' HG3' ' A' ' 85' ' ' LYS . 29.2 m -120.67 156.28 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.435 0.636 . . . . 0.0 110.637 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.845 ' HE1' ' CD1' ' A' ' 66' ' ' ILE . 2.5 m-90 -105.62 104.49 14.21 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.182 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -98.93 110.26 22.9 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.844 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.98 96.35 3.31 Favored Pre-proline 0 C--N 1.334 -0.097 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.224 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -55.75 146.31 66.99 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.882 1.721 . . . . 0.0 111.308 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.562 ' CD ' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.68 -29.11 37.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.613 -178.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -6.96 59.55 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -126.13 22.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.509 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.662 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 24.6 p -165.27 158.3 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.457 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 109' ' ' SER . 57.5 mt -112.58 124.62 69.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.627 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.895 ' CE2' HD23 ' A' ' 78' ' ' LEU . 72.4 m-85 -100.92 144.53 29.75 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 18.6 tt0 -125.75 97.59 5.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.838 ' CE2' HD22 ' A' ' 48' ' ' LEU . 8.1 m-85 -90.45 145.72 24.7 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -89.46 130.76 35.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.068 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.66 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -65.48 142.46 58.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.483 0.659 . . . . 0.0 110.265 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.805 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -59.24 0.19 0.11 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.678 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 55.1 t0 -107.15 4.43 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.77 23.2 36.64 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.0 OUTLIER -107.05 150.16 26.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.769 0.319 . . . . 0.0 110.35 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -90.52 128.8 36.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 0.0 111.359 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 100' ' ' THR . 14.1 mt -104.03 135.07 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -120.35 101.82 8.05 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.497 HG21 HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -142.25 132.89 24.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.063 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.2 m -74.34 145.34 43.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.153 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -63.86 -2.52 6.48 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.546 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -81.46 -22.79 37.87 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.121 -1.032 . . . . 0.0 112.62 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -69.22 -44.56 71.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.022 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -99.0 29.38 3.87 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.9 p -54.36 105.97 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.82 -40.49 0.31 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.685 -1.143 . . . . 0.0 114.735 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 119' ' ' MET . 21.2 mtm-85 -100.49 85.75 0.57 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.68 -23.45 76.32 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.472 -1.395 . . . . 0.0 108.472 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HD13 ' B' ' 45' ' ' LEU . 0.9 OUTLIER -68.59 -57.25 6.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.489 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 118' ' ' GLU . 26.4 ttp -24.8 -48.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.572 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 118' ' ' GLU . 2.9 tpm_? -82.58 -49.18 10.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.852 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -52.15 -39.11 59.51 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.495 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 123' ' ' LYS . 1.3 ptmt -88.22 -34.92 17.6 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.917 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 122' ' ' LYS . 87.7 tttt 56.57 146.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.149 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.31 150.32 51.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.46 ' N ' ' CD2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -95.35 -52.5 4.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 46.2 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.572 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.2 mttm . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.286 179.728 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.524 ' O ' HG12 ' B' ' 13' ' ' ILE . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.58 ' H ' ' CD ' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -53.73 -37.28 63.19 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.009 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.539 ' HG2' ' HD2' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -65.41 -46.64 79.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.276 1.036 . . . . 0.0 109.38 178.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.624 ' O ' ' CD ' ' B' ' 16' ' ' GLU . 0.0 OUTLIER -64.92 -51.05 63.99 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.314 -1.767 . . . . 0.0 112.433 -176.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.524 HG12 ' O ' ' B' ' 9' ' ' GLU . 1.8 pt -62.61 -27.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.5 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.418 ' HB2' ' HB1' ' B' ' 50' ' ' ALA . . . -70.57 -38.14 74.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.418 ' HD3' HH21 ' B' ' 12' ' ' ARG . 37.1 mttt -60.85 -47.2 87.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.823 0.344 . . . . 0.0 110.702 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.635 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.0 OUTLIER -67.31 -38.43 84.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.436 -0.505 . . . . 0.0 110.366 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.678 ' NE ' ' HA ' ' B' ' 17' ' ' ARG . 2.6 mmp_? -67.39 -52.31 41.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.499 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' B' ' 19' ' ' ASP . 0.0 OUTLIER -57.48 -42.53 81.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 6.9 m-20 -71.71 -32.42 67.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -71.33 -53.82 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.951 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.1 -33.54 76.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.951 ' N ' HD13 ' B' ' 21' ' ' LEU . 0.6 OUTLIER -52.1 -44.33 64.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.943 178.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 18.7 p -73.86 -31.9 63.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.331 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG1' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -68.46 -58.21 4.67 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.084 0.468 . . . . 0.0 110.028 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.26 -42.41 52.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.82 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -60.03 -50.65 72.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.529 0.68 . . . . 0.0 110.031 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.875 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 2.9 ttm180 -67.9 -37.74 82.12 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.958 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.213 ' O ' ' N ' ' B' ' 32' ' ' SER . 0.8 OUTLIER -86.75 -42.86 15.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.363 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.787 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 25.2 t80 -39.17 -49.11 4.44 Favored Pre-proline 0 CA--C 1.509 -0.624 0 CA-C-N 119.982 1.265 . . . . 0.0 108.689 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.875 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 40.3 Cg_endo -54.45 -46.85 30.35 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.389 2.06 . . . . 0.0 106.747 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 34.8 t80 -93.53 -14.51 26.52 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.534 -2.121 . . . . 0.0 112.37 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.213 ' N ' ' O ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -163.49 95.98 1.05 Allowed Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.409 ' HA ' ' CD2' ' B' ' 29' ' ' PHE . 52.3 Cg_exo -54.63 -45.09 43.57 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 123.197 2.598 . . . . 0.0 114.684 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.77 -53.65 53.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.745 ' CD2' HH21 ' B' ' 38' ' ' ARG . 32.4 mt -51.78 -58.39 6.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.118 0.485 . . . . 0.0 110.997 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -52.7 -30.92 34.82 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.398 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.653 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.02 -41.75 70.45 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.612 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.745 HH21 ' CD2' ' B' ' 35' ' ' LEU . 2.4 ttm-85 -63.26 -46.98 84.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.897 ' CB ' HD23 ' B' ' 21' ' ' LEU . 2.2 m-85 -67.91 -40.06 83.46 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.942 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.4 t -46.63 -40.96 4.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.901 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.57 -38.73 84.5 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.821 HD11 ' OE1' ' A' ' 73' ' ' GLU . 17.9 mt -66.91 -45.43 77.96 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.718 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.581 ' HB2' HD11 ' B' ' 21' ' ' LEU . . . -58.0 -30.54 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.364 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.823 HD11 ' OH ' ' B' ' 62' ' ' TYR . 60.6 mt -69.02 -54.77 13.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.071 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.723 HD13 ' HA ' ' A' ' 118' ' ' GLU . 3.1 pp -57.4 -30.85 65.27 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.947 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.958 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 58.0 t -62.05 -47.13 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.525 0.679 . . . . 0.0 109.479 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.66 -56.12 10.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.384 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 5.7 pt20 -80.21 -46.74 15.77 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -72.21 -38.31 69.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.593 -178.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -86.03 -9.63 56.43 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 63.02 74.01 0.44 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.4 -1.273 . . . . 0.0 112.307 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.35 154.84 29.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.221 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -113.63 117.09 30.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.776 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.465 HD12 HD12 ' B' ' 18' ' ' ILE . 0.4 OUTLIER -135.61 142.99 43.08 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.962 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . 0.408 ' O ' ' CB ' ' B' ' 56' ' ' ARG . 19.7 Cg_endo -59.47 -32.26 96.07 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.217 1.944 . . . . 0.0 112.123 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.462 ' H ' HG23 ' B' ' 54' ' ' ILE . 48.8 ttm-85 78.37 81.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' B' ' 59' ' ' LYS . 0.5 OUTLIER -79.7 -22.94 42.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.82 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.496 ' C ' ' H ' ' B' ' 60' ' ' ARG . 5.0 m0 -58.51 -0.15 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.098 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' B' ' 57' ' ' LYS . 25.6 pttt -61.37 -6.84 2.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' B' ' 58' ' ' TRP . 11.8 ptp180 -93.08 -21.9 19.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.973 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.851 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -145.76 29.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.373 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.823 ' OH ' HD11 ' B' ' 44' ' ' LEU . 24.2 t80 -122.4 151.6 41.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.449 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.567 ' N ' ' CD1' ' B' ' 62' ' ' TYR . 1.5 t -123.04 114.3 20.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.524 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -83.83 9.13 12.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 109.567 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.504 ' HB2' ' SG ' ' B' ' 95' ' ' CYS . 9.1 mmmt -99.34 -40.4 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.01 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.4 p -136.79 9.29 3.07 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.271 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.547 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.4 m80 54.84 122.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.782 0.325 . . . . 0.0 111.073 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' B' ' 67' ' ' HIS . . . 172.22 -171.68 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.163 0.506 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.653 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 1.8 t80 -123.6 105.4 9.7 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.937 ' N ' HD22 ' B' ' 70' ' ' LEU . 0.2 OUTLIER -111.42 124.97 53.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.507 -177.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.55 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 66.5 t -106.23 127.21 28.72 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.728 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . 0.495 ' HB3' HG22 ' B' ' 78' ' ' VAL . 50.2 Cg_exo -47.9 125.98 12.28 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.174 1.916 . . . . 0.0 112.372 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.24 -35.93 4.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.5 -76.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.22 19.29 13.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -150.31 166.78 28.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.047 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -147.43 134.73 20.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.886 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.608 ' O ' HG23 ' B' ' 78' ' ' VAL . 34.5 m -133.15 111.89 17.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.093 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -142.66 149.74 39.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.468 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.832 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.3 OUTLIER -123.09 142.46 50.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.653 0.739 . . . . 0.0 112.187 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -88.3 136.27 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.56 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.28 98.93 10.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.6 ' O ' ' O ' ' B' ' 84' ' ' ARG . 4.3 tptp -166.89 98.72 0.55 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.599 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.6 ' O ' ' O ' ' B' ' 83' ' ' LYS . 52.1 mtt-85 41.15 105.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 110.328 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.541 ' O ' ' CE1' ' B' ' 87' ' ' HIS . 5.7 mtt 58.15 61.86 5.25 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -37.68 159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.321 2.68 . . . . 0.0 112.607 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' B' ' 85' ' ' MET . 1.2 m80 -142.03 131.6 23.94 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.454 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' B' ' 101' ' ' TYR . 0.4 OUTLIER -84.05 148.07 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.816 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.584 HG13 ' O ' ' B' ' 99' ' ' MET . 23.4 t -120.35 128.14 75.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.105 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' B' ' 99' ' ' MET . 1.6 p -118.9 131.34 71.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -144.33 148.73 35.13 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.054 -1.059 . . . . 0.0 113.462 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.572 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.3 OUTLIER -85.33 129.0 34.9 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.499 179.428 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 37.4 mt -93.18 0.35 57.12 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -92.16 -51.68 5.06 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.848 ' SG ' ' O ' ' B' ' 95' ' ' CYS . 6.2 p -121.18 78.48 1.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.48 94.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.41 -176.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -127.94 132.88 49.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.69 -1.255 . . . . 0.0 109.77 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 83.5 mt -100.85 122.89 53.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.712 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.584 ' O ' HG13 ' B' ' 89' ' ' VAL . 18.7 mtt -121.8 148.46 44.64 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.092 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -109.05 148.2 31.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.672 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' B' ' 88' ' ' ILE . 0.3 OUTLIER -145.11 95.98 5.04 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.453 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -54.06 168.51 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.214 1.943 . . . . 0.0 112.316 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -140.89 86.15 2.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.042 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 mt -109.64 129.55 64.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.78 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 10.4 mttp . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.319 179.698 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.84 0.44 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 22' ' ' GLU . 96.4 p -62.66 -24.99 67.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.751 0.31 . . . . 0.0 110.682 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.674 ' HB3' HG11 ' A' ' 86' ' ' VAL . 8.1 m-85 -40.19 -58.85 1.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.97 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -49.57 -15.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.749 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 19' ' ' SER . 49.0 tp10 -104.49 -33.13 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.656 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.6 mm -100.83 18.7 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 111.209 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.0 tp -79.66 117.61 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.421 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 113.66 -38.1 3.33 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.537 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.7 32.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.738 0.769 . . . . 0.0 111.32 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.648 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -44.82 -11.91 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.642 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.9 t-105 -59.74 -59.85 4.78 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.162 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.858 HD12 HG12 ' B' ' 28' ' ' VAL . 17.8 pt -60.93 -10.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.216 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CD2' HD11 ' B' ' 24' ' ' LEU . 39.3 m-85 -94.19 -19.26 20.92 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' A' ' 33' ' ' ALA . 6.5 mmm-85 -80.7 -69.15 0.62 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.528 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.33 44.16 1.11 Allowed Glycine 0 CA--C 1.518 0.276 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -158.09 -38.87 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.44 ' CD2' ' H ' ' A' ' 49' ' ' ILE . 44.7 t-80 -109.49 100.05 9.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.776 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -154.03 13.47 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.788 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.51 163.55 0.04 OUTLIER Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.636 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 7.8 ttt180 -67.84 112.34 4.84 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.369 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.813 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 54.5 t -90.19 136.37 24.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -165.6 145.95 6.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.048 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' NE1' ' A' ' 45' ' ' TRP . 59.9 tttm -47.14 -54.4 10.66 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.421 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.551 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 47.1 pttt -62.82 -4.46 2.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.645 ' N ' ' O ' ' A' ' 39' ' ' ASN . 7.0 m120 -121.68 -4.61 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.439 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -88.87 -40.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.745 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.899 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -87.38 10.08 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 122.993 1.378 . . . . 0.0 107.394 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.899 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.98 -38.4 2.61 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 112.975 -1.92 . . . . 0.0 107.636 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.721 ' HD1' ' CG2' ' B' ' 13' ' ' ILE . 0.0 OUTLIER -58.4 174.48 0.3 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.755 177.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' OE2' ' CZ ' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -100.76 109.05 21.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 176.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.873 ' O ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -76.54 117.05 17.79 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 117.585 -1.646 . . . . 0.0 108.055 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -162.56 40.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.93 -29.17 0.59 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.504 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.932 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -45.54 137.62 4.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.492 ' H ' HD23 ' A' ' 51' ' ' LEU . 4.4 ttpt -77.79 128.9 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.785 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HG21 ' A' ' 80' ' ' ILE . 5.2 p -148.4 169.37 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.39 0.614 . . . . 0.0 111.211 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.733 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -139.26 146.98 41.08 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.994 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 89' ' ' VAL . 66.2 t -98.15 98.88 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -91.17 -51.57 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.996 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -126.06 118.32 25.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 64' ' ' VAL . 4.0 p -148.72 159.97 43.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.454 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.591 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -88.64 80.43 7.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 59' ' ' THR . 5.7 m170 -167.62 116.27 0.66 Allowed Pre-proline 0 C--N 1.326 -0.413 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.77 -4.85 14.11 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.817 1.678 . . . . 0.0 113.961 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.43 32.88 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 119.998 -1.096 . . . . 0.0 113.686 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -141.26 -21.32 0.77 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.032 0.916 . . . . 0.0 111.645 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG12 ' OG ' ' A' ' 58' ' ' SER . 3.5 m -72.38 138.41 21.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.262 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 99.14 5.8 56.01 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.053 177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.674 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.23 157.81 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 118.356 1.078 . . . . 0.0 112.047 -178.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.2 tm-20 -123.9 126.83 47.07 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.441 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.694 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.28 174.19 27.15 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.862 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 81' ' ' ALA . 6.4 m-85 -95.09 120.34 35.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -48.77 151.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 111.55 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 81' ' ' ALA . 48.4 mt -142.64 -58.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 4.8 t0 -107.91 143.65 36.24 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 3.3 mp0 -146.38 106.92 4.07 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.955 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.599 HG22 ' NH1' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -138.41 -175.01 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.054 0.454 . . . . 0.0 110.944 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 9.4 ttp180 -50.76 -31.85 18.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.124 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 75' ' ' ARG . 94.0 m-20 -138.11 31.66 2.41 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.517 ' HG3' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -155.12 158.97 39.82 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.784 -1.167 . . . . 0.0 113.713 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -156.6 110.01 2.65 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 71' ' ' ILE . 73.3 t -111.49 145.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.222 0.534 . . . . 0.0 112.319 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -133.82 140.25 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.261 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.025 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -113.37 135.57 53.72 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.95 0.405 . . . . 0.0 111.48 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -145.77 159.2 27.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 82' ' ' GLY . 5.1 pt-20 32.72 -109.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 110.847 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -127.28 33.72 4.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.88 0.372 . . . . 0.0 110.46 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' H ' ' A' ' 86' ' ' VAL . 23.9 tttp -143.1 160.49 40.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.398 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 20' ' ' TYR . 4.2 m -114.07 155.4 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.721 0.772 . . . . 0.0 110.903 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.822 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.2 m-90 -97.71 135.29 39.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -125.97 96.04 4.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.41 101.61 3.78 Favored Pre-proline 0 N--CA 1.462 0.132 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.429 -179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.512 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.6 Cg_exo -55.66 145.19 72.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.696 1.597 . . . . 0.0 111.064 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.898 ' HZ2' ' H ' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -53.28 -37.71 62.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.078 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.04 -6.38 56.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 93' ' ' VAL . 3.3 t -125.22 29.81 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.659 -0.417 . . . . 0.0 111.41 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.697 ' SG ' ' CE2' ' A' ' 96' ' ' PHE . 31.6 p -168.02 165.32 13.6 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 118.931 -1.108 . . . . 0.0 113.926 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -114.46 133.97 58.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.157 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.743 ' CE2' HD23 ' A' ' 78' ' ' LEU . 50.0 m-85 -117.06 130.79 56.89 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 53' ' ' VAL . 6.4 tt0 -116.96 94.84 4.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.72 ' CE2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -89.81 146.48 24.43 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 105' ' ' LYS . 45.9 tt0 -88.49 127.77 35.53 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.85 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.621 HG23 HD11 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -63.91 142.36 58.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.219 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.813 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.66 -0.02 0.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.668 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.545 ' OD1' ' CD2' ' A' ' 101' ' ' TRP . 1.1 m-20 -107.19 16.51 23.99 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.95 23.72 73.9 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.63 149.7 26.95 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.646 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 99' ' ' GLU . 58.9 mmtt -92.15 131.86 37.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.731 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' THR . 27.5 mt -107.17 135.25 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.912 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -118.04 101.31 8.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -139.13 139.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.212 -177.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.438 ' O ' HD13 ' A' ' 108' ' ' ILE . 17.4 p -78.49 149.0 33.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.089 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -71.43 -1.87 46.13 Favored Glycine 0 CA--C 1.508 -0.368 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -86.9 -22.44 25.69 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.597 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -63.03 -47.69 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.221 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.601 ' O ' ' NZ ' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -95.2 28.43 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.6 p -52.17 104.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.898 ' H ' ' HZ2' ' A' ' 91' ' ' LYS . . . 68.14 -41.48 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 114.376 175.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 24.5 mmt180 -101.86 88.03 1.16 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.53 -25.49 34.97 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 N-CA-C 108.106 -1.536 . . . . 0.0 108.106 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.796 ' HB3' HD22 ' B' ' 45' ' ' LEU . 12.8 pt-20 -66.21 -55.24 17.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.163 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 23.9 mmm -34.2 -41.74 0.12 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.128 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.697 ' HE ' ' CA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -75.93 -43.91 42.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.887 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.871 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -61.78 -41.09 97.27 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.146 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HZ1' ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -85.21 -25.16 27.53 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.831 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 122' ' ' LYS . 21.2 ttpp 35.5 82.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.036 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -139.31 124.82 19.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.119 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -40.9 156.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.161 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 126' ' ' ARG . 4.7 mtt180 -37.78 89.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 125' ' ' TRP . 35.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.48 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.839 ' N ' ' HE ' ' B' ' 12' ' ' ARG . 7.4 pt-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -79.77 -45.89 18.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.388 -0.525 . . . . 0.0 112.238 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' B' ' 14' ' ' ALA . 20.2 ttpt -72.44 -33.48 67.09 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 122.726 1.251 . . . . 0.0 108.617 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 1.041 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 0.3 OUTLIER -62.6 -51.86 65.67 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.658 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.721 ' CG2' ' HD1' ' A' ' 46' ' ' HIS . 33.5 mt -64.94 -27.51 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 11' ' ' LYS . . . -65.27 -48.5 73.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.244 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -52.18 -48.71 64.84 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.037 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.937 ' O ' HD13 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -70.12 -38.03 75.47 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.965 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.633 ' CZ ' ' OE2' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -65.82 -52.03 53.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.366 0.603 . . . . 0.0 110.451 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.55 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -63.85 -42.76 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.19 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.446 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 1.5 m-20 -71.82 -22.18 61.59 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.446 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.937 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.2 mp -75.49 -56.59 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.998 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -62.98 -34.43 77.52 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.998 ' H ' HD13 ' B' ' 21' ' ' LEU . 2.8 t80 -53.12 -44.06 67.38 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.921 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 58.3 m -64.66 -40.16 94.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.922 ' O ' HG13 ' B' ' 28' ' ' VAL . 1.9 mm? -56.9 -57.55 12.03 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.776 0.798 . . . . 0.0 109.297 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.04 -33.35 17.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.392 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.811 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 57.5 mt-10 -77.12 -55.82 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.914 0.864 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.852 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 79.9 mtt-85 -67.95 -35.88 79.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.474 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.182 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -85.48 -50.69 14.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.673 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.754 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 27.8 t80 -36.3 -49.34 1.73 Allowed Pre-proline 0 CA--C 1.509 -0.599 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.173 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.852 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 36.5 Cg_endo -53.26 -47.86 25.17 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 N-CA-C 106.506 -2.151 . . . . 0.0 106.506 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.795 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 62.2 t80 -94.5 -15.17 24.41 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 112.289 -2.232 . . . . 0.0 113.08 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.182 ' N ' ' O ' ' B' ' 28' ' ' VAL . 43.0 p -158.04 91.19 2.21 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.84 -41.9 73.91 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.977 2.451 . . . . 0.0 113.88 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' B' ' 34' ' ' GLU . 55.8 mp0 -66.67 -54.25 25.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 25.9 mt -52.09 -55.38 21.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.985 0.422 . . . . 0.0 110.155 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -54.35 -30.24 50.96 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.331 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.704 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.48 -47.11 57.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.884 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.701 ' CD ' ' C ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -60.54 -53.3 59.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.799 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.956 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.2 m-85 -59.69 -42.57 93.25 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' B' ' 39' ' ' TYR . 1.1 t -45.05 -34.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.568 ' CD ' HH21 ' B' ' 38' ' ' ARG . 0.0 OUTLIER -70.65 -44.86 66.25 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' B' ' 39' ' ' TYR . 49.4 mt -65.45 -47.89 74.59 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.961 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.72 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -57.17 -31.16 65.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.535 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -62.73 -50.94 69.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.383 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.796 HD22 ' HB3' ' A' ' 118' ' ' GLU . 2.1 pp -61.95 -39.29 91.62 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 120.117 -0.633 . . . . 0.0 112.015 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.736 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 40.2 t -61.22 -49.23 85.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.381 0.61 . . . . 0.0 111.49 -177.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -49.6 72.39 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.714 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.84 -55.96 4.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.986 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.62 ' N ' ' O ' ' B' ' 45' ' ' LEU . 6.6 mmpt? -59.0 -43.29 91.46 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -79.07 -16.21 57.09 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 26.1 mttt 70.75 43.54 0.72 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.748 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.74 124.77 47.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -108.87 108.06 18.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.15 0.5 . . . . 0.0 110.664 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' B' ' 55' ' ' PRO . 5.7 tt -137.4 128.56 16.23 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.442 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . 0.431 ' C ' ' O ' ' B' ' 54' ' ' ILE . 67.9 Cg_exo -33.84 116.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.201 1.934 . . . . 0.0 111.976 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.429 ' O ' ' CD ' ' B' ' 59' ' ' LYS . 1.5 mpp_? -92.16 83.08 5.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.698 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.609 ' C ' ' H ' ' B' ' 59' ' ' LYS . 55.0 pttt -86.47 -11.76 50.9 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' NH1' ' B' ' 60' ' ' ARG . 5.4 m-90 -51.2 4.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.225 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' B' ' 57' ' ' LYS . 3.1 mptp? -66.75 -3.79 7.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.592 ' NH1' ' CD1' ' B' ' 58' ' ' TRP . 18.6 ptt-85 -82.28 -35.34 28.14 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.302 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -124.94 21.6 8.18 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.515 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -118.43 154.6 32.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.604 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 1.7 t -126.39 113.62 17.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.656 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -78.85 4.35 14.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.976 0.417 . . . . 0.0 109.986 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.558 ' HG3' ' CG ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -95.86 -38.23 10.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.538 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' B' ' 63' ' ' CYS . 2.0 p -138.72 -0.2 1.95 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.734 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' B' ' 68' ' ' ALA . 4.5 m80 61.52 128.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . 169.81 -171.41 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.065 0.46 . . . . 0.0 111.123 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.574 ' O ' ' CE2' ' B' ' 29' ' ' PHE . 13.2 t80 -121.19 103.02 8.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.842 ' N ' HD22 ' B' ' 70' ' ' LEU . 0.4 OUTLIER -113.58 119.26 36.89 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.411 0.624 . . . . 0.0 112.441 -177.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.602 ' C ' ' HB3' ' B' ' 76' ' ' ALA . 61.1 t -96.16 136.13 22.24 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.046 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.92 118.55 5.59 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.719 1.613 . . . . 0.0 111.531 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.64 -33.42 4.64 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.57 -78.09 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.006 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.556 ' HA ' HD12 ' B' ' 93' ' ' LEU . 19.3 m-20 -116.77 19.76 14.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.164 0.507 . . . . 0.0 109.749 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.829 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -145.3 158.8 43.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.929 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -148.46 130.12 15.02 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.441 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.676 ' O ' HG23 ' B' ' 78' ' ' VAL . 35.1 m -131.23 103.86 8.14 Favored 'Isoleucine or valine' 0 C--O 1.23 0.051 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.306 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.814 ' O ' HG22 ' B' ' 89' ' ' VAL . 66.7 mtt85 -132.45 140.47 48.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.133 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.869 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.2 OUTLIER -126.28 143.93 50.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.797 0.808 . . . . 0.0 111.939 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' B' ' 86' ' ' PRO . 0.2 OUTLIER -109.13 164.91 12.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 74.67 172.19 0.28 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.116 0.885 . . . . 0.0 111.477 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.654 ' O ' ' CB ' ' B' ' 84' ' ' ARG . 97.2 mttt -150.16 116.46 5.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.593 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.654 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 73.4 ttt180 119.07 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.556 ' N ' ' HD3' ' B' ' 86' ' ' PRO . 9.7 ttt -157.38 54.14 0.78 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.451 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' B' ' 85' ' ' MET . 62.6 Cg_endo -83.87 179.85 4.52 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 123.358 2.705 . . . . 0.0 113.88 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . 0.483 ' CD2' ' C ' ' B' ' 86' ' ' PRO . 1.5 m-70 -150.32 130.88 13.92 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.647 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' B' ' 101' ' ' TYR . 0.9 OUTLIER -88.96 150.49 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.28 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.814 HG22 ' O ' ' B' ' 79' ' ' ARG . 3.6 m -114.35 120.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.18 131.81 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' B' ' 97' ' ' HIS . 40.3 tttt -146.37 148.56 32.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.957 -1.097 . . . . 0.0 113.008 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.634 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.5 OUTLIER -88.45 127.31 35.51 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.88 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' B' ' 75' ' ' ASN . 84.0 mt -88.5 -2.63 58.7 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -90.79 -55.56 3.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.854 ' SG ' ' O ' ' B' ' 95' ' ' CYS . 5.1 p -115.79 76.72 1.03 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.5 94.16 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.977 -175.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.619 ' CD2' ' O ' ' B' ' 97' ' ' HIS . 0.2 OUTLIER -119.69 128.72 54.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 113.833 -1.184 . . . . 0.0 109.043 177.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 37.9 mt -99.28 119.2 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.929 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.434 ' HB2' ' HE2' ' B' ' 97' ' ' HIS . 3.6 mmt -128.71 164.36 23.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 100' ' ' ARG . 0.4 OUTLIER -120.95 155.82 33.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.553 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' B' ' 88' ' ' ILE . 0.8 OUTLIER -146.41 91.47 5.4 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.817 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.31 166.13 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.297 1.998 . . . . 0.0 111.743 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -99.7 84.03 2.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.767 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 86.0 mt -118.19 116.94 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.491 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 tttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.559 -179.805 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.58 97.24 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 22' ' ' GLU . 79.0 p -59.99 -49.59 77.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.697 0.284 . . . . 0.0 110.768 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' HG11 ' A' ' 79' ' ' VAL . 89.2 m-85 -37.45 -45.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.131 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -58.28 -21.58 49.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 19' ' ' SER . 4.5 tt0 -104.79 -38.0 6.83 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.458 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.818 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -87.61 24.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.462 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.651 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -80.01 118.98 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.048 0.451 . . . . 0.0 110.712 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.687 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 83.68 -7.0 71.12 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.656 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.708 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -64.09 21.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.516 0.658 . . . . 0.0 109.887 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.687 ' H ' ' C ' ' A' ' 25' ' ' GLY . 7.0 p -38.13 -16.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.387 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.708 ' N ' ' O ' ' A' ' 26' ' ' ARG . 7.0 t-105 -58.67 -57.0 14.91 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.763 ' CD1' HG12 ' B' ' 28' ' ' VAL . 6.1 pt -65.68 -11.27 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.609 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.771 ' CD2' HD11 ' B' ' 24' ' ' LEU . 88.7 m-85 -96.32 -37.37 10.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.8 mmt180 -61.0 -68.43 0.31 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.144 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.81 52.02 1.59 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HD22 ' B' ' 24' ' ' LEU . . . -150.43 -40.19 0.13 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.793 ' CE1' ' H ' ' A' ' 51' ' ' LEU . 1.9 m-70 -91.1 100.15 13.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.218 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -125.71 -20.54 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.984 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.707 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -40.67 146.6 0.34 Allowed Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HA ' ' CD1' ' A' ' 101' ' ' TRP . 2.9 ttm180 -67.11 118.96 11.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.808 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 59.1 t -92.8 136.69 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.681 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -164.98 150.74 9.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.124 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 42' ' ' ASN . 43.8 tttm -50.04 -55.68 13.8 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.217 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.61 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 52.2 pttt -58.85 -4.09 0.41 Allowed 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.593 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 73.8 m-20 -126.06 0.48 7.21 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.27 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.801 HD11 ' CG ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -89.41 -38.14 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.261 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.809 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -92.7 0.75 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.814 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -115.81 6.9 14.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.315 -1.766 . . . . 0.0 107.829 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -115.41 139.13 50.29 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.775 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.804 ' O ' ' OE2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -59.95 111.77 1.61 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.924 HD22 ' CZ ' ' A' ' 98' ' ' PHE . 0.4 OUTLIER -74.09 116.34 14.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 177.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 48' ' ' LEU . 3.7 mm -153.64 -29.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.289 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.663 ' H ' ' CE1' ' A' ' 34' ' ' HIS . . . -138.22 -25.38 0.35 Allowed Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.922 HD23 ' H ' ' A' ' 52' ' ' LYS . 1.5 tt -44.2 150.03 0.32 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.922 ' H ' HD23 ' A' ' 51' ' ' LEU . 82.8 tttt -93.62 131.41 38.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.057 0.456 . . . . 0.0 111.669 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.952 HG23 ' C ' ' A' ' 97' ' ' GLU . 7.9 p -148.77 166.74 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.88 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.572 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 65' ' ' GLY . 22.0 t -94.61 98.87 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -83.18 -48.09 17.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.451 -177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -132.94 120.77 21.88 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.956 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.561 ' OG ' HG12 ' A' ' 64' ' ' VAL . 1.5 p -147.25 172.71 13.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.093 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.623 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 4.4 t -104.14 77.08 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.062 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -169.28 96.87 0.51 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.72 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 -4.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.324 2.016 . . . . 0.0 113.237 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -122.74 19.28 7.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.507 -0.854 . . . . 0.0 114.474 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.43 ' CE1' ' N ' ' A' ' 88' ' ' LYS . 54.8 m-85 -142.34 -23.93 0.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.181 1.491 . . . . 0.0 112.28 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.561 HG12 ' OG ' ' A' ' 58' ' ' SER . 1.5 m -74.04 144.36 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 85.86 5.61 83.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.51 177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.605 HG22 ' CZ2' ' A' ' 87' ' ' TRP . 1.2 mt -107.53 153.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 117.924 0.862 . . . . 0.0 111.59 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' C ' ' CZ2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -116.58 126.46 53.31 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.518 179.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.472 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -147.3 173.78 27.31 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.93 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -96.73 117.69 31.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.634 0.374 . . . . 0.0 110.098 179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 98' ' ' PHE . 1.9 t -50.15 148.34 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.693 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.709 ' N ' ' O ' ' A' ' 79' ' ' VAL . 95.0 mt -143.87 -60.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -108.01 134.79 50.41 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.606 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -144.69 107.14 4.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.869 HG22 ' NH2' ' B' ' 38' ' ' ARG . 2.6 p -132.96 -169.6 2.29 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -52.76 -27.44 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -138.71 31.59 2.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.801 -0.76 . . . . 0.0 112.887 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 74' ' ' THR . 2.0 ptp -153.75 160.82 42.41 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 119.113 -1.035 . . . . 0.0 112.934 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.002 HD23 ' CE2' ' A' ' 96' ' ' PHE . 7.3 tp -163.86 110.15 1.09 Allowed 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.889 ' C ' HD13 ' A' ' 80' ' ' ILE . 74.5 t -117.25 129.75 73.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.018 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -111.55 152.36 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.027 178.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' TYR . . . -129.02 136.89 50.91 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.351 0.596 . . . . 0.0 112.417 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -152.32 158.74 28.0 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' GLY . 14.0 pt-20 33.89 -128.52 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.749 0.275 . . . . 0.0 110.622 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -110.17 33.68 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.925 0.393 . . . . 0.0 110.526 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 86' ' ' VAL . 3.1 tppt? -138.09 151.9 48.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.035 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 31.1 m -118.31 156.17 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 CA-C-O 121.351 0.596 . . . . 0.0 110.709 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.621 ' HB2' ' H ' ' A' ' 80' ' ' ILE . 2.0 m-90 -97.96 140.52 32.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.732 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' N ' ' CE1' ' A' ' 63' ' ' TYR . 72.3 tttt -127.92 92.76 3.53 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.46 107.05 3.12 Favored Pre-proline 0 N--CA 1.464 0.233 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.757 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.64 164.27 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.74 1.626 . . . . 0.0 111.31 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' HD3' HD22 ' A' ' 78' ' ' LEU . 10.1 mttt -67.84 -27.17 66.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -90.55 -5.29 56.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.55 9.86 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.966 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.698 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -161.23 173.99 14.25 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 118.916 -1.114 . . . . 0.0 113.077 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 93.2 mt -111.97 130.73 65.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.71 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.002 ' CE2' HD23 ' A' ' 78' ' ' LEU . 97.1 m-85 -108.96 126.1 52.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.952 ' C ' HG23 ' A' ' 53' ' ' VAL . 26.8 tt0 -107.97 93.97 4.82 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.924 ' CZ ' HD22 ' A' ' 48' ' ' LEU . 37.1 m-85 -80.0 143.66 33.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.85 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.649 ' O ' HD21 ' A' ' 51' ' ' LEU . 75.6 tt0 -93.47 129.61 39.59 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.687 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -72.68 143.32 48.14 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.123 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.808 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.35 -0.93 0.28 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.621 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.511 ' N ' ' CE3' ' A' ' 101' ' ' TRP . 27.5 t70 -107.14 20.18 19.36 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.33 22.62 78.56 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.578 ' O ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -106.29 149.76 26.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.475 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -93.48 131.0 39.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.973 0.416 . . . . 0.0 111.153 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 98' ' ' PHE . 10.4 mt -103.81 133.83 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -114.56 100.83 8.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -143.09 132.42 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.059 -178.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 111' ' ' GLU . 13.8 p -79.57 144.95 33.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.213 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.17 -1.35 4.01 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -80.42 -22.59 41.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.4 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -69.89 -47.3 63.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.654 HD13 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -95.88 28.67 3.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.2 p -45.77 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.617 0.723 . . . . 0.0 112.876 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' LYS . . . 66.83 -42.29 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 114.702 -1.135 . . . . 0.0 113.674 175.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HB3' ' H ' ' A' ' 119' ' ' MET . 71.1 mtm180 -101.89 99.17 11.38 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -175.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.469 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.7 Cg_endo -70.12 -26.54 25.75 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 N-CA-C 107.294 -1.849 . . . . 0.0 107.294 174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.1 pt-20 -65.45 -45.87 82.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 112.966 -1.925 . . . . 0.0 109.833 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.516 ' N ' ' CG ' ' A' ' 118' ' ' GLU . 1.9 tpt -39.74 -33.71 0.21 Allowed 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.479 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -78.75 -56.74 4.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.652 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.736 HD12 HG13 ' B' ' 46' ' ' VAL . 0.1 OUTLIER -58.56 -42.32 87.67 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 118.313 -1.355 . . . . 0.0 107.836 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -84.91 1.02 49.11 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.501 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' CA ' ' O ' ' A' ' 119' ' ' MET . 10.3 mtpm? 46.48 -175.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -66.3 127.03 30.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.434 ' CG ' ' N ' ' A' ' 126' ' ' ARG . 26.3 t-105 -137.34 -140.26 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.915 0.388 . . . . 0.0 110.763 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.434 ' N ' ' CG ' ' A' ' 125' ' ' TRP . 11.8 mtp180 -92.68 -107.55 0.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.759 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.542 -179.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.636 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 1.2 mp0 . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -78.72 -31.45 46.4 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.241 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.733 ' H ' HH11 ' B' ' 12' ' ' ARG . 8.7 ttpt -73.86 -34.18 64.38 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.809 1.29 . . . . 0.0 108.122 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.924 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 4.7 mpt_? -60.96 -51.33 69.72 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.028 -2.351 . . . . 0.0 111.777 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -72.97 -29.06 27.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.543 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.409 ' CB ' ' HB1' ' B' ' 50' ' ' ALA . . . -70.56 -51.77 26.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.49 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' B' ' 16' ' ' GLU . 0.6 OUTLIER -55.28 -46.81 76.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.519 ' N ' ' HD3' ' B' ' 15' ' ' LYS . 9.3 pt-20 -72.08 -38.08 69.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.603 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 39.3 ttt180 -62.63 -54.19 43.3 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.703 0.763 . . . . 0.0 110.387 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.3 OUTLIER -56.73 -34.28 42.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.519 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -69.42 -33.28 72.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.707 HD11 ' HA3' ' A' ' 36' ' ' GLY . 94.7 mt -69.61 -58.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.019 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.05 -35.4 76.81 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.019 ' N ' HD13 ' B' ' 21' ' ' LEU . 4.1 t80 -53.79 -38.94 65.03 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.05 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.7 m -66.9 -40.27 87.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.431 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.836 HD12 HG11 ' B' ' 28' ' ' VAL . 2.3 mm? -61.23 -58.79 6.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.524 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.404 ' HA ' ' CB ' ' B' ' 36' ' ' ALA . . . -49.46 -36.48 22.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.527 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.805 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -71.73 -60.26 2.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.407 0.623 . . . . 0.0 109.875 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.843 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 6.8 ttm-85 -64.43 -37.4 87.39 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.992 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.144 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.3 m -84.12 -50.86 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.536 -1.266 . . . . 0.0 112.275 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.719 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 29.7 t80 -36.37 -49.9 1.79 Allowed Pre-proline 0 CA--C 1.51 -0.572 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.359 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.843 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 35.7 Cg_endo -51.93 -46.13 34.23 Favored 'Trans proline' 0 C--N 1.298 -2.081 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.816 ' N ' ' O ' ' B' ' 28' ' ' VAL . 10.2 t80 -92.87 -32.21 14.69 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.101 -2.318 . . . . 0.0 112.678 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.144 ' N ' ' O ' ' B' ' 28' ' ' VAL . 61.7 p -144.2 96.91 5.29 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.682 ' C ' ' HZ3' ' B' ' 37' ' ' LYS . 32.1 Cg_exo -55.88 -42.13 70.16 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.791 2.327 . . . . 0.0 114.019 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.96 -53.77 28.44 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.527 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 10.6 mt -51.05 -53.21 35.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.262 0.554 . . . . 0.0 110.281 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.74 ' O ' HG23 ' B' ' 40' ' ' VAL . . . -55.59 -34.14 64.55 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.11 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.682 ' HZ3' ' C ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -71.45 -41.78 69.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.233 179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.869 ' NH2' HG22 ' A' ' 74' ' ' THR . 0.0 OUTLIER -58.79 -53.96 52.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.306 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.932 ' CB ' HD23 ' B' ' 21' ' ' LEU . 1.3 m-85 -60.68 -39.04 86.98 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.94 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.769 ' O ' HD23 ' B' ' 44' ' ' LEU . 3.7 t -45.87 -34.96 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' B' ' 38' ' ' ARG . 50.7 tt0 -72.21 -43.92 63.74 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' B' ' 39' ' ' TYR . 28.6 mt -63.78 -46.63 84.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.873 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -59.88 -34.03 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.796 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 40' ' ' VAL . 1.6 mm? -64.43 -45.02 89.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.592 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -63.91 -34.56 78.23 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.521 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.736 HG13 HD12 ' A' ' 121' ' ' LEU . 51.0 t -70.88 -56.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.16 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.447 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 17.0 pt20 -71.86 -51.06 24.21 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.332 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 121' ' ' LEU . 5.0 tmtt? -82.27 -35.64 27.87 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.375 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' B' ' 46' ' ' VAL . . . -65.4 -12.41 51.94 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.21 30.48 15.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.678 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 t -96.56 92.54 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.046 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -84.18 117.95 23.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.588 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.87 151.1 75.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.011 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.2 127.48 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.116 1.878 . . . . 0.0 111.574 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.43 ' C ' ' N ' ' B' ' 58' ' ' TRP . 89.3 mtt-85 -87.89 45.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.999 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' B' ' 59' ' ' LYS . 0.3 OUTLIER -45.57 -25.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.677 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 17.4 m0 -55.65 -0.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.398 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' B' ' 57' ' ' LYS . 37.3 mtpt -62.63 -7.86 5.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' B' ' 58' ' ' TRP . 18.1 ptt180 -87.85 -21.66 24.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.442 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.824 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -146.88 20.23 1.27 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.094 -178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' B' ' 58' ' ' TRP . 50.1 t80 -114.78 154.42 28.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.643 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 0.7 OUTLIER -126.41 116.97 21.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.135 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -87.02 16.28 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.133 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.498 ' HG2' ' SG ' ' B' ' 63' ' ' CYS . 0.0 OUTLIER -116.59 -22.06 8.85 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.741 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.669 ' O ' ' O ' ' B' ' 67' ' ' HIS . 0.8 OUTLIER -153.73 21.59 0.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.869 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.669 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.2 OUTLIER 34.37 115.65 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 111.877 179.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.481 ' HB3' HD11 ' B' ' 70' ' ' LEU . . . -177.45 -176.99 0.66 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' NH1' ' B' ' 61' ' ' ARG . 0.5 OUTLIER -115.37 104.61 11.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.824 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -106.62 129.46 54.53 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.75 -177.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 48.7 t -113.38 124.16 31.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.053 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . 0.584 ' HB3' HG22 ' B' ' 78' ' ' VAL . 50.5 Cg_exo -46.89 126.1 10.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.886 1.724 . . . . 0.0 112.119 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.98 -36.54 3.97 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 87.6 mt -93.5 -77.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.66 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.23 19.65 16.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -155.65 171.53 19.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.24 0.543 . . . . 0.0 111.266 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -147.08 132.61 18.71 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.027 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.584 HG22 ' HB3' ' B' ' 72' ' ' PRO . 15.5 m -138.89 120.75 16.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.643 ' O ' HG12 ' B' ' 89' ' ' VAL . 0.7 OUTLIER -153.8 147.23 24.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.896 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -126.07 141.61 51.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.536 0.684 . . . . 0.0 111.927 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . 0.764 ' N ' ' HE ' ' B' ' 81' ' ' ARG . 0.0 OUTLIER -94.58 136.25 35.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.536 179.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -100.26 -7.23 24.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -42.52 -83.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.935 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -81.04 -78.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.729 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.75 126.28 23.27 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.228 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.97 101.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.435 2.09 . . . . 0.0 112.709 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' B' ' 80' ' ' LEU . 25.6 m-70 -129.41 129.58 44.88 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.749 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -95.7 151.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.267 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.643 HG12 ' O ' ' B' ' 79' ' ' ARG . 1.4 p -126.71 126.79 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.979 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.71 132.81 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -148.51 147.08 28.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.999 -1.08 . . . . 0.0 113.049 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.499 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.1 OUTLIER -86.52 128.51 34.98 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.962 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -89.79 0.43 57.01 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -91.49 -52.87 4.57 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.797 ' SG ' ' O ' ' B' ' 95' ' ' CYS . 14.1 p -120.86 79.05 1.45 Allowed 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 112.9 -1.954 . . . . 0.0 105.877 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.33 93.71 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.117 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.597 ' CD2' ' C ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -124.1 134.53 53.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.843 -1.178 . . . . 0.0 109.569 179.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.04 121.94 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.993 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 2.9 mmt -129.14 160.69 32.05 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.935 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.82 154.5 42.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.129 0.49 . . . . 0.0 111.247 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -152.04 91.1 3.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.632 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.13 164.79 9.81 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.41 2.073 . . . . 0.0 112.771 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -142.87 97.11 3.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.497 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . 0.425 ' N ' HD13 ' B' ' 104' ' ' ILE . 0.0 OUTLIER -131.01 145.08 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.45 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 tptm . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.429 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 18' ' ' GLY . 31.7 tt0 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 17' ' ' GLN . . . -19.96 107.06 0.01 OUTLIER Glycine 0 CA--C 1.528 0.852 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.896 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 22' ' ' GLU . 93.1 p -60.36 -29.42 68.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.718 ' HB3' HG11 ' A' ' 86' ' ' VAL . 83.1 m-85 -35.49 -63.41 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.094 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -16.37 39.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.194 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 19' ' ' SER . 41.8 tp10 -92.06 -30.4 16.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.154 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 ' CE2' ' B' ' 31' ' ' TYR . 6.2 mm -106.7 13.55 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -79.34 126.87 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.853 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.783 ' N ' HD13 ' A' ' 24' ' ' ILE . . . 106.78 -35.17 5.21 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.312 -0.471 . . . . 0.0 112.38 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -64.15 27.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.975 0.388 . . . . 0.0 110.736 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.642 ' H ' ' C ' ' A' ' 25' ' ' GLY . 13.9 p -43.75 -14.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.884 0.849 . . . . 0.0 108.745 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.741 ' HE1' HH12 ' B' ' 27' ' ' ARG . 38.1 t-105 -57.85 -52.52 65.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.294 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.861 ' CD1' HG12 ' B' ' 28' ' ' VAL . 12.7 pt -71.88 -11.8 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 119.906 -0.717 . . . . 0.0 110.587 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' B' ' 24' ' ' LEU . 58.5 m-85 -89.87 -23.46 21.64 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 33' ' ' ALA . 2.4 tpp85 -80.88 -68.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.56 35.67 0.17 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.701 ' H ' ' C ' ' A' ' 31' ' ' ARG . . . -145.41 -39.02 0.25 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -95.95 105.93 18.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.797 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.92 1.33 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.45 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' B' ' 20' ' ' ILE . . . -47.25 156.95 0.68 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.611 ' O ' ' CE1' ' A' ' 46' ' ' HIS . 6.1 ttm-85 -67.98 118.49 11.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 42.2 t -97.48 139.31 20.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.677 ' O ' ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -166.66 154.65 9.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.435 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' HG22 ' A' ' 43' ' ' ILE . 75.9 tttt -51.72 -55.94 16.69 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' CD2' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -59.15 -3.79 0.43 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.698 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 55.0 m-20 -125.41 2.61 7.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.815 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.76 -39.75 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.563 0.221 . . . . 0.0 110.935 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.838 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.81 4.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.596 1.189 . . . . 0.0 108.084 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.877 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER -116.46 -21.92 8.99 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.04 -179.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.698 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -81.8 146.92 29.66 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.655 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -64.26 108.74 1.67 Allowed 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 177.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.862 ' O ' HG12 ' A' ' 49' ' ' ILE . 8.2 mt -76.21 110.45 10.72 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.881 HD13 ' CD1' ' B' ' 39' ' ' TYR . 3.9 mt -170.78 55.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 124.032 0.832 . . . . 0.0 109.496 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 143.95 -27.82 2.02 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.935 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.2 tt -53.14 133.5 39.06 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.904 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' N ' HD23 ' A' ' 51' ' ' LEU . 1.7 tmtp? -69.61 124.38 23.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.097 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.92 HG23 ' C ' ' A' ' 97' ' ' GLU . 13.8 p -149.19 169.7 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.108 0.48 . . . . 0.0 110.654 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.688 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -137.65 149.62 46.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.138 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 89' ' ' VAL . 92.2 t -99.4 100.23 10.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.28 -36.98 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.433 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -135.1 120.19 18.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 110.476 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.83 166.35 27.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.665 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.587 ' C ' ' CG ' ' A' ' 60' ' ' HIS . 1.7 t -103.52 75.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CG ' ' C ' ' A' ' 59' ' ' THR . 0.8 OUTLIER -169.82 105.34 0.45 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.545 179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.18 -4.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 122.178 1.919 . . . . 0.0 113.909 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -129.4 31.13 3.49 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.645 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -141.31 -21.59 0.76 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.876 1.338 . . . . 0.0 111.794 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.0 144.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 84.02 6.52 86.55 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.152 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.63 ' HB ' ' NE1' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 118.447 1.124 . . . . 0.0 111.79 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.5 tt0 -120.1 125.88 49.35 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.318 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.665 ' C ' HG22 ' A' ' 80' ' ' ILE . . . -146.44 172.88 26.89 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.527 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 81' ' ' ALA . 3.9 m-85 -99.57 121.73 41.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.6 t -48.76 148.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.903 0.383 . . . . 0.0 111.572 -178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 81' ' ' ALA . 79.2 mt -138.51 -60.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.962 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.779 ' CG ' ' HE ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -101.99 140.25 36.54 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.767 ' O ' ' NH1' ' B' ' 38' ' ' ARG . 70.6 tt0 -149.62 105.05 3.4 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.187 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.756 HG22 HH22 ' B' ' 38' ' ' ARG . 6.8 t -152.01 -178.92 7.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.543 0.687 . . . . 0.0 111.515 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.705 ' HE ' HH22 ' A' ' 116' ' ' ARG . 32.5 ttm180 -55.07 -6.79 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.227 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 74' ' ' THR . 46.9 m-80 -138.52 0.0 2.01 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.888 ' C ' ' HZ1' ' A' ' 91' ' ' LYS . 2.4 ptp -165.44 149.99 8.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 117.952 -1.499 . . . . 0.0 114.794 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.714 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.9 tp -135.09 110.71 9.2 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 71' ' ' ILE . 77.6 t -114.41 147.2 18.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 121.441 0.638 . . . . 0.0 112.553 -176.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -131.4 142.18 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.278 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.04 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -114.83 135.29 54.35 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.864 -0.523 . . . . 0.0 111.746 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' CZ3' ' A' ' 87' ' ' TRP . . . -153.4 125.66 1.81 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 69.09 -115.61 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -124.62 19.98 8.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.821 0.343 . . . . 0.0 110.415 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 17.8 tttp -126.19 167.33 15.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.344 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 20' ' ' TYR . 5.7 m -121.55 153.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.665 0.745 . . . . 0.0 110.596 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 80' ' ' ILE . 1.4 m-90 -99.14 110.8 23.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.475 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -108.03 96.7 6.56 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.079 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 55' ' ' VAL . 2.7 m -148.87 95.7 3.88 Favored Pre-proline 0 CA--C 1.518 -0.264 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.073 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 93' ' ' VAL . 65.0 Cg_exo -43.23 161.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 120.942 1.095 . . . . 0.0 110.518 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.888 ' HZ1' ' C ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -63.53 -30.31 71.45 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -89.17 -4.95 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 90' ' ' PRO . 2.5 m -112.41 11.48 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.72 ' SG ' ' CE1' ' A' ' 96' ' ' PHE . 0.5 OUTLIER -167.19 169.23 12.82 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.856 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.38 140.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.343 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.72 ' CE1' ' SG ' ' A' ' 94' ' ' CYS . 87.0 m-85 -117.61 131.67 56.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.92 ' C ' HG23 ' A' ' 53' ' ' VAL . 21.3 tt0 -115.04 95.07 5.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.865 ' CD1' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -90.89 145.49 24.7 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.743 ' O ' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -89.68 133.17 34.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.243 0.544 . . . . 0.0 111.604 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.605 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.2 OUTLIER -70.87 144.05 50.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.849 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.879 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.1 0.12 0.18 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.626 -1.17 . . . . 0.0 113.221 -178.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.574 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 74.4 m-20 -107.52 15.17 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.12 22.9 72.83 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 100' ' ' THR . 0.2 OUTLIER -106.17 146.56 30.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.756 0.312 . . . . 0.0 110.358 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -90.74 132.82 35.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.072 0.463 . . . . 0.0 111.324 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 11.3 mt -105.72 134.42 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -120.27 106.49 11.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.61 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.216 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 111' ' ' GLU . 1.6 p -94.99 145.68 24.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.22 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.62 -1.65 0.36 Allowed Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.43 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 109' ' ' SER . 21.0 pt-20 -68.26 -31.5 71.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.678 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -75.13 -47.44 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.493 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 29.1 1.44 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 114' ' ' VAL . 9.9 p -63.71 106.06 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.7 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.46 -40.47 0.29 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 114.551 -1.204 . . . . 0.0 114.034 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.705 HH22 ' HE ' ' A' ' 75' ' ' ARG . 5.6 mmp_? -100.59 85.06 0.51 Allowed Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.449 ' HB2' HH22 ' B' ' 17' ' ' ARG . 26.9 Cg_endo -66.74 -26.01 45.78 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.629 ' HB3' HD22 ' B' ' 45' ' ' LEU . 6.0 pt-20 -67.99 -48.46 65.72 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' LYS . 37.6 tpp -36.37 -47.1 0.58 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.724 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.554 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -71.61 -47.91 51.54 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.368 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.793 HD21 ' O ' ' A' ' 45' ' ' TRP . 0.7 OUTLIER -62.29 -31.87 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 118' ' ' GLU . 3.8 mmtt -85.26 -33.8 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.869 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.579 ' N ' ' O ' ' A' ' 119' ' ' MET . 0.1 OUTLIER 25.13 99.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.519 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -57.3 138.31 54.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.217 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -84.15 52.6 2.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.884 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 40.86 66.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.623 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.609 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 4.3 mm-40 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.418 ' H ' ' HG2' ' B' ' 10' ' ' LYS . 2.3 mmtp -79.35 -32.05 43.14 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.911 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.719 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.6 OUTLIER -73.2 -33.96 65.68 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.708 1.242 . . . . 0.0 108.159 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.931 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 5.0 mpt_? -60.99 -51.38 69.5 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.392 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.769 HG21 ' HB2' ' A' ' 45' ' ' TRP . 10.3 mt -70.44 -26.72 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.124 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.56 -52.19 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.584 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.443 ' O ' HG22 ' B' ' 18' ' ' ILE . 4.1 ptmm? -57.54 -48.42 79.36 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.546 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 16' ' ' GLU . 3.1 pt-20 -68.94 -37.35 78.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.342 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.811 ' HE ' HG22 ' B' ' 46' ' ' VAL . 3.0 ttt180 -62.72 -52.07 64.71 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.542 0.686 . . . . 0.0 110.673 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' B' ' 21' ' ' LEU . 0.0 OUTLIER -55.73 -35.55 39.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.098 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.41 -27.04 63.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.42 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.552 HD11 ' HA3' ' A' ' 36' ' ' GLY . 8.6 mt -69.15 -58.6 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.039 HD13 ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -66.08 -33.34 75.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.894 0.854 . . . . 0.0 108.832 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.039 ' N ' HD13 ' B' ' 21' ' ' LEU . 2.0 t80 -52.92 -46.51 68.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.073 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 20' ' ' ILE . 11.6 p -64.8 -42.04 95.34 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.967 HD12 HG11 ' B' ' 28' ' ' VAL . 0.3 OUTLIER -56.1 -58.42 7.99 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.493 0.664 . . . . 0.0 110.096 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -35.56 26.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.449 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.788 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.9 OUTLIER -71.58 -57.12 4.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.388 0.614 . . . . 0.0 110.774 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.888 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 5.2 ttt-85 -70.22 -32.5 70.4 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.73 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.184 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.2 m -83.78 -50.44 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.733 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 33.8 t80 -36.23 -49.73 1.71 Allowed Pre-proline 0 CA--C 1.509 -0.625 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.293 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.888 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 39.1 Cg_endo -54.02 -46.86 30.5 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 N-CA-C 106.532 -2.142 . . . . 0.0 106.532 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.81 ' N ' ' O ' ' B' ' 28' ' ' VAL . 48.6 t80 -94.54 -17.04 22.75 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.928 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.184 ' N ' ' O ' ' B' ' 28' ' ' VAL . 27.6 p -155.81 90.39 2.81 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.01 -42.98 63.93 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.883 2.389 . . . . 0.0 113.792 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -66.44 -53.9 30.23 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.557 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 9.0 mt -52.52 -56.73 13.17 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 120.951 0.405 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -52.44 -29.78 26.25 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.054 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.675 ' HD2' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -71.7 -47.84 51.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.726 179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.779 ' HE ' ' CG ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -64.48 -35.55 81.32 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.121 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.914 ' HB3' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -71.15 -44.43 65.54 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 119.516 -0.874 . . . . 0.0 108.957 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.546 ' O ' HD23 ' B' ' 44' ' ' LEU . 2.1 t -45.51 -38.93 2.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.719 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -67.9 -42.37 81.25 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.739 HD12 HD11 ' A' ' 49' ' ' ILE . 48.3 mt -64.26 -47.75 78.4 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.601 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -55.53 -31.3 61.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.434 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 ' O ' ' B' ' 40' ' ' VAL . 0.8 OUTLIER -64.08 -54.39 34.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 118' ' ' GLU . 4.1 pp -61.61 -27.48 68.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.365 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.935 ' O ' ' HB3' ' B' ' 50' ' ' ALA . 63.8 t -64.41 -47.24 90.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.32 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -66.5 -57.09 8.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.61 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' B' ' 44' ' ' LEU . 12.8 pt20 -81.96 -49.58 10.12 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.604 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 0.0 OUTLIER -65.77 -33.48 75.97 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -92.64 5.83 49.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 mttm 54.01 75.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.502 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.89 134.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.306 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -123.71 109.52 13.8 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.672 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' PRO . 31.0 mt -135.68 137.25 25.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.638 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' B' ' 54' ' ' ILE . 52.2 Cg_exo -33.53 100.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.245 1.963 . . . . 0.0 111.467 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -86.32 77.0 9.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.664 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' B' ' 59' ' ' LYS . 50.1 pttt -72.55 -14.92 61.75 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.623 ' NE1' ' CE1' ' B' ' 22' ' ' PHE . 14.2 m0 -58.22 -2.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.537 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' B' ' 57' ' ' LYS . 32.4 pttt -68.18 -3.62 11.18 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.476 ' H ' ' C ' ' B' ' 58' ' ' TRP . 5.9 ptm180 -83.67 -30.74 26.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.8 -1.545 . . . . 0.0 110.888 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -130.45 21.78 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.938 -178.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' B' ' 63' ' ' CYS . 81.9 t80 -118.95 155.76 30.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.334 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' B' ' 66' ' ' CYS . 3.5 t -127.17 126.08 42.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.266 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -87.91 6.54 35.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 109.908 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.83 ' HB3' ' HZ3' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -107.26 -22.97 12.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.381 -178.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.582 ' O ' ' O ' ' B' ' 67' ' ' HIS . 2.5 p -150.84 17.11 0.78 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.335 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.582 ' O ' ' O ' ' B' ' 66' ' ' CYS . 0.9 OUTLIER 35.21 106.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 111.443 179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' B' ' 37' ' ' LYS . . . -164.75 -175.04 3.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' B' ' 61' ' ' ARG . 9.4 t80 -118.17 102.93 9.38 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.838 ' N ' HD22 ' B' ' 70' ' ' LEU . 0.4 OUTLIER -110.77 120.72 43.32 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.857 -177.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' B' ' 29' ' ' PHE . 53.6 t -92.78 117.42 67.56 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.061 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.24 119.38 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.307 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.73 -41.96 1.86 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.768 HG23 ' H ' ' B' ' 75' ' ' ASN . 3.8 tt -102.95 -65.73 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 117.219 0.51 . . . . 0.0 111.293 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.768 ' H ' HG23 ' B' ' 74' ' ' ILE . 5.8 t-20 -112.26 12.97 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.748 0.309 . . . . 0.0 110.856 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.819 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -151.85 164.4 37.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.273 0.559 . . . . 0.0 111.306 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' B' ' 93' ' ' LEU . 41.0 mtp180 -150.45 134.23 16.7 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.048 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' B' ' 89' ' ' VAL . 12.9 m -139.0 132.25 38.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.783 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' B' ' 79' ' ' ARG . 29.7 ttm-85 -146.7 150.61 35.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.918 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' B' ' 80' ' ' LEU . 1.2 pp -123.73 131.74 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.802 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -137.98 166.48 23.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' B' ' 84' ' ' ARG . 2.5 mt-30 -76.58 20.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.724 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' B' ' 85' ' ' MET . 31.2 mtpt -52.4 89.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' B' ' 85' ' ' MET . 20.9 ttt180 72.24 -13.89 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.383 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.503 ' CG ' ' O ' ' B' ' 84' ' ' ARG . 1.3 mtt 159.49 153.57 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.662 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -46.07 105.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.11 1.873 . . . . 0.0 111.325 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . 0.554 ' ND1' ' O ' ' B' ' 87' ' ' HIS . 1.4 p-80 -138.86 131.63 29.18 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.412 HG21 HD13 ' B' ' 88' ' ' ILE . 0.6 OUTLIER -91.83 130.88 40.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.0 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.61 ' O ' HG13 ' B' ' 89' ' ' VAL . 7.3 p -98.2 121.06 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 90' ' ' VAL . 1.1 m -112.2 127.07 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -141.32 136.14 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.295 -177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.533 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.1 OUTLIER -80.53 132.51 35.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.688 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.466 HD11 ' HG3' ' B' ' 77' ' ' ARG . 95.5 mt -93.83 -4.84 49.38 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.31 -54.56 4.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.869 ' SG ' ' O ' ' B' ' 95' ' ' CYS . 5.2 p -113.22 75.45 0.92 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -36.54 92.75 0.01 OUTLIER Glycine 0 C--N 1.324 -0.138 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.597 ' N ' ' O ' ' B' ' 95' ' ' CYS . 0.1 OUTLIER -129.47 124.85 35.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.672 -1.264 . . . . 0.0 110.15 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . 0.671 ' H ' HD12 ' B' ' 98' ' ' ILE . 2.3 mp -92.36 120.3 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.615 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.414 ' O ' HG23 ' B' ' 89' ' ' VAL . 36.7 mmm -128.17 163.83 23.81 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.893 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -126.31 141.86 51.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.634 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -138.1 91.75 12.84 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.378 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -52.5 165.64 1.0 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.386 2.057 . . . . 0.0 112.203 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -142.82 105.39 4.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.928 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.16 127.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.185 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.272 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.508 ' O ' ' C ' ' A' ' 18' ' ' GLY . 36.3 mt-30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.508 ' C ' ' O ' ' A' ' 17' ' ' GLN . . . 24.28 93.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.781 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLU . 80.3 p -54.01 -35.06 61.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.459 . . . . 0.0 110.076 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.639 ' HB3' HG11 ' A' ' 86' ' ' VAL . 52.8 m-85 -40.45 -61.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.384 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.06 -8.79 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 19' ' ' SER . 42.5 tp10 -103.95 -40.72 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.263 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' B' ' 31' ' ' TYR . 3.5 mm -95.19 32.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.761 0.315 . . . . 0.0 111.09 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -81.2 127.34 39.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -178.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.678 ' C ' ' H ' ' A' ' 27' ' ' THR . . . 82.15 -18.1 14.93 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -62.81 27.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.826 1.313 . . . . 0.0 110.793 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.678 ' H ' ' C ' ' A' ' 25' ' ' GLY . 1.3 p -42.03 -15.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' ARG . 33.6 t-105 -57.17 -53.81 53.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.46 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' B' ' 28' ' ' VAL . 16.8 pt -69.31 -11.86 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.609 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.791 ' CD2' HD11 ' B' ' 24' ' ' LEU . 33.7 m-85 -91.15 -26.37 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -70.07 -64.59 0.86 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.173 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.86 48.65 3.31 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 29' ' ' ILE . . . -162.38 -38.35 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 50' ' ' GLY . 38.9 t-80 -110.71 100.37 9.15 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.613 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -150.75 10.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.975 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.54 ' H ' HG12 ' B' ' 20' ' ' ILE . . . -41.77 164.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.646 ' O ' ' NE2' ' A' ' 46' ' ' HIS . 33.9 ttp180 -66.59 133.02 49.44 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.802 ' HB ' ' H ' ' A' ' 101' ' ' TRP . 63.2 t -113.26 135.66 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.666 ' O ' ' N ' ' A' ' 42' ' ' ASN . 6.0 m120 -166.3 149.07 7.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.831 -1.532 . . . . 0.0 108.016 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 42' ' ' ASN . 56.1 tttp -46.04 -53.79 9.58 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.197 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' C ' ' CD1' ' A' ' 45' ' ' TRP . 13.4 pttp -60.84 -4.63 1.04 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.072 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.735 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 88.9 m-20 -125.13 0.23 7.83 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.082 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -88.45 -39.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.06 179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.856 HG13 ' NE1' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -91.06 5.25 5.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.856 ' NE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -119.92 -6.18 10.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.869 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.735 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -98.74 151.64 20.54 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.735 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.676 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -72.73 110.83 7.36 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 49' ' ' ILE . 12.5 mt -74.21 116.1 14.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 48' ' ' LEU . 1.1 mm -155.28 -31.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.596 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.674 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -134.5 -22.23 0.71 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.912 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.939 ' O ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER -44.82 153.25 0.18 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.783 ' H ' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -100.49 128.49 46.54 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.988 HG23 ' C ' ' A' ' 97' ' ' GLU . 12.9 p -149.16 171.52 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.399 0.618 . . . . 0.0 111.572 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.722 ' N ' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -134.51 152.28 51.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.756 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.716 ' O ' ' N ' ' A' ' 65' ' ' GLY . 59.9 t -96.22 98.95 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.31 -51.86 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.415 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -128.53 118.35 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.557 ' OG ' ' ND1' ' A' ' 60' ' ' HIS . 47.9 t -149.07 173.53 13.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.184 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 33.7 p -102.98 78.6 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.724 ' CD2' ' O ' ' A' ' 59' ' ' THR . 21.6 m80 -166.57 96.15 0.72 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.251 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.11 -4.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.535 2.157 . . . . 0.0 114.015 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' HIS . . . -132.0 23.32 4.16 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.638 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.639 ' O ' HG22 ' A' ' 66' ' ' ILE . 29.2 m-85 -141.11 -14.1 0.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.793 1.296 . . . . 0.0 111.615 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 60' ' ' HIS . 1.3 m -71.62 138.89 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . 81.9 6.71 88.74 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.35 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.142 HG23 ' NE1' ' A' ' 87' ' ' TRP . 2.3 tt -108.32 146.92 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 117.712 0.756 . . . . 0.0 112.243 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 6.9 tm-20 -116.15 131.87 56.82 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' HG22 ' A' ' 80' ' ' ILE . . . -147.24 174.95 26.85 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.487 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -93.55 115.72 28.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 51' ' ' LEU . 1.9 t -45.19 145.04 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.015 0.436 . . . . 0.0 111.457 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 81' ' ' ALA . 15.8 mt -136.48 -61.51 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 19.9 t0 -94.89 148.01 22.76 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.833 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.78 ' O ' HD11 ' B' ' 42' ' ' LEU . 10.7 tt0 -156.52 105.11 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.844 HG23 ' H ' ' A' ' 76' ' ' ASN . 14.6 t -162.49 176.68 10.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 111.798 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 54.5 ttt85 -58.72 -1.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.864 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.844 ' H ' HG23 ' A' ' 74' ' ' THR . 7.6 t-20 -133.47 -11.58 2.77 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -166.66 156.21 11.25 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.669 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 ' CE1' ' A' ' 96' ' ' PHE . 5.3 tp -139.33 110.94 7.11 Favored 'General case' 0 C--O 1.251 1.176 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.908 ' C ' HD13 ' A' ' 80' ' ' ILE . 61.3 t -119.95 145.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.939 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -117.88 152.25 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.142 178.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.92 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -125.12 136.44 53.63 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.108 0.48 . . . . 0.0 111.963 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.446 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . -149.91 155.78 26.42 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 24' ' ' ILE . 6.1 pt-20 31.83 -115.48 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.561 0.219 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -121.24 33.31 5.59 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.917 0.389 . . . . 0.0 110.176 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 86' ' ' VAL . 30.4 tttp -133.52 158.84 42.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.631 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 20' ' ' TYR . 16.1 m -123.62 155.54 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 110.688 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 1.142 ' NE1' HG23 ' A' ' 66' ' ' ILE . 2.5 m-90 -100.35 145.49 28.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.325 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -128.22 94.13 3.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 m -146.36 99.17 4.21 Favored Pre-proline 0 C--N 1.342 0.266 0 C-N-CA 118.787 -1.165 . . . . 0.0 112.253 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -57.33 146.03 84.63 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.483 1.455 . . . . 0.0 110.231 177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.602 ' CD ' ' H ' ' A' ' 115' ' ' GLY . 27.2 mttm -54.17 -22.13 10.56 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -90.63 -6.38 54.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.502 ' O ' ' OG ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -128.52 35.67 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.64 ' SG ' ' CZ ' ' A' ' 96' ' ' PHE . 0.0 OUTLIER -166.95 155.72 10.24 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.027 179.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.552 ' N ' ' SG ' ' A' ' 94' ' ' CYS . 77.2 mt -111.14 116.11 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.833 ' HB3' HG21 ' A' ' 53' ' ' VAL . 88.1 m-85 -98.53 127.11 44.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.988 ' C ' HG23 ' A' ' 53' ' ' VAL . 24.3 tt0 -110.12 94.74 5.17 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.742 ' CD1' HD11 ' A' ' 43' ' ' ILE . 4.8 m-85 -87.55 145.66 26.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -90.2 127.39 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.804 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 104' ' ' THR . 0.1 OUTLIER -62.8 142.88 58.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.389 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.802 ' H ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -61.19 0.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.592 -1.185 . . . . 0.0 112.605 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.552 ' OD2' ' CH2' ' A' ' 101' ' ' TRP . 75.6 m-20 -106.85 13.39 27.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.36 21.64 66.71 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 100' ' ' THR . 16.7 m -106.74 150.0 26.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.826 0.346 . . . . 0.0 110.477 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -91.16 134.28 34.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 0.0 111.405 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CG ' ' A' ' 97' ' ' GLU . 7.7 mt -110.59 132.62 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -118.55 102.9 9.24 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.65 139.41 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.974 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 m -88.55 148.49 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.994 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.47 -0.59 4.9 Favored Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.018 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.65 -22.72 60.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -80.11 -47.55 14.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.362 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -95.69 28.13 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.1 p -59.32 106.26 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.602 ' H ' ' CD ' ' A' ' 91' ' ' LYS . . . 68.84 -40.89 0.32 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.496 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 116' ' ' ARG . 1.0 OUTLIER -101.18 87.63 0.92 Allowed Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -176.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.584 ' HB2' HH22 ' B' ' 17' ' ' ARG . 22.1 Cg_endo -67.34 -29.16 38.74 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.25 1.3 . . . . 0.0 108.828 176.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HB3' HD22 ' B' ' 45' ' ' LEU . 8.1 pt-20 -56.66 -49.51 74.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.915 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 123' ' ' LYS . 9.7 ttm -34.67 -64.83 0.24 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.821 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' CD ' ' CE3' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -59.17 -44.93 92.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.843 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.734 HD11 ' HD3' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -60.27 -40.32 89.95 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -102.02 18.79 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.752 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.558 ' C ' ' O ' ' A' ' 122' ' ' LYS . 87.9 tttt -15.86 104.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.612 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 126' ' ' ARG . 13.7 ttp180 -148.99 -97.92 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.338 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.486 ' CD1' ' C ' ' A' ' 124' ' ' ARG . 41.8 p-90 32.32 33.72 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.958 0.408 . . . . 0.0 111.051 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 124' ' ' ARG . 45.4 mtt180 -61.8 -50.94 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.725 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' OXT' ' O ' ' A' ' 126' ' ' ARG . 28.1 ttmt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.588 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . 0.627 ' N ' ' CZ ' ' B' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -78.63 -30.47 46.45 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.797 ' H ' HH11 ' B' ' 12' ' ' ARG . 0.0 OUTLIER -73.72 -34.25 64.71 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.799 1.285 . . . . 0.0 108.301 179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.953 ' CD ' ' H ' ' B' ' 12' ' ' ARG . 3.9 mpt_? -61.85 -51.26 68.94 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 112.126 -2.306 . . . . 0.0 111.667 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 9' ' ' GLU . 0.0 OUTLIER -71.32 -34.92 55.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.87 91.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.049 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.563 ' O ' HG22 ' B' ' 18' ' ' ILE . 6.8 tptm -58.85 -51.0 71.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.233 0.539 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.554 ' O ' HD13 ' B' ' 20' ' ' ILE . 10.8 pt-20 -71.63 -37.14 70.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.882 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.734 ' HD3' HD11 ' A' ' 121' ' ' LEU . 9.7 ttt180 -60.56 -51.02 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.593 0.711 . . . . 0.0 110.668 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.563 HG22 ' O ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -60.53 -38.33 77.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.17 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' B' ' 18' ' ' ILE . 13.2 m-20 -68.23 -30.44 69.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.492 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.554 HD13 ' O ' ' B' ' 16' ' ' GLU . 1.1 mp -71.53 -57.68 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 1.065 HD13 ' H ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER -61.2 -35.06 76.16 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.065 ' H ' HD13 ' B' ' 21' ' ' LEU . 5.4 t80 -53.75 -39.36 65.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.047 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -67.77 -40.8 83.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.383 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.939 HD12 HG11 ' B' ' 28' ' ' VAL . 0.4 OUTLIER -56.25 -58.02 9.76 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.731 0.777 . . . . 0.0 109.396 179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' B' ' 29' ' ' PHE . . . -49.23 -37.52 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.562 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.84 ' O ' ' CD ' ' B' ' 30' ' ' PRO . 0.0 OUTLIER -68.97 -59.27 3.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.313 0.577 . . . . 0.0 110.087 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.876 ' O ' ' HG2' ' B' ' 30' ' ' PRO . 7.2 ttm-85 -66.6 -36.91 83.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.809 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 1.199 ' O ' ' N ' ' B' ' 32' ' ' SER . 1.0 OUTLIER -82.99 -50.69 15.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.321 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.752 ' N ' ' HD2' ' B' ' 30' ' ' PRO . 41.1 t80 -36.75 -50.26 1.99 Allowed Pre-proline 0 CA--C 1.509 -0.63 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' PRO . . . . . 0.876 ' HG2' ' O ' ' B' ' 27' ' ' ARG . 37.4 Cg_endo -54.01 -46.84 30.62 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 106.576 -2.124 . . . . 0.0 106.576 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.777 ' H ' ' HG2' ' B' ' 30' ' ' PRO . 49.4 t80 -94.42 -13.24 26.46 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.335 -2.211 . . . . 0.0 112.708 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 1.199 ' N ' ' O ' ' B' ' 28' ' ' VAL . 57.4 p -160.51 92.87 1.6 Allowed Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.67 -41.59 76.06 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.736 2.291 . . . . 0.0 113.673 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.59 -54.41 23.81 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' LEU . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 39' ' ' TYR . 7.7 mt -52.22 -55.04 23.73 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.205 0.526 . . . . 0.0 110.604 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.544 ' CB ' ' HB2' ' B' ' 29' ' ' PHE . . . -55.77 -30.24 60.95 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.076 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.643 ' HD2' ' H ' ' B' ' 69' ' ' PHE . 0.0 OUTLIER -71.77 -48.93 43.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.543 -179.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -65.95 -38.7 89.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.77 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.916 ' CB ' HD23 ' B' ' 21' ' ' LEU . 3.5 m-85 -64.43 -44.71 90.31 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 118.627 -1.229 . . . . 0.0 108.327 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 36' ' ' ALA . 2.3 t -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.155 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.95 -41.5 77.94 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 73' ' ' GLU . 28.1 mt -65.48 -44.71 86.26 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.542 ' HB2' HD21 ' B' ' 21' ' ' LEU . . . -56.41 -30.66 63.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.946 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' B' ' 48' ' ' GLN . 14.2 mt -66.72 -54.34 23.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.588 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' N ' ' B' ' 46' ' ' VAL . 1.6 pp -57.25 -27.32 61.95 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.747 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . 0.963 ' N ' HD12 ' B' ' 45' ' ' LEU . 86.0 t -68.27 -46.38 81.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.017 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.658 ' HG2' HG22 ' B' ' 54' ' ' ILE . 0.4 OUTLIER -66.24 -57.1 8.3 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.818 -177.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' B' ' 49' ' ' LYS . 8.4 pt20 -81.32 -47.35 13.43 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' B' ' 45' ' ' LEU . 7.4 tptt -70.04 -32.74 71.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' B' ' 46' ' ' VAL . . . -88.22 -3.98 58.79 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.419 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 43.7 mttp 62.59 73.53 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.691 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HZ1' ' B' ' 11' ' ' LYS . 11.7 t -133.29 138.05 52.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.734 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -45.45 153.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.613 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.936 ' H ' HD13 ' B' ' 54' ' ' ILE . 0.1 OUTLIER -114.56 115.14 44.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.685 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' B' ' 57' ' ' LYS . 87.8 Cg_endo -81.91 -1.62 10.94 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.424 2.083 . . . . 0.0 112.414 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 37.12 18.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.503 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' B' ' 55' ' ' PRO . 0.0 OUTLIER -65.96 -37.72 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.095 0.474 . . . . 0.0 110.077 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.568 ' CD1' ' NH2' ' B' ' 61' ' ' ARG . 5.2 m-90 -62.04 7.25 0.06 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.778 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' B' ' 57' ' ' LYS . 33.1 pttt -65.89 -6.87 13.62 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' B' ' 58' ' ' TRP . 12.1 ptp180 -81.35 -25.44 36.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.833 ' HB2' ' O ' ' B' ' 70' ' ' LEU . 0.0 OUTLIER -141.25 22.97 2.2 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.418 -178.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' B' ' 67' ' ' HIS . 51.8 t80 -116.15 148.6 40.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.019 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' CYS . . . . . 0.558 ' C ' ' H ' ' B' ' 65' ' ' LYS . 8.2 t -126.54 107.79 10.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.633 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.496 ' H ' ' HD2' ' B' ' 64' ' ' LYS . 1.1 mptp? -66.21 5.47 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.664 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.611 ' HD3' ' ND1' ' B' ' 97' ' ' HIS . 0.2 OUTLIER -105.96 -17.66 14.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.609 -178.061 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' CYS . . . . . 0.643 ' HB3' ' SG ' ' B' ' 95' ' ' CYS . 14.5 p -150.81 6.75 0.53 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' B' ' 63' ' ' CYS . 2.0 m80 42.74 78.65 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.679 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.493 ' HB1' ' CE ' ' B' ' 37' ' ' LYS . . . -140.16 -172.14 3.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.303 0.573 . . . . 0.0 111.268 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' PHE . . . . . 0.643 ' H ' ' HD2' ' B' ' 37' ' ' LYS . 4.7 t80 -117.73 105.09 11.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.833 ' O ' ' HB2' ' B' ' 61' ' ' ARG . 0.6 OUTLIER -109.35 126.29 53.24 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -103.17 121.92 47.17 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.886 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.63 127.2 15.81 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.981 1.787 . . . . 0.0 111.733 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.67 -34.01 6.02 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 1.062 HG22 HD22 ' B' ' 75' ' ' ASN . 96.6 mt -93.89 -79.99 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 1.062 HD22 HG22 ' B' ' 74' ' ' ILE . 1.9 m-80 -110.86 15.94 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' B' ' 70' ' ' LEU . . . -148.11 161.53 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -143.45 138.71 29.48 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.606 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.815 HG12 HG12 ' B' ' 90' ' ' VAL . 10.5 m -139.1 110.85 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -129.49 143.01 50.65 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.706 ' O ' ' HG ' ' B' ' 80' ' ' LEU . 0.4 OUTLIER -107.92 128.17 54.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.023 -178.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' B' ' 82' ' ' GLN . 16.3 mmt85 -139.23 176.42 8.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' B' ' 83' ' ' LYS . 8.9 tm0? 81.21 136.81 0.06 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.516 ' O ' ' NE2' ' B' ' 82' ' ' GLN . 24.2 mmtp -103.05 155.57 18.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' B' ' 84' ' ' ARG . 45.0 mtt-85 66.16 -8.62 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.733 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' MET . . . . . 0.495 ' H ' ' C ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -149.31 66.22 8.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.389 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -44.2 115.49 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.637 2.225 . . . . 0.0 112.108 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -132.2 131.05 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.162 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' B' ' 80' ' ' LEU . 2.7 mt -115.5 146.31 20.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 78' ' ' VAL . 2.6 t -109.22 119.86 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.899 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.815 HG12 HG12 ' B' ' 78' ' ' VAL . 3.6 m -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.584 ' NZ ' ' CA ' ' B' ' 96' ' ' GLY . 6.4 tttp -145.04 151.19 38.16 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 118.719 -1.193 . . . . 0.0 113.728 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' CYS . . . . . 0.615 ' O ' ' HA2' ' B' ' 96' ' ' GLY . 0.6 OUTLIER -86.5 136.64 33.01 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.518 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.2 1.76 47.7 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.95 -32.03 12.81 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' B' ' 66' ' ' CYS . 0.0 OUTLIER -144.72 77.66 1.54 Allowed 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 112.231 -2.259 . . . . 0.0 106.764 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' B' ' 92' ' ' CYS . . . -38.12 92.73 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.611 ' ND1' ' HD3' ' B' ' 65' ' ' LYS . 66.5 t60 -122.99 134.93 54.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.397 -1.402 . . . . 0.0 109.524 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mm -99.67 120.88 49.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.638 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.56 ' CB ' HG23 ' B' ' 90' ' ' VAL . 5.9 mmm -116.33 172.29 7.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -121.12 147.75 45.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.891 0.376 . . . . 0.0 111.105 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' B' ' 101' ' ' TYR . 1.8 t80 -157.37 90.66 2.4 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.238 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -83.96 164.37 13.57 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.692 2.262 . . . . 0.0 112.723 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -137.88 101.81 4.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.921 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.24 118.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.542 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_